FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Tabosa, PMS
   Almeida, LCP
   Franca, RX
   Rocha-Bezerra, LCB
   Vasconcelos, IM
   Carvalho, AFU
AF Tabosa, Pedro M. S.
   Almeida Filho, Luiz C. P.
   Franca, Rute X.
   Rocha-Bezerra, Lady Clarissa B.
   Vasconcelos, Ilka M.
   Carvalho, Ana F. U.
TI Trypsin inhibitor fromEnterolobium contortisiliquumseeds impairsAedes
   aegyptidevelopment and enhances the activity ofBacillus
   thuringiensistoxins
SO PEST MANAGEMENT SCIENCE
LA English
DT Article
DE trypsin inhibitor; Enterolobium contortisiliquum; larvicidal; toxicity;
   Aedes aegypti
ID BACILLUS-THURINGIENSIS; ENTEROLOBIUM-CONTORTISILIQUUM; INSECTICIDAL
   ACTIVITY; SUBSP ISRAELENSIS; PROTEINASE-INHIBITORS; LARVAL DEVELOPMENT;
   CRY TOXINS; SEEDS; TOXICITY
AB BACKGROUND Disease vector insects are barriers for human development. The use of synthetic chemicals to control these vectors has caused damage to the environment and contributed to the arising of resistant insect populations. This has led to an increased search for plant-derived molecules with insecticidal activity or that show synergistic effects with known insecticidal substances, such as protease inhibitors. Thus, we aimed to evaluate the effect ofEnterolobium contortisiliquumtrypsin inhibitor (EcTI) onAedes aegyptidevelopment as well as its effect on insecticidal activity ofBacillus thuringiensistoxins. RESULTS EcTI showed an apparent molecular mass about of 20 kDa in SDS-PAGE and was able to inhibitin vitrothe activity of trypsin and proteases from midgut ofAe. aegyptilarvae. EcTI was not able to cause acute toxicity on mosquito larvae even at 1000 mu g mL(-1), however it promoted a delay in larval development after prolonged exposure. The zymogram results for EcTI-treated larvae (from 50 to 200 mu g mL(-1)) showed an increase of midgut proteases activity as a larvae defense mechanism, however no changes in the enzyme profile was observed. These same concentrations were able to enhance up to three fold the insecticidal activity ofB. thuringiensistoxins without causing toxicity toArtemiasp. nauplii, a non-target organism. CONCLUSIONS The results offer a novel approach by combining EcTI andB. thuringiensistoxins for combatingAe. aegyptilarvae.
C1 [Tabosa, Pedro M. S.; Rocha-Bezerra, Lady Clarissa B.; Vasconcelos, Ilka M.; Carvalho, Ana F. U.] Univ Fed Ceara, Biochem & Mol Biol Dept, Pici Campus, BR-60440970 Fortaleza, Ceara, Brazil.
   [Almeida Filho, Luiz C. P.; Franca, Rute X.; Carvalho, Ana F. U.] Univ Fed Ceara, Biol Dept, Fortaleza, Ceara, Brazil.
RP Carvalho, AFU (corresponding author), Univ Fed Ceara, Biochem & Mol Biol Dept, Pici Campus, BR-60440970 Fortaleza, Ceara, Brazil.
EM aurano@ufc.br
RI Carvalho, Ana/K-7344-2018
OI Carvalho, Ana/0000-0001-5293-9317; Reis, AlessanRSS/0000-0001-8486-7469
FU Programa de Pesquisa para o SUS: GestAo Compartilhada em Saude - PPSUS.
   Decit/SCTIE/MS, por intermedio do CNPq, o apoio da Funcap e SESA
   [3896340/2017]
FX This study was funded by the Programa de Pesquisa para o SUS: GestAo
   Compartilhada em Saude - PPSUS. Decit/SCTIE/MS, por intermedio do CNPq,
   o apoio da Funcap e SESA. Grant Number 3896340/2017.
CR Almeida LCP, 2018, PEST MANAG SCI, V74, P1362, DOI 10.1002/ps.4812
   Almeida LCP, 2017, PEST MANAG SCI, V73, P181, DOI 10.1002/ps.4284
   ANGSUTHANASOMBAT C, 1992, FEMS MICROBIOL LETT, V94, P63, DOI 10.1111/j.1574-6968.1992.tb05290.x
   Baldacchino F, 2015, PEST MANAG SCI, V71, P1471, DOI 10.1002/ps.4044
   Batista IFC, 1996, PHYTOCHEMISTRY, V41, P1017, DOI 10.1016/0031-9422(95)00710-5
   Ben-Dov E, 2014, TOXINS, V6, P1222, DOI 10.3390/toxins6041222
   Bendre AD, 2018, INT J BIOL MACROMOL, V113, P933, DOI 10.1016/j.ijbiomac.2018.02.148
   Bezerra CD, 2016, PROCESS BIOCHEM, V51, P792, DOI 10.1016/j.procbio.2016.03.008
   Borovsky D, 2004, ARCH INSECT BIOCHEM, V55, P124, DOI 10.1002/arch.10132
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Bravo A, 2015, COMPREHENSIVE SOURCEBOOK OF BACTERIAL PROTEIN TOXINS, 4TH EDITION, P858, DOI 10.1016/B978-0-12-800188-2.00030-6
   Bravo A, 2017, BACILLUS THURINGIENSIS AND LYSINIBACILLUS SPHAERICUS: CHARACTERIZATION AND USE IN THE FIELD OF BIOCONTROL, P53, DOI 10.1007/978-3-319-56678-8_4
   Broadway RM, 1997, J INSECT PHYSIOL, V43, P855, DOI 10.1016/S0022-1910(97)00028-0
   Cadavid-Restrepo G, 2012, MEM I OSWALDO CRUZ, V107, P74, DOI 10.1590/S0074-02762012000100010
   Corrêa J.C.R., 2011, Rev. bras. plantas med., V13, P500, DOI 10.1590/S1516-05722011000400016
   Deepak P, 2019, S AFR J BOT, V121, P257, DOI 10.1016/j.sajb.2018.11.011
   Dias LP, 2017, PROCESS BIOCHEM, V57, P228, DOI 10.1016/j.procbio.2017.03.015
   Elleuch J, 2015, TOXICON, V104, P83, DOI 10.1016/j.toxicon.2015.07.337
   ERLANGER BF, 1961, ARCH BIOCHEM BIOPHYS, V95, P271, DOI 10.1016/0003-9861(61)90145-X
   Farias DF, 2010, AN ACAD BRAS CIENC, V82, P585, DOI 10.1590/S0001-37652010000300006
   Jamal F, 2015, PROCESS BIOCHEM, V50, P311, DOI 10.1016/j.procbio.2014.12.003
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Labbe P, 2011, GENETICS AND EVOLUTION OF INFECTIOUS DISEASES, P363, DOI 10.1016/B978-0-12-384890-1.00014-5
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lagadic L, 2015, BACILLUS THURINGIENS, V1, P204
   Lima Rivete s. de, 2009, Braz. J. Bot., V32, P361, DOI 10.1590/S0100-84042009000200015
   Lorenzi H., 1998, ARVORES BRASILEIRAS
   Ma Y, 2013, PESTIC BIOCHEM PHYS, V105, P169, DOI 10.1016/j.pestbp.2013.01.007
   MACINTOSH SC, 1990, J AGR FOOD CHEM, V38, P1145, DOI 10.1021/jf00094a051
   MAZID S, 2011, INT J SC ADV TECHNOL, V1, P169, DOI DOI 10.1007/S10886-005-4244-2
   Moura FT, 2007, J AGR FOOD CHEM, V55, P260, DOI 10.1021/jf061623k
   Muturi EJ, 2011, TROP MED INT HEALTH, V16, P955, DOI 10.1111/j.1365-3156.2011.02796.x
   Nakahata AM, 2011, BIOL CHEM, V392, P327, DOI [10.1515/BC.2011.031, 10.1515/bc.2011.031]
   Narkhede CP, 2016, BIOCATAL AGRIC BIOTE, V8, P8, DOI 10.1016/j.bcab.2016.07.004
   Oppert B, 2011, PEST MANAG SCI, V67, P568, DOI 10.1002/ps.2099
   Pardo-Lopez L, 2009, PEPTIDES, V30, P589, DOI 10.1016/j.peptides.2008.07.027
   Ramos VD, 2009, COMP BIOCHEM PHYS A, V152, P255, DOI 10.1016/j.cbpa.2008.10.013
   Rubio-Infante N, 2016, J APPL TOXICOL, V36, P630, DOI 10.1002/jat.3252
   Ruckert C, 2018, TRENDS PARASITOL, V34, P310, DOI 10.1016/j.pt.2017.12.004
   Saboia-Vahia L, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-253
   Sarwar M., 2015, INT J PREVENTIVE MED, V1, P232
   Sasaki NY, 2015, BIOCHIMIE, V112, P172, DOI 10.1016/j.biochi.2015.03.011
   Schultz MJ, 2018, VIROLOGY, V518, P406, DOI 10.1016/j.virol.2018.03.022
   Shah KR, 2016, INT J BIOL MACROMOL, V83, P259, DOI 10.1016/j.ijbiomac.2015.11.068
   Shamsi T. N., 2018, Acta Ecologica Sinica - International Journal, V38, P325, DOI 10.1016/j.chnaes.2018.01.002
   Silva RGG, 2015, IND CROP PROD, V70, P48, DOI 10.1016/j.indcrop.2015.02.058
   Silva W., 2012, PROCESS BIOCHEM, V47, P257, DOI DOI 10.1016/J.PR0CBI0.2011.11.002
   Silveira ZD, 2017, ASIAN PAC J TROP BIO, V7, P945, DOI 10.1016/j.apjtb.2017.09.006
   Tetreau G, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-248
   Tetreau G, 2012, APPL ENVIRON MICROB, V78, P5189, DOI 10.1128/AEM.00903-12
   Carvalho AFU, 2011, J FOOD COMPOS ANAL, V24, P487, DOI 10.1016/j.jfca.2011.01.013
   World Health Organization, 2017, DENG MED CTR DENG HA
   Yarullina LG, 2016, RUSS J PLANT PHYSL+, V63, P193, DOI 10.1134/S1021443716020151
   Zhang JH, 2000, J INVERTEBR PATHOL, V75, P259, DOI 10.1006/jipa.2000.4936
   Zhu YC, 2007, PESTIC BIOCHEM PHYS, V87, P39, DOI 10.1016/j.pestbp.2006.05.004
   Zhu-Salzman K, 2015, ANNU REV ENTOMOL, V60, P233, DOI 10.1146/annurev-ento-010814-020816
NR 56
TC 0
Z9 0
U1 4
U2 4
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 1526-498X
EI 1526-4998
J9 PEST MANAG SCI
JI Pest Manag. Sci.
PD NOV
PY 2020
VL 76
IS 11
BP 3693
EP 3701
DI 10.1002/ps.5918
EA JUL 2020
PG 9
WC Agronomy; Entomology
SC Agriculture; Entomology
GA NV0MN
UT WOS:000546458900001
PM 32453460
DA 2020-12-08
ER

PT J
AU Neto, JJL
   de Almeida, TS
   de Lima, RDG
   Nunes, RGD
   Silva, JRD
   de Almeida, LL
   Kamdem, JP
   Carvalho, AFU
AF Lopes Neto, Jose Joaquim
   de Almeida, Thiago Silva
   Goncalves de Lima, Rita de Cassia
   dos Santos Nunes, Ricardo Gomes
   de Lima Silva, Jailson Renato
   de Almeida, Lecio Leone
   Kamdem, Jean Paul
   Carvalho, Ana Fontenele Urano
TI Metabolic aspects of phenolic compounds from Triplaris gardneriana seeds
   in the management of oxidative stress
SO DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
LA English
DT Article
DE Bioavailability; antioxidant activity; in vitro digestion;
   pharmacokinetics; Drosophila melanogaster
ID DIETARY FIBER; INDUCED TOXICITY; POLYPHENOLS; BIOAVAILABILITY; RELEASE;
   BIOACCESSIBILITY; EXTRACTS; FOODS
AB Objective: Considering the limited number of studies that analyze the behavior of plant preparations in human body, this study aimed to characterize the phenolic compounds from Triplaris gardneriana extract (EETg) in terms of antioxidant and metabolic aspects, integrating in vitro, in silico and in vivo strategies. Methods: EETg was analyzed in relation to polyphenols release from the plant matrix under in vitro digestion, as well as the pharmacokinetic prediction of their major compounds by in silico simulation and understanding of its in vivo antioxidant effect in an alternative animal model. Results: About 35.22% of polyphenols from EETg proved to be accessible after enzymatic hydrolysis. A kinetics study showed that 40% of the total content of these phytochemicals was released from the extract accompanied by increased antioxidant capacity after 180 min of gastrointestinal simulation. A computational approach revealed that 7 out of 9 major phenolic compounds of EETg showed good pharmacokinetic parameters such as intestinal absorption and bioavailability score. In addition, the extract showed a protective effect on copper-induced oxidative stress in Drosophila melanogaster, evidenced by the restoration of basal levels of thiol and malondialdehyde contents. These biochemical observations were supported by the examination of histological features of D. melanogaster brain. Conclusion: It was demonstrated that the oral administration of EETg would provide phenolic compounds partially absorbable by the human gut and capable of providing health benefits associated with the inhibition of oxidative stress. Additionally, the results highlight the need to implement new approaches for the rational development of plant-based medicines.
C1 [Lopes Neto, Jose Joaquim; de Almeida, Thiago Silva; Carvalho, Ana Fontenele Urano] Univ Fed Ceara, Dept Biochem & Mol Biol, Fortaleza, Ceara, Brazil.
   [Goncalves de Lima, Rita de Cassia; dos Santos Nunes, Ricardo Gomes; de Lima Silva, Jailson Renato; de Almeida, Lecio Leone; Kamdem, Jean Paul] Reg Univ Cariri, Dept Biol Sci, Crato, Brazil.
   [Carvalho, Ana Fontenele Urano] Univ Fed Ceara, Dept Biol, BR-60440900 Fortaleza, Ceara, Brazil.
RP Carvalho, AFU (corresponding author), Univ Fed Ceara, Dept Biol, BR-60440900 Fortaleza, Ceara, Brazil.
EM aurano@ufc.br
OI de Almeida, Lecio Leone/0000-0003-3636-2479
CR Alolga RN, 2015, SCI REP-UK, V5, DOI 10.1038/srep12961
   Armendariz-Barragan B, 2016, EXPERT OPIN DRUG DEL, V13, P1165, DOI 10.1080/17425247.2016.1182487
   Basheer L, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/854015
   Blancas-Benitez FJ, 2015, FOOD FUNCT, V6, P859, DOI [10.1039/C4FO00982G, 10.1039/c4fo00982g]
   Brewer George J, 2007, J Hepatol, V47, P621, DOI 10.1016/j.jhep.2007.07.001
   da Silva CS, 2018, CHEM-BIOL INTERACT, V282, P77, DOI 10.1016/j.cbi.2018.01.011
   da Silva MAB, 2010, REV BRAS FARMACOGN, V20, P549, DOI 10.1590/S0102-695X2010000400014
   Daina A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42717
   de Almeida TS, 2017, BIOMED PHARMACOTHER, V93, P1261, DOI 10.1016/j.biopha.2017.07.050
   Dolabela M., 2018, REV FITOS, V12, P227
   More GPD, 2017, MINI-REV MED CHEM, V17, P1646, DOI 10.2174/1389557517666170510112508
   Dutta S, 2016, DIS MODEL MECH, V9, P283, DOI 10.1242/dmm.022236
   Farias DF, 2013, BIOMED RES INT, V2013, P510736
   Ferreira LLG, 2019, DRUG DISCOV TODAY, V24, P1157, DOI 10.1016/j.drudis.2019.03.015
   Gaetke LM, 2014, ARCH TOXICOL, V88, P1929, DOI 10.1007/s00204-014-1355-y
   Gawlik-Dziki U, 2014, SCI WORLD J, DOI 10.1155/2014/782763
   Gonzalez-Aguilar GA, 2017, CURR OPIN FOOD SCI, V13, P84, DOI 10.1016/j.cofs.2017.03.004
   Jakobek L, 2019, TRENDS FOOD SCI TECH, V83, P235, DOI 10.1016/j.tifs.2018.11.024
   de Rodriguez DJ, 2019, IND CROP PROD, V138, DOI 10.1016/j.indcrop.2019.06.007
   Klimaczewski CV, 2018, BIOMED PHARMACOTHER, V97, P1, DOI 10.1016/j.biopha.2017.09.130
   Kosmidis S, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00066
   Kretzschmar D, 1997, J NEUROSCI, V17, P7425
   Lessing D, 2009, NAT REV GENET, V10, P359, DOI 10.1038/nrg2563
   Lopes Neto JJ, 2020, J ETHNOPHARMACOL, V250, P112474
   Neto JJL, 2017, BIOMED PHARMACOTHER, V88, P999, DOI 10.1016/j.biopha.2017.01.109
   Lucas AJ, 2019, EXPERT OPIN DRUG DIS, V14, P1313, DOI 10.1080/17460441.2019.1660642
   Macagnan FT, 2016, FOOD RES INT, V85, P144, DOI 10.1016/j.foodres.2016.04.032
   Martin YC, 2005, J MED CHEM, V48, P3164, DOI 10.1021/jm0492002
   Mercado-Mercado G, 2015, J FUNCT FOODS, V18, P171, DOI 10.1016/j.jff.2015.07.001
   Mojzer EB, 2016, MOLECULES, V21, DOI 10.3390/molecules21070901
   Pade D, 2008, MOL PHARMACEUT, V5, P665, DOI 10.1021/mp700153h
   PROSKY L, 1988, J ASSOC OFF ANA CHEM, V71, P1017
   Quiros-Sauceda AE, 2014, FOOD FUNCT, V5, P1063, DOI 10.1039/c4fo00073k
   Roque A.A, 2010, Rev. bras. plantas med., V12, P31, DOI 10.1590/S1516-05722010000100006
   Sadgrove NJ, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02470
   Sawale PD, 2017, INT J FOOD PROP, V20, P3170, DOI 10.1080/10942912.2017.1280677
   Scheepens A, 2010, GENES NUTR, V5, P75, DOI 10.1007/s12263-009-0148-z
   Southon A, 2013, METALLOMICS, V5, P1346, DOI 10.1039/c3mt00105a
   Sudati JH, 2013, NEUROTOXICOLOGY, V37, P118, DOI 10.1016/j.neuro.2013.04.006
   Thiengsusuk A, 2020, EUR J DRUG METAB PH, V45, P173, DOI 10.1007/s13318-019-00582-8
   Trecco Alberto, 2014, Revista de Ciencias Farmaceuticas Basica e Aplicada, V35, P89
   Trotta V, 2017, DRUG DEV IND PHARM, V43, P1043, DOI 10.1080/03639045.2017.1293680
   Wise K, 2019, PHYTOMEDICINE, V59, DOI 10.1016/j.phymed.2018.11.023
   Yi F, 2018, CHIN MED-UK, V13, DOI 10.1186/s13020-018-0190-0
   Zahin M, 2018, DRUG CHEM TOXICOL, V41, P358, DOI 10.1080/01480545.2018.1429459
NR 45
TC 0
Z9 0
U1 2
U2 3
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0363-9045
EI 1520-5762
J9 DRUG DEV IND PHARM
JI Drug Dev. Ind. Pharm.
PD JUN 2
PY 2020
VL 46
IS 6
BP 1026
EP 1033
DI 10.1080/03639045.2020.1767126
PG 8
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA LT5KD
UT WOS:000537108600016
PM 32393135
DA 2020-12-08
ER

PT J
AU Arantes, MR
   Peijnenburg, A
   Hendriksen, PJM
   Stoopen, G
   Almeida, TS
   Souza, TM
   Farias, DF
   Carvalho, AFU
   Rocha, TM
   Leal, LKAM
   Vasconcelos, IM
   Oliveira, JTA
AF Arantes, Mariana Reis
   Peijnenburg, Ad
   Hendriksen, Peter J. M.
   Stoopen, Geert
   Almeida, Thiago Silva
   Souza, Terezinha Maria
   Farias, Davi Felipe
   Urano Carvalho, Ana Fontenele
   Rocha, Talita Magalhaes
   Almeida Moreira Leal, Luzia Kalyne
   Vasconcelos, Ilka Maria
   Abreu Oliveira, Jose Tadeu
TI In vitro toxicological characterisation of the antifungal compound
   soybean toxin (SBTX)
SO TOXICOLOGY IN VITRO
LA English
DT Article
DE SBTX; Antifungal agent; Toxicogenomics; Cytotoxicity
ID CELL NUCLEAR ANTIGEN; CENP-A; CANDIDA-ALBICANS; CHOLESTEROL; INHIBITOR;
   PROTEINS; COMPLEX; TRANSCRIPTION; INFLAMMATION; INFECTIONS
AB Soybean toxin (SBTX) is a protein isolated from soybean seeds and composed of two polypeptide subunits (17 and 27 kDa). SBTX has in vitro activity against phytopathogenic fungi such as Cercospora sojina, Aspergillus niger, and Penicillium herguei, and yeasts like Candida albicans, C. parapsilosis, Kluyveromyces marxiannus, and Pichia membranifaciens. The present study aimed to analyze in vitro whether SBTX causes any side effects on non-target bacterial and mammalian cells that could impede its potential use as a novel antifungal agent. SBTX at 100 mu g/mL and 200 mu g/mL did not hinder the growth of the bacteria Salmonella enterica (subspecies enterica serovar choleraesuis), Bacillus subtilis (subspecies spizizenii) and Staphylococcus aureus. Moreover, SBTX at concentrations up to 500 mu g/mL did not significantly affect the viability of erythrocytes, neutrophils, and human intestinal Caco-2 cells. To study whether SBTX could induce relevant alterations in gene expression, in vitro DNA microarray experiments were conducted in which differentiated Caco-2 cells were exposed for 24 h to 100 mu g/mL or 200 mu g/mL SBTX. SBTX up-regulated genes involved in cell cycle and immune response pathways, but downregulated genes that play a role in cholesterol biosynthesis and platelet degranulation pathways. Thus, although SBTX did not affect bacteria, nor induced cytotoxity in mammalian cells, it affected some biological pathways in the human Caco-2 cell line that warrants further investigation.
C1 [Arantes, Mariana Reis; Almeida, Thiago Silva; Urano Carvalho, Ana Fontenele; Vasconcelos, Ilka Maria; Abreu Oliveira, Jose Tadeu] Univ Fed Ceara, Dept Biochem & Mol Biol, BR-60020181 Fortaleza, Ceara, Brazil.
   [Peijnenburg, Ad; Hendriksen, Peter J. M.; Stoopen, Geert] Wageningen Univ & Res Ctr, WFSR, POB 230, NL-6700 AE Wageningen, Netherlands.
   [Souza, Terezinha Maria] Maastricht Univ, GROW Sch Oncol & Dev Biol, Dept Toxicogen, NL-6229 ER Maastricht, Netherlands.
   [Farias, Davi Felipe] Univ Fed Paraiba, Dept Mol Biol, BR-58051900 Joao Pessoa, Paraiba, Brazil.
   [Rocha, Talita Magalhaes; Almeida Moreira Leal, Luzia Kalyne] Univ Fed Ceara, Dept Pharm, BR-60430370 Fortaleza, Ceara, Brazil.
RP Oliveira, JTA (corresponding author), Univ Fed Ceara, Dept Biochem & Mol Biol, BR-60020181 Fortaleza, Ceara, Brazil.
EM ad.peijnenburg@wur.nl; peter.hendriksen@wur.nl; geert.stoopen@wur.nl;
   t.souza@maastrichtuniversity.nl; davi@dbm.ufpb.br; imvasco@ufc.br;
   jtaolive@ufc.br
RI Rocha, Talita/ABD-7309-2020; LEAL, LUZIA KALYNE/I-7959-2016
OI LEAL, LUZIA KALYNE/0000-0002-3826-2677; Rocha,
   Talita/0000-0002-6076-7030; Felipe Farias, Davi/0000-0001-5438-1919
FU National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [308107/2013-6, 307783/2013-8, 310694/2014-0, 431511/2016-0];
   Council for Advanced Professional Training (CAPES)CAPES; CNPq research
   fellowshipNational Council for Scientific and Technological Development
   (CNPq) [140780/2015-7]
FX This work was supported by the National Council for Scientific and
   Technological Development (CNPq, grants 308107/2013-6, 307783/2013-8,
   310694/2014-0, 431511/2016-0) and Council for Advanced Professional
   Training (CAPES). M.R.A. was a recipient of CNPq research fellowship
   number 140780/2015-7.
CR Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X
   Al-Balushi ZM, 2018, PLANT DIS, V102, P202, DOI 10.1094/PDIS-11-16-1680-RE
   Barbosa MC, 2016, BASIC CLIN PHARMACOL, V118, P271, DOI 10.1111/bcpt.12487
   Batista AB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111427
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Bernheimer A.W., 1986, METHOD ENZYMOL, V165, P213
   Bodero M, 2018, TOXICOL IN VITRO, V46, P102, DOI 10.1016/j.tiv.2017.09.018
   Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185
   Bonaccorsi P, 2013, J SULFUR CHEM, V34, P684, DOI 10.1080/17415993.2013.778259
   BROWN K, 1993, P NATL ACAD SCI USA, V90, P2532, DOI 10.1073/pnas.90.6.2532
   Buesen R, 2017, REGUL TOXICOL PHARM, V91, pS3, DOI 10.1016/j.yrtph.2017.09.002
   Cao FJ, 2019, ECOTOX ENVIRON SAFE, V170, P227, DOI 10.1016/j.ecoenv.2018.11.110
   CHANTRET I, 1988, CANCER RES, V48, P1936
   Cheeseman IM, 2008, MOL BIOL CELL, V19, P587, DOI 10.1091/mbc.E07-10-1051
   Chopra DP, 2010, STEM CELLS DEV, V19, P131, DOI 10.1089/scd.2009.0109
   CONAB: Companhia Nacional de Abastecimento, 2017, MONITORAMENTO AGRICO, V4, P1
   Costa S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00063
   Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179
   Delattin N, 2014, ANTIMICROB AGENTS CH, V58, P2647, DOI 10.1128/AAC.01274-13
   Dimopoulou M, 2017, TOXICOL APPL PHARM, V322, P15, DOI 10.1016/j.taap.2017.03.001
   Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863
   European Food Safety Authority, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3638
   Fisher MC, 2018, SCIENCE, V360, P739, DOI 10.1126/science.aap7999
   Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397
   Gant TW, 2017, REGUL TOXICOL PHARM, V91, pS36, DOI 10.1016/j.yrtph.2017.11.001
   Georgiadis G, 2018, TOXICOLOGY, V406, P129, DOI 10.1016/j.tox.2018.07.019
   Guinea J, 2014, CLIN MICROBIOL INFEC, V20, P5, DOI 10.1111/1469-0691.12539
   Hancock REW, 2000, EXPERT OPIN INV DRUG, V9, P1723, DOI 10.1517/13543784.9.8.1723
   Hashem MA, 2018, ENVIRON SCI POLLUT R, V25, P1270, DOI 10.1007/s11356-017-0542-9
   Heise T, 2018, ARCH TOXICOL, V92, P859, DOI 10.1007/s00204-017-2087-6
   Horikawa T, 2019, DIGESTION, V100, P286, DOI 10.1159/000496687
   Hurley BP, 2016, FOOD CHEM TOXICOL, V92, P75, DOI 10.1016/j.fct.2016.04.003
   Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015
   Islam A, 2008, APPL BIOSAF, V13, P222, DOI DOI 10.1177/
   Kabeya Luciana M., 2002, Research Communications in Molecular Pathology and Pharmacology, V111, P103
   Kamada Katsuhiko, 2012, Subcell Biochem, V62, P135, DOI 10.1007/978-94-007-4572-8_8
   Kamburov A, 2013, NUCLEIC ACIDS RES, V41, pD793, DOI 10.1093/nar/gks1055
   KANEDA S, 1990, J BIOL CHEM, V265, P20277
   Kim MH, 2006, BIOCHEM BIOPH RES CO, V346, P681, DOI 10.1016/j.bbrc.2006.05.186
   Koch C, 2015, ANTIMICROB AGENTS CH, V59, P1617, DOI 10.1128/AAC.04446-14
   Kumari A., 2018, SWEET BIOCH REMEMBER, P27, DOI [10.1016/B978-0-12-814453-4.00007-8., DOI 10.1016/B978-0-12-814453-4.00007-8]
   Lai PZ, 2018, REC NAT PROD, V12, P291, DOI 10.25135/rnp.31.17.07.046
   LEE SH, 1991, J BIOL CHEM, V266, P594
   Lindhorst E, 1997, BBA-PROTEIN STRUCT M, V1339, P143, DOI 10.1016/S0167-4838(96)00227-0
   Liu H, 2015, MOL CELL, V59, P426, DOI 10.1016/j.molcel.2015.06.018
   Looke M, 2017, GENE DEV, V31, P291, DOI 10.1101/gad.291336.116
   LUCISANO YM, 1984, J IMMUNOL, V132, P2015
   Luck J, 2011, PLANT PATHOL, V60, P113, DOI 10.1111/j.1365-3059.2010.02414.x
   Maaser C, 2002, Z GASTROENTEROL, V40, P525, DOI 10.1055/s-2002-32808
   MOLMENTI EP, 1993, J BIOL CHEM, V268, P14116
   Morais JKS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070425
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Mulcahy ME, 2016, TRENDS MICROBIOL, V24, P872, DOI 10.1016/j.tim.2016.06.012
   Nagy K, 2019, SCI TOTAL ENVIRON, V647, P1052, DOI 10.1016/j.scitotenv.2018.08.067
   Niemirowicz K, 2016, NANOMED-NANOTECHNOL, V12, P2395, DOI 10.1016/j.nano.2016.07.006
   Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443
   Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396
   Olejnik A., 2003, METHODOL NOV FOOD EV, V12, P60
   Orsine JVC, 2012, INT J NUTR MET, V4, P19, DOI DOI 10.5897/IJNAM11.064
   Pan H, 2019, TRANSBOUND EMERG DIS, V66, P1044, DOI 10.1111/tbed.13099
   Pant N, 2003, J APPL TOXICOL, V23, P271, DOI 10.1002/jat.919
   Pappas PG, 2016, CLIN INFECT DIS, V62, pE1, DOI 10.1093/cid/civ933
   Sakakura Y, 2001, BIOCHEM BIOPH RES CO, V286, P176, DOI 10.1006/bbrc.2001.5375
   Salas CE, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/102129
   Requena JFS, 2011, FUEL PROCESS TECHNOL, V92, P190, DOI 10.1016/j.fuproc.2010.03.004
   Sartor MA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-538
   Sauer UG, 2017, REGUL TOXICOL PHARM, V91, pS14, DOI 10.1016/j.yrtph.2017.09.020
   Singh P, 2013, PLOS ONE, V8, P1, DOI DOI 10.1371/J0URNAL.P0NE.0058833
   Sorokulova IB, 2008, DIGEST DIS SCI, V53, P954, DOI 10.1007/s10620-007-9959-1
   Spampinato C, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/204237
   Suarez Y, 2002, EUR J BIOCHEM, V269, P1761, DOI 10.1046/j.1432-1327.2002.02822.x
   SULLIVAN KF, 1994, J CELL BIOL, V127, P581, DOI 10.1083/jcb.127.3.581
   Taylor M, 2018, REGUL TOXICOL PHARM, V93, P62, DOI 10.1016/j.yrtph.2017.08.016
   Ticau S, 2015, CELL, V161, P513, DOI 10.1016/j.cell.2015.03.012
   Trick WE, 2002, CLIN INFECT DIS, V35, P627, DOI 10.1086/342300
   TSURIMOTO T, 1990, P NATL ACAD SCI USA, V87, P1023, DOI 10.1073/pnas.87.3.1023
   Van de Wiele T, 2015, IMPACT FOOD BIOACTIV
   Vasconcelos IM, 2008, TOXICON, V51, P952, DOI 10.1016/j.toxicon.2007.10.005
   VAZQUEZ JA, 1993, J INFECT DIS, V168, P195, DOI 10.1093/infdis/168.1.195
   Vidal RO, 2012, GENET MOL BIOL, V35, P331, DOI 10.1590/S1415-47572012000200014
   Williams IR, 2006, ANN NY ACAD SCI, V1072, P52, DOI 10.1196/annals.1326.036
   Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946
   Wu SY, 2018, ECOTOX ENVIRON SAFE, V153, P8, DOI 10.1016/j.ecoenv.2018.01.045
   Zheng N, 2018, TOXICON, V150, P77, DOI 10.1016/j.toxicon.2018.04.017
NR 84
TC 0
Z9 0
U1 1
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0887-2333
J9 TOXICOL IN VITRO
JI Toxicol. Vitro
PD JUN
PY 2020
VL 65
AR 104824
DI 10.1016/j.tiv.2020.104824
PG 9
WC Toxicology
SC Toxicology
GA LB0SY
UT WOS:000524349000022
PM 32165152
DA 2020-12-08
ER

PT J
AU de Medeiros, JL
   de Almeida, TS
   Neto, JJL
   Almeida, LCP
   Ribeiro, PRV
   Brito, ES
   Morgano, MA
   da Silva, MG
   Farias, DF
   Carvalho, AFU
AF de Medeiros, Jackeline Lima
   de Almeida, Thiago Silva
   Lopes Neto, Jose Joaquim
   Pereira Almeida Filho, Luiz Carlos
   Vasconcelos Ribeiro, Paulo Riceli
   Brito, Edy Sousa
   Morgano, Marcelo Antonio
   da Silva, Marta Gomes
   Farias, Davi Felipe
   Urano Carvalho, Ana Fontenele
TI Chemical composition, nutritional properties, and antioxidant activity
   of Licania tomentosa (Benth.) fruit
SO FOOD CHEMISTRY
LA English
DT Article
DE Antioxidant activity; Chrysobalanaceae; Edible fruits; Phenolic
   compounds; Nutritional composition
AB Licania tomentosa is a Brazilian plant species that produces edible fruits, yet there is little information available concerning their nutritional and/or bioactive composition. This study aimed to evaluate the nutritional and polyphenol composition of L. tomentosa fruits (pulp and seeds) and measure antioxidant activity in ethanolic extracts.The pulp and seeds were excellent sources of fiber (25.62%-41.70%) as well as minerals and vitamins. L. tomentosa contained no lectins or protease inhibitors (chymotrysin and trypsin) and 12 polyphenol compounds were identified in the seed extracts with a predominance of flavonoids. The seeds also presented antioxidant activities using the DPPH (SC(50)10.30-15.87 mu g/mL), TBARS (IC50 18.46-20.84 mu g/mL), and FRAP (RC50 0.203-0.309 mu g/mL) assays. Due to its nutrient and antioxidant content, L. tomentosa may be used for food applications.
C1 [de Medeiros, Jackeline Lima; de Almeida, Thiago Silva; Lopes Neto, Jose Joaquim; Pereira Almeida Filho, Luiz Carlos; Urano Carvalho, Ana Fontenele] Univ Fed Ceara, Dept Biochem & Mol Biol, Campus Pici,BL 909, BR-60400900 Fortaleza, CE, Brazil.
   [Vasconcelos Ribeiro, Paulo Riceli; Brito, Edy Sousa] Embrapa Trop Agroind, BR-60511110 Fortaleza, Ceara, Brazil.
   [Morgano, Marcelo Antonio; da Silva, Marta Gomes] Inst Food Technol, BR-13070178 Campinas, SP, Brazil.
   [Farias, Davi Felipe] Univ Fed Paraiba, Dept Mol Biol, BR-58051900 Joao Pessoa, PB, Brazil.
RP Carvalho, AFU (corresponding author), Univ Fed Ceara, Dept Biochem & Mol Biol, Campus Pici,BL 909, BR-60400900 Fortaleza, CE, Brazil.
EM aurano@ufc.br
RI de Brito, Edy Sousa/I-3587-2012; Farias, Davi Felipe/AAH-1868-2020;
   Gomes da Silva, Marta/E-9593-2012; Carvalho, Ana/K-7344-2018; Almeida,
   Thiago/L-9833-2013
OI de Brito, Edy Sousa/0000-0003-4084-8076; Felipe Farias,
   Davi/0000-0001-5438-1919; Gomes da Silva, Marta/0000-0002-3196-7092;
   Carvalho, Ana/0000-0001-5293-9317; Almeida, Thiago/0000-0002-7401-0637;
   Vasconcelos Ribeiro, Paulo Riceli/0000-0002-5258-4015
FU ITAL (Institute of Food Technology); Embrapa Tropical Agroindustry; INSA
   (National Institute of Semiarid)/CNPq (National Council for Scientific
   and Technological Development [35/2010-562857/2010-9]
FX The authors thank the financial support of ITAL (Institute of Food
   Technology); Embrapa Tropical Agroindustry and INSA (National Institute
   of Semiarid)/CNPq (National Council for Scientific and Technological
   Development [Grant number 35/2010-562857/2010-9].
CR Agra Maria de Fátima, 2007, Rev. bras. farmacogn., V17, P114, DOI 10.1590/S0102-695X2007000100021
   Al-Farsi MA, 2008, CRIT REV FOOD SCI, V48, P877, DOI 10.1080/10408390701724264
   Association of Official Analytical Chemists, 2012, OFFICIAL METHODS ANA
   BAETHGEN WE, 1989, COMMUN SOIL SCI PLAN, V20, P961, DOI 10.1080/00103628909368129
   Bampi M, 2010, CIENC RURAL, V40, P2361, DOI 10.1590/S0103-84782010001100018
   Benzie IFF, 1999, METHOD ENZYMOL, V299, P15
   BRUBACHER G, 1985, METHODS DETERMINATIO, P97
   Pires PCC, 2015, FRUITS, V70, P29, DOI 10.1051/fruits/2014040
   CARVALHO PRN, 1992, CHROMATOGRAPHIA, V33, P133, DOI 10.1007/BF02275893
   Celep E, 2012, FOOD CHEM TOXICOL, V50, P3329, DOI 10.1016/j.fct.2012.06.010
   Chang CC, 2002, J FOOD DRUG ANAL, V10, P178
   Chang SK, 2016, J FUNCT FOODS, V21, P113, DOI 10.1016/j.jff.2015.11.034
   Chun J, 2006, J FOOD COMPOS ANAL, V19, P196, DOI 10.1016/j.jfca.2005.08.001
   de Almeida TS, 2017, BIOMED PHARMACOTHER, V93, P1261, DOI 10.1016/j.biopha.2017.07.050
   Denardin CC, 2015, J FOOD DRUG ANAL, V23, P387, DOI 10.1016/j.jfda.2015.01.006
   Diaby M., 2016, EUROPEAN ACAD RES, V4, P4602
   Moreira-Araujo RSD, 2019, REV BRAS FRUTIC, V41, DOI 10.1590/0100-29452019011
   Duenas M, 2010, J PHARMACEUT BIOMED, V51, P443, DOI 10.1016/j.jpba.2009.04.007
   Ekpete O A, 2013, BRIT J APPL SCI TECH, V3, P1447, DOI DOI 10.9734/BJAST/2014/4431
   ERLANGER BF, 1961, ARCH BIOCHEM BIOPHYS, V95, P271, DOI 10.1016/0003-9861(61)90145-X
   Farias DF, 2013, BIOMED RES INT, V2013, DOI [10.1155/2013/605831, 10.1155/2013/510736, 10.1155/2013/340605, 10.1155/2013/263509]
   Feitosa EA, 2012, REV BRAS FARMACOGN, V22, P1181, DOI 10.1590/S0102-695X2012005000080
   FUNCEME, 2018, GRAF CHUV POST PLUV
   Kinupp VF, 2014, PLANTAS ALIMENTICIAS
   Nascimento EMM, 2018, FOOD CHEM TOXICOL, V119, P457, DOI 10.1016/j.fct.2017.11.042
   Onivogui G, 2014, J FOOD NUTR RES, V2, P281, DOI DOI 10.12691/JFNR-2-6-3
   Parra Pessoa Igor, 2016, Molecules, V21, DOI 10.3390/molecules21121755
   Perveen R, 2015, CRIT REV FOOD SCI, V55, P919, DOI 10.1080/10408398.2012.657809
   Raiola A, 2015, INT J MOL SCI, V16, P29250, DOI 10.3390/ijms161226163
   Rizvi Saliha, 2014, Sultan Qaboos Univ Med J, V14, pe157
   Sabir SM, 2008, J ETHNOPHARMACOL, V120, P226, DOI 10.1016/j.jep.2008.08.017
   Sampaio BL, 2016, SCI REP-UK, V6, DOI 10.1038/srep29265
   SOUSA E. P., 2013, TECNOLOGIA CIENCIA A, V7, P39
   Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009
   Vasconcelos IM, 2010, J FOOD COMPOS ANAL, V23, P54, DOI 10.1016/j.jfca.2009.05.008
   Zhang XL, 2014, FOOD CHEM, V152, P300, DOI 10.1016/j.foodchem.2013.11.153
NR 36
TC 1
Z9 1
U1 1
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0308-8146
EI 1873-7072
J9 FOOD CHEM
JI Food Chem.
PD MAY
PY 2020
VL 313
AR 126117
DI 10.1016/j.foodchem.2019.126117
PG 7
WC Chemistry, Applied; Food Science & Technology; Nutrition & Dietetics
SC Chemistry; Food Science & Technology; Nutrition & Dietetics
GA KF6ZV
UT WOS:000509390400023
PM 31951881
DA 2020-12-08
ER

PT J
AU Neto, JJL
   de Almeida, TS
   Almeida, LCP
   Rocha, TM
   Nogara, PA
   Nogara, KF
   da Rocha, JBT
   Leal, LKAM
   Carvalho, AFU
AF Lopes Neto, Jose Joaquim
   de Almeida, Thiago Silva
   Pereira Almeida Filho, Luiz Carlos
   Rocha, Talita Magalhaes
   Nogara, Pablo Andrei
   Nogara, Karise Fernanda
   Teixeira da Rocha, Joao Batista
   Almeida Moreira Leal, Luzia Kalyne
   Urano Carvalho, Ana Fontenele
TI Triplaris gardneriana seeds extract exhibits in vitro anti-inflammatory
   properties in human neutrophils after oxidative treatment
SO JOURNAL OF ETHNOPHARMACOLOGY
LA English
DT Article
DE Triplaris gardneriana; Myeloperoxidase; Antioxidant; Neutrophil; Docking
ID ANTIOXIDANT ACTIVITY; PHENOLIC-COMPOUNDS; MYELOPEROXIDASE; DENATURATION;
   OPTIMIZATION; INHIBITION; FLAVONOIDS; STRESS; ASSAY; TRAP
AB Ethnopharmacological relevance: Triplaris gardneriana Wedd. (Polygonaceae family) is a plant species from Brazilian semiarid region which is used in local traditional medicine for the treatment of inflammatory conditions such as hemorrhoids.
   Aim of the study: In this study, the in vitro anti-inflammatory activity of different concentrations of ethanolic extract from T. gardneriana seeds (EETg) was performed in order to contribute to the knowledge about etnomedicinal use of this plant species.
   Materials and methods: The anti-inflammatory properties were evaluated through different approaches, such as in vitro protein anti-denaturation test, scavenging of reactive oxygen species (ROS) and myeloperoxidase (MPO) inhibition in human neutrophils activated by phorbol-12-myristate-13-acetate (PMA). Besides that, molecular docking was performed to provide new insights about the interaction between the major phenolic components in the plant extract and MPO.
   Results: EETg was characterized showing a total phenol content of 153.5 +/- 6.3 mu g gallic acid equivalent/mg extract, ability to remove hydrogen peroxide (H2O2) in a concentration-dependent manner and had a spectroscopic profile which suggests the presence of hydroxyl groups. EETg was able to prevent protein denaturation ranging from 40.17 to 75.09%. The extract, at 10 and 20 mu g/mL, was able to modulate neutrophils pro-inflammatory functions, such as degranulation and burst respiratory. In both assays, the EETg had anti-inflammatory effect comparable to nonsteroidal anti-inflammatory drugs. Among the main phenolic compounds of EETg, quercitrin, quercetin and catechin showed the highest binding affinity in silico to MPO.
   Conclusion: This study demonstrated, for the first time, that the anti-inflammatory effect of T. gardneriana seeds occurs due to its modulatory effect on human neutrophil degranulation and free-radical scavenging activity.
C1 [Lopes Neto, Jose Joaquim; de Almeida, Thiago Silva; Urano Carvalho, Ana Fontenele] Univ Fed Ceara, Dept Biochem & Mol Biol, BR-60020181 Fortaleza, CE, Brazil.
   [Pereira Almeida Filho, Luiz Carlos; Urano Carvalho, Ana Fontenele] Univ Fed Ceara, Dept Biol, BR-60440900 Fortaleza, CE, Brazil.
   [Rocha, Talita Magalhaes; Almeida Moreira Leal, Luzia Kalyne] Univ Fed Ceara, Fac Pharm Dent & Nursing, Pharmaceut & Cosmet Studies Ctr CEFAC, BR-60430370 Fortaleza, CE, Brazil.
   [Nogara, Pablo Andrei; Nogara, Karise Fernanda; Teixeira da Rocha, Joao Batista] Univ Fed Santa Maria, Dept Biochem & Mol Biol, BR-97105900 Santa Maria, RS, Brazil.
RP Carvalho, AFU (corresponding author), Univ Fed Ceara, Dept Biol, BR-60440900 Fortaleza, CE, Brazil.
EM aurano@ufc.br
RI Rocha, Talita/ABD-7309-2020; Almeida, Thiago S./L-9833-2013
OI Almeida, Thiago S./0000-0002-7401-0637; Rocha,
   Talita/0000-0002-6076-7030
FU National Council for Scientific and Technological Development (CNPq,
   Brazil)National Council for Scientific and Technological Development
   (CNPq) [141687/2017-7]
FX This work was supported by National Council for Scientific and
   Technological Development (CNPq, Brazil) (Process: 141687/2017-7).
CR Abdullah MZ, 2017, INT J FOOD PROP, V20, pS846, DOI [10.1080/10942912.2017.1315591, 10.15405/epsbs.2017.08.1]
   Ahmad S, 2015, BIOL RES, V48, DOI 10.1186/s40659-015-0010-2
   Alhakmani Fatma, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, pS656
   Ambriz-Perez DL, 2016, FOOD SCI TECHNOL, V2, P1, DOI DOI 10.1080/23311932.2015.1131412
   Azab A, 2016, MOLECULES, V21, DOI 10.3390/molecules21101321
   Bannour M, 2016, CHEM BIODIVERS, V13, P1527, DOI 10.1002/cbdv.201600086
   Bonnefond L., 2015, CRYSTAL STRUCTURE HU, DOI 10.1002/10.2210/pdb5FIW/pdb
   Chatterjee P, 2012, J ADV PHARM TECHNOL, V3, P136, DOI 10.4103/2231-4040.97298
   Dassault Systemes BIOVIA, 2017, DISC STUD MOD ENV RE
   de Almeida TS, 2017, BIOMED PHARMACOTHER, V93, P1261, DOI 10.1016/j.biopha.2017.07.050
   Denev P, 2014, ACTA BIOCHIM POL, V61, P359
   Desmarchelier C, 1997, INT J PHARMACOGN, V35, P288, DOI 10.1076/phbi.35.4.288.13303
   Farias DF, 2013, BIOMED RES INT, V2013, DOI [10.1155/2013/605831, 10.1155/2013/510736, 10.1155/2013/340605, 10.1155/2013/263509]
   Macedo JGF, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/6769193
   Ferreira PMP, 2011, AN ACAD BRAS CIENC, V83, P1045, DOI 10.1590/S0001-37652011005000017
   Figueiredo-Rinhel ASG, 2017, J PHARM PHARMACOL, V69, P1829, DOI 10.1111/jphp.12822
   Gau J, 2016, FREE RADICAL BIO MED, V97, P307, DOI 10.1016/j.freeradbiomed.2016.06.026
   Ghagane SC, 2017, INTEGR MED RES, V6, P79, DOI 10.1016/j.imr.2017.01.004
   Gonzaga M. L. C., 2013, Bioactive Carbohydrates and Dietary Fibre, V2, P152
   Guazelli CFS, 2018, BIOMED PHARMACOTHER, V102, P175, DOI 10.1016/j.biopha.2018.03.057
   Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17
   Hussain T, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/7432797
   Inocente Camones Miguel Angel, 2010, Rev. Soc. Quím. Perú, V76, P34
   Kabeya Luciana M., 2002, Research Communications in Molecular Pathology and Pharmacology, V111, P103
   Liu HX, 2006, SPECTROCHIM ACTA A, V64, P321, DOI 10.1016/j.saa.2005.07.026
   Neto JJL, 2017, BIOMED PHARMACOTHER, V88, P999, DOI 10.1016/j.biopha.2017.01.109
   Lopez-Ramos A, 2018, OPHTHAL EPIDEMIOL, V25, P412, DOI 10.1080/09286586.2018.1501498
   LUCISANO YM, 1984, J IMMUNOL, V132, P2015
   Macedo S. K. S., 2015, Journal of Medicinal Plants Research, V9, P207
   Magalhaes KD, 2019, J ETHNOPHARMACOL, V237, P314, DOI 10.1016/j.jep.2019.03.032
   Meng D, 2017, J FUNCT FOODS, V38, P36, DOI 10.1016/j.jff.2017.08.041
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Murugan Rajan, 2014, Journal of King Saud University Science, V26, P267, DOI 10.1016/j.jksus.2013.09.006
   Nastasijevic B, 2012, J PHARMACEUT BIOMED, V66, P191, DOI 10.1016/j.jpba.2012.03.052
   Nayeem N., 2016, J APPL PHARM, V8, DOI [10.4172/1920-4159.1000213, DOI 10.4172/1920-4159.1000213]
   Ondua M, 2019, J ETHNOPHARMACOL, V234, P27, DOI 10.1016/j.jep.2018.12.030
   Padmanabhan P, 2012, INT J BASIC APPL MED, V2, P109, DOI DOI 10.1186/S13104-015-1384-5
   Parra Pessoa Igor, 2016, Molecules, V21, DOI 10.3390/molecules21121755
   Paun G, 2018, REV BRAS FARMACOGN, V28, P57, DOI 10.1016/j.bjp.2017.10.008
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Pinto NB, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/161092
   Prigent SVE, 2003, J AGR FOOD CHEM, V51, P5088, DOI 10.1021/jf021229w
   Rivera DE, 2019, SAUDI J BIOL SCI, V26, P1758, DOI 10.1016/j.sjbs.2018.05.030
   Sant'Anna V, 2012, SEP PURIF TECHNOL, V100, P82, DOI 10.1016/j.seppur.2012.09.004
   Sharma V, 2018, ASIAN J PHARM PHARM, V4, P179, DOI DOI 10.31024/AJPP.2018.4.2.13
   Shiba Y, 2008, CHEM RES TOXICOL, V21, P1600, DOI 10.1021/tx8000835
   SILVA JOC, 2006, REV BRAS FARMACOGN, V16, P671
   Silva-Brambilla Melissa Graciotto, 2001, Acta Scientiarum Universidade Estadual de Maringa, V23, P571
   Singh SK, 2018, J INTEGR MED-JIM, V16, P273, DOI 10.1016/j.joim.2018.04.005
   Stewart JJP, 2007, J MOL MODEL, V13, P1173, DOI 10.1007/s00894-007-0233-4
   Stewart JJP, 2012, STEWART COMPUTATIONA
   Tian R, 2017, J AGR FOOD CHEM, V65, P3198, DOI 10.1021/acs.jafc.7b00631
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   Tsumbu CN, 2012, INT J MOL SCI, V13, P628, DOI 10.3390/ijms13010628
   Ubeda A., 2002, ACTIVACION CELULAR D, P27
   Vorobjeva NV, 2016, IMMUNOBIOLOGY, V221, P208, DOI 10.1016/j.imbio.2015.09.005
   Williams LAD, 2008, W INDIAN MED J, V57, P327
   YEN GC, 1995, J AGR FOOD CHEM, V43, P27, DOI 10.1021/jf00049a007
   Yuan K., 2017, J TRADIT CHIN MED SC, V4, P50, DOI [10.1016/j.jtcms.2017.05.007, DOI 10.1016/J.JTCMS.2017.05.007]
   Zhang H, 2016, CURR OPIN FOOD SCI, V8, P33, DOI 10.1016/j.cofs.2016.02.002
NR 61
TC 1
Z9 1
U1 2
U2 7
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-8741
EI 1872-7573
J9 J ETHNOPHARMACOL
JI J. Ethnopharmacol.
PD MAR 25
PY 2020
VL 250
AR 112474
DI 10.1016/j.jep.2019.112474
PG 8
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary
   Medicine; Pharmacology & Pharmacy
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary
   Medicine
GA KH9FI
UT WOS:000510954100007
PM 31836515
DA 2020-12-08
ER

PT J
AU Almeida, TS
   Arantes, MR
   Neto, JJL
   Souza, TM
   Pessoa, IP
   Medeiros, JL
   Tabosa, PMS
   Moreira, TB
   Farias, DF
   Carvalho, AFU
AF Almeida, Thiago S.
   Arantes, Mariana R.
   Lopes Neto, Jose J.
   Souza, Terezinha M.
   Pessoa, Igor P.
   Medeiros, Jackeline L.
   Tabosa, Pedro M. S.
   Moreira, Thais B.
   Farias, Davi F.
   Carvalho, Ana F. U.
TI Evaluation of seeds ethanolic extracts of Triplaris gardneriana Wedd.
   using in vitro and in vivo toxicological methods
SO JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES
LA English
DT Article
DE Medicinal plant; ATP-Lite; toxicogenomics; toxicity; MCF7 cells;
   quercetin
ID GENE-EXPRESSION; HUMAN ERYTHROCYTES; PHENOLIC-COMPOUNDS; CONNECTIVITY
   MAP; ANTIOXIDANT; QUERCETIN; APOPTOSIS; HEMOLYSIS; TOXICITY; STRESS
AB Triplaris gardneriana Wedd. is a tree used in folk medicine to treat venereal diseases and inflammation as well as a source of biological compounds with antioxidant capacity. In order to assess the safety of these bioactive compounds, the present study aimed to determine the toxicity of an ethanolic extract of T. gardneriana, (EETg). Toxicological tests included hemolytic activity, toxicity toward the brine shrimp Artemia, cytotoxicity against breast cancer cells (MCF7) and acute oral toxicity in rodents. In addition, toxicogenomics techniques were used to determine genome expression in MCF7 cells exposed to EETg. The results showed that the extract exhibits approximately 60% of hemolytic activity at the highest tested concentration (64 mu g/ml) and toxicity against nauplii of Artemia sp. (LC50 of 67.85 mu g/ml). Further, EETg appears to be cytotoxic to MCF7 (cell viability reduced to 40% at 250 mu g/ml after 24 hr). Genomic data demonstrated differential expression of 14 genes. Data analysis indicated possible altered pathways (e.g., xenobiotic metabolism), possible adverse health risks (e.g., hepatotoxicity), and drugs with similar gene expression profile (e.g., antimicrobials). The investigation provides important information on potentially adverse aspects of EETg, which need to be considered prior to the therapeutic utilization of this plant.
C1 [Almeida, Thiago S.; Arantes, Mariana R.; Lopes Neto, Jose J.; Pessoa, Igor P.; Medeiros, Jackeline L.; Tabosa, Pedro M. S.; Moreira, Thais B.; Carvalho, Ana F. U.] Univ Fed Ceara, Dept Biochem & Mol Biol, BR-60020181 Fortaleza, Ceara, Brazil.
   [Souza, Terezinha M.] Maastricht Univ, Dept Toxicogen, Maastricht, Netherlands.
   [Farias, Davi F.] Univ Fed Paraiba, Dept Mol Biol, Joao Pessoa, Paraiba, Brazil.
RP Carvalho, AFU (corresponding author), Univ Fed Ceara, Dept Biochem & Mol Biol, BR-60020181 Fortaleza, Ceara, Brazil.
EM aurano@ufc.br
OI Felipe Farias, Davi/0000-0001-5438-1919
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil
   (CAPES)CAPES [001, PVE-A006_2013]
FX This investigation in part by the Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior -Brasil (CAPES) - Finance Code 001, for
   supporting grants (PVE-A006_2013).
CR Alminger M, 2014, COMPR REV FOOD SCI F, V13, P413, DOI 10.1111/1541-4337.12081
   [Anonymous], 2001, 423 OECD
   Ashrap P, 2017, P NATL ACAD SCI USA, V114, P6062, DOI 10.1073/pnas.1700558114
   Baumann E, 2000, ACTA HISTOCHEM, V102, P21, DOI 10.1078/0065-1281-00534
   BERNHEIMER AW, 1988, METHOD ENZYMOL, V165, P213
   Braga R., 1976, PLANTAS NORDESTE ESP
   Cartaxo SL, 2010, J ETHNOPHARMACOL, V131, P326, DOI 10.1016/j.jep.2010.07.003
   Chen DQ, 2016, CHEM-BIOL INTERACT, V252, P114, DOI 10.1016/j.cbi.2016.03.028
   Cheok CY, 2014, FOOD RES INT, V59, P16, DOI 10.1016/j.foodres.2014.01.057
   Crozier A, 2010, MOL ASPECTS MED, V31, P446, DOI 10.1016/j.mam.2010.09.007
   da Silva FC, 2019, J TOXICOL ENV HEAL A, V82, P956, DOI 10.1080/15287394.2019.1671279
   de Almeida TS, 2017, BIOMED PHARMACOTHER, V93, P1261, DOI 10.1016/j.biopha.2017.07.050
   De Sousa JA, 2019, J TOXICOL ENV HEAL A, V82, P62, DOI 10.1080/15287394.2018.1562392
   Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863
   Farias DF, 2013, BIOMED RES INT, V2013, DOI [10.1155/2013/605831, 10.1155/2013/510736, 10.1155/2013/340605, 10.1155/2013/263509]
   Farias DF, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/810490
   Filipa Brito A, 2015, QUERCETIN CANC TREAT
   Franco ES, 2015, J TOXICOL ENV HEAL A, V78, P1083, DOI 10.1080/15287394.2014.1004007
   George P., 2011, Journal of Applied Pharmaceutical Science, V1, P40
   Gibellini L, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/neq053
   Guttula Satya Vani, 2012, Int J Alzheimers Dis, V2012, P649456, DOI 10.1155/2012/649456
   HAMIDI MR, 2014, MACED PHARM B, V60, P9, DOI DOI 10.33320/maced.pharm.bull.2014.60.01.002
   Herwig R, 2016, NAT PROTOC, V11, P1889, DOI 10.1038/nprot.2016.117
   Hsieh CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119516
   Huo DS, 2019, J TOXICOL ENV HEAL A, V82, P1027, DOI 10.1080/15287394.2019.1684028
   Inocente Camones Miguel Angel, 2010, Rev. Soc. Quím. Perú, V76, P34
   Rodriguez MI, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003531
   Kanehisa M, 2019, NUCLEIC ACIDS RES, V47, pD590, DOI 10.1093/nar/gky962
   Lamb J, 2007, NAT REV CANCER, V7, P54, DOI 10.1038/nrc2044
   Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939
   Lee JH, 2013, J KOREAN SURG SOC, V85, P249, DOI 10.4174/jkss.2013.85.6.249
   Lee J, 2016, ONCOL REP, V35, P2473, DOI 10.3892/or.2016.4598
   Neto JJL, 2020, J ETHNOPHARMACOL, V250, DOI 10.1016/j.jep.2019.112474
   Neto JJL, 2017, BIOMED PHARMACOTHER, V88, P999, DOI 10.1016/j.biopha.2017.01.109
   Macedo S. K. S., 2015, Journal of Medicinal Plants Research, V9, P207
   Mandimika T, 2007, J AGR FOOD CHEM, V55, P10055, DOI 10.1021/jf0724320
   Martins N, 2016, TRENDS FOOD SCI TECH, V48, P1, DOI 10.1016/j.tifs.2015.11.008
   Matos F.J.A., 1988, INTRO FITOQUIMICA EX
   MERKER MP, 1986, TOXICON, V24, P451, DOI 10.1016/0041-0101(86)90077-2
   MEYER BN, 1982, PLANTA MED, V45, P31, DOI 10.1055/s-2007-971236
   Olaru OT, 2015, ONCOL LETT, V10, P1323, DOI 10.3892/ol.2015.3453
   Parshina E. Yu., 2009, Biofizika, V54, P1051
   Peteros NP, 2010, J MED PLANTS RES, V4, P407
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Rocha TA, 2019, J TOXICOL ENV HEAL A, V82, P216, DOI 10.1080/15287394.2019.1576563
   Sahreen S, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0736-y
   Saikia P, 2010, J VIROL, V84, P13036, DOI 10.1128/JVI.01194-10
   Scapagnini G, 2004, ANTIOXID REDOX SIGN, V6, P811, DOI 10.1089/ars.2004.6.811
   Seo HS, 2016, ONCOL REP, V36, P31, DOI 10.3892/or.2016.4786
   Shao J, 2014, ARCH TOXICOL, V88, P673, DOI 10.1007/s00204-013-1179-1
   Sharma P, 2001, J ETHNOPHARMACOL, V74, P239, DOI 10.1016/S0378-8741(00)00370-6
   Shintyapina AB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176939
   Suwalsky M, 2016, J MEMBRANE BIOL, V249, P769, DOI 10.1007/s00232-016-9924-z
   Svhmeits PCJ, 2014, TOXICOL LETT, V224, P395, DOI 10.1016/j.toxlet.2013.11.005
   Tong W., 2009, INTERDISCIP BIOL CEN, V1, P101, DOI [10.4051/ibc.2009.3.0010, DOI 10.4051/IBC.2009.3.0010]
   Waidyanath S, 2019, FOOD CHEM TOXICOL, V131, DOI 10.1016/j.fct.2019.110586
   Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031
   Wilson VS, 2013, TOXICOL APPL PHARM, V271, P299, DOI 10.1016/j.taap.2011.01.017
   Xu CJ, 2005, ARCH PHARM RES, V28, P249, DOI 10.1007/BF02977789
   Zhou XL, 2018, ONCOL REP, V40, P1897, DOI 10.3892/or.2018.6589
NR 60
TC 5
Z9 5
U1 0
U2 0
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1528-7394
EI 1087-2620
J9 J TOXICOL ENV HEAL A
JI J. Toxicol. Env. Health Part A
PD FEB 16
PY 2020
VL 83
IS 4
BP 135
EP 152
DI 10.1080/15287394.2020.1731035
EA MAR 2020
PG 18
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Toxicology
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Toxicology
GA KU8TE
UT WOS:000518253600001
PM 32114934
DA 2020-12-08
ER

PT J
AU Sa, CA
   Vieira, LR
   Almeida, LCP
   Real-Guerra, R
   Lopes, FC
   Souza, TM
   Vasconcelos, IM
   Staniscuaski, F
   Carlini, CR
   Carvalho, AFU
   Farias, DF
AF Sa, Chayenne Alves
   Vieira, Leonardo Rogerio
   Pereira Almeida Filho, Luiz Carlos
   Real-Guerra, Rafael
   Lopes, Fernanda Cortez
   Souza, Terezinha Maria
   Vasconcelos, Ilka Maria
   Staniscuaski, Fernanda
   Carlini, Celia Regina
   Urano Carvalho, Ana Fontenele
   Farias, Davi Felipe
TI Risk assessment of the antifungal and insecticidal peptide Jaburetox and
   its parental protein the Jack bean (Canavalia ensiformis) urease
SO FOOD AND CHEMICAL TOXICOLOGY
LA English
DT Article
DE Allergen prediction; Candidate protein; Food safety assessment;
   Genetically modified crops; In vitro digestibility
ID FOOD SAFETY ASSESSMENT; TOXIC PROTEIN; PROTEOLYTIC ACTIVATION;
   RHODNIUS-PROLIXUS; GENUS CANAVALIA; IN-VITRO; CANATOXIN; EXPRESSION;
   HEMIPTERA; CHANNELS
AB Jaburetox (JBTX) is an insecticidal and antifungal peptide derived from jack bean (Canavalia ensiformis) urease that has been considered a candidate for developing genetically modified crops. This study aimed to perform the risk assessment of the peptide JBTX following the general recommendations of the two-tiered, weight-of-evidence approach proposed by International Life Sciences Institute. The urease of C. ensiformis (JBU) and its isoform JBURE IIb (the JBTX parental protein) were assessed. The history of safe use revealed no hazard reports for the studied proteins. The available information shows that JBTX possesses selective activity against insects and fungi. JBTX and JBU primary amino acids sequences showed no relevant similarity to toxic, antinutritional or allergenic proteins. Additionally, JBTX and JBU were susceptible to in vitro digestibility, and JBU was also susceptible to heat treatment. The results did not identify potential risks of adverse effects and reactions associated to JBTX. However, further allergen (e.g. serum IgE binding test) and toxicity (e.g. rodent toxicity tests) experimentation can be done to gather additional safety information on JBTX, and to meet regulatory inquiries for commercial approval of transgenic cultivars expressing this peptide.
C1 [Sa, Chayenne Alves; Vieira, Leonardo Rogerio; Vasconcelos, Ilka Maria; Urano Carvalho, Ana Fontenele; Farias, Davi Felipe] Univ Fed Ceara, Grad Program Biochem, BR-60440900 Fortaleza, CE, Brazil.
   [Pereira Almeida Filho, Luiz Carlos; Urano Carvalho, Ana Fontenele] Univ Fed Ceara, Dept Biol, BR-60440900 Fortaleza, CE, Brazil.
   [Real-Guerra, Rafael] Univ Fed Rio Grande do Sul, Ctr Coastal Limnol & Marine Studies CECLIMAR, BR-95625000 Imbe, RS, Brazil.
   [Real-Guerra, Rafael] Univ Fed Rio Grande do Sul, Interdisciplinary Dept, BR-95625000 Tramandai, RS, Brazil.
   [Lopes, Fernanda Cortez; Staniscuaski, Fernanda; Carlini, Celia Regina] Univ Fed Rio Grande do Sul, Ctr Biotechnol, Av Bento Gocalves 9500,Bldg 43431, BR-91501970 Porto Alegre, RS, Brazil.
   [Lopes, Fernanda Cortez; Staniscuaski, Fernanda; Carlini, Celia Regina] Univ Fed Rio Grande do Sul, Grad Program Cellular & Mol Biol, Av Bento Gocalves 9500,Bldg 43431, BR-91501970 Porto Alegre, RS, Brazil.
   [Souza, Terezinha Maria] Maastricht Univ, GROW Sch Oncol & Dev Biol, Dept Toxicogen, NL-6229 ER Maastricht, Netherlands.
   [Staniscuaski, Fernanda] Univ Fed Rio Grande do Sul, Dept Mol Biol & Biotechnol, Av Bento Goncalves 9500,Bldg 43431, BR-91501970 Porto Alegre, RS, Brazil.
   [Carlini, Celia Regina] Pontifical Catholic Univ Rio Grande Sul PUCRS, Brain Inst, Inst Cerebro INSCER, Av Ipiranga 6690,Bldg 63, BR-90610000 Porto Alegre, RS, Brazil.
   [Farias, Davi Felipe] Univ Fed Paraiba, Lab Risk Assesment Novel Technol LabRisk, Dept Mol Biol, BR-58051900 Joao Pessoa, Paraiba, Brazil.
RP Farias, DF (corresponding author), Univ Fed Paraiba, Lab Risk Assesment Novel Technol LabRisk, Dept Mol Biol, BR-58051900 Joao Pessoa, Paraiba, Brazil.
EM davi@dbm.ufpb.br
RI Staniscuaski, Fernanda/F-8926-2012; Carvalho, Ana/K-7344-2018; Carlini,
   Celia R/H-4017-2011; Souza, Terezinha/L-8727-2015
OI Rogerio Vieira, Leonardo/0000-0002-8505-941X; Carvalho,
   Ana/0000-0001-5293-9317; Felipe Farias, Davi/0000-0001-5438-1919;
   Carlini, Celia R/0000-0002-7027-2445; Souza,
   Terezinha/0000-0002-9580-3310
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq),
   BrazilNational Council for Scientific and Technological Development
   (CNPq) [461182-9]
FX We thank to Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq), Brazil, for supporting this research with grants
   (Grant number 461182-9) and scholarships.
CR Aalberse RC, 2000, J ALLERGY CLIN IMMUN, V106, P228, DOI 10.1067/mai.2000.108434
   Akpapunam MA, 1997, PLANT FOOD HUM NUTR, V50, P93, DOI 10.1007/BF02436029
   Arya S., 2013, THESIS
   Barros PR, 2009, BBA-PROTEINS PROTEOM, V1794, P1848, DOI 10.1016/j.bbapap.2009.09.001
   Becker-Ritt AB, 2017, J VENOM ANIM TOXINS, V23, DOI 10.1186/s40409-017-0122-y
   Bogh KL, 2016, CRIT REV FOOD SCI, V56, P1545, DOI 10.1080/10408398.2013.779569
   Broll V, 2017, COLLOID SURFACE B, V159, P849, DOI 10.1016/j.colsurfb.2017.08.053
   Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844
   Carlini CR, 2016, TOXICON, V110, P90, DOI 10.1016/j.toxicon.2015.11.020
   Carlini CR, 1997, J ECON ENTOMOL, V90, P340, DOI 10.1093/jee/90.2.340
   CARLINI CR, 1984, ACTA PHARMACOL TOX, V54, P161
   CARLINI CR, 1981, TOXICON, V19, P667, DOI 10.1016/0041-0101(81)90104-5
   Carrazoni T, 2018, PESTIC BIOCHEM PHYS, V146, P63, DOI 10.1016/j.pestbp.2018.02.009
   Carrazoni T, 2016, TOXICOLOGY, V368, P162, DOI 10.1016/j.tox.2016.09.007
   Codex Alimentarius, 2009, FOOD DERIVED MODERN
   Constable A, 2007, FOOD CHEM TOXICOL, V45, P2513, DOI 10.1016/j.fct.2007.05.028
   Defferrari MS, 2014, TOXICON, V82, P18, DOI 10.1016/j.toxicon.2014.02.006
   Defferrari MS, 2014, BBA-GEN SUBJECTS, V1840, P396, DOI 10.1016/j.bbagen.2013.09.016
   Defferrari MS, 2011, INSECT BIOCHEM MOLEC, V41, P388, DOI 10.1016/j.ibmb.2011.02.008
   Delaney B, 2008, FOOD CHEM TOXICOL, V46, pS71, DOI 10.1016/j.fct.2008.01.045
   Delaney B, 2017, FOOD CHEM TOXICOL, V110, P425, DOI 10.1016/j.fct.2017.09.029
   DIXON NE, 1980, CAN J BIOCHEM CELL B, V58, P1323, DOI 10.1139/o80-180
   Do AB, 2016, FOOD CHEM, V190, P581, DOI 10.1016/j.foodchem.2015.05.113
   dos Santos DS, 2019, PESTIC BIOCHEM PHYS, V153, P67, DOI 10.1016/j.pestbp.2018.11.003
   FAO/WHO (Food and Agriculture Organization of the United Nations/World Health Organization), 2001, EV ALL GEN MOD FOODS
   Farias DF, 2015, BIOENGINEERED, V6, P323, DOI 10.1080/21655979.2015.1109755
   Farias DF, 2015, FOOD CHEM TOXICOL, V81, P81, DOI 10.1016/j.fct.2015.04.008
   Ferreira-DaSilva CT, 2000, ARCH INSECT BIOCHEM, V44, P162, DOI 10.1002/1520-6327(200008)44:4&lt;162::AID-ARCH3&gt;3.0.CO;2-#
   Follmer C, 2004, EUR J BIOCHEM, V271, P1357, DOI 10.1111/j.1432-1033.2004.04046.x
   Follmer C, 2001, BIOCHEM J, V360, P217, DOI 10.1042/0264-6021:3600217
   Fruttero LL, 2017, ACTA TROP, V168, P54, DOI 10.1016/j.actatropica.2017.01.009
   Fruttero LL, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1710-3
   Galvani GL, 2015, BBA-GEN SUBJECTS, V1850, P255, DOI 10.1016/j.bbagen.2014.11.008
   Garrido-Arandia M, 2014, FOOD SCI NUTR, V2, P260, DOI 10.1002/fsn3.99
   Hamzah N.A., 2014, J BABYLON U PURE APP, V22, P1071
   Herouet-Guicheney C, 2009, REGUL TOXICOL PHARM, V54, P143, DOI 10.1016/j.yrtph.2009.03.005
   Kaefer C, 2013, REPROD TOXICOL, V38, P72, DOI 10.1016/j.reprotox.2013.03.003
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lopes FC, 2015, FEBS J, V282, P1043, DOI 10.1111/febs.13201
   Martinelli AHS, 2014, BBA-GEN SUBJECTS, V1840, P935, DOI 10.1016/j.bbagen.2013.11.010
   Moyetta NR, 2017, COMP BIOCHEM PHYS C, V200, P17, DOI 10.1016/j.cbpc.2017.06.001
   Mulinari F, 2007, PEPTIDES, V28, P2042, DOI 10.1016/j.peptides.2007.08.009
   Mulinari F, 2011, BBA-PROTEINS PROTEOM, V1814, P1758, DOI 10.1016/j.bbapap.2011.07.022
   Pinto CEM, 2015, FOOD CHEM TOXICOL, V83, P1, DOI 10.1016/j.fct.2015.05.012
   Piovesan AR, 2014, ARCH BIOCHEM BIOPHYS, V547, P6, DOI [10.1016/j.abb.2014.02.0060003-9861, 10.1016/j.abb.2014.02.006]
   Piovesan AR, 2008, INSECT BIOCHEM MOLEC, V38, P1023, DOI 10.1016/j.ibmb.2008.09.004
   Pires-Alves M, 2003, PLANT CELL PHYSIOL, V44, P139, DOI 10.1093/pcp/pcg018
   Postal M, 2012, PEPTIDES, V38, P22, DOI 10.1016/j.peptides.2012.08.010
   Rathinam M, 2017, BMC BIOTECHNOL, V17, DOI 10.1186/s12896-017-0384-z
   Real-Guerra R, 2013, TOXICON, V71, P76, DOI 10.1016/j.toxicon.2013.05.008
   Reshetnik E.Y., 2007, USE SOYA MILK CONCEN
   Saha S, 2006, NUCLEIC ACIDS RES, V34, pW202, DOI 10.1093/nar/gkl343
   Sasipriya G, 2013, TROP ANIM HEALTH PRO, V45, P811, DOI 10.1007/s11250-012-0293-z
   SAVAGE WD, 1995, J FOOD SCI, V60, P164, DOI 10.1111/j.1365-2621.1995.tb05630.x
   SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2
   Sprawka I, 2014, J INSECT SCI, V14, DOI 10.1093/jisesa/ieu094
   Sridhar KR, 2006, FOOD CHEM, V99, P267, DOI 10.1016/j.foodchem.2005.07.049
   Staniscuaski F, 2005, TOXICON, V45, P753, DOI 10.1016/j.toxicon.2005.01.014
   Staniscuaski F, 2010, J INSECT PHYSIOL, V56, P1078, DOI 10.1016/j.jinsphys.2010.03.002
   Staniscuaski F, 2012, TOXINS, V4, P55, DOI 10.3390/toxins4020055
   Staniscuaski F, 2009, J INSECT PHYSIOL, V55, P255, DOI 10.1016/j.jinsphys.2008.12.002
   Sumner JB, 1926, J BIOL CHEM, V69, P435
   TAKISHIMA K, 1988, EUR J BIOCHEM, V175, P151, DOI 10.1111/j.1432-1033.1988.tb14177.x
   Tompa P, 2012, TRENDS BIOCHEM SCI, V37, P509, DOI 10.1016/j.tibs.2012.08.004
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   Vasconcelos IM, 2004, TOXICON, V44, P385, DOI 10.1016/j.toxicon.2004.05.005
   WEATHERBURN MW, 1967, ANAL CHEM, V39, P971, DOI 10.1021/ac60252a045
   Xu WT, 2009, FOOD CHEM TOXICOL, V47, P1459, DOI 10.1016/j.fct.2009.03.029
   Zverev S., 2018, J FOOD SCI, V12, P512, DOI [10.5219/940, DOI 10.5219/940]
NR 69
TC 1
Z9 1
U1 1
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0278-6915
EI 1873-6351
J9 FOOD CHEM TOXICOL
JI Food Chem. Toxicol.
PD FEB
PY 2020
VL 136
AR 110977
DI 10.1016/j.fct.2019.110977
PG 13
WC Food Science & Technology; Toxicology
SC Food Science & Technology; Toxicology
GA KM3IS
UT WOS:000514015300033
PM 31759068
DA 2020-12-08
ER

PT J
AU Almeida, LCP
   Tabosa, PMS
   Hissa, DC
   Vasconcelos, IM
   Carvalho, AFU
AF Almeida Filho, Luiz C. P.
   Tabosa, Pedroms M. S.
   Hissa, Denise C.
   Vasconcelos, Ilka M.
   Carvalho, Ana F. U.
TI First insights into insecticidal activity against Aedes aegypti and
   partial biochemical characterization of a novel low molecular mass
   chymotrypsin-trypsin inhibitor purified from Lonchocarpus sericeus seeds
SO PEST MANAGEMENT SCIENCE
LA English
DT Article
DE chymotrypsin inhibitor; Lonchocarpus; legume seeds; dengue; zika; midgut
   enzymes
ID BOWMAN-BIRK INHIBITOR; KUNITZ-TYPE INHIBITOR; PROTEINASE-INHIBITOR;
   BIOINSECTICIDAL ACTIVITY; TOXIC PROTEINS; L. SEEDS; PURIFICATION;
   LARVAE; IDENTIFICATION; PROTEASES
AB BACKGROUNDArboviroses such as dengue, Zika and chikungunya represent a serious public health issue as a consequence of the absence of approved vaccines or specific antiviral drugs against the arboviruses that cause them. One way to prevent these diseases is by combating the vector mosquito, Aedes aegypti (Diptera), which has serine proteases in the midgut. Protease inhibitors are molecules that can block enzyme activity, impairing digestion and nutrition, which can lead to death. Thus, we purified and characterized a novel chymotrypsin-trypsin inhibitor (LsCTI) from Lonchocarpus sericeus seeds and investigated its effect upon Ae. aegypti egg hatching, larval development and digestive proteases.
   RESULTSLsCTI showed a single protein band in sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and the molecular mass determined by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF-MS) was 8870.45 Da. Kinetics analyses revealed a noncompetitive type of inhibition and low inhibition constant (K-i) for chymotrypsin (8.24 x 10(-8) m). The thermal resistance was remarkable, even at 100 degrees C for 180 min. The inhibitor concentration required for 50-percent enzyme inhibition (IC50) of LsCTI was 4.7 x 10(-7) m for Ae. aegypti midgut larval enzymes. LsCTI did not affect egg hatchability at 0.3 mg mL(-1), but caused a high larval mortality rate (77%) and delayed development (37%).
   CONCLUSIONSLsCTI is a novel protease inhibitor with remarkable biochemical characteristics and is a potential tool to control Ae. aegypti development. (c) 2017 Society of Chemical Industry
C1 [Hissa, Denise C.; Carvalho, Ana F. U.] Univ Fed Ceara, Biol Dept, Pici Campus, BR-60440900 Fortaleza, Ceara, Brazil.
   [Almeida Filho, Luiz C. P.; Tabosa, Pedroms M. S.; Vasconcelos, Ilka M.] Univ Fed Ceara, Biochem & Mol Biol Dept, Pici Campus, Fortaleza, Ceara, Brazil.
RP Carvalho, AFU (corresponding author), Univ Fed Ceara, Biol Dept, Pici Campus, BR-60440900 Fortaleza, Ceara, Brazil.
EM aurano@ufc.br
RI Hissa, Denise/X-3314-2019; Almeida Filho, Luiz/K-7313-2018; Carvalho,
   Ana/K-7344-2018
OI Almeida Filho, Luiz/0000-0001-6234-2418; Carvalho,
   Ana/0000-0001-5293-9317
FU Brazilian Agency Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq) [448150/2014-0]; MCT-INSA/CNPq/CT [35/2010];
   Coordenacao de Aperfeicoamento de Pessoal do Ensino Superior
   (CAPES)CAPES
FX The authors thank The Brazilian Agency Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) for a research grant
   provided to DCH (Process N. 448150/2014-0) and are also grateful to
   MCT-INSA/CNPq/CT for financial support of this research through
   Hidro/Acao Tranversal No 35/2010-Desenvolvimento Sustentavel do
   Semiarido Brasileiro and Coordenacao de Aperfeicoamento de Pessoal do
   Ensino Superior (CAPES).
CR ABE M, 1992, EUR J BIOCHEM, V209, P933, DOI 10.1111/j.1432-1033.1992.tb17365.x
   Alencar NMN, 2005, J PHARM PHARMACOL, V57, P919, DOI 10.1211/0022357056352
   Almeida LCP, 2017, PEST MANAG SCI, V73, P181, DOI 10.1002/ps.4284
   Altizer S, 2011, SCIENCE, V331, P296, DOI 10.1126/science.1194694
   Araujo CL, 2005, J AGR FOOD CHEM, V53, P4381, DOI 10.1021/jf0502505
   Baldacchino F, 2015, PEST MANAG SCI, V71, P1471, DOI 10.1002/ps.4044
   Bezerra CD, 2016, PROCESS BIOCHEM, V51, P792, DOI 10.1016/j.procbio.2016.03.008
   Bhattacharyya A, 2009, PHYTOCHEMISTRY, V70, P703, DOI 10.1016/j.phytochem.2009.04.001
   BIRK Y, 1961, BIOCHIM BIOPHYS ACTA, V54, P378, DOI 10.1016/0006-3002(61)90387-0
   Brand GD, 2017, ARCH BIOCHEM BIOPHYS, V618, P9, DOI 10.1016/j.abb.2017.01.009
   Carlini CR, 2002, TOXICON, V40, P1515, DOI 10.1016/S0041-0101(02)00240-4
   Cruz ACB, 2013, PLANT PHYSIOL BIOCH, V70, P61, DOI 10.1016/j.plaphy.2013.04.023
   Cunha GMD, 2003, PHYTOTHER RES, V17, P155, DOI 10.1002/ptr.1096
   Dang LY, 2015, PHYTOCHEMISTRY, V117, P51, DOI 10.1016/j.phytochem.2015.05.020
   Dantzger M, 2015, PHYTOCHEMISTRY, V118, P224, DOI 10.1016/j.phytochem.2015.08.013
   Santos NDD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044840
   Dias LP, 2017, PROCESS BIOCHEM, V57, P228, DOI 10.1016/j.procbio.2017.03.015
   DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170
   DOMONEY C, 1995, FEBS LETT, V360, P15, DOI 10.1016/0014-5793(95)00070-P
   Duarte G, 2017, REV BRAS GINECOL OBS, V39, P235, DOI 10.1055/s-0037-1603450
   Ee KY, 2009, J AGR FOOD CHEM, V57, P7022, DOI 10.1021/jf900923t
   Fang EF, 2011, PROTEIN PEPTIDE LETT, V18, P64
   Fontenele JB, 2005, PHARM BIOL, V43, P726, DOI 10.1080/13880200500387406
   Guimaraes LC, 2015, PESTIC BIOCHEM PHYS, V118, P1, DOI 10.1016/j.pestbp.2014.12.001
   Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142
   Jamal F, 2015, PROCESS BIOCHEM, V50, P311, DOI 10.1016/j.procbio.2014.12.003
   Jamal F, 2013, PHYTOCHEM REV, V12, P1, DOI 10.1007/s11101-012-9231-y
   Johansson S, 2002, J NAT PROD, V65, P32, DOI 10.1021/np010323o
   Klomklao S, 2011, FOOD CHEM, V129, P1348, DOI 10.1016/j.foodchem.2011.05.029
   Koodalingam A, 2013, ACTA TROP, V126, P249, DOI 10.1016/j.actatropica.2013.02.021
   Krishnan V.G.M., 2015, FOOD SCI HUM WELL, V4, P97, DOI DOI 10.1016/j.fshw.2015.06.003
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lannoo N, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00397
   Lingaraju MH, 2008, BBA-PROTEINS PROTEOM, V1784, P850, DOI 10.1016/j.bbapap.2008.02.013
   Lyu JC, 2015, ACTA BIOCH BIOPH SIN, V47, P376, DOI 10.1093/abbs/gmv022
   Maag D, 2015, BIOESSAYS, V37, P167, DOI 10.1002/bies.201400124
   Macedo MLR, 2004, J AGR FOOD CHEM, V52, P2533, DOI 10.1021/jf035389z
   Macedo MLR, 2002, PLANT PHYSIOL BIOCH, V40, P891, DOI 10.1016/S0981-9428(02)01441-9
   MAZID S, 2011, INT J SC ADV TECHNOL, V1, P169, DOI DOI 10.1007/S10886-005-4244-2
   Migliolo L, 2010, J MOL GRAPH MODEL, V29, P148, DOI 10.1016/j.jmgm.2010.05.006
   Morrison SC, 2007, FOOD CHEM, V100, P1, DOI 10.1016/j.foodchem.2005.07.062
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nakahata AM, 2006, INT J BIOL MACROMOL, V40, P22, DOI 10.1016/j.ijbiomac.2006.05.008
   Oyedeji OA, 2015, AFR J FOOD SCI TECHN, V6, P131
   Paiva PMG, 2013, LECTINS TRYPSIN INHI, P17
   Pilon AM, 2006, PESTIC BIOCHEM PHYS, V86, P23, DOI 10.1016/j.pestbp.2005.11.005
   Pontual EV, 2014, PARASITOL RES, V113, P727, DOI 10.1007/s00436-013-3702-y
   Pontual EV, 2012, ARCH INSECT BIOCHEM, V79, P135, DOI 10.1002/arch.21012
   Prasad ER, 2010, PHYTOCHEMISTRY, V71, P363, DOI 10.1016/j.phytochem.2009.11.006
   Prasad ER, 2010, J AGR FOOD CHEM, V58, P2838, DOI 10.1021/jf903675d
   Ragg EM, 2006, FEBS J, V273, P4024, DOI 10.1111/j.1742-4658.2006.05406.x
   de Oliveira CFR, 2012, PROCESS BIOCHEM, V47, P929, DOI 10.1016/j.procbio.2012.02.022
   Ramos MV, 2009, MEM I OSWALDO CRUZ, V104, P805, DOI 10.1590/S0074-02762009000600001
   Macedo MLR, 2007, PHYTOCHEMISTRY, V68, P1104, DOI 10.1016/j.phytochem.2007.01.024
   Ruan JJ, 2017, PESTIC BIOCHEM PHYS, V142, P141, DOI 10.1016/j.pestbp.2017.06.013
   Rufino FPS, 2013, PLANT PHYSIOL BIOCH, V63, P70, DOI 10.1016/j.plaphy.2012.11.013
   Sarwar M., 2014, J ECOL ENV SCI, V2, P24
   Sarwar M, 2015, BIOMED ENG, V3, P311
   Sasaki NY, 2015, BIOCHIMIE, V112, P172, DOI 10.1016/j.biochi.2015.03.011
   Senthil-Nathan S., 2015, ENV SUSTAINABILITY, P49, DOI DOI 10.1007/978-81-322-2056-5
   Senthilkumar R, 2010, PLANT BIOTECHNOL J, V8, P65, DOI 10.1111/j.1467-7652.2009.00466.x
   Silva RGG, 2015, IND CROP PROD, V70, P48, DOI 10.1016/j.indcrop.2015.02.058
   Singh RR, 2002, BBA-PROTEIN STRUCT M, V1597, P280, DOI 10.1016/S0167-4838(02)00301-1
   Soares TS, 2011, GENE, V489, P70, DOI 10.1016/j.gene.2011.08.018
   Souza TM, 2011, J MED ENTOMOL, V48, P846, DOI 10.1603/ME10205
   Carvalho AFU, 2011, J FOOD COMPOS ANAL, V24, P487, DOI 10.1016/j.jfca.2011.01.013
   Venancio TM, 2009, INSECT MOL BIOL, V18, P33, DOI 10.1111/j.1365-2583.2008.00845.x
   WHO, 2017, DENG SEV DENG
   WHO, 2017, VECT BORN DIS
NR 69
TC 4
Z9 4
U1 0
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1526-498X
EI 1526-4998
J9 PEST MANAG SCI
JI Pest Manag. Sci.
PD JUN
PY 2018
VL 74
IS 6
BP 1362
EP 1373
DI 10.1002/ps.4812
PG 12
WC Agronomy; Entomology
SC Agriculture; Entomology
GA GF1CP
UT WOS:000431670200018
PM 29193604
OA Bronze
DA 2020-12-08
ER

PT J
AU Miskowiak, KW
   Burdick, KE
   Martinez-Aran, A
   Bonnin, CM
   Bowie, CR
   Carvalho, AF
   Gallagher, P
   Lafer, B
   Lopez-Jaramillo, C
   Sumiyoshi, T
   McIntyre, RS
   Schaffer, A
   Porter, RJ
   Purdon, S
   Torres, IJ
   Yatham, LN
   Young, AH
   Kessing, LV
   Vieta, E
AF Miskowiak, K. W.
   Burdick, K. E.
   Martinez-Aran, A.
   Bonnin, C. M.
   Bowie, C. R.
   Carvalho, A. F.
   Gallagher, P.
   Lafer, B.
   Lopez-Jaramillo, C.
   Sumiyoshi, T.
   McIntyre, R. S.
   Schaffer, A.
   Porter, R. J.
   Purdon, S.
   Torres, I. J.
   Yatham, L. N.
   Young, A. H.
   Kessing, L. V.
   Vieta, E.
TI Assessing and addressing cognitive impairment in bipolar disorder: the
   International Society for Bipolar Disorders Targeting Cognition Task
   Force recommendations for clinicians
SO BIPOLAR DISORDERS
LA English
DT Review
DE bipolar disorder; cognitive impairment; neuropsychological;
   recommendations; screening
ID RATING ASSESSMENT COBRA; FUNCTIONAL REMEDIATION; I DISORDER;
   ASSOCIATION; PERFORMANCE; DEPRESSION; RESERVE; MOOD; REHABILITATION;
   ERYTHROPOIETIN
AB ObjectivesCognition is a new treatment target to aid functional recovery and enhance quality of life for patients with bipolar disorder. The International Society for Bipolar Disorders (ISBD) Targeting Cognition Task Force aimed to develop consensus-based clinical recommendations on whether, when and how to assess and address cognitive impairment.
   MethodsThe task force, consisting of 19 international experts from nine countries, discussed the challenges and recommendations in a face-to-face meeting, telephone conference call and email exchanges. Consensus-based recommendations were achieved through these exchanges with no need for formal consensus methods.
   ResultsThe identified questions were: (I) Should cognitive screening assessments be routinely conducted in clinical settings? (II) What are the most feasible screening tools? (III) What are the implications if cognitive impairment is detected? (IV) What are the treatment perspectives? Key recommendations are that clinicians: (I) formally screen cognition in partially or fully remitted patients whenever possible, (II) use brief, easy-to-administer tools such as the Screen for Cognitive Impairment in Psychiatry and Cognitive Complaints in Bipolar Disorder Rating Assessment, and (III) evaluate the impact of medication and comorbidity, refer patients for comprehensive neuropsychological evaluation when clinically indicated, and encourage patients to build cognitive reserve. Regarding question (IV), there is limited evidence for current evidence-based treatments but intense research efforts are underway to identify new pharmacological and/or psychological cognition treatments.
   ConclusionsThis task force paper provides the first consensus-based recommendations for clinicians on whether, when, and how to assess and address cognition, which may aid patients' functional recovery and improve their quality of life.
C1 [Miskowiak, K. W.; Kessing, L. V.] Rigshosp, Copenhagen Affect Disorder Res Ctr CADIC, Copenhagen Univ Hosp, Psychiat Ctr Copenhagen, Copenhagen, Denmark.
   [Miskowiak, K. W.] Univ Copenhagen, Deparment Psychol, Copenhagen, Denmark.
   [Burdick, K. E.] Harvard Med Sch, Brigham & Womens Hosp, Dept Psychiat, Boston, MA USA.
   [Martinez-Aran, A.; Bonnin, C. M.; Vieta, E.] Univ Barcelona, Hosp Clin, Clin Inst Neurosci, IDIBAPS,CIBERSAM, Barcelona, Catalonia, Spain.
   [Bowie, C. R.] Queens Univ, Dept Psychol, Kingston, ON, Canada.
   [Carvalho, A. F.] Univ Fed Ceara, Dept Clin Med, Fortaleza, Ceara, Brazil.
   [Carvalho, A. F.] Univ Fed Ceara, Fac Med, Translat Psychiat Res Grp, Fortaleza, Ceara, Brazil.
   [Gallagher, P.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England.
   [Lafer, B.] Univ Sao Paulo, Fac Med FMUSP, Dept Psiquiatria, Bipolar Disorder Res Program, Sao Paulo, SP, Brazil.
   [Lopez-Jaramillo, C.] Univ Antioquia, Res Grp Psychiat, Dept Psychiat, Medellin, Colombia.
   [Sumiyoshi, T.] Natl Ctr Neurol & Psychiat, Translat Med Ctr, Dept Clin Epidemiol, Tokyo, Japan.
   [McIntyre, R. S.] Univ Toronto, Brain & Cognit Discovery Fdn, Mood Disorders Psychopharmacol Unit, Toronto, ON, Canada.
   [Schaffer, A.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada.
   [Porter, R. J.] Univ Otago, Dept Psychol Med, Christchurch, New Zealand.
   [Purdon, S.] Univ Alberta, Dept Psychiat, Edmonton, AB, Canada.
   [Torres, I. J.; Yatham, L. N.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada.
   [Young, A. H.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychol Med, London, England.
RP Miskowiak, KW (corresponding author), Rigshosp, Neurocognit & Emot Affect Disorder NEAD Grp, Copenhagen Affect Disorder Res Ctr, Psychiat Ctr Copenhagen,Copenhagen Univ Hosp, Copenhagen, Denmark.; Miskowiak, KW (corresponding author), Univ Copenhagen, Dept Psychol, Copenhagen, Denmark.
EM Kamilla.miskowiak@regionh.dk
RI Jaramillo, Carlos Lopez/X-5806-2019; Vieta, Eduard/Y-2919-2019;
   McIntyre, Roger/AAU-1000-2020; Lafer, Beny/C-1055-2012; Martinez-Aran,
   Anabel/U-8394-2017
OI Vieta, Eduard/0000-0002-0548-0053; McIntyre, Roger/0000-0003-4733-2523;
   Lafer, Beny/0000-0002-6132-9999; Miskowiak, Kamilla/0000-0003-2572-1384;
   Young, Allan/0000-0003-2291-6952; Bonnin, Caterina del
   Mar/0000-0002-1197-1596; Martinez-Aran, Anabel/0000-0002-0623-6263
FU LundbeckLundbeck Corporation; AllerganAllergan; OtsukaOtsuka
   Pharmaceutical; PfizerPfizer; AstraZenecaAstraZeneca; Bristol-Myers
   Siquibb; Brain and Behaviour Foundation; Spanish Ministry of Economy and
   Competitiveness; Instituto de Salud Carlos IIIInstituto de Salud Carlos
   III; TakedaTakeda Pharmaceutical Company Ltd; COLCIENCIASDepartamento
   Administrativo de Ciencia, Tecnologia e Innovacion Colciencias;
   Universidad de Antioquia-CODI; NIMHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Mental Health (NIMH); Sumitomo Dainippon; Alkermes; Bristol
   Myers SquibbBristol-Myers Squibb; CANMAT; CIHRCanadian Institutes of
   Health Research (CIHR); Dainippon Sumitomo PharmaDainippon Sumitomo
   Pharma Co., Ltd.; JanssenJohnson & Johnson USAJanssen Biotech Inc;
   Sunovion; Teva; AB-Biotics; Alexza; Almirall; Angelini; Bristol-Myers
   SquibbBristol-Myers Squibb; Cephalon; Eli LillyEli Lilly; Ferrer;
   ForestResearch Institute; Gedeon Richter;
   GlaxoSmith-KlineGlaxoSmithKline; Janssen-CilagJohnson & Johnson
   USAJanssen Biotech Inc; Jazz; Johnson JohnsonJohnson & Johnson USA;
   MerckMerck & Company; NovartisNovartis; Organon; Pierre-Fabre; Qualigen;
   RocheRoche Holding; Sanofi-AventisSanofi-Aventis; Schering; Plough;
   ServierServier; Shire; Solvay; CIBERSAM; Seventh European Framework
   Programme (ENBREC)European Union (EU); Stanley Medical Research
   Institute; United Biosource Cooperation; WyethWyeth
FX KWM reports having received consultancy fees from Lundbeck and Allergan.
   KEB has served on advisory boards for Sunovion, Sumitomo Dainippon,
   Takeda-Lundbeck, and Neuralstem. AMA has received funding for research
   projects and/or honoraria as a consultant or speaker for the following
   companies and institutions: Otsuka, Pfizer, AstraZeneca, Bristol-Myers
   Siquibb, Lundbeck, Brain and Behaviour Foundation (NARSAD Independent
   Investigator), the Spanish Ministry of Economy and Competitiveness and
   Instituto de Salud Carlos III. CRB has been a consultant or advisor for
   BoehringerIngelheim, Lundbeck, Otsuka, and Takeda and has received grant
   money from Pfizer and Takeda. RSM is a consultant for and/or has
   received honoraria for speaking from Sunovian, Johnson & Johnson,
   Otsuka, Lundbeck, Pfizer, Allergan, BMS, Shire, and Purdue. CLJ has
   received grants from COLCIENCIAS, Universidad de Antioquia-CODI, NIMH.
   He has served as a consultant, advisor or Continuing Medical Education
   (CME) speaker for the following companies: AstraZeneca, Eli Lilly,
   Glaxo-SmithKline, Janssen, Lundbeck and Pfizer. AS has been a consultant
   for or received honoraria from Allergan, BMS, Lundbeck, Otsuka, and
   Sunovion. IJT has received consultant fees from Lundbeck and Sumitomo
   Dainippon. RJP uses software for research at no cost from Scientific
   Brain Training Pro. TS has received honoraria for serving on advisory
   boards, for consultations, and/or for serving as a speaker from
   Dainippon Sumitomo Pharmaceutical, Meiji Seika Pharma, Novartis, Otsuka
   Pharmaceutical and Takeda. LNY has been on speaker/advisory boards for,
   or has received research grants from, Alkermes, Allergan, AstraZeneca,
   Bristol Myers Squibb, CANMAT, CIHR, Dainippon Sumitomo Pharma, Janssen,
   Lundbeck, Otsuka, Sunovion, and Teva. AHY is employed by King's College
   London, and is an honorary consultant for SLaM (NHS UK). He has given
   paid lectures and is on advisory boards for all major pharmaceutical
   companies producing drugs used in affective and related disorders. He
   has no shareholdings in pharmaceutical companies. He has carried out
   investigator-initiated studies for AZ, Eli Lilly and Lundbeck. LVK has
   within the preceding 3 years been a consultant for Lundbeck, AstraZenica
   and Sunovion. EV has received grants, CME-related honoraria, or
   consulting fees from AB-Biotics, Alexza, Almirall, Angelini,
   AstraZeneca, Bristol-Myers Squibb, Cephalon, Eli Lilly, Ferrer,
   ForestResearch Institute, Gedeon Richter, GlaxoSmith-Kline, Janssen,
   Janssen-Cilag, Jazz, Johnson & Johnson, Lundbeck, Merck, Novartis,
   Organon, Otsuka, Pfizer, Pierre-Fabre, Qualigen, Roche, Sanofi-Aventis,
   Schering, Plough, Servier, Shire, Solvay, Takeda, Teva, CIBERSAM, the
   Seventh European Framework Programme (ENBREC), the Stanley Medical
   Research Institute, United Biosource Cooperation, and Wyeth. All other
   authors report no biomedical financial interests or potential conflicts
   of interest.
CR Bonnin CM, 2016, BRIT J PSYCHIAT, V208, P87, DOI 10.1192/bjp.bp.114.162123
   Bonnin CM, 2016, PSYCHOL MED, V46, P291, DOI 10.1017/S0033291715001713
   Bonnin CM, 2010, J AFFECT DISORDERS, V121, P156, DOI 10.1016/j.jad.2009.05.014
   Bourne C, 2013, ACTA PSYCHIAT SCAND, V128, P149, DOI 10.1111/acps.12133
   Bowie CR, 2017, PSYCHIATR REHABIL J, V40, P53, DOI 10.1037/prj0000189
   Breitborde Nicholas Jk, 2014, BMC Psychol, V2, P41, DOI 10.1186/s40359-014-0041-4
   Burdick KE, 2014, PSYCHOL MED, V44, P3083, DOI 10.1017/S0033291714000439
   Burdick KE, 2005, PSYCHIAT RES, V136, P43, DOI 10.1016/j.psychres.2004.12.009
   Chen MH, 2015, J AM MED DIR ASSOC, V16, P504, DOI 10.1016/j.jamda.2015.01.084
   da Silva J, 2013, BRIT J PSYCHIAT, V202, P177, DOI 10.1192/bjp.bp.111.101931
   Decker L, 2017, EDORIUM J DISABILITY, V3, P69
   Deckersbach T, 2010, CNS NEUROSCI THER, V16, P298, DOI 10.1111/j.1755-5949.2009.00110.x
   Demant KM, 2015, PSYCHIAT RES, V229, P565, DOI 10.1016/j.psychres.2015.05.022
   Demant KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127955
   Depp CA, 2012, BIPOLAR DISORD, V14, P217, DOI 10.1111/j.1399-5618.2012.01011.x
   Duff K, 2012, ARCH CLIN NEUROPSYCH, V27, P248, DOI 10.1093/arclin/acr120
   Forcada I, 2015, EUR NEUROPSYCHOPHARM, V25, P214, DOI 10.1016/j.euroneuro.2014.07.018
   Glahn DC, 2006, J AFFECT DISORDERS, V92, P309, DOI 10.1016/j.jad.2006.01.025
   Gomes BC, 2017, TRIALS, V18, DOI 10.1186/s13063-017-1896-5
   Grande I, 2017, J AFFECT DISORDERS, V208, P621, DOI 10.1016/j.jad.2016.10.012
   Grande I, 2016, LANCET, V388, P869
   Gualtieri CT, 2008, PROG NEURO-PSYCHOPH, V32, P962, DOI 10.1016/j.pnpbp.2007.12.030
   Harada CN, 2013, CLIN GERIATR MED, V29, P737, DOI 10.1016/j.cger.2013.07.002
   Huxley N, 2007, BIPOLAR DISORD, V9, P183, DOI 10.1111/j.1399-5618.2007.00430.x
   Jensen JH, 2016, J AFFECT DISORDERS, V205, P378, DOI 10.1016/j.jad.2016.08.018
   Jensen JH, 2015, J AFFECT DISORDERS, V187, P10, DOI 10.1016/j.jad.2015.07.039
   Kaser M, 2017, BIOL PSYCHIAT-COGN N, V2, P115, DOI 10.1016/j.bpsc.2016.11.009
   Kogan JN, 2004, BIPOLAR DISORD, V6, P460, DOI 10.1111/j.1399-5618.2004.00158.x
   Kupfer DJ, 2002, J CLIN PSYCHIAT, V63, P120, DOI 10.4088/JCP.v63n0206
   KUYKEN W, 1995, SOC SCI MED, V41, P1403, DOI 10.1016/0277-9536(95)00112-k
   Lewandowski KE, 2017, J CLIN PSYCHIAT, V78, pE1242, DOI 10.4088/JCP.17m11476
   Lewandowski KE, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1275-7
   Li YL, 2016, ARCH CLIN NEUROPSYCH, V31, P365, DOI 10.1093/arclin/acw017
   Mackala SA, 2014, J AFFECT DISORDERS, V168, P119, DOI 10.1016/j.jad.2014.06.045
   Mago R, 2014, HARVARD REV PSYCHIAT, V22, P363, DOI 10.1097/HRP.0000000000000017
   Malhi GS, 2016, BIPOLAR DISORD, V18, P102, DOI 10.1111/bdi.12375
   Martinez-Aran A, 2007, BIPOLAR DISORD, V9, P103, DOI 10.1111/j.1399-5618.2007.00327.x
   Marwaha S, 2013, ACTA PSYCHIAT SCAND, V128, P179, DOI 10.1111/acps.12087
   Meusel LAC, 2013, PSYCHIAT RES-NEUROIM, V214, P142, DOI 10.1016/j.pscychresns.2013.06.007
   Miskowiak KW, 2017, BIPOLAR DISORD, V19, P614, DOI 10.1111/bdi.12534
   Miskowiak KW, 2016, EUR NEUROPSYCHOPHARM, V26, P1845, DOI 10.1016/j.euroneuro.2016.09.641
   Miskowiak KW, 2016, ACTA PSYCHIAT SCAND, V134, P511, DOI 10.1111/acps.12649
   Miskowiak KW, 2014, J CLIN PSYCHIAT, V75, P1347, DOI 10.4088/JCP.13m08839
   Miskowiak KW, 2014, NEUROPSYCHOPHARMACOL, V39, P1399, DOI 10.1038/npp.2013.335
   Naismith SL, 2010, J AFFECT DISORDERS, V121, P258, DOI 10.1016/j.jad.2009.06.028
   Ott C, 2017, TRIALS IN PRESS
   Ott CV, 2016, EUR NEUROPSYCHOPHARM, V26, P1264, DOI 10.1016/j.euroneuro.2016.05.009
   Preiss M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00108
   Purdon S, 2005, SCREEN COGNITIVE IMP
   Rej S, 2018, BIPOLAR DISORD, V20, P359, DOI 10.1111/bdi.12566
   Roebuck-Spencer TM, 2017, ARCH CLIN NEUROPSYCH, V32, P491, DOI 10.1093/arclin/acx021
   Rojo E, 2010, SCHIZOPHR RES, V116, P243, DOI 10.1016/j.schres.2009.08.005
   Rosa AR, 2013, J AFFECT DISORDERS, V150, P29, DOI 10.1016/j.jad.2013.02.022
   Smith J, 2017, MOL PSYCHIATR, V2017, P1
   Sole B, 2016, BIPOLAR DISORD, V18, P288, DOI 10.1111/bdi.12385
   Stern RA, 1996, ARCH NEUROL-CHICAGO, V53, P148, DOI 10.1001/archneur.1996.00550020052015
   Strawbridge R, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1472-4
   Svendsen AM, 2012, NORD J PSYCHIAT, V66, P248, DOI 10.3109/08039488.2011.626870
   Torrent C, 2013, AM J PSYCHIAT, V170, P852, DOI 10.1176/appi.ajp.2012.12070971
   Torrent Carla, 2012, J Clin Psychiatry, V73, pe899, DOI 10.4088/JCP.11m07471
   Toyoshima K, 2017, PSYCHIAT RES, V254, P85, DOI 10.1016/j.psychres.2017.04.043
   Tse S, 2014, BIPOLAR DISORD, V16, P217, DOI 10.1111/bdi.12148
   Van Camp LSC, 2016, COGN NEUROPSYCHIATRY, V21, P130, DOI 10.1080/13546805.2015.1137214
   Veeh J, 2017, INT J BIPOLAR DISORD, V5, DOI 10.1186/s40345-017-0079-3
   Vieta E, 2016, WORLD PSYCHIATRY, V15, P288, DOI 10.1002/wps.20351
   Watson S, 2012, BIOL PSYCHIAT, V72, P943, DOI 10.1016/j.biopsych.2012.05.029
   Xiao L, 2015, J AFFECT DISORDERS, V173, P226, DOI 10.1016/j.jad.2014.11.011
   Yatham LN, 2017, LANCET PSYCHIAT, V4, P208, DOI 10.1016/S2215-0366(17)30046-9
   Yatham LN, 2010, BIPOLAR DISORD, V12, P351, DOI 10.1111/j.1399-5618.2010.00830.x
   Yen CF, 2008, COMPR PSYCHIAT, V49, P335, DOI 10.1016/j.comppsych.2007.12.006
   Young AH, 2004, NEUROPSYCHOPHARMACOL, V29, P1538, DOI 10.1038/sj.npp.1300471
   Zhang MWB, 2016, INT J NEUROPSYCHOPH, V19, P134
NR 72
TC 44
Z9 44
U1 3
U2 22
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1398-5647
EI 1399-5618
J9 BIPOLAR DISORD
JI Bipolar Disord.
PD MAY
PY 2018
VL 20
IS 3
BP 184
EP 194
DI 10.1111/bdi.12595
PG 11
WC Clinical Neurology; Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA GF0LE
UT WOS:000431621200003
PM 29345040
DA 2020-12-08
ER

PT J
AU Dandekar, MP
   Fenoy, AJ
   Carvalho, AF
   Soares, JC
   Quevedo, J
AF Dandekar, M. P.
   Fenoy, A. J.
   Carvalho, A. F.
   Soares, J. C.
   Quevedo, J.
TI Deep brain stimulation for treatment-resistant depression: an
   integrative review of preclinical and clinical findings and
   translational implications
SO MOLECULAR PSYCHIATRY
LA English
DT Article
ID MEDIAL FOREBRAIN-BUNDLE; OBSESSIVE-COMPULSIVE DISORDER; VENTRAL
   TEGMENTAL AREA; SUBCALLOSAL CINGULATE GYRUS; INFERIOR THALAMIC PEDUNCLE;
   HIGH-FREQUENCY STIMULATION; PREFRONTAL CORTEX STIMULATION; SUBGENUAL
   ANTERIOR CINGULATE; VAGUS NERVE-STIMULATION; MAJOR DEPRESSION
AB Although deep brain stimulation (DBS) is an established treatment choice for Parkinson's disease (PD), essential tremor and movement disorders, its effectiveness for the management of treatment-resistant depression (TRD) remains unclear. Herein, we conducted an integrative review on major neuroanatomical targets of DBS pursued for the treatment of intractable TRD. The aim of this review article is to provide a critical discussion of possible underlying mechanisms for DBS-generated antidepressant effects identified in preclinical studies and clinical trials, and to determine which brain target(s) elicited the most promising outcomes considering acute and maintenance treatment of TRD. Major electronic databases were searched to identify preclinical and clinical studies that have investigated the effects of DBS on depression-related outcomes. Overall, 92 references met inclusion criteria, and have evaluated six unique DBS targets namely the subcallosal cingulate gyrus (SCG), nucleus accumbens (NAc), ventral capsule/ventral striatum or anterior limb of internal capsule (ALIC), medial forebrain bundle (MFB), lateral habenula (LHb) and inferior thalamic peduncle for the treatment of unrelenting TRD. Electrical stimulation of these pertinent brain regions displayed differential effects on mood transition in patients with TRD. In addition, 47 unique references provided preclinical evidence for putative neurobiological mechanisms underlying antidepressant effects of DBS applied to the ventromedial prefrontal cortex, NAc, MFB, LHb and subthalamic nucleus. Preclinical studies suggest that stimulation parameters and neuroanatomical locations could influence DBS-related antidepressant effects, and also pointed that modulatory effects on monoamine neurotransmitters in target regions or interconnected brain networks following DBS could have a role in the antidepressant effects of DBS. Among several neuromodulatory targets that have been investigated, DBS in the neuroanatomical framework of the SCG, ALIC and MFB yielded more consistent antidepressant response rates in samples with TRD. Nevertheless, more well-designed randomized double-blind, controlled trials are warranted to further assess the efficacy, safety and tolerability of these more promising DBS targets for the management of TRD as therapeutic effects have been inconsistent across some controlled studies.
C1 [Dandekar, M. P.; Quevedo, J.] Univ Texas Hlth Sci Ctr Houston UTHlth, McGovern Med Sch, Dept Psychiat & Behav Sci, Translat Psychiat Program, 1941 East Rd,Suite 3216, Houston, TX 77054 USA.
   [Fenoy, A. J.] Univ Texas Hlth Sci Ctr Houston UTHlth, McGovern Med Sch, Dept Neurosurg, Houston, TX USA.
   [Carvalho, A. F.] Univ Fed Ceara, Fac Med, Dept Clin Med, Fortaleza, Ceara, Brazil.
   [Carvalho, A. F.] Univ Fed Ceara, Fac Med, Translat Psychiat Res Grp, Fortaleza, Ceara, Brazil.
   [Soares, J. C.; Quevedo, J.] Univ Texas Hlth Sci Ctr Houston, Ctr Excellence Mood Disorders, McGovern Med Sch, Dept Psychiat & Behav Sci, Houston, TX 77030 USA.
   [Quevedo, J.] Univ Texas Houston, Grad Sch Biomed Sci, Neurosci Grad Program, Houston, TX USA.
   [Quevedo, J.] Univ Southern Santa Catarina, Hlth Sci Unit, Grad Program Hlth Sci, Lab Neurosci, Criciuma, Brazil.
RP Quevedo, J (corresponding author), Univ Texas Hlth Sci Ctr Houston UTHlth, McGovern Med Sch, Dept Psychiat & Behav Sci, Translat Psychiat Program, 1941 East Rd,Suite 3216, Houston, TX 77054 USA.
EM Joao.L.DeQuevedo@uth.tmc.edu
RI de Quevedo, Joao Luciano/N-1407-2019; de Quevedo, Joao
   Luciano/E-5491-2013; Dandekar, Manoj/H-7767-2019
OI de Quevedo, Joao Luciano/0000-0003-3114-6611; de Quevedo, Joao
   Luciano/0000-0003-3114-6611; Soares, Jair C./0000-0002-5466-5628
FU Department of Psychiatry and Behavioral Sciences, McGovern Medical
   School, The University of Texas Health Science Center at Houston
   (UTHealth); CNPqNational Council for Scientific and Technological
   Development (CNPq); FAPESC; Instituto Cerebro e Mente; UNESC; Pat
   Rutherford, Jr Endowed Chair in Psychiatry; John S Dunn Foundation from
   United States; NIMHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Mental Health (NIMH) [R01MH085667-01A1]; Stanley Medical Research
   Institute; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA; NATIONAL INSTITUTE OF
   MENTAL HEALTHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Mental Health
   (NIMH) [R01MH085667] Funding Source: NIH RePORTER
FX The Translational Psychiatry Program (USA) is funded by the Department
   of Psychiatry and Behavioral Sciences, McGovern Medical School, The
   University of Texas Health Science Center at Houston (UTHealth).
   Laboratory of Neurosciences (Brazil) is one of the centers of the
   National Institute for Molecular Medicine (INCT-MM) and one of the
   members of the Center of Excellence in Applied Neurosciences of Santa
   Catarina (NENASC). Its research is supported by grants from CNPq (JQ),
   FAPESC (JQ); Instituto Cerebro e Mente (JQ) and UNESC (JQ). JQ is a 1A
   CNPq Research Fellow. Dr Jair C Soares has received grants/research
   supports from the Pat Rutherford, Jr Endowed Chair in Psychiatry (JCS),
   John S Dunn Foundation from United States (JCS) and NIMH
   (R01MH085667-01A1; JCS), Stanley Medical Research Institute, and NIH.
CR Accolla EA, 2016, J AFFECT DISORDERS, V194, P33, DOI 10.1016/j.jad.2016.01.022
   Alonso P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133591
   Anderson RJ, 2012, NEUROSCI BIOBEHAV R, V36, P1920, DOI 10.1016/j.neubiorev.2012.06.001
   Aono M, 2014, J CLIN NEUROSCI, V21, P1595, DOI 10.1016/j.jocn.2013.12.020
   Aouizerate B, 2004, J NEUROSURG, V101, P682, DOI 10.3171/jns.2004.101.4.0682
   Appleby BS, 2007, MOVEMENT DISORD, V22, P1722, DOI 10.1002/mds.21551
   Bambico FR, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.166
   Bejjani BP, 2002, NEUROLOGY, V59, P1425, DOI 10.1212/01.WNL.0000031428.31861.23
   BENABID AL, 1987, APPL NEUROPHYSIOL, V50, P344
   Benabid AL, 1998, MOVEMENT DISORD, V13, P119
   Bergfeld IO, 2017, PSYCHOL MED, V47, P1647, DOI 10.1017/S0033291717000113
   Bergfeld IO, 2016, JAMA PSYCHIAT, V73, P456, DOI 10.1001/jamapsychiatry.2016.0152
   Berlim MT, 2007, EUR NEUROPSYCHOPHARM, V17, P696, DOI 10.1016/j.euroneuro.2007.03.009
   Berlim MT, 2014, J AFFECT DISORDERS, V159, P31, DOI 10.1016/j.jad.2014.02.016
   Bewernick BH, 2017, BRAIN STIMUL, V10, P664, DOI 10.1016/j.brs.2017.01.581
   Bewernick BH, 2012, NEUROPSYCHOPHARMACOL, V37, P1975, DOI 10.1038/npp.2012.44
   Bewernick BH, 2010, BIOL PSYCHIAT, V67, P110, DOI 10.1016/j.biopsych.2009.09.013
   Bezchlibnyk YB, 2017, BRAIN STIMUL, V10, P315, DOI 10.1016/j.brs.2016.11.013
   Blomstedt P, 2017, CLIN CASE REP, V5, P679, DOI 10.1002/ccr3.856
   Blumberger DM, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0368-1
   Bogod NM, 2014, J NEUROPSYCH CLIN N, V26, P126, DOI 10.1176/appi.neuropsych.12110287
   Bregman T, 2018, BRAIN STIMUL, V11, P423, DOI 10.1016/j.brs.2017.11.008
   Bregman T, 2015, BRAIN STIMUL, V8, P708, DOI 10.1016/j.brs.2015.02.007
   Broadway JM, 2012, NEUROPSYCHOPHARMACOL, V37, P1764, DOI 10.1038/npp.2012.23
   Bromet E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-90
   Bruchim-Samuel M, 2016, EXP NEUROL, V283, P255, DOI 10.1016/j.expneurol.2016.05.016
   Campbell MC, 2012, J NEUROPSYCH CLIN N, V24, P28, DOI 10.1176/appi.neuropsych.11030060
   Carlson PJ, 2013, BIOL PSYCHIAT, V73, P1213, DOI 10.1016/j.biopsych.2013.02.008
   Carvalho AF, 2016, PSYCHOTHER PSYCHOSOM, V85, P270, DOI 10.1159/000447034
   Carvalho AF, 2014, PSYCHOTHER PSYCHOSOM, V83, P70, DOI 10.1159/000357500
   Chakravarty MM, 2016, NEUROIMAGE, V125, P422, DOI 10.1016/j.neuroimage.2015.10.049
   Cho YST, 2013, NEUROIMAGE, V66, P508, DOI 10.1016/j.neuroimage.2012.10.013
   CHRISTOPH GR, 1986, J NEUROSCI, V6, P613
   Coenen VA, 2012, J NEUROPSYCH CLIN N, V24, P223, DOI 10.1176/appi.neuropsych.11080180
   Coenen VA, 2011, NEUROSCI BIOBEHAV R, V35, P1971, DOI 10.1016/j.neubiorev.2010.12.009
   Coenen VA, 2009, NEUROSURGERY, V64, P1106, DOI 10.1227/01.NEU.0000345631.54446.06
   Coenen VA, 2012, INT REV NEUROBIOL, V107, P207, DOI 10.1016/B978-0-12-404706-8.00011-5
   Creed MC, 2013, BRAIN STIMUL, V6, P506, DOI 10.1016/j.brs.2012.09.012
   Crowell AL, 2015, FRONT INTEGR NEUROSC, V9, DOI [10.3389/fnint.2010.00041, 10.3389/fnint.2015.00041]
   Czernecki V, 2005, J NEUROL NEUROSUR PS, V76, P775, DOI 10.1136/jnnp.2003.033258
   Dandekar MP, 2017, J AFFECT DISORDERS, V217, P80, DOI 10.1016/j.jad.2017.03.074
   Dougherty DD, 2015, BIOL PSYCHIAT, V78, P240, DOI 10.1016/j.biopsych.2014.11.023
   Dournes C, 2013, PROG NEURO-PSYCHOPH, V40, P213, DOI 10.1016/j.pnpbp.2012.07.019
   Drevets WC, 2008, CNS SPECTRUMS, V13, P663, DOI 10.1017/S1092852900013754
   Drevets WC, 2000, PROG BRAIN RES, V126, P413
   Dumitriu D, 2008, MT SINAI J MED, V75, P263, DOI 10.1002/msj.20044
   Edemann-Callesen H, 2015, BRAIN STIMUL, V8, P714, DOI 10.1016/j.brs.2015.02.009
   Eggers AE, 2014, MED HYPOTHESES, V83, P62, DOI 10.1016/j.mehy.2014.04.007
   Eisenstein SA, 2014, BRAIN STIMUL, V7, P701, DOI 10.1016/j.brs.2014.06.002
   Eitan R, 2018, J PSYCHIATR RES, V96, P124, DOI 10.1016/j.jpsychires.2017.09.026
   Epstein J, 2006, AM J PSYCHIAT, V163, P1784, DOI 10.1176/appi.ajp.163.10.1784
   Etievant A, 2015, EBIOMEDICINE, V2, P898, DOI 10.1016/j.ebiom.2015.06.023
   Etievant A, 2016, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00509
   Faggiani E, 2015, NEUROBIOL DIS, V82, P342, DOI 10.1016/j.nbd.2015.07.010
   Falowski SM, 2011, NEUROSURGERY, V69, P1281, DOI 10.1227/NEU.0b013e3182237346
   Fenoy AJ, 2016, J AFFECT DISORDERS, V203, P143, DOI 10.1016/j.jad.2016.05.064
   Ferenczi EA, 2016, SCIENCE, V351, DOI 10.1126/science.aac9698
   Fernandes BS, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0849-x
   Forray MI, 2004, BRAIN RES REV, V47, P145, DOI 10.1016/j.brainresrev.2004.07.011
   Friedman A, 2011, NEUROPHARMACOLOGY, V60, P381, DOI 10.1016/j.neuropharm.2010.10.006
   Funayama M, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0717-x
   Funkiewiez A, 2004, J NEUROL NEUROSUR PS, V75, P834, DOI 10.1136/jnnp.2002.009803
   Furlanetti LL, 2016, BEHAV BRAIN RES, V299, P132, DOI 10.1016/j.bbr.2015.11.036
   Furlanetti LL, 2015, EXP BRAIN RES, V233, P3073, DOI 10.1007/s00221-015-4375-9
   Furlanetti LL, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/256196
   Galvez JF, 2015, PROG NEURO-PSYCHOPH, V58, P59, DOI 10.1016/j.pnpbp.2014.12.003
   Geisler S, 2008, CNS SPECTRUMS, V13, P484, DOI 10.1017/S1092852900016710
   Gersner R, 2010, BIOL PSYCHIAT, V67, P125, DOI 10.1016/j.biopsych.2009.09.015
   Grubert C, 2011, WORLD J BIOL PSYCHIA, V12, P516, DOI 10.3109/15622975.2011.583940
   Guinjoan SM, 2010, J NEUROPSYCH CLIN N, V22, P265, DOI 10.1176/appi.neuropsych.22.3.265
   Hamani C, 2016, BIOL PSYCHIAT, V80, pE45, DOI 10.1016/j.biopsych.2016.01.007
   Hamani C, 2014, NEUROBIOL DIS, V71, P205, DOI 10.1016/j.nbd.2014.08.007
   Hamani C, 2012, AM J PSYCHIAT, V169, P1320, DOI 10.1176/appi.ajp.2012.12060754
   Hamani C, 2012, BIOL PSYCHIAT, V71, P30, DOI 10.1016/j.biopsych.2011.08.025
   Hamani C, 2011, BIOL PSYCHIAT, V69, P301, DOI 10.1016/j.biopsych.2010.09.034
   Hamani C, 2010, EUR J NEUROSCI, V32, P1109, DOI 10.1111/j.1460-9568.2010.07414.x
   Hamani C, 2010, J PSYCHIATR RES, V44, P683, DOI 10.1016/j.jpsychires.2009.12.010
   Hamani C, 2010, BIOL PSYCHIAT, V67, P117, DOI 10.1016/j.biopsych.2009.08.025
   Hamani C, 2009, J NEUROSURG, V111, P1209, DOI 10.3171/2008.10.JNS08763
   Hilimire MR, 2015, BRAIN STIMUL, V8, P185, DOI 10.1016/j.brs.2014.11.010
   Holtzheimer PE, 2017, LANCET PSYCHIAT, V4, P839, DOI 10.1016/S2215-0366(17)30371-1
   Holtzheimer PE, 2012, ARCH GEN PSYCHIAT, V69, P150, DOI 10.1001/archgenpsychiatry.2011.1456
   Holtzheimer PE, 2011, ANNU REV NEUROSCI, V34, P289, DOI 10.1146/annurev-neuro-061010-113638
   Holtzheimer PE, 2010, AM J PSYCHIAT, V167, P1437, DOI 10.1176/appi.ajp.2010.10010141
   Hoyer C, 2013, MED HYPOTHESES, V81, P611, DOI 10.1016/j.mehy.2013.07.014
   Huguet G, 2017, CEREBELLUM, V16, P398, DOI 10.1007/s12311-016-0812-y
   Insel N, 2015, EXP NEUROL, V269, P1, DOI 10.1016/j.expneurol.2015.03.023
   Ji HF, 2007, J NEUROSCI, V27, P6923, DOI 10.1523/JNEUROSCI.0958-07.2007
   Jimenez F, 2007, ACTA NEUROCHIR SUPPL, V97, P393
   Jimenez F, 2005, NEUROSURGERY, V57, P585, DOI 10.1227/01.NEU.0000170434.44335.19
   Jimenez F, 2013, WORLD NEUROSURG, V80, DOI 10.1016/j.wneu.2012.07.010
   Jimenez-Sanchez L, 2016, NEUROPHARMACOLOGY, V108, P91, DOI 10.1016/j.neuropharm.2016.04.020
   Jimenez-Sanchez L, 2016, CEREB CORTEX, V26, P2778, DOI 10.1093/cercor/bhv133
   Johansen-Berg H, 2008, CEREB CORTEX, V18, P1374, DOI 10.1093/cercor/bhm167
   Kennedy SH, 2011, AM J PSYCHIAT, V168, P502, DOI 10.1176/appi.ajp.2010.10081187
   Kessler RC, 2013, ANNU REV PUBL HEALTH, V34, P119, DOI 10.1146/annurev-publhealth-031912-114409
   Kiening K, 2013, EMBO MOL MED, V5, P1151, DOI 10.1002/emmm.201302947
   Kim Y, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.84
   Kim Y, 2016, BEHAV BRAIN RES, V306, P170, DOI 10.1016/j.bbr.2016.02.039
   Knight EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056640
   Kopell BH, 2008, NEUROSCI BIOBEHAV R, V32, P408, DOI 10.1016/j.neubiorev.2007.07.004
   Kopell BH, 2011, NEUROSURGERY, V69, P1015, DOI 10.1227/NEU.0b013e318229cfcd
   Krishnan V, 2010, AM J PSYCHIAT, V167, P1305, DOI 10.1176/appi.ajp.2009.10030434
   Kubu CS, 2017, J NEUROL NEUROSUR PS, V88, P262, DOI 10.1136/jnnp-2016-313803
   Kuhn J, 2010, EXPERT REV NEUROTHER, V10, P1363, DOI [10.1586/ern.10.80, 10.1586/ERN.10.80]
   Lally N, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.105
   Laver B, 2014, J AFFECT DISORDERS, V161, P87, DOI 10.1016/j.jad.2014.03.007
   Laxton Adrian W, 2013, Handb Clin Neurol, V116, P307, DOI 10.1016/B978-0-444-53497-2.00025-5
   Li B, 2011, NATURE, V470, P535, DOI 10.1038/nature09742
   Lim LW, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.24
   Lim LW, 2015, BEHAV BRAIN RES, V279, P17, DOI 10.1016/j.bbr.2014.11.008
   Lozano AM, 2008, BIOL PSYCHIAT, V64, P461, DOI 10.1016/j.biopsych.2008.05.034
   Lozano AM, 2012, J NEUROSURG, V116, P315, DOI 10.3171/2011.10.JNS102122
   Lujan JL, 2013, BRAIN STIMUL, V6, P737, DOI 10.1016/j.brs.2013.03.008
   Mahgoub NA, 2009, J NEUROPSYCH CLIN N, V21, P468, DOI 10.1176/appi.neuropsych.21.4.468
   Malone Donald A Jr, 2010, Cleve Clin J Med, V77 Suppl 3, pS77, DOI 10.3949/ccjm.77.s3.14
   Malone DA, 2009, BIOL PSYCHIAT, V65, P267, DOI 10.1016/j.biopsych.2008.08.029
   Martin-Blanco A, 2015, J AFFECT DISORDERS, V173, P159, DOI 10.1016/j.jad.2014.10.035
   Mavridis IN, 2015, NEUROSCI BIOBEHAV R, V56, P345, DOI 10.1016/j.neubiorev.2015.03.015
   Mayberg HS, 2016, JAMA PSYCHIAT, V73, P439, DOI 10.1001/jamapsychiatry.2016.0173
   Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014
   Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471
   Mayberg HS, 1999, AM J PSYCHIAT, V156, P675
   McCracken CB, 2009, J NEUROSCI, V29, P5354, DOI 10.1523/JNEUROSCI.0131-09.2009
   McInerney SJ, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00074
   McIntyre CC, 2004, CLIN NEUROPHYSIOL, V115, P1239, DOI 10.1016/j.clinph.2003.12.024
   McIntyre RS, 2014, J AFFECT DISORDERS, V156, P1, DOI 10.1016/j.jad.2013.10.043
   McNeely HE, 2008, J NERV MENT DIS, V196, P405, DOI 10.1097/NMD.0b013e3181710927
   Meng HM, 2011, BRAIN RES, V1422, P32, DOI 10.1016/j.brainres.2011.08.041
   Merkl A, 2018, J AFFECT DISORDERS, V227, P521, DOI 10.1016/j.jad.2017.11.024
   Merkl A, 2013, EXP NEUROL, V249, P160, DOI 10.1016/j.expneurol.2013.08.017
   Millet B, 2014, EUR NEUROPSYCHOPHARM, V24, P1229, DOI 10.1016/j.euroneuro.2014.05.006
   Mohr P, 2011, NEUROPSYCHOBIOLOGY, V64, P170, DOI 10.1159/000325225
   Moreines JL, 2014, DEPRESS ANXIETY, V31, P690, DOI 10.1002/da.22263
   Morishita T, 2014, NEUROTHERAPEUTICS, V11, P475, DOI 10.1007/s13311-014-0282-1
   Moshe H, 2016, BRAIN STIMUL, V9, P243, DOI 10.1016/j.brs.2015.10.009
   Mrazek DA, 2014, PSYCHIAT SERV, V65, P977, DOI 10.1176/appi.ps.201300059
   Narang P, 2016, SOUTH MED J, V109, P700, DOI 10.14423/SMJ.0000000000000554
   Neimat JS, 2008, AM J PSYCHIAT, V165, P687, DOI 10.1176/appi.ajp.2008.07081298
   Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018
   Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647
   Neumann WJ, 2014, MOL PSYCHIATR, V19, P1186, DOI 10.1038/mp.2014.2
   Papadimitropoulou K, 2017, CURR MED RES OPIN, V33, P701, DOI 10.1080/03007995.2016.1277201
   Papakostas GI, 2015, MOL PSYCHIATR, V20, P1142, DOI 10.1038/mp.2015.92
   Parthoens J, 2014, MOL IMAGING BIOL, V16, P838, DOI 10.1007/s11307-014-0757-9
   Perez-Caballero L, 2014, MOL PSYCHIATR, V19, P607, DOI 10.1038/mp.2013.63
   Puigdemont D, 2015, J PSYCHIATR NEUROSCI, V40, P224, DOI 10.1503/jpn.130295
   Puigdemont D, 2012, INT J NEUROPSYCHOPH, V15, P121, DOI 10.1017/S1461145711001088
   Puigdemont Dolors, 2009, Biol Psychiatry, V66, pe11, DOI 10.1016/j.biopsych.2009.03.018
   Quraan MA, 2014, NEUROPSYCHOPHARMACOL, V39, P1270, DOI 10.1038/npp.2013.330
   Ramasubbu R, 2013, J PSYCHIATR NEUROSCI, V38, P325, DOI 10.1503/jpn.120160
   Rauch SL, 2006, J NEUROSURG, V104, P558, DOI 10.3171/jns.2006.104.4.558
   Raymaekers S, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.66
   Rea E, 2014, BRAIN STIMUL, V7, P21, DOI 10.1016/j.brs.2013.09.002
   Richardson RM, 2015, NEUROSURGERY, V77, pN23, DOI 10.1227/01.neu.0000467300.48881.7a
   Richieri R, 2016, BRAIN STIMUL, V9, P636, DOI 10.1016/j.brs.2016.05.001
   Riva-Posse P., 2017, MOL PSYCHIA IN PRESS
   Riva-Posse P, 2014, BIOL PSYCHIAT, V76, P963, DOI 10.1016/j.biopsych.2014.03.029
   Riva-Posse P, 2013, WORLD NEUROSURG, V80, DOI 10.1016/j.wneu.2012.11.074
   Rizvi SJ, 2011, INT REV PSYCHIATR, V23, P424, DOI 10.3109/09540261.2011.630993
   Rosenblat JD, 2015, CURR NEUROPHARMACOL, V13, P636, DOI 10.2174/1570159X13666150630175044
   Rummel J, 2016, J PSYCHIATR RES, V81, P36, DOI 10.1016/j.jpsychires.2016.06.016
   Rush AJ, 2006, NEW ENGL J MED, V354, P1231, DOI 10.1056/NEJMoa052963
   Sako W, 2014, J NEUROL NEUROSUR PS, V85, P982, DOI 10.1136/jnnp-2013-306090
   Saleh C, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-015-0565-1
   Sanacora G, 2017, JAMA PSYCHIAT, V74, P399, DOI 10.1001/jamapsychiatry.2017.0080
   Sartorius A, 2007, MED HYPOTHESES, V69, P1305, DOI 10.1016/j.mehy.2007.03.021
   Sartorius A, 2010, BIOL PSYCHIAT, V67, pE9, DOI 10.1016/j.biopsych.2009.08.027
   Schlaepfer TE, 2008, NEUROPSYCHOPHARMACOL, V33, P368, DOI 10.1038/sj.npp.1301408
   Schlaepfer TE, 2015, BIOL PSYCHIAT, V78, P218, DOI 10.1016/j.biopsych.2015.06.020
   Schlaepfer TE, 2014, NEUROPSYCHOPHARMACOL, V39, P1303, DOI 10.1038/npp.2014.28
   Schlaepfer TE, 2013, BIOL PSYCHIAT, V73, P1204, DOI 10.1016/j.biopsych.2013.01.034
   Schmuckermair C, 2013, NEUROPSYCHOPHARMACOL, V38, P1234, DOI 10.1038/npp.2013.21
   Schneider F, 2003, ARCH GEN PSYCHIAT, V60, P296, DOI 10.1001/archpsyc.60.3.296
   Serra-Blasco M, 2015, PSYCHIAT RES, V225, P341, DOI 10.1016/j.psychres.2014.11.076
   SESACK SR, 1992, J COMP NEUROL, V320, P145, DOI 10.1002/cne.903200202
   Sesia T, 2010, EXP NEUROL, V225, P302, DOI 10.1016/j.expneurol.2010.06.022
   Smith DF, 2014, ACTA NEUROPSYCHIATR, V26, P382, DOI 10.1017/neu.2014.22
   Souery D, 2006, J CLIN PSYCHIAT, V67, P16
   Srejic LR, 2015, EUR J NEUROSCI, V41, P1219, DOI 10.1111/ejn.12856
   Strong DR, 2012, J ADDICT MED, V6, P94, DOI 10.1097/ADM.0b013e318240acf5
   Sun YM, 2015, BRAIN STIMUL, V8, P1033, DOI 10.1016/j.brs.2015.06.010
   TABER MT, 1995, J NEUROCHEM, V65, P1407
   Taghva AS, 2013, WORLD NEUROSURG, V80, DOI 10.1016/j.wneu.2012.10.068
   Temel Y, 2007, NEUROSURGERY, V61, P346, DOI [10.1227/01.neu.0000303993.82149.98, 10.1227/01.NEU.0000280137.83797.6F]
   Torres CV, 2013, BIPOLAR DISORD, V15, P719, DOI 10.1111/bdi.12102
   Torres-Sanchez S, 2018, BRAIN STIMUL, V11, P222, DOI 10.1016/j.brs.2017.10.003
   Tye SJ, 2009, MAYO CLIN PROC, V84, P522, DOI 10.1016/S0025-6196(11)60584-3
   van den Munckhof Pepijn, 2013, Acta Neurochir Suppl, V117, P53, DOI 10.1007/978-3-7091-1482-7_9
   van der Plasse G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033455
   van Dijk A, 2012, J NEUROCHEM, V123, P897, DOI 10.1111/jnc.12054
   van Dijk A, 2011, J NEUROSCI METH, V202, P113, DOI 10.1016/j.jneumeth.2011.04.034
   Van Laere K, 2006, J NUCL MED, V47, P740
   Veerakumar A, 2014, BIOL PSYCHIAT, V76, P203, DOI 10.1016/j.biopsych.2013.12.009
   Velasco M, 2006, CLIN NEUROPHYSIOL, V117, P320, DOI 10.1016/j.clinph.2005.10.023
   Wallis JD, 2012, NAT NEUROSCI, V15, P13, DOI 10.1038/nn.2956
   Winter C, 2015, J PSYCHIATR RES, V68, P27, DOI 10.1016/j.jpsychires.2015.05.012
   You ZB, 2001, NEUROSCIENCE, V107, P629, DOI 10.1016/S0306-4522(01)00379-7
   Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856
   Zhou CJ, 2018, PROG NEURO-PSYCHOPH, V82, P224, DOI 10.1016/j.pnpbp.2017.11.012
NR 200
TC 43
Z9 44
U1 1
U2 24
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1359-4184
EI 1476-5578
J9 MOL PSYCHIATR
JI Mol. Psychiatr.
PD MAY
PY 2018
VL 23
IS 5
BP 1094
EP 1112
DI 10.1038/mp.2018.2
PG 19
WC Biochemistry & Molecular Biology; Neurosciences; Psychiatry
SC Biochemistry & Molecular Biology; Neurosciences & Neurology; Psychiatry
GA GF0IV
UT WOS:000431614600002
PM 29483673
DA 2020-12-08
ER

PT J
AU Bonnin, CM
   Yatham, LN
   Michalak, EE
   Martinez-Aran, A
   Dhanoa, T
   Torres, I
   Santos-Pascual, C
   Valls, E
   Carvalho, AF
   Sanchez-Moreno, J
   Valenti, M
   Grande, I
   Hidalgo-Mazzei, D
   Vieta, E
   Reinares, M
AF Bonnin, C. M.
   Yatham, L. N.
   Michalak, E. E.
   Martinez-Aran, A.
   Dhanoa, T.
   Torres, I.
   Santos-Pascual, C.
   Valls, E.
   Carvalho, A. F.
   Sanchez-Moreno, J.
   Valenti, M.
   Grande, I.
   Hidalgo-Mazzei, D.
   Vieta, E.
   Reinares, M.
TI Psychometric properties of the well-being index (WHO-5) spanish version
   in a sample of euthymic patients with bipolar disorder
SO JOURNAL OF AFFECTIVE DISORDERS
LA English
DT Article
DE Well-being; Subjective measures; Validation; Bipolar disorder; WHO-5
ID QUALITY-OF-LIFE; RATING-SCALE; FUNCTIONAL REMEDIATION; VALIDITY;
   POPULATION; DEPRESSION; HEALTH; RELIABILITY; SYMPTOMS; MANIA
AB Background: The concept of well-being which focuses on positive emotions has received increased research attention. However, a consensus definition of this term is lacking. The Well-Being Index scale (WHO-5) is a generic, self-report scale that contains five Likert-type items to evaluate psychological well-being. This construct may provide a relevant outcome in bipolar disorder (BD) research and care beyond the rating of mood symptoms. Thus, in the current study, the psychometric properties of the WHO-5 Spanish version were assessed in a sample of euthymic patients with BD.
   Methods: Patients with BD-I and BD-II and healthy controls completed the Well-Being Index (WHO-5) together with an assessment of depressive (Hamilton Depression Rating Scale-17; HAM-D) and manic symptoms (Young Mania Rating Scale; YMRS); and a measure of psychosocial functioning (Functioning Assessment Short Test; FAST). Internal consistency reliability was measured through Cronbach's alpha. Test-retest reliability was calculated comparing the WHO-5 total score at baseline and after 10 days of the first administration. To assess the structure of the scale, a principal component analysis (PCA) was carried out. Correlations between the WHO-5, HAM-D, YMRS and FAST were calculated. Finally, a t-test for independent samples was applied to compare the WHO-5 total score in the patient and control groups.
   Results: A total of 104 patients with BD and 40 healthy controls were included in this study. A Chronbach's alpha of 0.83 indicated acceptable internal consistency. A paired sample t-test revealed no significant differences between WHO-5 total score at baseline and at follow-up (tn = -0.72; df = 15; p = 0.48). The PCA provided a single factor solution that accounted for 59.74% of the variation in WHO-5. Test-retest reliability was high (r = 0.83; p< 0.001). Moderate negative correlations were observed between the WHO-5 total score, the FAST (r = -0.46.; p< 0.001) and the HAM-D (r = -0.68; p< 0.001), but not with the YMRS (r = -0.07; p = 0.42). Finally, significant differences were found when comparing the WHO-5 total score between patient and healthy controls (t = 5.1; df = 147; p< 0.001).
   Limitations: some limitations include the lack of a comparator scale to test for validity construct and the small sample size in the test-retest reliability
   Conclusions: The WHO-5 shows an acceptable reliability index and measures a unitary construct in a Spanish population of euthymic patients with BD.
C1 [Bonnin, C. M.; Martinez-Aran, A.; Santos-Pascual, C.; Valls, E.; Sanchez-Moreno, J.; Valenti, M.; Grande, I.; Hidalgo-Mazzei, D.; Vieta, E.; Reinares, M.] Univ Barcelona, CIBERSAM, Hosp Clin Barcelona, Dept Psychiat & Psychol,IDIBAPS, Barcelona, Catalonia, Spain.
   [Yatham, L. N.; Michalak, E. E.; Dhanoa, T.; Torres, I.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada.
   [Carvalho, A. F.] Univ Fed Ceara, Translat Psychiat Res Grp, Fac Med, Fortaleza, Ceara, Brazil.
RP Martinez-Aran, A; Vieta, E (corresponding author), Univ Barcelona, CIBERSAM, Hosp Clin Barcelona, Dept Psychiat & Psychol,IDIBAPS, Barcelona, Catalonia, Spain.
EM amartiar@clinic.cat; evieta@clinic.cat
RI Vieta, Eduard/Y-2919-2019; Sanchez-Moreno, Jose/N-3194-2014;
   Martinez-Aran, Anabel/U-8394-2017
OI Vieta, Eduard/0000-0002-0548-0053; Sanchez-Moreno,
   Jose/0000-0003-1520-093X; Martinez-Aran, Anabel/0000-0002-0623-6263;
   Bonnin, Caterina del Mar/0000-0002-1197-1596; Hidalgo-Mazzei,
   Diego/0000-0002-2693-6849
FU Instituto de Salud Carlos IIIInstituto de Salud Carlos III; CIBER of
   Mental Health (CIBERSAM) (Banco de Instrumentos del CIBERSAM); Spanish
   Ministry of Economy, Industry and Competitiveness [PI15/00283,
   PI15/00330/PI16/00187]; Departament de Salut de la Generalitat de
   Catalunya with PERIS grant [SLT002/16/00331]; Instituo de Salud Carlos
   III, Spanish Ministry of Economy and Competiveness [JR/00012]
FX This study was supported by the Instituto de Salud Carlos III, the CIBER
   of Mental Health (CIBERSAM) (Banco de Instrumentos del CIBERSAM;
   http://bi.cibersam.es/proyectos-de-investigacion), the Spanish Ministry
   of Economy, Industry and Competitiveness (PI15/00283,
   PI15/00330/PI16/00187) integrated into the Plan Nacional de I+D+I y
   cofinanciadopor el ISCIII-Subdireccion General de Evaluacion y el
   FondoEuropeo de Desarrollo Regional (FEDER).; Dr. Bonnin would like to
   thank the Departament de Salut de la Generalitat de Catalunya with PERIS
   grant (SLT002/16/00331).; Dr. Grande would like to thank Instituo de
   Salud Carlos III, Spanish Ministry of Economy and Competiveness for Juan
   Rodes research contract (JR/00012).
CR Anaya C, 2016, ACTA PSYCHIAT SCAND, V133, P386, DOI 10.1111/acps.12535
   Arnfred SM, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-016-1175-0
   Awata S, 2007, PSYCHIAT CLIN NEUROS, V61, P112, DOI 10.1111/j.1440-1819.2007.01619.x
   Bech P, 2006, PSYCHOTHER PSYCHOSOM, V75, P362, DOI 10.1159/000095442
   Bech P, 2003, INT J METH PSYCH RES, V12, P85, DOI 10.1002/mpr.145
   Bonnin CM, 2016, BRIT J PSYCHIAT, V208, P87, DOI 10.1192/bjp.bp.114.162123
   Bonnin CM, 2012, J AFFECT DISORDERS, V136, P650, DOI 10.1016/j.jad.2011.10.012
   Bonsignore M, 2001, EUR ARCH PSY CLIN N, V251, P27
   Christensen KS, 2015, FAM PRACT, V32, P359, DOI 10.1093/fampra/cmv011
   Colom F, 2002, MED CLIN-BARCELONA, V119, P366, DOI 10.1016/S0025-7753(02)73419-2
   Cordero Villafafila A., ACTAS LUSO ESP NEURO, V14, P339
   de Wit M, 2007, DIABETES CARE, V30, P2003, DOI 10.2337/dc07-0447
   Dias VV, 2008, J AFFECT DISORDERS, V110, P75, DOI 10.1016/j.jad.2008.01.010
   Ellervik C, 2014, NORD J PSYCHIAT, V68, P507, DOI 10.3109/08039488.2013.877074
   Gazalle FK, 2007, J AFFECT DISORDERS, V103, P247, DOI 10.1016/j.jad.2007.01.013
   Goldberg JF, 2005, J AFFECT DISORDERS, V89, P79, DOI 10.1016/j.jad.2005.08.008
   Grande I, 2016, LANCET, V387, P1561, DOI 10.1016/S0140-6736(15)00241-X
   Guico-Pabia CJ, 2012, INT CLIN PSYCHOPHARM, V27, P1, DOI 10.1097/YIC.0b013e32834c2488
   Hajos TRS, 2013, DIABETIC MED, V30, pE63, DOI 10.1111/dme.12040
   HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56
   Hayhurst H, 2006, QUAL LIFE RES, V15, P1271, DOI 10.1007/s11136-006-0059-z
   Heun R, 1999, ACTA PSYCHIAT SCAND, V99, P171, DOI 10.1111/j.1600-0447.1999.tb00973.x
   Katschnig H, 2006, WORLD PSYCHIATRY, V5, P139
   Kobau R, 2010, APPL PSYCHOL-HLTH WE, V2, P272, DOI 10.1111/j.1758-0854.2010.01035.x
   Kong C L, 2016, East Asian Arch Psychiatry, V26, P18
   Lauritsen L, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.6673
   Mackala SA, 2014, J AFFECT DISORDERS, V168, P119, DOI 10.1016/j.jad.2014.06.045
   Martiny K, 2012, J CLIN PSYCHIAT, V73, P1234, DOI 10.4088/JCP.11m07625
   Michalak Erin E, 2005, Health Qual Life Outcomes, V3, P72, DOI 10.1186/1477-7525-3-72
   Michalak EE, 2010, BIPOLAR DISORD, V12, P727, DOI 10.1111/j.1399-5618.2010.00865.x
   Moller Leimkuhler A. M., 2007, J AFFECT DISORD
   Mortazavi F, 2015, TURK PSIKIYATR DERG, V26, P48
   Morton E., 2017, PSYCHOL MED
   Morton E, 2017, J AFFECT DISORDERS, V212, P128, DOI 10.1016/j.jad.2017.01.026
   Murray G, 2012, BIPOLAR DISORD, V14, P793, DOI 10.1111/bdi.12016
   NASBY W, 1994, COGNITION EMOTION, V8, P259, DOI 10.1080/02699939408408941
   Reinares M, 2014, J AFFECT DISORDERS, V156, P46, DOI 10.1016/j.jad.2013.12.017
   Ritsner M., 2002, SUBJECTIVE QUALITY L, P553
   Rosa AR, 2008, PSYCHOTHER PSYCHOSOM, V77, P390, DOI 10.1159/000151520
   Rosa Adriane R, 2007, Clin Pract Epidemiol Ment Health, V3, P5, DOI 10.1186/1745-0179-3-5
   Sanchez-Moreno J, 2009, PSYCHOTHER PSYCHOSOM, V78, P285, DOI 10.1159/000228249
   Tennant R, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-63
   Topp CW, 2015, PSYCHOTHER PSYCHOSOM, V84, DOI 10.1159/000376585
   Torrent C, 2013, AM J PSYCHIAT, V170, P852, DOI 10.1176/appi.ajp.2012.12070971
   Vieta E, 2016, WORLD PSYCHIATRY, V15, P288, DOI 10.1002/wps.20351
   Vieta E, 2011, WORLD PSYCHIATRY, V10, P152
   Vojta C, 2001, COMPR PSYCHIAT, V42, P190, DOI 10.1053/comp.2001.23143
   Vothknecht S, 2013, PSYCHIAT RES, V206, P62, DOI 10.1016/j.psychres.2012.09.004
   World Health Organization, 2004, PROMOTING MEANTL HEA
   YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429
NR 50
TC 11
Z9 11
U1 1
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-0327
EI 1573-2517
J9 J AFFECT DISORDERS
JI J. Affect. Disord.
PD MAR 1
PY 2018
VL 228
BP 153
EP 159
DI 10.1016/j.jad.2017.12.006
PG 7
WC Clinical Neurology; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA FV1NU
UT WOS:000424331400020
PM 29248821
DA 2020-12-08
ER

PT J
AU Munoz, ES
   McGuiness, A
   Jacka, F
   Vieta, E
   Grande, I
   Carvalho, AF
   Berk, M
   Fernandes, BS
AF Salagre Munoz, E.
   McGuiness, A.
   Jacka, F.
   Vieta, E.
   Grande, I.
   Carvalho, A. F.
   Berk, M.
   Fernandes, B. S.
TI Depression is associated with increased insulin resistance: a
   meta-analysis
SO EUROPEAN NEUROPSYCHOPHARMACOLOGY
LA English
DT Meeting Abstract
CT European-College-of-Neuropsychopharmacology Workshop for Junior
   Scientists in Europe
CY MAR 15-18, 2017
CL Nice, FRANCE
SP European Coll Neuropsychopharmacol
ID MECHANISMS
C1 [Salagre Munoz, E.; Vieta, E.; Grande, I.] Univ Barcelona, Hosp Clin, Inst Neurosci, IDIBAPS,CIBERSAM,Bipolar Unit, Barcelona, Spain.
   [McGuiness, A.] Univ Fed Rio Grande do Sul, Dept Biochem, Lab Calcium Binding Prot Cent Nervous Syst, Porto Alegre, RS, Brazil.
   [Jacka, F.; Berk, M.; Fernandes, B. S.] Deakin Univ, Sch Med, Geelong, Vic, Australia.
   [Jacka, F.; Berk, M.; Fernandes, B. S.] Barwon Hlth, IMPACT Strateg Res Ctr, Geelong, Vic, Australia.
   [Carvalho, A. F.] Univ Fed Ceara, Fac Med, Translat Psychiat Res Grp, Fortaleza, Ceara, Brazil.
   [Carvalho, A. F.] Univ Fed Ceara, Fac Med, Dept Clin Med, Fortaleza, Ceara, Brazil.
RI Vieta, Eduard/Y-2919-2019; Berk, Michael/M-7891-2013; Fernandes,
   Brisa/B-6614-2009; Berk, Michael/M-3585-2019
OI Vieta, Eduard/0000-0002-0548-0053; Berk, Michael/0000-0002-5554-6946;
   Fernandes, Brisa/0000-0002-3797-7582; Berk, Michael/0000-0002-5554-6946
FU Deakin University, Australia; CNPq, BrazilNational Council for
   Scientific and Technological Development (CNPq) [MCTI/CNPQ/Universal
   14/2014461833/2014-0]; NHMRC Senior Principal Research
   FellowshipNational Health and Medical Research Council of Australia
   [1059660]; Juan Rodes Contract [JR15/00012]; Proyecto de Investigacion
   en Salud from Instituto de Salud Carlos III, Spanish Ministry of Economy
   and Competiveness, Spain [PI16/00187]; AB-Biotics; Actavis;
   AllerganAllergan; AstraZenecaAstraZeneca; Bristol-Myers
   SquibbBristol-Myers Squibb; Ferrer; Forest Research Institute; Gedeon
   Richter; Glaxo-Smith-KlineGlaxoSmithKline; JanssenJohnson & Johnson
   USAJanssen Biotech Inc; LundbeckLundbeck Corporation; OtsukaOtsuka
   Pharmaceutical; PfizerPfizer; RocheRoche Holding;
   Sanofi-AventisSanofi-Aventis; ServierServier; Shire; Sunovion;
   TakedaTakeda Pharmaceutical Company Ltd; Telefonica; Brain and Behaviour
   Foundation; Spanish Ministry of Science and Innovation (CIBERSAM)Spanish
   Government; Seventh European Framework Programme (ENBREC)European Union
   (EU); Stanley Medical Research Institute
FX BSF is supported by a postdoctoral research fellowship from Deakin
   University, Australia, and by a research grant MCTI/CNPQ/Universal
   14/2014461833/2014-0 from CNPq, Brazil. MB is supported by a NHMRC
   Senior Principal Research Fellowship 1059660. IG is supported by a Juan
   Rodes Contract (JR15/00012) and grant Proyecto de Investigacion en Salud
   PI16/00187 from Instituto de Salud Carlos III, Spanish Ministry of
   Economy and Competiveness, Spain, and has served as a consultant for
   Ferrer and as a speaker for AstraZeneca, Ferrer and Janssen-Cilag. EV
   has received grants and served as consultant, advisor or CME speaker for
   the following entities: AB-Biotics, Actavis, Allergan, AstraZeneca,
   Bristol-Myers Squibb, Ferrer, Forest Research Institute, Gedeon Richter,
   Glaxo-Smith-Kline, Janssen, Lundbeck, Otsuka, Pfizer, Roche,
   Sanofi-Aventis, Servier, Shire, Sunovion, Takeda, Telefonica, the Brain
   and Behaviour Foundation, the Spanish Ministry of Science and Innovation
   (CIBERSAM), the Seventh European Framework Programme (ENBREC), and the
   Stanley Medical Research Institute.
CR Guha P, 2014, INDIAN J CLIN BIOCHE, V29, P51, DOI 10.1007/s12291-012-0292-x
   Lang UE, 2013, CELL PHYSIOL BIOCHEM, V31, P761, DOI 10.1159/000350094
   Pillinger T, 2017, JAMA PSYCHIAT, V74, P261, DOI 10.1001/jamapsychiatry.2016.3803
   Stuart MJ, 2012, NEUROSCI BIOBEHAV R, V36, P658, DOI 10.1016/j.neubiorev.2011.10.001
NR 4
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0924-977X
EI 1873-7862
J9 EUR NEUROPSYCHOPHARM
JI Eur. Neuropsychopharmacol.
PD MAR
PY 2018
VL 28
SU 1
MA P.3.001
BP S61
EP S62
DI 10.1016/j.euroneuro.2017.12.091
PG 2
WC Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry
SC Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry
GA GF7XM
UT WOS:000432181700073
DA 2020-12-08
ER

PT J
AU Miskowiak, K
   Burdick, KE
   Martinez-Aran, A
   Bonnin, CM
   Bowie, CR
   Carvalho, AF
   Gallagher, P
   Lafer, B
   Lopez-Jaramillo, C
   Sumiyoshi, T
   McIntyre, RS
   Schaffer, A
   Porter, RJ
   Torres, IJ
   Yatham, LN
   Young, AH
   Kessing, LV
   Vieta, E
AF Miskowiak, K.
   Burdick, K. E.
   Martinez-Aran, A.
   Bonnin, C. M.
   Bowie, C. R.
   Carvalho, A. F.
   Gallagher, P.
   Lafer, B.
   Lopez-Jaramillo, C.
   Sumiyoshi, T.
   McIntyre, R. S.
   Schaffer, A.
   Porter, R. J.
   Torres, I. J.
   Yatham, L. N.
   Young, A. H.
   Kessing, L. V.
   Vieta, E.
TI Methodological recommendations for cognition trials in bipolar disorder
   by the International Society for Bipolar Disorders targeting cognition
   task force
SO BIPOLAR DISORDERS
LA English
DT Meeting Abstract
CT 20th Annual Conference of the
   International-Society-for-Bipolar-Disorders
CY MAR 07-10, 2018
CL Mexico City, MEXICO
SP Int Soc Bipolar Disorders
C1 [Miskowiak, K.; Kessing, L. V.] Rigshosp, Copenhagen Univ Hosp, Copenhagen Affect Disorder Res Ctr, Sychiatr Ctr Copenhagen, Copenhagen, Denmark.
   [Miskowiak, K.] Univ Copenhagen, Dept Psychol, Copenhagen, Denmark.
   [Burdick, K. E.] Harvard Med Sch, Brigham & Womens Hosp, Dept Psychiat, Boston, MA USA.
   [Martinez-Aran, A.; Bonnin, C. M.; Vieta, E.] Univ Barcelona, Hosp Clin, Clin Inst Neurosci, IDIBAPS,CIBERSAM, Barcelona, Catalonia, Spain.
   [Bowie, C. R.] Queens Univ, Dept Psychol, Kingston, ON, Canada.
   [Carvalho, A. F.] Univ Fed Ceara, Dept Clin Med, Fortaleza, Ceara, Brazil.
   [Gallagher, P.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England.
   [Lafer, B.] Univ Sao Paulo, Inst Psychiat, Bipolar Disorder Res Program, Sch Med, Sao Paulo, Brazil.
   [Lopez-Jaramillo, C.] Univ Antioquia, Dept Psychiat, Res Grp Psychiat, Medellin, Colombia.
   [Sumiyoshi, T.] Natl Ctr Neurol & Psychiat, Dept Clin Epidemiol, Tokyo, Japan.
   [McIntyre, R. S.] Univ Toronto, Mood Disorders Psychopharmacol Unit, Brain & Cognit Discovery Fdn, Toronto, ON, Canada.
   [Schaffer, A.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada.
   [Porter, R. J.] Univ Otago, Dept Psychol Med, Christchurch, New Zealand.
   [Torres, I. J.; Yatham, L. N.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada.
   [Young, A. H.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychol Med, London, England.
RI Vieta, Eduard/Y-2919-2019; McIntyre, Roger/AAU-1000-2020
OI Vieta, Eduard/0000-0002-0548-0053; McIntyre, Roger/0000-0003-4733-2523
NR 0
TC 0
Z9 0
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1398-5647
EI 1399-5618
J9 BIPOLAR DISORD
JI Bipolar Disord.
PD MAR
PY 2018
VL 20
SU 1
SI SI
MA S-01
BP 11
EP 11
PG 1
WC Clinical Neurology; Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA FY1XC
UT WOS:000426605800009
DA 2020-12-08
ER

PT J
AU Miskowiak, KW
   Burdick, KE
   Martinez-Aran, A
   Bonnin, CM
   Bowie, CR
   Carvalho, AF
   Gallagher, P
   Lafer, B
   Lopez-Jaramillo, C
   Sumiyoshi, T
   McIntyre, R
   Schaffer, A
   Porter, RJ
   Torres, IJ
   Yatham, LN
   Young, AH
   Purdon, S
   Kessing, LV
   Vieta, E
AF Miskowiak, K. W.
   Burdick, K. E.
   Martinez-Aran, A.
   Bonnin, C. M.
   Bowie, C. R.
   Carvalho, A. F.
   Gallagher, P.
   Lafer, B.
   Lopez-Jaramillo, C.
   Sumiyoshi, T.
   McIntyre, R.
   Schaffer, A.
   Porter, R. J.
   Torres, I. J.
   Yatham, L. N.
   Young, A. H.
   Purdon, S.
   Kessing, L. V.
   Vieta, E.
TI Assessing and addressing cognitive impairment in bipolar disorder: the
   International Society for Bipolar Disorders targeting cognition task
   force recommendations for clinicians
SO BIPOLAR DISORDERS
LA English
DT Meeting Abstract
CT 20th Annual Conference of the
   International-Society-for-Bipolar-Disorders
CY MAR 07-10, 2018
CL Mexico City, MEXICO
SP Int Soc Bipolar Disorders
C1 [Miskowiak, K. W.; Kessing, L. V.] Rigshosp, Copenhagen Univ Hosp, Copenhagen Affect Disorder Res Ctr, Psychiat Ctr Copenhagen, Copenhagen, Denmark.
   [Miskowiak, K. W.] Univ Copenhagen, Dept Psychol, Copenhagen, Denmark.
   [Burdick, K. E.] Harvard Med Sch, Brigham & Womens Hosp, Dept Psychiat, Boston, MA USA.
   [Martinez-Aran, A.; Bonnin, C. M.; Vieta, E.] Univ Barcelona, Hosp Clin, Clin Inst Neurosci, IDIBAPS,CIBERSAM, Barcelona, Catalonia, Spain.
   [Bowie, C. R.] Queens Univ, Dept Psychol, Kingston, ON, Canada.
   [Carvalho, A. F.] Univ Fed Ceara, Dept Clin Med, Fortaleza, Ceara, Brazil.
   [Gallagher, P.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England.
   [Lafer, B.] Univ Sao Paulo, Inst Psychiat, Bipolar Disorder Res Program, Sch Med, Sao Paulo, Brazil.
   [Lopez-Jaramillo, C.] Univ Antioquia, Dept Psychiat, Res Grp Psychiat, Medellin, Colombia.
   [Sumiyoshi, T.] Natl Ctr Neurol & Psychiat, Dept Clin Epidemiol, Tokyo, Japan.
   [McIntyre, R.] Univ Toronto, Brain & Cognit Discovery Fdn, Mood Disorders Psychopharmacol Unit, Toronto, ON, Canada.
   [Schaffer, A.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada.
   [Porter, R. J.] Univ Otago, Dept Psychol Med, Christchurch, New Zealand.
   [Torres, I. J.; Yatham, L. N.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada.
   [Young, A. H.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychol Med, London, England.
   [Purdon, S.] Univ Alberta, Dept Psychiat, Edmonton, AB, Canada.
RI Vieta, Eduard/Y-2919-2019; McIntyre, Roger/AAU-1000-2020; Lafer,
   Beny/F-9390-2015
OI Vieta, Eduard/0000-0002-0548-0053; McIntyre, Roger/0000-0003-4733-2523;
   Lafer, Beny/0000-0002-6132-9999
NR 0
TC 0
Z9 0
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1398-5647
EI 1399-5618
J9 BIPOLAR DISORD
JI Bipolar Disord.
PD MAR
PY 2018
VL 20
SU 1
SI SI
MA S-02
BP 11
EP 11
PG 1
WC Clinical Neurology; Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA FY1XC
UT WOS:000426605800010
DA 2020-12-08
ER

PT J
AU Stubbs, B
   Vancampfort, D
   Veronese, N
   Thompson, T
   Fornaro, M
   Schofield, P
   Solmi, M
   Mugisha, J
   Carvalho, AF
   Koyanagi, A
AF Stubbs, B.
   Vancampfort, D.
   Veronese, N.
   Thompson, T.
   Fornaro, M.
   Schofield, P.
   Solmi, M.
   Mugisha, J.
   Carvalho, A. F.
   Koyanagi, A.
TI Depression and pain: primary data and meta-analysis among 237952 people
   across 47 low- and middle-income countries
SO PSYCHOLOGICAL MEDICINE
LA English
DT Article
DE Comorbidity; depression; depressive symptoms; pain
ID PHYSICAL-ACTIVITY; OLDER-ADULTS; MENTAL-DISORDERS; SEDENTARY TIME;
   HEALTH; PREVALENCE; SYMPTOMS; ANXIETY; IMPACT; LIFE
AB Background Depression and pain are leading causes of global disability. However, there is a paucity of multinational population data assessing the association between depression and pain, particularly among low- and middle-income countries (LMICs) where both are common. Therefore, we investigated this association across 47 LMICs.
   Methods Community-based data on 273952 individuals from 47 LMICs were analysed. Multivariable logistic and linear regression analyses were performed to assess the association between the International Classification of Diseases, 10th Revision depression/depression subtypes (over the past 12 months) and pain in the previous 30 days based on self-reported data. Country-wide meta-analysis adjusting for age and sex was also conducted.
   Results The prevalence of severe pain was 8.0, 28.2, 20.2, and 34.0% for no depression, subsyndromal depression, brief depressive episode, and depressive episode, respectively. Logistic regression adjusted for socio-demographic variables, anxiety and chronic medical conditions (arthritis, diabetes, angina, asthma) demonstrated that compared with no depression, subsyndromal depression, brief depressive episode, and depressive episode were associated with a 2.16 [95% confidence interval (CI) 1.83-2.55], 1.45 (95% CI 1.22-1.73), and 2.11 (95% CI 1.87-2.39) increase in odds of severe pain, respectively. Similar results were obtained when a continuous pain scale was used as the outcome. Depression was significantly associated with severe pain in 44/47 countries with a pooled odds ratio of 3.93 (95% CI 3.54-4.37).
   Conclusion Depression and severe pain are highly comorbid across LMICs, independent of anxiety and chronic medical conditions. Whether depression treatment or pain management in patients with comorbid pain and depression leads to better clinical outcome is an area for future research.
C1 [Stubbs, B.] South London & Maudsley NHS Fdn Trust, Physiotherapy Dept, Denmark Hill, London SE5 8AZ, England.
   [Stubbs, B.] Kings Coll London, Hlth Serv, Crespigny Pk, London SE5 8AF, England.
   [Stubbs, B.] Kings Coll London, Populat Res Dept, Inst Psychiat Psychol & Neurosci, Crespigny Pk, London SE5 8AF, England.
   [Vancampfort, D.] Katholieke Univ Leuven, Dept Rehabil Sci, Leuven, Belgium.
   [Vancampfort, D.] Katholieke Univ Leuven, Univ Psychiat Ctr, Leuven Kortenberg, Belgium.
   [Veronese, N.] Univ Padua, Dept Med DIMED, Geriatr Div, Padua, Italy.
   [Veronese, N.] Inst Clin Res & Educ Med IREM, Padua, Italy.
   [Thompson, T.] Univ Greenwich, Fac Educ & Hlth, London, England.
   [Fornaro, M.] Columbia Univ, New York Psychiat Inst, New York, NY USA.
   [Schofield, P.] Anglia Ruskin Univ, Fac Hlth Social Care & Educ, Chelmsford, England.
   [Solmi, M.] Univ Padua, Dept Neurosci, Padua, Italy.
   [Mugisha, J.] Kyambogo Univ, Kampala, Uganda.
   [Mugisha, J.] Butabika Natl Referral & Mental Hlth Hosp, Kampala, Uganda.
   [Carvalho, A. F.] Univ Fed Ceara, Dept Clin Med, Fortaleza, Ceara, Brazil.
   [Carvalho, A. F.] Univ Fed Ceara, Translat Psychiat Res Grp, Fac Med, Fortaleza, Ceara, Brazil.
   [Koyanagi, A.] Univ Barcelona, Fdn St Joan Deu, Parc Sanitari St Joan Deu, Res & Dev Unit, Dr Antoni Pujadas 42,St Boi Llobregat, Barcelona 08830, Spain.
   [Koyanagi, A.] CIBERSAM, Ctr Invest Biomed Red Salud Mental, Inst Salud Carlos III, Monforte Lemos 3-5 Pabellon 11, Madrid 28029, Spain.
RP Stubbs, B (corresponding author), South London & Maudsley NHS Fdn Trust, Physiotherapy Dept, Denmark Hill, London SE5 8AZ, England.
EM brendon.stubbs@kcl.ac.uk
RI Stubbs, Brendon/X-1904-2018; Solmi, Marco/K-3906-2018; Koyanagi,
   Ai/D-3833-2018; Vancampfort, Davy/AAD-1987-2019
OI Stubbs, Brendon/0000-0001-7387-3791; Solmi, Marco/0000-0003-4877-7233;
   Koyanagi, Ai/0000-0002-9565-5004; 
FU National Institute for Health Research Collaboration for Leadership in
   Applied Health Research and Care Funding scheme; Miguel Servet contract
   [CP13/00150, PI15/00862]; ISCIII - General Branch Evaluation and
   Promotion of Health Research - and the European Regional Development
   Fund (ERDF-FEDER)
FX BS receives funding from the National Institute for Health Research
   Collaboration for Leadership in Applied Health Research and Care Funding
   scheme. The views expressed in this publication are those of the
   author(s) and not necessarily those of the NHS, the National Institute
   for Health Research or the Department of Health. AK's work was supported
   by the Miguel Servet contract financed by the CP13/00150 and PI15/00862
   projects, integrated into the National R+D+I and funded by the ISCIII -
   General Branch Evaluation and Promotion of Health Research - and the
   European Regional Development Fund (ERDF-FEDER). This paper received no
   specific grant of direct funding.
CR Andreasen P, 2014, EUR J PUBLIC HEALTH, V24, P40, DOI 10.1093/eurpub/ckt014
   Asante A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152866
   Ayuso-Mateos JL, 2010, BRIT J PSYCHIAT, V196, P365, DOI 10.1192/bjp.bp.109.071191
   Bai YM, 2014, J AFFECT DISORDERS, V155, P28, DOI 10.1016/j.jad.2013.10.019
   Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433
   Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009
   Breivik H, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1229
   De Hert M, 2011, WORLD PSYCHIATRY, V10, P138
   De Hert M, 2011, WORLD PSYCHIATRY, V10, P52, DOI 10.1002/j.2051-5545.2011.tb00014.x
   Demyttenaere K, 2007, PAIN, V129, P332, DOI 10.1016/j.pain.2007.01.022
   Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547
   Fornaro M, 2011, NEUROPSYCH DIS TREAT, V7, P217, DOI 10.2147/NDT.S17949
   Fornaro Michele, 2009, Ann Gen Psychiatry, V8, P21, DOI 10.1186/1744-859X-8-21
   Guerra M, 2016, J AFFECT DISORDERS, V190, P362, DOI 10.1016/j.jad.2015.09.004
   Gureje O, 2008, PAIN, V135, P82, DOI 10.1016/j.pain.2007.05.005
   Hamer M, 2014, MED SCI SPORT EXER, V46, P1946, DOI 10.1249/MSS.0000000000000317
   Hamer M, 2012, OBESITY, V20, P2113, DOI 10.1038/oby.2012.61
   Hamer M, 2012, CIRCULATION, V126, P928, DOI 10.1161/CIRCULATIONAHA.112.103879
   Henningsen P, 2003, PSYCHOSOM MED, V65, P528, DOI 10.1097/01.PSY.0000075977.90337.E7
   Hooten WM, 2016, MAYO CLIN PROC, V91, P955, DOI 10.1016/j.mayocp.2016.04.029
   Jackson T, 2016, ANESTH ANALG, V122, P2028, DOI 10.1213/ANE.0000000000001287
   Jackson T, 2015, LANCET, V385, P10, DOI 10.1016/S0140-6736(15)60805-4
   Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168
   Koyanagi A, 2016, PSYCHOL MED, V46, P2655, DOI 10.1017/S0033291716001422
   Koyanagi A, 2015, J PSYCHIATR RES, V69, P19, DOI 10.1016/j.jpsychires.2015.07.020
   Mogil JS, 2012, NAT REV NEUROSCI, V13, P859, DOI 10.1038/nrn3360
   Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9
   Mugisha J, 2016, INT J MENT HEALTH SY, V10, DOI 10.1186/s13033-016-0057-7
   Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4
   Nicholl BI, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0350-4
   Nuevo R, 2013, ACTA PSYCHIAT SCAND, V127, P482, DOI 10.1111/acps.12010
   Nuevo R, 2012, SCHIZOPHRENIA BULL, V38, P475, DOI 10.1093/schbul/sbq099
   Paller CJ, 2009, PAIN MED, V10, P289, DOI 10.1111/j.1526-4637.2008.00558.x
   Pan YJ, 2015, J PSYCHIATR RES, V63, P123, DOI 10.1016/j.jpsychires.2015.01.019
   Prina AM, 2011, PSYCHOL MED, V41, P2047, DOI 10.1017/S0033291711000444
   Rayner L, 2016, PAIN, V157, P1472, DOI 10.1097/j.pain.0000000000000542
   ROSE GA, 1962, B WORLD HEALTH ORGAN, V27, P645
   Salagre E, 2016, J AFFECT DISORDERS, V200, P235, DOI 10.1016/j.jad.2016.04.047
   Schuch FB, 2016, J PSYCHIATR RES, V77, P42, DOI 10.1016/j.jpsychires.2016.02.023
   Schuch FB, 2016, NEUROSCI BIOBEHAV R, V61, P1, DOI 10.1016/j.neubiorev.2015.11.012
   Strawbridge R, 2015, EUR NEUROPSYCHOPHARM, V25, P1532, DOI 10.1016/j.euroneuro.2015.06.007
   Stubbs B, 2016, EXP GERONTOL, V82, P30, DOI 10.1016/j.exger.2016.05.016
   Stubbs B, 2016, J PSYCHIATR RES, V72, P72, DOI 10.1016/j.jpsychires.2015.10.019
   Stubbs B, 2015, PAIN, V156, P2121, DOI 10.1097/j.pain.0000000000000304
   Stubbs B, 2014, PAIN MED, V15, P1861, DOI 10.1111/pme.12570
   Tsang A, 2008, J PAIN, V9, P883, DOI 10.1016/j.jpain.2008.05.005
   Uthman OA, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5555
   Vancampfort D, 2015, PSYCHIAT DANUB, V27, P210
   Webster LR, 2016, POSTGRAD MED, V128, P76, DOI 10.1080/00325481.2016.1113841
   Wong KO, 2013, PULM MED, V2013, DOI 10.1155/2013/929028
   World Health Organization, 1993, ICD 10 CLASS MENT BE
NR 51
TC 24
Z9 24
U1 0
U2 16
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0033-2917
EI 1469-8978
J9 PSYCHOL MED
JI Psychol. Med.
PD DEC
PY 2017
VL 47
IS 16
BP 2906
EP 2917
DI 10.1017/S0033291717001477
PG 12
WC Psychology, Clinical; Psychiatry; Psychology
SC Psychology; Psychiatry
GA FN5JX
UT WOS:000416044800015
PM 28637534
OA Green Accepted
DA 2020-12-08
ER

PT J
AU Miskowiak, KW
   Burdick, KE
   Martinez-Aran, A
   Bonnin, CM
   Bowie, CR
   Carvalho, AF
   Gallagher, P
   Lafer, B
   Lopez-Jaramillo, C
   Sumiyoshi, T
   McIntyre, RS
   Schaffer, A
   Porter, RJ
   Torres, IJ
   Yatham, LN
   Young, AH
   Kessing, LV
   Vieta, E
AF Miskowiak, K. W.
   Burdick, K. E.
   Martinez-Aran, A.
   Bonnin, C. M.
   Bowie, C. R.
   Carvalho, A. F.
   Gallagher, P.
   Lafer, B.
   Lopez-Jaramillo, C.
   Sumiyoshi, T.
   McIntyre, R. S.
   Schaffer, A.
   Porter, R. J.
   Torres, I. J.
   Yatham, L. N.
   Young, A. H.
   Kessing, L. V.
   Vieta, E.
TI Methodological recommendations for cognition trials in bipolar disorder
   by the International Society for Bipolar Disorders Targeting Cognition
   Task Force
SO BIPOLAR DISORDERS
LA English
DT Editorial Material
DE bipolar disorder; cognitive impairment; methodology; recommendations;
   treatment
ID MAJOR DEPRESSIVE DISORDER; WORKING-MEMORY TASK; PSYCHIATRY SCIP-S; I
   DISORDER; ADULT NEUROGENESIS; EXECUTIVE FUNCTION; EUTHYMIC PATIENTS;
   EPISODIC MEMORY; MOOD DISORDERS; SCHIZOPHRENIA
AB ObjectivesTo aid the development of treatment for cognitive impairment in bipolar disorder, the International Society for Bipolar Disorders (ISBD) convened a task force to create a consensus-based guidance paper for the methodology and design of cognition trials in bipolar disorder.
   MethodsThe task force was launched in September 2016, consisting of 18 international experts from nine countries. A series of methodological issues were identified based on literature review and expert opinion. The issues were discussed and expanded upon in an initial face-to-face meeting, telephone conference call and email exchanges. Based upon these exchanges, recommendations were achieved.
   ResultsKey methodological challenges are: lack of consensus on how to screen for entry into cognitive treatment trials, define cognitive impairment, track efficacy, assess functional implications, and manage mood symptoms and concomitant medication. Task force recommendations are to: (i) enrich trials with objectively measured cognitively impaired patients; (ii) generally select a broad cognitive composite score as the primary outcome and a functional measure as a key secondary outcome; and (iii) include remitted or partly remitted patients. It is strongly encouraged that trials exclude patients with current substance or alcohol use disorders, neurological disease or unstable medical illness, and keep non-study medications stable. Additional methodological considerations include neuroimaging assessments, targeting of treatments to illness stage and using a multimodal approach.
   ConclusionsThis ISBD task force guidance paper provides the first consensus-based recommendations for cognition trials in bipolar disorder. Adherence to these recommendations will likely improve the sensitivity in detecting treatment efficacy in future trials and increase comparability between studies.
C1 [Miskowiak, K. W.; Kessing, L. V.] Rigshosp, Copenhagen Univ Hosp, Psychiat Ctr Copenhagen, Copenhagen Affect Disorder Res Ctr, Copenhagen, Denmark.
   [Miskowiak, K. W.] Univ Copenhagen, Dept Psychol, Oster Farimagsgade 2A, DK-1353 Copenhagen, Denmark.
   [Burdick, K. E.] Harvard Med Sch, Brigham & Womens Hosp, Dept Psychiat, Boston, MA USA.
   [Martinez-Aran, A.; Bonnin, C. M.; Vieta, E.] Univ Barcelona, IDIBAPS, CIBERSAM, Clin Inst Neurosci,Hosp Clin, Barcelona, Catalonia, Spain.
   [Bowie, C. R.] Queens Univ, Dept Psychol, Kingston, ON, Canada.
   [Carvalho, A. F.] Univ Fed Ceara, Dept Clin Med, Fortaleza, Ceara, Brazil.
   [Gallagher, P.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England.
   [Lafer, B.] Univ Sao Paulo, Sch Med, Inst Psychiat, Bipolar Disorder Res Program, Sao Paulo, Brazil.
   [Lopez-Jaramillo, C.] Univ Antioquia, Res Grp Psychiat, Dept Psychiat, Medellin, Colombia.
   [Sumiyoshi, T.] Natl Ctr Neurol & Psychiat, Dept Clin Epidemiol, Tokyo, Japan.
   [McIntyre, R. S.] Univ Toronto, Brain & Cognit Discovery Fdn, Mood Disorders Psychopharmacol Unit, Toronto, ON, Canada.
   [Schaffer, A.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada.
   [Porter, R. J.] Univ Otago, Dept Psychol Med, Christchurch, New Zealand.
   [Torres, I. J.; Yatham, L. N.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada.
   [Young, A. H.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychol Med, London, England.
RP Miskowiak, KW (corresponding author), Univ Copenhagen, Dept Psychol, Oster Farimagsgade 2A, DK-1353 Copenhagen, Denmark.; Miskowiak, KW (corresponding author), Rigshosp, Copenhagen Univ Hosp, Neurocognit & Emot Affect Disorder NEAD Grp, Copenhagen Affect Disorder Res Ctr,Psychiat Ctr C, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.
EM Kamilla.miskowiak@regionh.dk
RI Lafer, Beny/F-9390-2015; Jaramillo, Carlos Lopez/X-5806-2019; Vieta,
   Eduard/Y-2919-2019; McIntyre, Roger/AAU-1000-2020; Martinez-Aran,
   Anabel/U-8394-2017
OI Lafer, Beny/0000-0002-6132-9999; Vieta, Eduard/0000-0002-0548-0053;
   McIntyre, Roger/0000-0003-4733-2523; Young, Allan/0000-0003-2291-6952;
   Kessing, Lars/0000-0001-9377-9436; Miskowiak,
   Kamilla/0000-0003-2572-1384; Bonnin, Caterina del
   Mar/0000-0002-1197-1596; Gallagher, Peter/0000-0002-9808-7460;
   Martinez-Aran, Anabel/0000-0002-0623-6263
FU Lundbeck FoundationLundbeckfonden; Weimann Foundation
FX Lundbeck Foundation; Weimann Foundation
CR Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707
   Bet PM, 2013, BIPOLAR DISORD, V15, P446, DOI 10.1111/bdi.12067
   Bonnin C. M., 2015, PSYCHOL MED, P1
   Bourne C, 2013, ACTA PSYCHIAT SCAND, V128, P149, DOI 10.1111/acps.12133
   Bradley AJ, 2017, PSYCHOL MED, V47, P1678, DOI 10.1017/S0033291717000186
   Buchanan RW, 2005, SCHIZOPHRENIA BULL, V31, P5, DOI 10.1093/schbul/sbi020
   Burdick KE, 2014, PSYCHOL MED, V44, P3083, DOI 10.1017/S0033291714000439
   Burdick KE, 2015, J CLIN PSYCHIAT, V76, pE342, DOI 10.4088/JCP.14cs09399
   Burdick KE, 2014, NEUROPSYCHOPHARMACOL, V39, P274, DOI 10.1038/npp.2013.177
   Burdick KE, 2012, J CLIN PSYCHIAT, V73, P103, DOI 10.4088/JCP.11m07299
   Burdick KE, 2011, NEUROPSYCHOPHARMACOL, V36, P1587, DOI 10.1038/npp.2011.36
   Corp SA, 2014, J CLIN PSYCHIAT, V75, P1010, DOI 10.4088/JCP.13r08851
   Demant KM, 2015, PSYCHIAT RES, V229, P565, DOI 10.1016/j.psychres.2015.05.022
   Dietsche B, 2014, HUM BRAIN MAPP, V35, P4293, DOI 10.1002/hbm.22475
   Eack SM, 2010, ARCH GEN PSYCHIAT, V67, P674, DOI 10.1001/archgenpsychiatry.2010.63
   Fawcett J, 2016, AM J PSYCHIAT, V173, P107, DOI 10.1176/appi.ajp.2015.15060788
   Fernandez-Corcuera P, 2013, J AFFECT DISORDERS, V148, P170, DOI 10.1016/j.jad.2012.04.009
   Forcada I, 2015, EUR NEUROPSYCHOPHARM, V25, P214, DOI 10.1016/j.euroneuro.2014.07.018
   Frangou S, 2008, EUR PSYCHIAT, V23, P300, DOI 10.1016/j.eurpsy.2007.05.002
   Fulford D, 2014, J AFFECT DISORDERS, V152, P491, DOI 10.1016/j.jad.2013.08.034
   Gandelman-Marton R, 2017, J CLIN NEUROPHYSIOL, V34, P49, DOI 10.1097/WNP.0000000000000301
   Glahn DC, 2006, J AFFECT DISORDERS, V92, P309, DOI 10.1016/j.jad.2006.01.025
   Goldberg JF, 2008, COGNITIVE DYSFUNCTION IN BIPOLAR DISORDER: A GUIDE FOR CLINICIANS, P1
   Grande I, 2016, J AFFECT DISORD S, VS0165-0327, P31330
   Grande I, 2016, LANCET, V387, P1561, DOI 10.1016/S0140-6736(15)00241-X
   Gualtieri CT, 2008, J CLIN PSYCHIAT, V69, P1122, DOI 10.4088/JCP.v69n0712
   Guilera G, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-28
   Hamilton LS, 2009, HUM BRAIN MAPP, V30, P3958, DOI 10.1002/hbm.20820
   Hassouna I, 2016, MOL PSYCHIATR, V21, P1752, DOI 10.1038/mp.2015.212
   Hoertnagl CM, 2015, J CLIN PSYCHIAT, V76, pE779, DOI 10.4088/JCP.14m08990
   Jensen JH, 2016, J AFFECT DISORDERS, V205, P378, DOI 10.1016/j.jad.2016.08.018
   Jensen JH, 2015, J AFFECT DISORDERS, V187, P10, DOI 10.1016/j.jad.2015.07.039
   Kaser M, 2017, BIOL PSYCHIAT-COGN N, V2, P115, DOI 10.1016/j.bpsc.2016.11.009
   Keefe RSE, 2016, SCHIZOPHR RES, V175, P90, DOI 10.1016/j.schres.2016.03.038
   Kessing LV, 2017, ACTA PSYCHIAT SCAND, V135, P51, DOI 10.1111/acps.12667
   Malhi GS, 2016, AUST NZ J PSYCHIAT, V50, P203, DOI 10.1177/0004867416634208
   Martinez-Aran A, 2004, AM J PSYCHIAT, V161, P262, DOI 10.1176/appi.ajp.161.2.262
   Maud C, 2016, AUSTRALAS PSYCHIATRY, V24, P206, DOI 10.1177/1039856215614986
   McIntyre R. S., 2016, INT J NEUROPSYCHOPH
   McIntyre RS, 2017, J CLIN PSYCHIAT, V78, P115, DOI 10.4088/JCP.16m10744
   Minzenberg MJ, 2009, ARCH GEN PSYCHIAT, V66, P811, DOI 10.1001/archgenpsychiatry.2009.91
   Miskowiak KW, 2016, ACTA PSYCHIAT SCAND, V134, P511, DOI 10.1111/acps.12649
   Miskowiak K, 2008, EXP BRAIN RES, V184, P313, DOI 10.1007/s00221-007-1102-1
   Miskowiak K, 2007, J NEUROSCI, V27, P2788, DOI 10.1523/JNEUROSCI.5013-06.2007
   Miskowiak KW, 2016, EUR NEUROPSYCHOPHARM, V26, P1541, DOI 10.1016/j.euroneuro.2016.08.011
   Miskowiak KW, 2015, BIOL PSYCHIAT, V78, P270, DOI 10.1016/j.biopsych.2014.12.013
   Miskowiak KW, 2014, J CLIN PSYCHIAT, V75, P1347, DOI 10.4088/JCP.13m08839
   Miskowiak KW, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-97
   Miskowiak KW, 2009, PSYCHOPHARMACOLOGY, V207, P133, DOI 10.1007/s00213-009-1641-1
   Miskowiak KW, 2016, J CLIN PSYCHIAT, V77, pE1639, DOI 10.4088/JCP.15m10480
   Monks PJ, 2004, BIPOLAR DISORD, V6, P550, DOI 10.1111/j.1399-5618.2004.00147.x
   Ott CV, 2016, EUR NEUROPSYCHOPHARM, V26, P1264, DOI 10.1016/j.euroneuro.2016.05.009
   Patterson TL, 2001, SCHIZOPHRENIA BULL, V27, P235, DOI 10.1093/oxfordjournals.schbul.a006870
   Pavlova B, 2015, LANCET PSYCHIAT, V2, P710, DOI 10.1016/S2215-0366(15)00112-1
   Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133
   Porter RJ, 2015, BIPOLAR DISORD, V17, P21, DOI 10.1111/bdi.12342
   Purdon S, 2005, SCREEN COGNITIVE IMP
   Ragland JD, 2009, AM J PSYCHIAT, V166, P863, DOI 10.1176/appi.ajp.2009.08091307
   Ramsay IS, 2015, SCHIZOPHRENIA BULL, V41, P1276, DOI 10.1093/schbul/sbv025
   Rojo E, 2010, SCHIZOPHR RES, V116, P243, DOI 10.1016/j.schres.2009.08.005
   Rosa Adriane R, 2007, Clin Pract Epidemiol Ment Health, V3, P5, DOI 10.1186/1745-0179-3-5
   Rosa AR, 2013, J AFFECT DISORDERS, V150, P29, DOI 10.1016/j.jad.2013.02.022
   Rosenblat JD, 2015, J AFFECT DISORDERS, V188, P149, DOI 10.1016/j.jad.2015.08.058
   Sole B, 2016, BIPOLAR DISORD, V18, P288, DOI 10.1111/bdi.12385
   Sperry SH, 2015, J INT NEUROPSYCH SOC, V21, P468, DOI 10.1017/S1355617715000442
   Stern RA, 1996, ARCH NEUROL-CHICAGO, V53, P148, DOI 10.1001/archneur.1996.00550020052015
   Thompson JM, 2005, BRIT J PSYCHIAT, V186, P32, DOI 10.1192/bjp.186.1.32
   Toniolo RA, 2016, J AFFECT DISORD
   Torrent C, 2013, AM J PSYCHIAT, V170, P852, DOI 10.1176/appi.ajp.2012.12070971
   TOWNSEND J, 2010, PSYCHIAT RES, V30, P22
   Tse S, 2014, BIPOLAR DISORD, V16, P217, DOI 10.1111/bdi.12148
   Van Rheenen TE, 2014, BIPOLAR DISORD, V16, P318, DOI 10.1111/bdi.12134
   Vieta E, 2011, NEUROTOX RES, V19, P279, DOI 10.1007/s12640-010-9197-8
   Vieta E, 2009, ACTA PSYCHIAT SCAND, V120, P414, DOI 10.1111/j.1600-0447.2009.01503.x
   Vita A, 2013, SCHIZOPHR RES, V150, P51, DOI 10.1016/j.schres.2013.08.011
   Watson S, 2004, BRIT J PSYCHIAT, V184, P496, DOI 10.1192/bjp.184.6.496
   Watson S, 2012, BIOL PSYCHIAT, V72, P943, DOI 10.1016/j.biopsych.2012.05.029
   Yang JC, 2016, SCI REP-UK, V6, DOI 10.1038/srep21719
   Yatham LN, 2017, LANCET PSYCHIAT, V4, P208, DOI 10.1016/S2215-0366(17)30046-9
   Yatham LN, 2010, BIPOLAR DISORD, V12, P351, DOI 10.1111/j.1399-5618.2010.00830.x
   Yilmaz R, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00271
   Young AH, 2004, NEUROPSYCHOPHARMACOL, V29, P1538, DOI 10.1038/sj.npp.1300471
NR 82
TC 61
Z9 61
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1398-5647
EI 1399-5618
J9 BIPOLAR DISORD
JI Bipolar Disord.
PD DEC
PY 2017
VL 19
IS 8
BP 614
EP 626
DI 10.1111/bdi.12534
PG 13
WC Clinical Neurology; Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA FQ5SO
UT WOS:000418421500001
PM 28895274
OA Other Gold, Green Published
DA 2020-12-08
ER

PT J
AU Paula, PC
   Oliveira, JTA
   Sousa, DOB
   Alves, BGT
   Carvalho, AFU
   Franco, OL
   Vasconcelos, IM
AF Paula, P. C.
   Oliveira, J. T. A.
   Sousa, D. O. B.
   Alves, B. G. T.
   Carvalho, A. F. U.
   Franco, O. L.
   Vasconcelos, I. M.
TI Insulin-like plant proteins as potential innovative drugs to treat
   diabetes-The Moringa oleifera case study
SO NEW BIOTECHNOLOGY
LA English
DT Article
DE Insulin-like plant protein; Hypoglycemic protein; Prospection; Diabetes
   therapy; Moringa
ID GOURD MOMORDICA-CHARANTIA; WHEAT-GERM-AGGLUTININ; HYPOGLYCEMIC ACTIVITY;
   BAUHINIA-VARIEGATA; SEQUENCE HOMOLOGY; ISOLATED RAT; IN-VITRO; PEPTIDE;
   LECTINS; EXTRACT
AB Various plant species have long been used in traditional medicine worldwide to treat diabetes. Among the plant-based compounds with hypoglycemic properties, studies on insulin-like proteins isolated from leaves, fruits and seeds are rarely reported in the relevant literature. Our research group has been investigating the presence of insulin-like proteins in Moringa oleifera, a plant species native to India, and we have obtained a leaf protein isolate and semi-purified derived fractions, as well as a seed coat protein fraction (Mo-SC), with hypoglycemic activity in chemically induced diabetic mice that have increased tolerance to orally administered glucose. Equally importantly, Mo-SC possesses insulin-like antigenic epitopes. In this context, the present review aims to highlight that prospection of insulin-like proteins in plants is of the utmost importance both for finding new drugs for the treatment of diabetes and for shedding light on the mechanisms involved in diabetes. (C) 2016 Elsevier B. V. All rights reserved.
C1 [Paula, P. C.; Oliveira, J. T. A.; Sousa, D. O. B.; Alves, B. G. T.; Vasconcelos, I. M.] Univ Fed Ceara, Dept Biochem & Mol Biol, Campus Pici, BR-60440900 Fortaleza, Ceara, Brazil.
   [Carvalho, A. F. U.] Univ Fed Ceara, Dept Biol, Campus Pici, BR-60440900 Fortaleza, Ceara, Brazil.
   [Franco, O. L.] Univ Catolica Brasilia, Ctr Prote & Biochem Anal, Brasilia, DF, Brazil.
   [Franco, O. L.] Catholic Univ Dom Bosco, S Inova, Biotechnol, Campo Grande, MS, Brazil.
RP Vasconcelos, IM (corresponding author), Univ Fed Ceara, Dept Biochem & Mol Biol, Campus Pici, BR-60440900 Fortaleza, Ceara, Brazil.
EM imvasco@ufc.br
RI Carvalho, Ana/K-7344-2018; Franco, Octavio L/T-3020-2017
OI Carvalho, Ana/0000-0001-5293-9317; Franco, Octavio/0000-0001-9546-0525
FU National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordination of Improvement of Higher Education (CAPES),
   BrazilCAPES
FX This work was supported by the National Council for Scientific and
   Technological Development (CNPq) and the Coordination of Improvement of
   Higher Education (CAPES), Brazil.
CR Abd El Latif A, 2014, BIOCHEM CELL BIOL, V92, P413, DOI 10.1139/bcb-2014-0081
   Ahmed BA, 2009, J AGR TECHNOL, V5, P361
   Ahmed I, 2001, DIABETES RES CLIN PR, V51, P155, DOI 10.1016/S0168-8227(00)00224-2
   Azevedo CR, 2006, BRAZ J MED BIOL RES, V39, P1435, DOI 10.1590/S0100-879X2006001100007
   Babji A. S., 2010, International Food Research Journal, V17, P303
   Baby Joseph, 2013, Asian Pacific Journal of Tropical Disease, V3, P93, DOI 10.1016/S2222-1808(13)60052-3
   Baeshen NA, 2014, MICROB CELL FACT, V13, DOI 10.1186/s12934-014-0141-0
   Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054
   Bahadoran Z, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-43
   BAILEY CJ, 1989, DIABETES CARE, V12, P553, DOI 10.2337/diacare.12.8.553
   Bailey CJ, 1996, NEW ENGL J MED, V334, P574, DOI 10.1056/NEJM199602293340906
   Bandyopadhyay P, 2012, FOOD FUNCT, V3, P592, DOI 10.1039/c2fo00006g
   Banting FG, 1922, CAN MED ASSOC J, V7, P141
   Batista AB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111427
   Best CH, 1924, ENDOCRINOLOGY, V8, P617, DOI 10.1210/endo-8-5-617
   Bhat Vishnu, 2010, Journal of Pharmacy Research, V3, P608
   Boura-Halfon S, 2009, AM J PHYSIOL-ENDOC M, V296, pE581, DOI 10.1152/ajpendo.90437.2008
   CANAS X, 1995, ENDOCRINOLOGY, V136, P3871, DOI 10.1210/en.136.9.3871
   Chan SJ, 2000, AM ZOOL, V40, P213
   Chau Diane, 2001, Clinical Diabetes, V19, P172, DOI 10.2337/diaclin.19.4.172
   COLLIER E, 1987, J BIOL CHEM, V262, P6238
   Collip JB, 1923, NATURE, V111, P571, DOI 10.1038/111571b0
   Cryer PE, 2003, DIABETES CARE, V26, P1902, DOI 10.2337/diacare.26.6.1902
   CUATRECASAS P, 1973, P NATL ACAD SCI USA, V70, P485, DOI 10.1073/pnas.70.2.485
   CZECH MP, 1973, BIOCHIM BIOPHYS ACTA, V297, P368, DOI 10.1016/0304-4165(73)90084-6
   Dimitriadis G, 2011, DIABETES RES CLIN PR, V93, pS52, DOI 10.1016/S0168-8227(11)70014-6
   Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5
   Duarte MR, 2007, LAT AM J PHARM, V26, P837
   FOWDEN AL, 1992, EARLY HUM DEV, V29, P177, DOI 10.1016/0378-3782(92)90135-4
   Fowler MJ, 2008, CLIN DIABETES, V26, P77, DOI [DOI 10.2337/DIACLIN.26.2.77, 10.2337/diaclin.26.2.77]
   Freire JE, 2015, PLOS ONE, V10
   Geigenberger P, 2011, PLANT PHYSIOL, V155, P1566, DOI 10.1104/pp.110.170399
   GEIGER DR, 1994, ANNU REV PLANT PHYS, V45, P235, DOI 10.1146/annurev.pp.45.060194.001315
   Ghazavi MK, 2011, CLIN DERMATOL, V29, P300, DOI 10.1016/j.clindermatol.2010.11.009
   Gijzen M, 1999, PLANT PHYSIOL, V120, P951, DOI 10.1104/pp.120.4.951
   GOODMAN DBP, 1993, BIOCHEM BIOPH RES CO, V190, P440, DOI 10.1006/bbrc.1993.1067
   Guo X, 2012, ACTA PHARM SIN B, V2, P358, DOI 10.1016/j.apsb.2012.06.002
   Gupte AA, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/916585
   Hassan RJ, 2014, IOSR J PHARM BIOL SC, V9, P41
   HEDO JA, 1981, BIOCHEMISTRY-US, V20, P3385, DOI 10.1021/bi00515a013
   Hirsch IB, 2005, NEW ENGL J MED, V352, P174, DOI 10.1056/NEJMra040832
   Hubbard SR, 2013, NATURE, V493, P171, DOI 10.1038/493171a
   Iffiu-Soltesz Z, 2010, PHARMACOL RES, V61, P355, DOI 10.1016/j.phrs.2009.12.014
   Jaiswal D, 2009, J ETHNOPHARMACOL, V123, P392, DOI 10.1016/j.jep.2009.03.036
   Joshi BN, 2013, BIOCHEM BIOPH RES CO, V436, P278, DOI 10.1016/j.bbrc.2013.05.093
   Kar A, 2003, J ETHNOPHARMACOL, V84, P105, DOI 10.1016/S0378-8741(02)00144-7
   Kavalali G, 2003, J ETHNOPHARMACOL, V84, P241, DOI 10.1016/S0378-8741(02)00315-X
   KHANNA P, 1981, J NAT PROD, V44, P648, DOI 10.1021/np50018a002
   Khanna P, 2004, U. S. Patent No, Patent No. 6831162
   Kumar R, 2010, INT J PHARM SCI RES, V1, P96, DOI 10.13040/IJPSR.0975-8232.1(8).96-01
   Lamba SS, 2000, STUD NAT PROD CHEM, V21, P457
   Laron Zvi, 2008, Archives of Physiology and Biochemistry, V114, P11, DOI [10.1080/13813450801928356, 10.1080/13813450801928356 ]
   Lenzen S, 2014, J BIOL CHEM, V289, P12189, DOI 10.1074/jbc.R114.557314
   LEROITH D, 1980, P NATL ACAD SCI-BIOL, V77, P6184
   Lis H, 1998, CHEM REV, V98, P637, DOI 10.1021/cr940413g
   Liu SX, 2010, MOL BIOL REP, V37, P1781, DOI 10.1007/s11033-009-9609-0
   Mbikay M, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00024
   McCrimmon RJ, 2010, DIABETES, V59, P2333, DOI 10.2337/db10-0103
   Menting JG, 2013, NATURE, V493, P241, DOI 10.1038/nature11781
   Mentreddy SR, 2007, J SCI FOOD AGR, V87, P743, DOI 10.1002/jsfa.2811
   Naeem S, 2012, PAK J PHARM SCI, V25, P535
   NAG B, 2000, Patent No. 6127338
   Namdeo K, 2013, INT J PHARM RES BIO, V2, P475
   Neumiller JJ, 2009, DIABETES SPECTRUM, V22, P85, DOI DOI 10.2337/diaspect.22.2.85
   NG TB, 1986, J ETHNOPHARMACOL, V15, P107, DOI 10.1016/0378-8741(86)90106-6
   NG TB, 1987, AM J CHINESE MED, V15, P31, DOI 10.1142/S0192415X87000059
   NG TB, 1985, J ETHNOPHARMACOL, V14, P93, DOI 10.1016/0378-8741(85)90033-9
   NG TB, 1986, INT J PEPT PROT RES, V28, P163
   Oliveira AEA, 1999, PROTEIN PEPTIDE LETT, V6, P15
   Oliveira AEA, 2004, PLANT GROWTH REGUL, V43, P57, DOI 10.1023/B:GROW.0000038259.34384.0c
   Ozougwu JC, 2011, J MED PLANTS RES, V5, P1134
   Pang G, 2014, FOOD SCI HUM WELL, V3, P89, DOI DOI 10.1016/j.fshw.2015.01.001
   Pereira ML, 2011, PROTEIN PEPTIDE LETT, V18, P1078
   PEUMANS WJ, 1995, PLANT PHYSIOL, V109, P347, DOI 10.1104/pp.109.2.347
   Piejko M, 2015, J BIOL CHEM, V290, P5947, DOI 10.1074/jbc.M114.608844
   Pokhrel NR, 2002, WORLD J MICROB BIOT, V18, P69, DOI 10.1023/A:1013969628634
   PONZIO G, 1990, CELL SIGNAL, V2, P377, DOI 10.1016/0898-6568(90)90068-L
   PURRELLO F, 1983, SCIENCE, V221, P462, DOI 10.1126/science.6346487
   Qaseem A, 2012, ANN INTERN MED, V156, P218, DOI 10.7326/0003-4819-156-3-201202070-00011
   Rajasekhar MD, 2010, J ETHNOPHARMACOL, V128, P58, DOI 10.1016/j.jep.2009.12.025
   Rajkapoor B, 2006, J ETHNOPHARMACOL, V104, P407, DOI 10.1016/j.jep.2005.08.074
   Raman A, 1996, PHYTOMEDICINE, V2, P349, DOI 10.1016/S0944-7113(96)80080-8
   Rao BK, 1999, J ETHNOPHARMACOL, V67, P103, DOI 10.1016/S0378-8741(99)00004-5
   Rao BK, 2001, J ETHNOPHARMACOL, V78, P67, DOI 10.1016/S0378-8741(01)00324-5
   Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468
   Rorsman P., 2005, BR J DIABETES VASC D, V5, P187
   Rosskamp RH, 1999, DIABETES CARE, V22, pB109
   Sangeetha MK, 2009, J MED, V1, P24
   Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143
   Sheng Qingkai, 2004, Zhong Yao Cai, V27, P414
   Shetty AJ, 2010, J CLIN DIAGN RES, V4, P2617
   Silva José Carlos da, 2003, Sci. agric. (Piracicaba, Braz.), V60, P239, DOI 10.1590/S0103-90162003000200006
   Silva LB, 2002, BRAZ J MED BIOL RES, V35, P297, DOI 10.1590/S0100-879X2002000300004
   SMITH JD, 1981, SCIENCE, V214, P799, DOI 10.1126/science.6117128
   Stein SA, 2013, EXPERT OPIN DRUG SAF, V12, P153, DOI 10.1517/14740338.2013.752813
   STEPKA M, 1993, AGING-CLIN EXP RES, V5, P117
   Sulaiman M., 2015, J CHEM PHARM RES, V7, P132
   SUZUKI T, 1984, METABOLISM, V33, P572, DOI 10.1016/0026-0495(84)90014-3
   Taiz L, 2010, PLANT PHYSL
   Tende J. A., 2011, British Journal of Pharmacology and Toxicology, V2, P1
   Terruzzi I, 2011, NUTR METAB CARDIOVAS, V21, P197, DOI 10.1016/j.numecd.2009.09.004
   Tolman Keith G, 2003, Clin Liver Dis, V7, P369, DOI 10.1016/S1089-3261(03)00020-5
   Vashishta A, 2014, U. S. Patent No, Patent No. [8, 669,348, 8669348]
   Venancio TM, 2003, BRAZ J MED BIOL RES, V36, P1167, DOI 10.1590/S0100-879X2003000900004
   Virdi J, 2003, J ETHNOPHARMACOL, V88, P107, DOI 10.1016/S0378-8741(03)00184-3
   Wallis M, 2015, GROWTH HORM IGF RES, V25, P158, DOI 10.1016/j.ghir.2015.06.004
   Wang BL, 2011, J SCI FOOD AGR, V91, P2443, DOI 10.1002/jsfa.4485
   Wang FJ, 2012, APPL BIOCHEM BIOTECH, V166, P612, DOI 10.1007/s12010-011-9452-3
   Waterman C, 2015, MOL NUTR FOOD RES, V59, P1013, DOI 10.1002/mnfr.201400679
   Xavier-Filho José, 2003, Braz. J. Plant Physiol., V15, P67, DOI 10.1590/S1677-04202003000200002
   Yabe D, 2011, PROG BIOPHYS MOL BIO, V107, P248, DOI 10.1016/j.pbiomolbio.2011.07.010
   Yamamoto Y, 2001, LIFE SCI, V70, P471, DOI 10.1016/S0024-3205(01)01432-1
   Yang BW, 2014, EUR J MED CHEM, V73, P105, DOI 10.1016/j.ejmech.2013.11.043
   Yang BW, 2013, CHEM BIOL DRUG DES, V82, P99, DOI 10.1111/cbdd.12137
   Yibchok-Anun S, 2006, BIOL PHARM BULL, V29, P1126, DOI 10.1248/bpb.29.1126
   Yuan XQ, 2008, J FOOD BIOCHEM, V32, P107, DOI 10.1111/j.1745-4514.2007.00150.x
   Yuan XQ, 2008, FOOD CHEM, V111, P415, DOI 10.1016/j.foodchem.2008.04.006
NR 117
TC 9
Z9 10
U1 1
U2 38
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1871-6784
EI 1876-4347
J9 NEW BIOTECHNOL
JI New Biotech.
PD OCT 25
PY 2017
VL 39
BP 99
EP 109
DI 10.1016/j.nbt.2016.10.005
PN A
PG 11
WC Biochemical Research Methods; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA FH1PW
UT WOS:000410912900013
PM 27737801
DA 2020-12-08
ER

PT J
AU de Almeida, TS
   Neto, JJL
   de Sousa, NM
   Pessoa, IP
   Vieira, LR
   de Medeiros, JL
   Boligon, AA
   Hamers, ARM
   Farias, DF
   Peijnenburg, A
   Carvalho, AFU
AF de Almeida, Thiago Silva
   Lopes Neto, Jose Joaquim
   de Sousa, Nathanna Mateus
   Pessoa, Igor Parra
   Vieira, Leonardo Rogerio
   de Medeiros, Jackeline Lima
   Boligon, Aline Augusti
   Hamers, Astrid R. M.
   Farias, Davi Felipe
   Peijnenburg, Ad
   Carvalho, Ana Fontenele Urano
TI Phenolic compounds of Triplaris gardneriana can protect cells against
   oxidative stress and restore oxidative balance
SO BIOMEDICINE & PHARMACOTHERAPY
LA English
DT Article
DE Medicinal plant; DPPH; Cell imaging; TBARS; MCF-7 cells
ID THIOL OXIDATION; PLANT DEFENSE; ELLAGIC ACID; APOPTOSIS; MENADIONE;
   CONSTITUENTS; ANTIOXIDANTS; RADICALS
AB This work aimed to add value to an underexploited plant species from Brazil, Triplaris gardneriana. To that, the phenolic compounds profile of its seed ethanolic extract and fractions was examined by HPLC and the antioxidant capacity assessed using chemical assays as well as in vitro cell imaging. Twelve compounds were quantified and classified as either phenolic acids or flavonoids. The fractionation process did not generate fractions with different compositions except for chloroformic fraction, which showed only 6 out of 12 standard compounds used. DPPH assay revealed samples with a concentration-dependent radical scavenging activity, being methanolic fraction the one with the largest activity (SC50 11.45 +/- 0.02 mg/mL). Lipid peroxidation assessment, in the presence and absence of stress inducer, showed that particularly the ethanol extract (IC50 26.75 +/- 0.08 mg/mL) and the ethyl acetate fraction (IC50 6.14 +/- 0.03 mg/mL) could inhibit lipid peroxidation. The ethyl acetate fraction performed best in chelating iron (48% complexation at 1000 mg/mL). Cell imaging experiments showed that the ethanolic extract could protect cells against oxidative stress as well as restore the oxidative balance upon stress induction. In conclusion, T. gardneriana seeds showed a promising phenolic compounds profile and antioxidant activity that may be further exploited. (C) 2017 Elsevier Masson SAS. All rights reserved.
C1 [de Almeida, Thiago Silva; Lopes Neto, Jose Joaquim; de Sousa, Nathanna Mateus; Pessoa, Igor Parra; Vieira, Leonardo Rogerio; de Medeiros, Jackeline Lima; Carvalho, Ana Fontenele Urano] Univ Fed Ceara, Dept Biochem & Mol Biol, BR-60020181 Fortaleza, Ceara, Brazil.
   [Boligon, Aline Augusti] Univ Fed Santa Maria, Pharmaceut Sci, BR-97105900 Santa Maria, RS, Brazil.
   [Hamers, Astrid R. M.; Peijnenburg, Ad] Wageningen Univ & Res Ctr, Rikilt Inst Food Safety, POB 230, NL-6700 AE Wageningen, Netherlands.
   [Farias, Davi Felipe] Univ Fed Paraiba, Dept Mol Biol, BR-58051900 Joao Pessoa, Paraiba, Brazil.
RP Carvalho, AFU (corresponding author), Univ Fed Ceara, Dept Biochem & Mol Biol, BR-60020181 Fortaleza, Ceara, Brazil.
EM aurano@ufc.br
RI Farias, Davi Felipe/AAH-1868-2020; Almeida, Thiago S./L-9833-2013;
   Carvalho, Ana/K-7344-2018; Lopes Neto, Jose Joaquim/M-1979-2018
OI Almeida, Thiago S./0000-0002-7401-0637; Carvalho,
   Ana/0000-0001-5293-9317; Felipe Farias, Davi/0000-0001-5438-1919;
   Rogerio Vieira, Leonardo/0000-0002-8505-941X
FU Coordination for the Improvement of Higher Education Personnel (CAPES,
   Brasilia, Brazil)CAPES [PVE-A006_2013]
FX This work was supported by Coordination for the Improvement of Higher
   Education Personnel (CAPES, Brasilia, Brazil) [Grant: PVE-A006_2013].
CR Anandhi D., 2014, International Journal of Current Microbiology and Applied Sciences, V3, P1043
   BENNETT RN, 1994, NEW PHYTOL, V127, P617, DOI 10.1111/j.1469-8137.1994.tb02968.x
   Bhatti JS, 2017, BBA-MOL BASIS DIS, V1863, P1066, DOI 10.1016/j.bbadis.2016.11.010
   Boligon AA, 2013, ACTA PHYSIOL PLANT, V35, P2229, DOI 10.1007/s11738-013-1259-0
   Bone B., 2013, J IMMUNOL, V190, P211
   Braga R., 1976, PLANTAS NORDESTE ESP
   Cartaxo SL, 2010, J ETHNOPHARMACOL, V131, P326, DOI 10.1016/j.jep.2010.07.003
   Chandra J, 2000, FREE RADICAL BIO MED, V29, P323, DOI 10.1016/S0891-5849(00)00302-6
   CRANE D, 1983, H-S Z PHYSIOL CHEM, V364, P977, DOI 10.1515/bchm2.1983.364.2.977
   DAVIES MJ, 1989, BIOCHEM J, V257, P603, DOI 10.1042/bj2570603
   DIMONTE D, 1984, ARCH BIOCHEM BIOPHYS, V235, P343, DOI 10.1016/0003-9861(84)90207-8
   Edris AE, 2009, CURR CLIN PHARMACOL, V4, P43, DOI 10.2174/157488409787236137
   Farias DF, 2013, BIOMED RES INT, V2013, DOI [10.1155/2013/605831, 10.1155/2013/510736, 10.1155/2013/340605, 10.1155/2013/263509]
   Goswami SK, 2014, PHARMACOGN MAG, V10, P581, DOI 10.4103/0973-1296.139790
   GRAYER RJ, 1994, PHYTOCHEMISTRY, V37, P19, DOI 10.1016/0031-9422(94)85005-4
   Hagerman AE, 1998, J AGR FOOD CHEM, V46, P1887, DOI 10.1021/jf970975b
   Halliwell B, 2008, ARCH BIOCHEM BIOPHYS, V476, P107, DOI 10.1016/j.abb.2008.01.028
   Hussein AA, 2005, J NAT PROD, V68, P231, DOI 10.1021/np049803g
   Inocente Camones Miguel Angel, 2010, Rev. Soc. Quím. Perú, V76, P34
   Jayashree GV, 2015, IND CROP PROD, V78, P102, DOI 10.1016/j.indcrop.2015.10.024
   Katiyar Chandrakant, 2012, Ayu, V33, P10, DOI 10.4103/0974-8520.100295
   Kucera O, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/752506
   Kumar S, 2013, SCI WORLD J, DOI 10.1155/2013/162750
   Kumar TR, 2007, J ANDROL, V28, P77, DOI 10.2164/jandrol.106.000265
   Laux I, 2001, CLIN IMMUNOL, V101, P335, DOI 10.1006/clim.2001.5129
   Leopoldini M, 2004, J PHYS CHEM A, V108, P4916, DOI 10.1021/jp037247d
   Leopoldini M, 2011, FOOD CHEM, V125, P288, DOI 10.1016/j.foodchem.2010.08.012
   Luize Patrícia Shima, 2005, Rev. Bras. Cienc. Farm., V41, P85, DOI 10.1590/S1516-93322005000100010
   Macedo S. K. S., 2015, Journal of Medicinal Plants Research, V9, P207
   Mazzone G, 2013, J AGR FOOD CHEM, V61, P9650, DOI 10.1021/jf403262k
   Meng ZQ, 2014, AM J CHINESE MED, V42, P1471, DOI 10.1142/S0192415X1450092X
   Jimenez-Garcia SN, 2013, FOOD RES INT, V54, P1195, DOI 10.1016/j.foodres.2012.11.004
   Oliveira PES, 2008, BIOCHEM SYST ECOL, V36, P134, DOI 10.1016/j.bse.2007.06.001
   Osbourn AE, 1996, PLANT CELL, V8, P1821, DOI 10.1105/tpc.8.10.1821
   Parra Pessoa Igor, 2016, Molecules, V21, DOI 10.3390/molecules21121755
   Rahman K, 2007, CLIN INTERV AGING, V2, P219
   Sata N, 1997, FREE RADICAL BIO MED, V23, P844, DOI 10.1016/S0891-5849(97)00064-6
NR 37
TC 6
Z9 6
U1 0
U2 3
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0753-3322
EI 1950-6007
J9 BIOMED PHARMACOTHER
JI Biomed. Pharmacother.
PD SEP
PY 2017
VL 93
BP 1261
EP 1268
DI 10.1016/j.biopha.2017.07.050
PG 8
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA FE0PU
UT WOS:000407923000138
PM 28738543
DA 2020-12-08
ER

PT J
AU Stubbs, B
   Vancampfort, D
   Veronese, N
   Kahl, KG
   Mitchell, AJ
   Lin, PY
   Tseng, PT
   Mugisha, J
   Solmi, M
   Carvalho, AF
   Koyanagi, A
AF Stubbs, B.
   Vancampfort, D.
   Veronese, N.
   Kahl, K. G.
   Mitchell, A. J.
   Lin, P. -Y.
   Tseng, P. -T.
   Mugisha, J.
   Solmi, M.
   Carvalho, A. F.
   Koyanagi, A.
TI Depression and physical health multimorbidity: primary data and
   country-wide meta-analysis of population data from 190 593 people across
   43 low- and middle-income countries
SO PSYCHOLOGICAL MEDICINE
LA English
DT Article
DE Depression; low- and middle-income countries; multimorbidity; physical
   health; psychiatry
ID BIPOLAR DISORDER; RISK; CARE; SCHIZOPHRENIA; EPIDEMIOLOGY; MORTALITY;
   DISEASES
AB Background. Despite the known heightened risk and burden of various somatic diseases in people with depression, very little is known about physical health multimorbidity (i.e. two or more physical health co-morbidities) in individuals with depression. This study explored physical health multimorbidity in people with clinical depression, subsyndromal depression and brief depressive episode across 43 low-and middle-income countries (LMICs).
   Method. Cross-sectional, community-based data on 190 593 individuals from 43 LMICs recruited via the World Health Survey were analysed. Multivariable logistic regression analysis was done to assess the association between depression and physical multimorbidity.
   Results. Overall, two, three and four ormore physical health conditionswere present in 7.4, 2.4 and 0.9% of non-depressive individuals compared with 17.7, 9.1 and 4.9% among people with any depressive episode, respectively. Compared with thosewith no depression, subsyndromal depression, brief depressive episode and depressive episodewere significantly associated with 2.62, 2.14 and 3.44 times higher odds for multimorbidity, respectively. A significant positive association between multimorbidity and any depression was observed across 42 of the 43 countries, with particularly high odds ratios (ORs) in China (OR 8.84), Laos (OR 5.08), Ethiopia (OR 4.99), the Philippines (OR 4.81) and Malaysia (OR 4.58). The pooled OR for multimorbidity and depression estimated by meta-analysis across 43 countries was 3.26 (95% confident interval 2.98-3.57).
   Conclusions. Our large multinational study demonstrates that physical health multimorbidity is increased across the depression spectrum. Public health interventions are required to address this global health problem.
C1 [Stubbs, B.] South London & Maudsley NHS Fdn Trust, Physiotherapy Dept, Denmark Hill, London SE5 8AZ, England.
   [Stubbs, B.] Kings Coll London, Hlth Serv & Populat Res Dept, Inst Psychiat Psychol & Neurosci, De Crespigny Pk, London, England.
   [Vancampfort, D.] Katholieke Univ Leuven, Dept Rehabil Sci, Leuven, Belgium.
   [Vancampfort, D.] Katholieke Univ Leuven, Univ Psychiat Ctr, Leuven Kortenberg, Belgium.
   [Veronese, N.] Univ Padua, Div Geriatr, Dept Med, DIMED, Padua, Italy.
   [Veronese, N.] Inst Clin Res & Educ Med IREM, Padua, Italy.
   [Kahl, K. G.] Hannover Med Sch, Dept Psychiat Social Psychiat & Psychotherapy, Hannover, Germany.
   [Mitchell, A. J.] Univ Leicester, Dept Canc & Mol Med, Leicester, Leics, England.
   [Lin, P. -Y.] Kaohsiung Chang Gung Mem Hosp, Dept Psychiat, Kaohsiung, Taiwan.
   [Lin, P. -Y.] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.
   [Lin, P. -Y.] Kaohsiung Chang Gung Mem Hosp, Inst Translat Res Biomed Sci, Kaohsiung, Taiwan.
   [Tseng, P. -T.] Tsyr Huey Mental Hosp, Dept Psychiat, Kaohsiung Jen Ais Home, Kaohsiung, Taiwan.
   [Mugisha, J.] Kyambogo Univ, Kampala, Uganda.
   [Mugisha, J.] Butabika Natl Referral & Mental Hlth Hosp, Kampala, Uganda.
   [Solmi, M.] Univ Padua, Dept Neurosci, Padua, Italy.
   [Carvalho, A. F.] Univ Fed Ceara, Dept Clin Med, Fac Med, BR-60430040 Fortaleza, Ceara, Brazil.
   [Carvalho, A. F.] Univ Fed Ceara, Translat Psychiat Res Grp, Fac Med, BR-60430040 Fortaleza, Ceara, Brazil.
   [Koyanagi, A.] Univ Barcelona, Fundacio St Joan de Deu, Res & Dev Unit, Parc Sanitari St Joan de Deu,Dr Antoni Pujadas 42, Barcelona 08830, Spain.
   [Koyanagi, A.] Inst Salud Carlos III, Ctr Invest Biomed Red Salud Mental, CIBERSAM, Monforte Lemos 3-5 Pabellon 11, Madrid 28029, Spain.
RP Stubbs, B (corresponding author), South London & Maudsley NHS Fdn Trust, Physiotherapy Dept, Denmark Hill, London SE5 8AZ, England.
EM brendon.stubbs@kcl.ac.uk
RI Koyanagi, Ai/D-3833-2018; Stubbs, Brendon/X-1904-2018; Solmi,
   Marco/K-3906-2018; Vancampfort, Davy/AAD-1987-2019; Mitchell,
   Alex/Z-1920-2019; Lin, Pao-Yen/V-2495-2019; Mitchell, Alex J/A-3090-2009
OI Koyanagi, Ai/0000-0002-9565-5004; Stubbs, Brendon/0000-0001-7387-3791;
   Solmi, Marco/0000-0003-4877-7233; Mitchell, Alex/0000-0001-6014-598X;
   Mitchell, Alex J/0000-0001-6014-598X
FU National Institute for Health Research Collaboration for Leadership in
   Applied Health Research & Care Funding scheme; Miguel Servet contract -
   integrated into the National R + D + I [CP13/00150, PI15/00862]; ISCIII
   - General Branch Evaluation and Promotion of Health Research; European
   Regional Development Fund (ERDF-FEDER)European Union (EU); Research
   Foundation - Flanders (FWO - Vlaanderen)FWO
FX This article received no specific funding or grant. B.S. receives
   funding from the National Institute for Health Research Collaboration
   for Leadership in Applied Health Research & Care Funding scheme. The
   views expressed in this publication are those of the author(s) and not
   necessarily those of the National Health Service, the National Institute
   for Health Research or the Department of Health. A.K.'s work was
   supported by the Miguel Servet contract financed by the CP13/00150 and
   PI15/00862 projects, integrated into the National R + D + I and funded
   by the ISCIII - General Branch Evaluation and Promotion of Health
   Research - and the European Regional Development Fund (ERDF-FEDER). D.V.
   is funded by the Research Foundation - Flanders (FWO - Vlaanderen).
CR Ayuso-Mateos JL, 2010, BRIT J PSYCHIAT, V196, P365, DOI 10.1192/bjp.bp.109.071191
   Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2
   Correll CU, 2015, WORLD PSYCHIATRY, V14, P119, DOI 10.1002/wps.20204
   Di Angelantonio E, 2015, JAMA-J AM MED ASSOC, V314, P52, DOI 10.1001/jama.2015.7008
   Fortin Martin, 2004, Health Qual Life Outcomes, V2, P51, DOI 10.1186/1477-7525-2-51
   Fortin M, 2012, ANN FAM MED, V10, P142, DOI 10.1370/afm.1337
   Freeman EE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063315
   Gallo JJ, 2016, J GEN INTERN MED, V31, P380, DOI 10.1007/s11606-015-3524-y
   Garin N, 2016, J GERONTOL A-BIOL, V71, P205, DOI 10.1093/gerona/glv128
   Ghio L, 2015, J AFFECT DISORDERS, V175, P224, DOI 10.1016/j.jad.2015.01.014
   Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168
   Kessler RC, 2013, ANNU REV PUBL HEALTH, V34, P119, DOI 10.1146/annurev-publhealth-031912-114409
   Koyanagi A, 2016, PSYCHOL MED, V46, P2655, DOI 10.1017/S0033291716001422
   Lehnert T, 2011, MED CARE RES REV, V68, P387, DOI 10.1177/1077558711399580
   Ludwick JJ, 2009, AFR J PSYCHIATRY, V12, P287
   Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9
   Mugisha J, 2016, INT J MENT HEALTH SY, V10, DOI 10.1186/s13033-016-0057-7
   Oni T, 2014, BMC PUBLIC HEALTH, V14, P1
   Pan A, 2011, JAMA-J AM MED ASSOC, V306, P1241, DOI 10.1001/jama.2011.1282
   Ryan A, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0355-9
   Schuch F, 2017, J AFFECT DISORDERS, V210, P139, DOI 10.1016/j.jad.2016.10.050
   Smith DJ, 2014, J CLIN PSYCHIAT, V75, P1202, DOI 10.4088/JCP.14m09147
   Storr CL, 2010, TOB CONTROL, V19, P65, DOI 10.1136/tc.2009.032474
   Vancampfort D, 2016, WORLD PSYCHIATRY, V15, P166, DOI 10.1002/wps.20309
   Vancampfort D, 2015, WORLD PSYCHIATRY, V14, P339, DOI 10.1002/wps.20252
   Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6
NR 26
TC 38
Z9 38
U1 1
U2 10
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0033-2917
EI 1469-8978
J9 PSYCHOL MED
JI Psychol. Med.
PD SEP
PY 2017
VL 47
IS 12
BP 2107
EP 2117
DI 10.1017/S0033291717000551
PG 11
WC Psychology, Clinical; Psychiatry; Psychology
SC Psychology; Psychiatry
GA FD0EO
UT WOS:000407212800007
PM 28374652
DA 2020-12-08
ER

PT J
AU Verdolini, N
   Murru, A
   Attademo, L
   Garinella, R
   Pacchiarotti, I
   Bonnin, CDM
   Samalin, L
   Pauselli, L
   Piselli, M
   Tamantini, A
   Quartesan, R
   Carvalho, AF
   Vieta, E
   Tortorella, A
AF Verdolini, N.
   Murru, A.
   Attademo, L.
   Garinella, R.
   Pacchiarotti, I.
   Bonnin, C. del Mar
   Samalin, L.
   Pauselli, L.
   Piselli, M.
   Tamantini, A.
   Quartesan, R.
   Carvalho, A. F.
   Vieta, E.
   Tortorella, A.
TI The aggressor at the mirror: Psychiatric correlates of deliberate
   self-harm in male prison inmates
SO EUROPEAN PSYCHIATRY
LA English
DT Article
DE Deliberate self-harm; Forensic psychiatry; Affective disorders;
   Substance use disorders; Psychosis
ID BORDERLINE PERSONALITY-DISORDER; ADDICTION SEVERITY INDEX; SUBSTANCE USE
   DISORDERS; SUICIDE ATTEMPTS; MENTAL-HEALTH; RISK-FACTORS; DISTINGUISHING
   FEATURES; MUTILATION; BEHAVIOR; INJURY
AB Background: Deliberate self-harm (DSH) causes important concern in prison inmates as it worsens morbidity and increases the risk for suicide. The aim of the present study is to investigate the prevalence and correlates of DSH in a large sample of male prisoners.
   Methods: A cross-sectional study evaluated male prisoners aged 18+ years. Current and lifetime psychiatric diagnoses were assessed with the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders -DSM-IV Axis I and Axis II Disorders and with the Addiction Severity Index-Expanded Version. DSH was assessed with The Deliberate Self-Harm Inventory. Multivariable logistic regression models were used to identify independent correlates of lifetime DSH.
   Results: Ninety-three of 526 inmates (17.7%) reported at least 1 lifetime DSH behavior, and 58/93 (62.4%) of those reported a DSH act while in prison. After multivariable adjustment (sensitivity 41.9%, specificity 96.1%, area under the curve = 0.854, 95% confidence interval CI = 0.811-0.897, P < 0.001), DSH was significantly associated with lifetime psychotic disorders (adjusted Odds Ratio aOR = 6.227, 95% CI = 2.183-17.762, P = 0.001), borderline personality disorder (aOR = 6.004, 95% CI = 3.305-10.907, P < 0.001), affective disorders (aOR = 2.856, 95% CI = 1.350-6.039, P = 0.006) and misuse of multiple substances (aOR = 2.024, 95% CI = 1.111-3.687, P = 0.021).
   Conclusions: Borderline personality disorder and misuse of multiple substances are established risk factors of DSH, but psychotic and affective disorders were also associated with DSH in male prison inmates. This points to possible DSH-related clinical sub-groups, that bear specific treatment needs. (C) 2017 Elsevier Masson SAS. All rights reserved.
C1 [Verdolini, N.; Murru, A.; Pacchiarotti, I.; Bonnin, C. del Mar; Samalin, L.; Vieta, E.] Univ Barcelona, Hosp Clin, IDIBAPS CIBERSAM, Bipolar Disorders Unit,Inst Neurosci, C Villarroel 170,12-0, Barcelona 08036, Spain.
   [Verdolini, N.; Attademo, L.; Garinella, R.; Pauselli, L.; Quartesan, R.; Tortorella, A.] Univ Perugia, Santa Maria Misericordia Hosp, Dept Med, Div Psychiat Clin Psychol & Rehabil, Edificio Ellisse,8 Piano, I-06132 Perugia, Italy.
   [Attademo, L.] Azienda Sociosanit Terr Papa Giovanni XXIII, Dept Mental Hlth, Div Psychiat 1, Piazza OMS 1, I-24127 Bergamo, Italy.
   [Garinella, R.] Italian Minist Def, Ctr Selez & Reclutamento Nazl Esercito, Viale Mezzetti 2, I-06034 Perugia, Italy.
   [Samalin, L.] Univ Auvergne, CHU Clermont Ferrand, Dept Psychiat, EA 7280, 58 Rue Montalembert, F-63000 Clermont Ferrand, France.
   [Samalin, L.] Hop Albert Chenevier, Fdn FondaMental, Pole Psychiat, 40 Rue Mesly, F-94000 Creteil, France.
   [Pauselli, L.] Columbia Univ, Med Ctr, New York Psychiat Inst, 1051 Riverside Dr,Unit 100, New York, NY 10032 USA.
   [Piselli, M.; Tamantini, A.] Univ Perugia, Osped S Giovanni Battista, Serv Psichiatr Diag & Cura, Funct Area Psychiat,AUSL Umbria 2, Via Massimo Arcamone, I-06034 Perugia, Italy.
   [Carvalho, A. F.] Univ Fed Ceara, Fac Med, Dept Clin Med, Translat Psychiat Res Grp, Ave Univ 2853, BR-60020180 Fortaleza, CE, Brazil.
RP Vieta, E (corresponding author), Univ Barcelona, Hosp Clin, IDIBAPS CIBERSAM, Bipolar Disorders Unit,Inst Neurosci, C Villarroel 170,12-0, Barcelona 08036, Spain.
EM evieta@clinic.cat
RI Verdolini, Norma/AAJ-1114-2020; Vieta, Eduard/Y-2919-2019; Samalin,
   Ludovic/AAP-6362-2020; Attademo, Luigi/F-3041-2014
OI Verdolini, Norma/0000-0001-9488-2881; Vieta, Eduard/0000-0002-0548-0053;
   Attademo, Luigi/0000-0001-5976-6738; Bonnin, Caterina del
   Mar/0000-0002-1197-1596
FU Spanish Ministry of Economy and Competitiveness - ISCIII-Subdireccion
   General de Evaluacion; Fondo Europeo de Desarrollo Regional
   (FEDER)European Union (EU); CIBERSAM (Centro de Investigacion Biomedica
   en Red de Salud Mental); Secretaria d'Universitats i Recerca del
   Departament d'Economia i Coneixement [2014_SGR_398]; CERCA
   Programme/Generalitat de Catalunya
FX This work was supported by the Spanish Ministry of Economy and
   Competitiveness integrated into the Plan Nacional de I+D+I co-financed
   by the ISCIII-Subdireccion General de Evaluacion and the Fondo Europeo
   de Desarrollo Regional (FEDER); the CIBERSAM (Centro de Investigacion
   Biomedica en Red de Salud Mental); the Secretaria d'Universitats i
   Recerca del Departament d'Economia i Coneixement (2014_SGR_398); the
   CERCA Programme/Generalitat de Catalunya.
CR American Psychiatric Association, 2000, DIAGN STAT MAN MENT
   ARBOLEDAFLOREZ J, 1994, CAN J PSYCHIAT, V39, P161, DOI 10.1177/070674379403900308
   Blaauw E, 2005, SUICIDE LIFE-THREAT, V35, P63, DOI 10.1521/suli.35.1.63.59268
   Blackburn R, 1999, J PERS DISORD, V13, P18, DOI 10.1521/pedi.1999.13.1.18
   Carli V, 2011, CNS SPECTRUMS, V16, P75, DOI 10.1017/S1092852912000211
   Carli V, 2010, J AFFECT DISORDERS, V123, P116, DOI 10.1016/j.jad.2010.02.119
   Carry G, 2004, ADDICTION SEVERITY I
   Carter G, 2016, AUST NZ J PSYCHIAT, V50, P939, DOI 10.1177/0004867416661039
   Chapman AL, 2005, SUICIDE LIFE-THREAT, V35, P558, DOI 10.1521/suli.2005.35.5.558
   Daffern M., 2007, INT J FORENSIC MENT, V6, P137, DOI [10.1080/14999013.2007.10471258, DOI 10.1080/14999013.2007.10471258]
   Darke S, 2010, SUICIDE LIFE-THREAT, V40, P587, DOI 10.1521/suli.2010.40.6.587
   Davis TM, 2003, DRUG ALCOHOL DEPEN, V69, P197, DOI 10.1016/S0376-8716(02)00317-4
   Dixon-Gordon K, 2012, INT J FORENSIC MENT, V11, P33, DOI 10.1080/14999013.2012.667513
   DULIT RA, 1994, AM J PSYCHIAT, V151, P1305
   Eke N, 2000, BJU INT, V85, P295, DOI 10.1046/j.1464-410x.2000.00438.x
   Favazza AR, 1998, J NERV MENT DIS, V186, P259, DOI 10.1097/00005053-199805000-00001
   Fazel S, 2008, J CLIN PSYCHIAT, V69, P1721, DOI 10.4088/JCP.v69n1107
   Fazel S, 2016, LANCET PSYCHIAT, V3, P871, DOI 10.1016/S2215-0366(16)30142-0
   First MB, 1996, STRUCTURED CLIN INTE
   FIRST MB, 1997, STRUCURED CLIN INTER
   Fotiadou M, 2006, INT J LAW PSYCHIAT, V29, P68, DOI 10.1016/j.ijlp.2004.06.009
   Fruehwald S, 2004, BRIT J PSYCHIAT, V185, P494, DOI 10.1192/bjp.185.6.494
   Fulwiler C, 1997, J AM ACAD PSYCHIATRY, V25, P69
   Gorodetsky E, 2016, GENES BRAIN BEHAV
   Gratz KL, 2001, J PSYCHOPATHOL BEHAV, V23, P253, DOI 10.1023/A:1012779403943
   Gray NS, 2003, J CONSULT CLIN PSYCH, V71, P443, DOI 10.1037/0022-006X.71.3.443
   Gunter TD, 2013, J AM ACAD PSYCHIATRY, V41, P245
   Hawton K, 2015, J AFFECT DISORDERS, V175, P147, DOI 10.1016/j.jad.2014.12.062
   Hawton K, 2014, LANCET, V383, P1147, DOI 10.1016/S0140-6736(13)62118-2
   Haycocki j, 1949, PSYCHIAT QUART, V60, P45
   HILLBRAND M, 1994, J NERV MENT DIS, V182, P9, DOI 10.1097/00005053-199401000-00003
   Ireland JL, 2000, J ADOLESCENCE, V23, P605, DOI 10.1006/jado.2000.0347
   Jeglic EL, 2005, INT J OFFENDER THER, V49, P131, DOI 10.1177/0306624X04271130
   Justes M, 2004, J FORENSIC SCI, V49, P137
   Kashyap S, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0464-3
   KEMPTON T, 1992, BEHAV RES THER, V30, P537, DOI 10.1016/0005-7967(92)90038-I
   Kendall T, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d7073
   Kirchner T, 2008, SUICIDE LIFE-THREAT, V38, P442, DOI 10.1521/suli.2008.38.4.442
   Klonsky ED, 2007, CLIN PSYCHOL REV, V27, P226, DOI 10.1016/j.cpr.2006.08.002
   Krysinska K, 2006, CURR OPIN PSYCHIATR, V19, P95, DOI 10.1097/01.yco.0000191498.69281.5e
   Langbehn D R, 1993, Ann Clin Psychiatry, V5, P45, DOI 10.3109/10401239309148923
   Lohner J, 2006, INT J LAW PSYCHIAT, V29, P370, DOI 10.1016/j.ijlp.2006.03.004
   Mandelli L, 2011, J PSYCHIATR RES, V45, P742, DOI 10.1016/j.jpsychires.2010.11.005
   Mannion A, 2009, J FORENSIC PSYCHI PS, V20, P322, DOI 10.1080/14789940802377106
   Martin MS, 2014, CAN J PSYCHIAT, V59, P259
   MaZZi F, 2000, ASSESSMENT DISTURBI
   Mazzi F, 2003, ASSESSINENT DISTURL
   MCLELLAN AT, 1985, J NERV MENT DIS, V173, P412, DOI 10.1097/00005053-198507000-00005
   MCLELLAN AT, 1980, J NERV MENT DIS, V168, P26, DOI 10.1097/00005053-198001000-00006
   Morales YM, 2014, ISSUES MENT HEALTH N, V35, P628, DOI 10.3109/01612840.2014.927943
   National Collaborating Centre for Mental Health, 2004, SELF HARM SHORT TERM
   oberg D, 1999, ASI X V1 1
   Penn JV, 2003, J AM ACAD CHILD PSY, V42, P762, DOI 10.1097/01.CHI.0000046869.56865.46
   Perry AE, 2009, SOC PSYCH PSYCH EPID, V44, P853, DOI 10.1007/s00127-009-0007-7
   Perry AE, 2009, INT J OFFENDER THER, V53, P385, DOI 10.1177/0306624X08319418
   Peters RH, 2000, J SUBST ABUSE TREAT, V18, P349, DOI 10.1016/S0740-5472(99)00081-1
   Piselli M, 2015, INT J LAW PSYCHIAT, V41, P82, DOI 10.1016/j.ijlp.2015.03.011
   Rivlin A, 2010, BRIT J PSYCHIAT, V197, P313, DOI 10.1192/bjp.bp.110.077883
   Rossi Monti M, 2010, PSICHIATR F PSICOTER, V29, P47
   Sakelliadis EI, 2010, EUR PSYCHIAT, V25, P151, DOI 10.1016/j.eurpsy.2009.07.014
   Sarchiapone M, 2009, SUICIDE LIFE-THREAT, V39, P343, DOI 10.1521/suli.2009.39.3.343
   Sendula-Jengic Vesna, 2004, Psychiatr Danub, V16, P29
   Skegg K, 2005, LANCET, V366, P1471, DOI 10.1016/S0140-6736(05)67600-3
   SOLOFF PH, 1994, J PERS DISORD, V8, P257, DOI 10.1521/pedi.1994.8.4.257
   Turner BJ, 2015, PSYCHIAT RES, V230, P28, DOI 10.1016/j.psychres.2015.07.058
   Verona E, 2004, AM J PSYCHIAT, V161, P444, DOI 10.1176/appi.ajp.161.3.444
   Warren JI, 2002, J AM ACAD PSYCHIATRY, V30, P502
   WOOL RJ, 1987, MED SCI LAW, V27, P297, DOI 10.1177/002580248702700412
   Yon W, 2014, INT J APPL SCI TECHN, V4, P9
   Young MH, 2006, J FORENSIC SCI, V51, P156, DOI 10.1111/j.1556-4029.2005.00023.x
   Zanarini MC, 2007, AM J PSYCHIAT, V164, P929, DOI 10.1176/appi.ajp.164.6.929
   Zanarini MC, 2000, J PERS DISORD, V14, P291, DOI 10.1521/pedi.2000.14.4.291
   Zlotnick C, 1999, J NERV MENT DIS, V187, P296, DOI 10.1097/00005053-199905000-00005
NR 73
TC 10
Z9 10
U1 0
U2 10
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 0924-9338
EI 1778-3585
J9 EUR PSYCHIAT
JI Eur. Psychiat.
PD JUL
PY 2017
VL 44
BP 153
EP 160
DI 10.1016/j.eurpsy.2017.04.002
PG 8
WC Psychiatry
SC Psychiatry
GA FC8FK
UT WOS:000407077000020
PM 28641217
DA 2020-12-08
ER

PT J
AU Dias, LP
   Oliveira, JTA
   Rocha-Bezerra, LCB
   Sousa, DOB
   Costa, HPS
   Araujo, NMS
   Carvalho, AFU
   Tabosa, PMS
   Monteiro-Moreira, ACO
   Lobo, MDP
   Moreno, FBMB
   Rocha, BAM
   Lopes, JLS
   Beltramini, LM
   Vasconcelos, IM
AF Dias, Lucas P.
   Oliveira, Jose T. A.
   Rocha-Bezerra, Lady C. B.
   Sousa, Daniele O. B.
   Costa, Helen P. S.
   Araujo, Nadine M. S.
   Carvalho, Ana F. U.
   Tabosa, Pedro M. S.
   Monteiro-Moreira, Ana C. O.
   Lobo, Marina D. P.
   Moreno, Frederico B. M. B.
   Rocha, Bruno A. M.
   Lopes, Jose L. S.
   Beltramini, Leila M.
   Vasconcelos, Ilka M.
TI A trypsin inhibitor purified from Cassia leiandra seeds has insecticidal
   activity against Aedes aegypti
SO PROCESS BIOCHEMISTRY
LA English
DT Article
DE Cassia leiandra; Protease inhibitor; Ktnitz inhibitor; Insecticidal
   activity; Aedes aegypti; Biocontrol
ID KUNITZ PROTEINASE-INHIBITORS; PROTEASE INHIBITOR; HELICOVERPA-ARMIGERA;
   PURIFICATION; SERINE; LEAVES; L.; FLOWERS; IDENTIFICATION; ACCUMULATION
AB A trypsin inhibitor from Cassia leiandra seeds, named ClTI, was purified, characterized, and its insecticidal activity against Aedes aegypti evaluated. ClTI was purified by DEAE-Cellulose and trypsin-Sepharose 4B chromatography, with a 15.5-fold purification and 2.4% yield. ClTI is composed of a 19,484 Da polypeptide chain as revealed by mass spectrometry, it is not a glycoprotein, its amino acid sequence is similar to other Kunitz-type inhibitors, and it comprises 35% beta-sheets, 14% beta-turns, and 50% disordered secondary structures. ClTI is an uncompetitive inhibitor of bovine trypsin (IC50 of 33.81 x 10(-8)M, Ki of 6.25 x 10(-8) M) stable over a broad range of pHs (2.2-10.0) and temperatures (30-70 degrees C), but dithiothreitol led to a partial loss of the inhibitory activity. ClTI, at 4.65 x 10(-6) M, reduced in 50% the activity of the Ae. aegypti midgut proteases. ClTI also promoted acute toxicity on the 3rd instar larvae of Ae. aegypti, with an LC50 of 2.28 x 10(-2) M. Moreover, it caused a 24-h delay of the larvae development and 44% mortality after ten days of exposure. Altogether, these results suggest that ClTI has potential as a natural compound to control Ae. aegypti, a vector of several infection diseases.
C1 [Dias, Lucas P.; Oliveira, Jose T. A.; Rocha-Bezerra, Lady C. B.; Sousa, Daniele O. B.; Costa, Helen P. S.; Araujo, Nadine M. S.; Tabosa, Pedro M. S.; Lobo, Marina D. P.; Rocha, Bruno A. M.; Vasconcelos, Ilka M.] Univ Fed Ceara, Dept Biochem & Mol Biol, BR-60440900 Fortaleza, CE, Brazil.
   [Carvalho, Ana F. U.] Univ Fed Ceara, Dept Biol, BR-60440900 Fortaleza, CE, Brazil.
   [Monteiro-Moreira, Ana C. O.; Lobo, Marina D. P.; Moreno, Frederico B. M. B.] Univ Fortaleza, Sch Pharm, BR-60811905 Fortaleza, CE, Brazil.
   [Lopes, Jose L. S.; Beltramini, Leila M.] Univ Sao Paulo, Inst Phys, BR-05508090 Sao Carlos, SP, Brazil.
RP Vasconcelos, IM (corresponding author), Univ Fed Ceara, Dept Biochem & Mol Biol, BR-60440900 Fortaleza, CE, Brazil.
EM imvasco@ufc.br
RI Lopes, Jose L S/D-3213-2012; Carvalho, Ana/K-7344-2018; Beltramini,
   Leila M/I-5523-2012; Rocha, B.A.M./E-2919-2015; Monteiro-Moreira, Ana
   Cristina/F-3685-2014
OI Lopes, Jose L S/0000-0003-1281-0521; Carvalho, Ana/0000-0001-5293-9317;
   Beltramini, Leila M/0000-0001-5741-8238; Rocha,
   B.A.M./0000-0002-7157-0321; Monteiro-Moreira, Ana
   Cristina/0000-0002-3606-6808; Silva da Costa, Helen
   Paula/0000-0001-9949-2989
FU National Council for Scientific and Technological Development (CNPq),
   BrazilNational Council for Scientific and Technological Development
   (CNPq); Coordination of Improvement of Higher Education (CAPES,
   Toxinology Project and AUXPE - PRO-AMAZONIA), Brazil [3267/2013,
   23038009478]
FX This study was supported by the National Council for Scientific and
   Technological Development (CNPq) and the Coordination of Improvement of
   Higher Education (CAPES, Toxinology Project and AUXPE - PRO-AMAZONIA
   3267/2013, Project number 23038009478/2013-04), Brazil.
CR Abd El-Latif AO, 2014, PESTIC BIOCHEM PHYS, V116, P40, DOI 10.1016/j.pestbp.2014.09.009
   ABE M, 1992, EUR J BIOCHEM, V209, P933, DOI 10.1111/j.1432-1033.1992.tb17365.x
   Almeida LCP, 2017, PEST MANAG SCI, V73, P181, DOI 10.1002/ps.4284
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Ashouri S, 2017, BIOCATAL AGR BIOTECH, V9, P113, DOI 10.1016/j.bcab.2016.12.005
   Bezerra CD, 2016, PROCESS BIOCHEM, V51, P792, DOI 10.1016/j.procbio.2016.03.008
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bijina B, 2011, PROCESS BIOCHEM, V46, P2291, DOI 10.1016/j.procbio.2011.09.008
   Borovsky D, 2004, ARCH INSECT BIOCHEM, V55, P124, DOI 10.1002/arch.10132
   Botelho S, 2008, J AGR FOOD CHEM, V56, P9404, DOI 10.1021/jf8013266
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Chaudhary NS, 2008, PHYTOCHEMISTRY, V69, P2120, DOI 10.1016/j.phytochem.2008.05.002
   Costa HPS, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00005
   Cruz ACB, 2013, PLANT PHYSIOL BIOCH, V70, P61, DOI 10.1016/j.plaphy.2013.04.023
   da Silva DS, 2014, J INSECT PHYSIOL, V61, P1, DOI 10.1016/j.jinsphys.2013.11.012
   Dabhade AR, 2016, PROCESS BIOCHEM, V51, P659, DOI 10.1016/j.procbio.2016.02.015
   Damle MS, 2005, PHYTOCHEMISTRY, V66, P2659, DOI 10.1016/j.phytochem.2005.09.006
   Dantzger M, 2015, PHYTOCHEMISTRY, V118, P224, DOI 10.1016/j.phytochem.2015.08.013
   de Souza DD, 2016, S AFR J BOT, V104, P30, DOI 10.1016/j.sajb.2015.11.008
   DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170
   Ee KY, 2011, FOOD CHEM, V129, P1224, DOI 10.1016/j.foodchem.2011.05.026
   ERLANGER BF, 1961, ARCH BIOCHEM BIOPHYS, V95, P271, DOI 10.1016/0003-9861(61)90145-X
   Fan SG, 2005, BOT BULL ACAD SINICA, V46, P273
   Gandreddi VDS, 2015, BMC BIOCHEM, V16, DOI 10.1186/s12858-015-0052-7
   Ge Y, 2016, CELL DEATH DIFFER, V23, P1493, DOI 10.1038/cdd.2016.34
   Grosse-Holz FM, 2016, NEW PHYTOL, V210, P794, DOI 10.1111/nph.13839
   Guimaraes LC, 2015, PESTIC BIOCHEM PHYS, V118, P1, DOI 10.1016/j.pestbp.2014.12.001
   Hansen D, 2007, BIOCHEM BIOPH RES CO, V360, P735, DOI 10.1016/j.bbrc.2007.06.144
   Haq SK, 2003, J PROTEIN CHEM, V22, P543, DOI 10.1023/B:JOPC.0000005504.57372.5b
   Hemingway J, 1998, MED VET ENTOMOL, V12, P1, DOI 10.1046/j.1365-2915.1998.00082.x
   Iwanaga S, 2005, BIOSCI BIOTECH BIOCH, V69, P220, DOI 10.1271/bbb.69.220
   Jamal F, 2015, PROCESS BIOCHEM, V50, P311, DOI 10.1016/j.procbio.2014.12.003
   Joshi RS, 2013, BBA-GEN SUBJECTS, V1830, P5087, DOI 10.1016/j.bbagen.2013.07.019
   Kaur AP, 2016, J ASIA-PAC ENTOMOL, V19, P1183, DOI 10.1016/j.aspen.2016.10.012
   Klomklao S, 2011, FOOD CHEM, V129, P1348, DOI 10.1016/j.foodchem.2011.05.029
   Krishnan V.G.M., 2015, FOOD SCI HUM WELL, V4, P97, DOI DOI 10.1016/j.fshw.2015.06.003
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Macedo MLR, 2003, BBA-GEN SUBJECTS, V1621, P170, DOI 10.1016/S0304-4165(03)00055-2
   Macedo MLR, 2000, PHYTOCHEMISTRY, V54, P553, DOI 10.1016/S0031-9422(00)00155-2
   Migliolo L, 2010, J MOL GRAPH MODEL, V29, P148, DOI 10.1016/j.jmgm.2010.05.006
   Munusamy R. G., 2016, Asian Pacific Journal of Tropical Disease, V6, P468, DOI 10.1016/S2222-1808(16)61070-8
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Oddepally R, 2013, PHYTOCHEMISTRY, V96, P26, DOI 10.1016/j.phytochem.2013.09.010
   Oliva MLV, 2010, BIOCHIMIE, V92, P1667, DOI 10.1016/j.biochi.2010.03.021
   Padul MV, 2012, PLANT PHYSIOL BIOCH, V52, P77, DOI 10.1016/j.plaphy.2011.10.018
   Pandey PK, 2016, BIOCATAL AGRIC BIOTE, V6, P202, DOI 10.1016/j.bcab.2016.04.005
   Pandey PK, 2014, PESTIC BIOCHEM PHYS, V116, P94, DOI 10.1016/j.pestbp.2014.10.001
   Patthy A, 2015, ARCH BIOCHEM BIOPHYS, V565, P9, DOI 10.1016/j.abb.2014.11.001
   Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2
   Ponnusamy S, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1155/2011/515647
   Pontual EV, 2014, PARASITOL RES, V113, P727, DOI 10.1007/s00436-013-3702-y
   Prasad ER, 2010, PESTIC BIOCHEM PHYS, V98, P80, DOI 10.1016/j.pestbp.2010.05.003
   de Oliveira CFR, 2012, PROCESS BIOCHEM, V47, P929, DOI 10.1016/j.procbio.2012.02.022
   Reegan Appadurai Daniel, 2016, Parasite Epidemiol Control, V1, P78, DOI 10.1016/j.parepi.2016.03.004
   Rocha HDR, 2015, ACTA TROP, V152, P66, DOI 10.1016/j.actatropica.2015.08.013
   Richardson M., 1991, METHODS PLANT BIOCH
   Rufino FPS, 2013, PLANT PHYSIOL BIOCH, V63, P70, DOI 10.1016/j.plaphy.2012.11.013
   Sarwar M., 2014, J ECOL ENV SCI, V2, P24
   Sasaki NY, 2015, BIOCHIMIE, V112, P172, DOI 10.1016/j.biochi.2015.03.011
   Shah KR, 2016, INT J BIOL MACROMOL, V83, P259, DOI 10.1016/j.ijbiomac.2015.11.068
   Shamsi TN, 2016, INT J BIOL MACROMOL, V91, P1120, DOI 10.1016/j.ijbiomac.2016.02.069
   Sharma K, 2015, INT J CURR RES ACA R, V3, P55
   Silva RGG, 2015, IND CROP PROD, V70, P48, DOI 10.1016/j.indcrop.2015.02.058
   Soares TS, 2011, GENE, V489, P70, DOI 10.1016/j.gene.2011.08.018
   Stevens JA, 2013, INSECT BIOCHEM MOLEC, V43, P197, DOI 10.1016/j.ibmb.2012.11.006
   Sumikawa JT, 2010, PHYTOCHEMISTRY, V71, P214, DOI 10.1016/j.phytochem.2009.10.009
   Swathi M, 2014, PLANT PHYSIOL BIOCH, V83, P77, DOI 10.1016/j.plaphy.2014.07.009
   Tripathi VR, 2014, PROCESS BIOCHEM, V49, P347, DOI 10.1016/j.procbio.2013.11.007
   Viana C.A.S., 2011, PLANTAS AMAZONIA 450, P3140
   Oliva MLV, 2011, CURR PROTEIN PEPT SC, V12, P348
   Volpicella M, 2011, CURR PROTEIN PEPT SC, V12, P386, DOI 10.2174/138920311796391098
   WHO, 2016, DENG SEV DENG
   WHO, 2005, GUID LAB FIELD TEST
   ZACHARIUS RM, 1969, ANAL BIOCHEM, V30, P148, DOI 10.1016/0003-2697(69)90383-2
   Zhu-Salzman K, 2015, ANNU REV ENTOMOL, V60, P233, DOI 10.1146/annurev-ento-010814-020816
NR 75
TC 16
Z9 16
U1 0
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1359-5113
EI 1873-3298
J9 PROCESS BIOCHEM
JI Process Biochem.
PD JUN
PY 2017
VL 57
BP 228
EP 238
DI 10.1016/j.procbio.2017.03.015
PG 11
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Engineering, Chemical
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Engineering
GA EX3GW
UT WOS:000403121600027
OA Bronze
DA 2020-12-08
ER

PT J
AU Miskowiak, KW
   Kjaerstad, HL
   Stottrup, MM
   Svendsen, AM
   Demant, KM
   Hoeffding, LK
   Werge, TM
   Burdick, KE
   Domschke, K
   Carvalho, AF
   Vieta, E
   Vinberg, M
   Kessing, LV
   Siebner, HR
   Macoveanu, J
AF Miskowiak, K. W.
   Kjaerstad, H. L.
   Stottrup, M. M.
   Svendsen, A. M.
   Demant, K. M.
   Hoeffding, L. K.
   Werge, T. M.
   Burdick, K. E.
   Domschke, K.
   Carvalho, A. F.
   Vieta, E.
   Vinberg, M.
   Kessing, L. V.
   Siebner, H. R.
   Macoveanu, J.
TI The catechol-O-methyltransferase (COMT) Val158Met genotype modulates
   working memory-related dorsolateral prefrontal response and performance
   in bipolar disorder
SO BIPOLAR DISORDERS
LA English
DT Article
DE bipolar disorder; catechol-O-methyltransferase (COMT) Val158Met;
   functional magnetic resonance imaging (fMRI); working memory
ID DOPAMINE REGULATING GENES; COGNITIVE IMPAIRMENT; EXECUTIVE FUNCTION;
   VAL(108/158) MET; METAANALYSIS; ACTIVATION; MOOD; RISK; FMRI;
   SCHIZOPHRENIA
AB ObjectivesCognitive dysfunction affects a substantial proportion of patients with bipolar disorder (BD), and genetic-imaging paradigms may aid in the elucidation of mechanisms implicated in this symptomatic domain. The Val allele of the functional Val158Met polymorphism of the catechol-O-methyltransferase (COMT) gene is associated with reduced prefrontal cortex dopamine and exaggerated working memory-related prefrontal activity. This functional magnetic resonance imaging (fMRI) study investigated for the first time whether the COMT Val158Met genotype modulates prefrontal activity during spatial working memory in BD.
   MethodsSixty-four outpatients with BD in full or partial remission were stratified according to COMT Val158Met genotype (ValVal [n=13], ValMet [n=34], and MetMet [n=17]). The patients completed a spatial n-back working memory task during fMRI and the Cambridge Neuropsychological Test Automated Battery (CANTAB) Spatial Working Memory test outside the scanner.
   ResultsDuring high working memory load (2-back vs 1-back), Val homozygotes displayed decreased activity relative to ValMet individuals, with Met homozygotes displaying intermediate levels of activity in the right dorsolateral prefrontal cortex (dlPFC) (P=.016). Exploratory whole-brain analysis revealed a bilateral decrease in working memory-related dlPFC activity in the ValVal group vs the ValMet group which was not associated with differences in working memory performance during fMRI. Outside the MRI scanner, Val carriers performed worse in the CANTAB Spatial Working Memory task than Met homozygotes (P.006), with deficits being most pronounced in Val homozygotes.
   ConclusionsThe association between Val allelic load, dlPFC activity and WM impairment points to a putative role of aberrant PFC dopamine tonus in the cognitive impairments in BD.
C1 [Miskowiak, K. W.; Kjaerstad, H. L.; Stottrup, M. M.; Demant, K. M.; Vinberg, M.; Kessing, L. V.; Macoveanu, J.] Copenhagen Univ Hosp, Copenhagen Affect Disorder Res Ctr, Rigshosp, Psychiat Ctr Copenhagen, Copenhagen, Denmark.
   [Miskowiak, K. W.; Siebner, H. R.; Macoveanu, J.] Univ Copenhagen, Danish Res Ctr Magnet Resonance, Ctr Funct & Diagnost Imaging & Res, Hvidovre Hosp, Copenhagen, Denmark.
   [Svendsen, A. M.] Mental Hlth Ctr Copenhagen, Copenhagen, Denmark.
   [Hoeffding, L. K.; Werge, T. M.] MHC Sct Hans, Inst Biol Psychiat, Mental Hlth Serv, Copenhagen, Denmark.
   [Hoeffding, L. K.; Werge, T. M.] Lundbeck Fdn Initiat Integrat Psychiat Res, IPSYCH, Aarhus, Denmark.
   [Hoeffding, L. K.] Univ Hosp Copenhagen, Dept Clin Immunol, Rigshosp, Copenhagen, Denmark.
   [Werge, T. M.] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark.
   [Burdick, K. E.] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA.
   [Domschke, K.] Univ Freiburg, Dept Psychiat, Freiburg, Germany.
   [Carvalho, A. F.] Univ Fed Ceara, Translat Psychiat Res Grp, Fortaleza, Ceara, Brazil.
   [Carvalho, A. F.] Univ Fed Ceara, Dept Clin Med, Fortaleza, Ceara, Brazil.
   [Vieta, E.] Univ Barcelona, Clin Inst Neurosci,Hosp Clin, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.
   [Siebner, H. R.] Copenhagen Univ Hosp, Dept Neurol, Bispebjerg, Denmark.
RP Miskowiak, KW (corresponding author), Copenhagen Univ Hosp, Psychiat Ctr Copenhagen, CADIC, Rigshosp, Copenhagen, Denmark.
EM Kamilla@miskowiak.dk
RI Macoveanu, Julian/H-4256-2019; Vieta, Eduard/Y-2919-2019
OI Macoveanu, Julian/0000-0001-6148-9477; Vieta,
   Eduard/0000-0002-0548-0053; Kjaerstad, Hanne Lie/0000-0001-7781-8853;
   Kessing, Lars/0000-0001-9377-9436; Miskowiak,
   Kamilla/0000-0003-2572-1384; Vinberg, Maj/0000-0002-5982-1335
FU Lundbeck FoundationLundbeckfonden [R219-2016-1030]; TrygFonden; Danish
   Council for Independent ResearchDet Frie Forskningsrad (DFF); Novo
   Nordisk FoundationNovo Nordisk Foundation [R144-A11605]; Beckett Fonden
   [525 PV/LS]; Savvaerksejer Juhl's Mindefond; Danish Council for
   Independent ResearchDet Frie Forskningsrad (DFF) [271-08-0937]; Lundbeck
   FoundationLundbeckfonden [R186-2015-2138, R155-2014-1724] Funding
   Source: researchfish
FX Lundbeck Foundation, Grant/Award Number: R219-2016-1030; TrygFonden;
   Danish Council for Independent Research; Novo Nordisk Foundation;
   Grant/Award Number: R144-A11605; Beckett Fonden; Grant/Award Number: 525
   PV/LS; Savvaerksejer Juhl's Mindefond; Danish Council for Independent
   Research; Grant/Award Number: 271-08-0937
CR Aguilera M, 2008, AM J MED GENET B, V147B, P898, DOI 10.1002/ajmg.b.30705
   Arts B, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-63
   Berk M, 2007, ACTA PSYCHIAT SCAND, V116, P41, DOI 10.1111/j.1600-0447.2007.01058.x
   Bertolino A, 2006, J NEUROSCI, V26, P3918, DOI 10.1523/JNEUROSCI.4975-05.2006
   Bertolino A, 2008, BIOL PSYCHIAT, V64, P226, DOI 10.1016/j.biopsych.2008.02.001
   Blanchard MM, 2011, PSYCHOL MED, V41, P611, DOI 10.1017/S003329171000098X
   Bora E, 2009, J AFFECT DISORDERS, V113, P1, DOI 10.1016/j.jad.2008.06.009
   Bourne C, 2013, ACTA PSYCHIAT SCAND, V128, P149, DOI 10.1111/acps.12133
   Bressan RA, 2002, SCHIZOPHR RES, V56, P31, DOI 10.1016/S0920-9964(01)00185-2
   Burdick KE, 2007, BIPOLAR DISORD, V9, P370, DOI 10.1111/j.1399-5618.2007.00384.x
   Burdick KE, 2012, J CLIN PSYCHIAT, V73, P103, DOI 10.4088/JCP.11m07299
   Caldu X, 2007, NEUROIMAGE, V37, P1437, DOI 10.1016/j.neuroimage.2007.06.021
   de Frias CM, 2010, J COGNITIVE NEUROSCI, V22, P1614, DOI 10.1162/jocn.2009.21318
   Demant KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127955
   Demant KM, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-378
   Depp CA, 2012, BIPOLAR DISORD, V14, P217, DOI 10.1111/j.1399-5618.2012.01011.x
   Drapier D, 2008, BIOL PSYCHIAT, V64, P513, DOI 10.1016/j.biopsych.2008.04.038
   Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598
   Farrell SM, 2012, BIOL PSYCHIAT, V71, P538, DOI 10.1016/j.biopsych.2011.12.023
   Fava M, 2009, PSYCHOTHER PSYCHOSOM, V78, P91, DOI 10.1159/000201934
   Fernandez-Corcuera P, 2013, J AFFECT DISORDERS, V148, P170, DOI 10.1016/j.jad.2012.04.009
   Flint J, 2007, PSYCHOL MED, V37, P163, DOI 10.1017/S0033291706008750
   Frangou S, 2008, EUR PSYCHIAT, V23, P300, DOI 10.1016/j.eurpsy.2007.05.002
   Giakoumaki SG, 2008, NEUROPSYCHOPHARMACOL, V33, P3058, DOI 10.1038/npp.2008.82
   Gonzalez-Castillo J, 2011, NEUROIMAGE, V54, P2764, DOI 10.1016/j.neuroimage.2010.11.020
   GRIER JB, 1971, PSYCHOL BULL, V75, P424, DOI 10.1037/h0031246
   Haas BW, 2007, BEHAV NEUROSCI, V121, P249, DOI 10.1037/0735-7044.121.2.249
   Hamilton LS, 2009, HUM BRAIN MAPP, V30, P3958, DOI 10.1002/hbm.20820
   Ihne JL, 2016, CORTEX, V74, P79, DOI 10.1016/j.cortex.2015.10.025
   Lambert G, 2000, ARCH GEN PSYCHIAT, V57, P787, DOI 10.1001/archpsyc.57.8.787
   Leung Winnie W, 2007, Neuropsychiatr Dis Treat, V3, P925
   Lim CS, 2013, NEUROSCI BIOBEHAV R, V37, P418, DOI 10.1016/j.neubiorev.2013.01.003
   Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1
   Malhi GS, 2015, BIPOLAR DISORD, V17, P3, DOI 10.1111/bdi.12353
   Martinez-Aran A, 2015, EUR NEUROPSYCHOPHARM, V25, P151, DOI 10.1016/j.euroneuro.2015.01.007
   Mattay VS, 2003, P NATL ACAD SCI USA, V100, P6186, DOI 10.1073/pnas.0931309100
   McDonald J.H., 2014, HDB BIOL STAT
   Meyer-Lindenberg A, 2006, MOL PSYCHIATR, V11, P867, DOI 10.1038/sj.mp.4001860
   Mier D, 2010, MOL PSYCHIATR, V15, P918, DOI 10.1038/mp.2009.36
   Minzenberg MJ, 2009, ARCH GEN PSYCHIAT, V66, P811, DOI 10.1001/archgenpsychiatry.2009.91
   Miskowiak KW, 2016, EUR NEUROPSYCHOPHARM, V26, P1845, DOI 10.1016/j.euroneuro.2016.09.641
   Miskowiak KW, 2016, PSYCHOL MED, V46, P1679, DOI 10.1017/S0033291716000209
   Miskowiak KW, 2014, J CLIN PSYCHIAT, V75, P1347, DOI 10.4088/JCP.13m08839
   Monks PJ, 2004, BIPOLAR DISORD, V6, P550, DOI 10.1111/j.1399-5618.2004.00147.x
   Papenberg G, 2014, PSYCHOL AGING, V29, P374, DOI 10.1037/a0033225
   Pathak G, 2015, NEUROPHARMACOLOGY, V95, P434, DOI 10.1016/j.neuropharm.2015.04.026
   Pomarol-Clotet E, 2015, BRIT J PSYCHIAT, V206, P136, DOI 10.1192/bjp.bp.114.152033
   Rajkowska G, 2001, BIOL PSYCHIAT, V49, P741, DOI 10.1016/S0006-3223(01)01080-0
   Schacht JP, 2016, PHARMACOGENOMICS J, V16, P430, DOI 10.1038/tpj.2016.43
   Soeiro-de-Souza MG, 2012, BIPOLAR DISORD, V14, P554, DOI 10.1111/j.1399-5618.2012.01030.x
   Sundermann EE, 2015, J NEUROVIROL, V21, P81, DOI 10.1007/s13365-014-0305-z
   Talairach J., 1988, COPLANAR STEREOTAXIC
   Tan HY, 2007, P NATL ACAD SCI USA, V104, P12536, DOI 10.1073/pnas.0610125104
   Thermenos HW, 2010, AM J MED GENET B, V153B, P120, DOI 10.1002/ajmg.b.30964
   Townsend J, 2010, PSYCHIAT RES-NEUROIM, V182, P22, DOI 10.1016/j.pscychresns.2009.11.010
   Tunbridge EM, 2006, BIOL PSYCHIAT, V60, P141, DOI 10.1016/j.biopsych.2005.10.024
   Tunbridge EM, 2011, CURR TOP BEHAV NEURO, V8, P119, DOI 10.1007/7854_2010_97
   Verhoeff NPLG, 2003, PHARMACOL BIOCHEM BE, V74, P425, DOI 10.1016/S0091-3057(02)01028-6
   Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255
   Wardle MC, 2013, NEUROPSYCHOPHARMACOL, V38, P1253, DOI 10.1038/npp.2013.24
   Wheaton MG, 2014, BIOL PSYCHOL, V101, P13, DOI 10.1016/j.biopsycho.2014.06.004
   Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060
   Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931
   Zarate CA, 2004, BIOL PSYCHIAT, V56, P54, DOI 10.1016/j.biopsych.2004.03.013
NR 64
TC 14
Z9 14
U1 0
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1398-5647
EI 1399-5618
J9 BIPOLAR DISORD
JI Bipolar Disord.
PD MAY
PY 2017
VL 19
IS 3
BP 214
EP 224
DI 10.1111/bdi.12497
PG 11
WC Clinical Neurology; Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA EX5FZ
UT WOS:000403265200006
PM 28544426
OA Green Published
DA 2020-12-08
ER

PT J
AU Neto, JJL
   de Almeida, TS
   de Medeirosa, JL
   Vieira, LR
   Moreira, TB
   Maia, AIV
   Ribeiro, PRV
   de Brito, ES
   Farias, DF
   Carvalho, AFU
AF Lopes Neto, Jose Joaquim
   de Almeida, Thiago Silva
   de Medeirosa, Jackeline Lima
   Vieira, Leonardo Rogerio
   Moreira, Thais Borges
   Vitorino Maia, Ana Isabel
   Vasconcelos Ribeiro, Paulo Riceli
   de Brito, Edy Sousa
   Farias, Davi Felipe
   Urano Carvalho, Ana Fontenele
TI Impact of bioaccessibility and bioavailability of phenolic compounds in
   biological systems upon the antioxidant activity of the ethanolic
   extract of Triplaris gardneriana seeds
SO BIOMEDICINE & PHARMACOTHERAPY
LA English
DT Article
DE In vitro digestion; In vivo study; UPLC-QTOF analysis; Pharmacokinetics
ID VITRO BIO-ACCESSIBILITY; IN-VITRO; POLYPHENOLS; L.; ABSORPTION;
   CAPACITY; PLANTS; ACID; PHYTOCHEMICALS; METABOLISM
AB The most studied bioactive potential of phenolic compounds corresponds to antioxidant activity, which in turn, is associated with a reduction in the incidence of various human diseases. However, the total quantity of these bioactive substances in foods and medicinal preparations does not reflect the amount absorbed and metabolized by the body. The present study aimed to investigate the bioaccessibility of Triplaris gardneriana seeds ethanolic extract (EETg) by determination of phenolic composition and antioxidant activities before and after in vitro digestion as well as to estimate its bioavailability by chemical analysis of plasma and urine in animal models after oral administration. The bioaccessibility indexes of phenolic compounds in EETg were 48.65 and 69.28% in the presence and absence of enzymes, respectively. Among the identified phenolics classes, flavonoids, represented by galloylated procyanidins type B, proved to be more bioaccessible, 81.48 and 96.29% in the post-intestinal phase with and without enzymes, respectively. The oral administration in Wistar rats resulted in a significant decrease in plasma of the total antioxidant capacity, TAC, by FRAP assay 4 h after beginning the experiment. For urine samples, an increase in TAC by DPPH and FRAP was observed from 1 and 4 h after administration, respectively. UPLC-QTOF analysis of urine detected 2 metabolites originated from the degradation of phenolic compounds, i.e. hippuric acid and phenylacetil glycine. These results suggest that phenolic compounds in T. gardneriana are unstable under gastrointestinal conditions, being flavonoids the components with higher bioaccessibility; besides that, they showed limited bioavailability due to their rapid biotransformation and urinary elimination. (C) 2017 Elsevier Masson SAS. All rights reserved.
C1 [Lopes Neto, Jose Joaquim; de Almeida, Thiago Silva; de Medeirosa, Jackeline Lima; Vieira, Leonardo Rogerio; Moreira, Thais Borges; Farias, Davi Felipe; Urano Carvalho, Ana Fontenele] Univ Fed Ceara, Dept Biochem & Mol Biol, BR-60020181 Fortaleza, CE, Brazil.
   [Vitorino Maia, Ana Isabel; Vasconcelos Ribeiro, Paulo Riceli; de Brito, Edy Sousa] Embrapa Trop Agroind, BR-60511110 Fortaleza, CE, Brazil.
   [Farias, Davi Felipe] Univ Fed Paraiba, Dept Mol Biol, BR-58051900 Joao Pessoa, PB, Brazil.
RP Carvalho, AFU (corresponding author), Univ Fed Ceara, Dept Biochem & Mol Biol, BR-60020181 Fortaleza, CE, Brazil.
EM aurano@ufc.br
RI Carvalho, Ana/K-7344-2018; Lopes Neto, Jose Joaquim/M-1979-2018;
   Ribeiro, Paulo Riceli Vasconcelos/P-4672-2019; Farias, Davi
   Felipe/AAH-1868-2020; Almeida, Thiago S./L-9833-2013; de Brito, Edy
   Sousa/I-3587-2012
OI Carvalho, Ana/0000-0001-5293-9317; Almeida, Thiago
   S./0000-0002-7401-0637; de Brito, Edy Sousa/0000-0003-4084-8076; Felipe
   Farias, Davi/0000-0001-5438-1919; Rogerio Vieira,
   Leonardo/0000-0002-8505-941X
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES),
   BrazilCAPES [23038.007715/2013-94]
FX This work was supported by Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES), Brazil [Grant: PVE Proc. No.
   23038.007715/2013-94].
CR Abu-Reidah IM, 2015, FOOD CHEM, V166, P179, DOI 10.1016/j.foodchem.2014.06.011
   Alminger M, 2014, COMPR REV FOOD SCI F, V13, P413, DOI 10.1111/1541-4337.12081
   Andriamadio JH, 2015, NAT PROD RES, V29, P2188, DOI 10.1080/14786419.2015.1007458
   Benzie IFF, 1999, METHOD ENZYMOL, V299, P15
   Borges G, 2007, MOL NUTR FOOD RES, V51, P714, DOI 10.1002/mnfr.200700024
   Carbonell-Capella JM, 2014, COMPR REV FOOD SCI F, V13, P155, DOI 10.1111/1541-4337.12049
   Cartaxo SL, 2010, J ETHNOPHARMACOL, V131, P326, DOI 10.1016/j.jep.2010.07.003
   Cheynier V, 2013, PLANT PHYSIOL BIOCH, V72, P1, DOI 10.1016/j.plaphy.2013.05.009
   Chiang CJ, 2013, LWT-FOOD SCI TECHNOL, V51, P417, DOI 10.1016/j.lwt.2012.11.014
   Crozier A, 2010, MOL ASPECTS MED, V31, P446, DOI 10.1016/j.mam.2010.09.007
   D'Antuono I, 2015, FOOD FUNCT, V6, P1268, DOI [10.1039/C5FO00137D, 10.1039/c5fo00137d]
   da Silva MAB, 2010, REV BRAS FARMACOGN, V20, P549, DOI 10.1590/S0102-695X2010000400014
   de Oliveira DM, 2011, QUIM NOVA, V34, P1051, DOI 10.1590/S0100-40422011000600023
   DEPAULA JE, 1993, PESQUI AGROPECU BRAS, V28, P153
   Farias DF, 2013, BIOMED RES INT, V2013, DOI [10.1155/2013/605831, 10.1155/2013/510736, 10.1155/2013/340605, 10.1155/2013/263509]
   Ferruzzi MG, 2009, J ALZHEIMERS DIS, V18, P113, DOI 10.3233/JAD-2009-1135
   Flamini R., 2013, ISRN CHROMATOGR, V2013
   Fukumoto LR, 2000, J AGR FOOD CHEM, V48, P3597, DOI 10.1021/jf000220w
   Funari C. S., 2006, CIENC TECNOL ALIMENT, V26, P71
   Galleano M, 2010, ARCH BIOCHEM BIOPHYS, V501, P23, DOI 10.1016/j.abb.2010.04.005
   Garbetta A, 2014, J FUNCT FOODS, V10, P456, DOI 10.1016/j.jff.2014.07.019
   Gawlik-Dziki U, 2012, J FUNCT FOODS, V4, P872, DOI 10.1016/j.jff.2012.06.004
   Gleichenhagen M, 2016, CURR OPIN FOOD SCI, V7, P43, DOI 10.1016/j.cofs.2015.10.004
   Hassimotto NMA, 2008, NUTR RES, V28, P198, DOI 10.1016/j.nutres.2007.12.012
   Helal A, 2014, J FUNCT FOODS, V7, P506, DOI 10.1016/j.jff.2014.01.005
   Jakobek L, 2015, FOOD CHEM, V175, P556, DOI 10.1016/j.foodchem.2014.12.013
   Jayawardena N, 2015, PLANT FOOD HUM NUTR, V70, P71, DOI 10.1007/s11130-014-0463-4
   Jia F, 2016, ANAL METHODS-UK, V8, P3088, DOI 10.1039/c6ay00260a
   Jilani H, 2016, IND CROP PROD, V84, P131, DOI 10.1016/j.indcrop.2016.02.002
   Kroll NG, 2003, FOOD SCI TECHNOL RES, V9, P205
   Krzyzanowska J, 2010, ADV EXP MED BIOL, V698, P74
   Laurent C, 2007, FOOD CHEM, V100, P1704, DOI 10.1016/j.foodchem.2005.10.016
   Li XC, 1999, PLANTA MED, V65, P780, DOI 10.1055/s-2006-960871
   Liu YJ, 2012, J BIOL CHEM, V287, P44406, DOI 10.1074/jbc.M112.403071
   Lucena RFP, 2007, ENVIRON MONIT ASSESS, V125, P281, DOI 10.1007/s10661-006-9521-1
   Macedo S. K. S., 2015, Journal of Medicinal Plants Research, V9, P207
   Martins N, 2016, TRENDS FOOD SCI TECH, V48, P1, DOI 10.1016/j.tifs.2015.11.008
   MATSUMOTO M, 1995, J VET MED SCI, V57, P205, DOI 10.1292/jvms.57.205
   Melo E., 2000, ACTA BOT BRAS, V14, P273, DOI DOI 10.1590/S0102-33062000000300006
   Moreno-Murillo B, 2008, REV COLOMB QUIM, V37, P287
   Mulder TP, 2005, AM J CLIN NUTR, V81, p256S, DOI 10.1093/ajcn/81.1.256S
   Oliveira PES, 2008, BIOCHEM SYST ECOL, V36, P134, DOI 10.1016/j.bse.2007.06.001
   Palafox-Carlos H, 2011, J FOOD SCI, V76, pR6, DOI 10.1111/j.1750-3841.2010.01957.x
   Pereira Júnior Lécio Resende, 2014, Floresta Ambient., V21, P509, DOI 10.1590/2179-8087.024212
   Ramirez-Moreno E, 2011, INT J FOOD SCI NUTR, V62, P839, DOI 10.3109/09637486.2011.580731
   Russo D., 2013, ISRN CHROMATOGR, V2013
   Santos AC, 2014, CURR DRUG METAB, V15, P96, DOI 10.2174/1389200214666131211155028
   Sauer JM, 1997, DRUG METAB DISPOS, V25, P732
   SAVIC IM, 2014, ADV TECHNOL, V3, P30, DOI DOI 10.5937/savteh1401030S
   Scalbert A, 2002, BIOMED PHARMACOTHER, V56, P276, DOI 10.1016/S0753-3322(02)00205-6
   Serra A, 2010, BRIT J NUTR, V103, P944, DOI 10.1017/S0007114509992741
   Singleton VL, 1999, METHOD ENZYMOL, V299, P152
   Tagliazucchi D, 2012, J FOOD BIOCHEM, V36, P555, DOI 10.1111/j.1745-4514.2011.00569.x
   Tagliazucchi D, 2010, FOOD CHEM, V120, P599, DOI 10.1016/j.foodchem.2009.10.030
   Wyrepkowski CC, 2014, MOLECULES, V19, P16039, DOI 10.3390/molecules191016039
NR 55
TC 13
Z9 13
U1 6
U2 53
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0753-3322
EI 1950-6007
J9 BIOMED PHARMACOTHER
JI Biomed. Pharmacother.
PD APR
PY 2017
VL 88
BP 999
EP 1007
DI 10.1016/j.biopha.2017.01.109
PG 9
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA EM7YJ
UT WOS:000395528000119
PM 28178632
DA 2020-12-08
ER

PT J
AU Solmi, M
   Veronese, N
   Beatrice, B
   Stella, R
   Paolo, S
   Davide, G
   Collantoni, E
   Pigato, G
   Favaro, A
   Stubbs, B
   Carvalho, AF
   Vacampfort, D
   Correll, CU
AF Solmi, M.
   Veronese, N.
   Beatrice, B.
   Stella, R.
   Paolo, S.
   Davide, G.
   Collantoni, E.
   Pigato, G.
   Favaro, A.
   Stubbs, B.
   Carvalho, A. F.
   Vacampfort, D.
   Correll, C. U.
TI Prevalence, incidence and comparative meta-analysis of all-cause and
   specific-cause cardiovascular disease in patients with serious mental
   illness
SO EUROPEAN PSYCHIATRY
LA English
DT Meeting Abstract
C1 [Solmi, M.; Stella, R.; Paolo, S.; Davide, G.; Collantoni, E.; Pigato, G.; Favaro, A.] Univ Padua, Neurosci Dept, Padua, Italy.
   [Solmi, M.; Veronese, N.; Beatrice, B.] Inst Clin Res & Educ Med, Neurosci Dept, Padua, Italy.
   [Solmi, M.] ULSS 17, Dept Mental Hlth, Padua, Italy.
   [Veronese, N.] Univ Padua, Dept Med, Padua, Italy.
   [Beatrice, B.] ULSS 10, Dept Mental Hlth, Portogruaro, Italy.
   [Stubbs, B.] South London & Maudsley NHS Fdn Trust, Physiotherapy Dept, London, England.
   [Stubbs, B.] Kings Coll London, Hlth Serv & Populat Res Dept, Inst Psychiat Psychol & Neurosci, London, England.
   [Carvalho, A. F.] Univ Fed Ceara, Fac Med, Dept Clin Med, Fortaleza, Ceara, Brazil.
   [Carvalho, A. F.] Univ Fed Ceara, Fac Med, Translat Psychiat Res Grp, Fortaleza, Ceara, Brazil.
   [Vacampfort, D.] Katholieke Univ Leuven, Dept Rehabil Sci, Leuven, Belgium.
   [Vacampfort, D.] Katholieke Univ Leuven, Univ Psychiat Ctr, Leuven, Belgium.
   [Correll, C. U.] Zucker Hillside Hosp, Psychiat Res, New York, NY USA.
   [Correll, C. U.] Albert Einstein Coll Med, Med, New York, NY USA.
   [Correll, C. U.] Feinstein Inst Med Res, Res, New York, NY USA.
   [Correll, C. U.] Hofstra Northwell Sch Med, Med, New York, NY USA.
RI Solmi, Marco/K-3906-2018; Correll, Christoph U/D-3530-2011; Stubbs,
   Brendon/X-1904-2018
OI Solmi, Marco/0000-0003-4877-7233; Correll, Christoph
   U/0000-0002-7254-5646; Stubbs, Brendon/0000-0001-7387-3791
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 0924-9338
EI 1778-3585
J9 EUR PSYCHIAT
JI Eur. Psychiat.
PD APR
PY 2017
VL 41
SU S
MA EW0624
BP S319
EP S320
DI 10.1016/j.eurpsy.2017.02.238
PG 2
WC Psychiatry
SC Psychiatry
GA EZ8CQ
UT WOS:000404952400053
DA 2020-12-08
ER

PT J
AU Paula, PC
   Sousa, DOB
   Oliveira, JTA
   Carvalho, AFU
   Alves, BGT
   Pereira, ML
   Farias, DF
   Viana, MP
   Santos, FA
   Morais, TC
   Vasconcelos, IM
AF Paula, Paulo C.
   Sousa, Daniele O. B.
   Oliveira, Jose T. A.
   Carvalho, Ana F. U.
   Alves, Bella G. T.
   Pereira, Mirella L.
   Farias, Davi F.
   Viana, Martonio P.
   Santos, Flavia A.
   Morais, Talita C.
   Vasconcelos, Ilka M.
TI A Protein Isolate from Moringa oleifera Leaves Has Hypoglycemic and
   Antioxidant Effects in Alloxan-Induced Diabetic Mice
SO MOLECULES
LA English
DT Article
DE Moringa; plant protein; hypoglycemic activity; antioxidant activity;
   diabetes therapy
ID CHITIN-BINDING PROTEIN; AQUEOUS EXTRACT; SUPEROXIDE-DISMUTASE;
   INSULIN-SECRETAGOGUE; SEQUENCE HOMOLOGY; LEAF EXTRACT; PURIFICATION;
   THERAPY; ENZYME; SEED
AB Moringa oleifera has been used in traditional medicine to treat diabetes. However, few studies have been conducted to relate its antidiabetic properties to proteins. In this study, a leaf protein isolate was obtained from M. oleifera leaves, named Mo-LPI, and the hypoglycemic and antioxidant effects on alloxan-induced diabetic mice were assessed. Mo-LPI was obtained by aqueous extraction, ammonium sulphate precipitation and dialysis. The electrophoresis profile and proteolytic hydrolysis confirmed its protein nature. Mo-LPI showed hemagglutinating activity, cross-reaction with anti-insulin antibodies and precipitation after zinc addition. Single-dose intraperitoneal (i.p.) administration of Mo-LPI (500 mg/kg<bold>bw</bold>) reduced the blood glucose level (reductions of 34.3%, 60.9% and 66.4% after 1, 3 and 5 h, respectively). The effect of Mo-LPI was also evidenced in the repeated dose test with a 56.2% reduction in the blood glucose level on the 7th day after i.p. administration. Mo-LPI did not stimulate insulin secretion in diabetic mice. Mo-LPI was also effective in reducing the oxidative stress in diabetic mice by a decrease in malondialdehyde level and increase in catalase activity. Mo-LPI (2500 mg/kg<bold>bw</bold>) did not cause acute toxicity to mice. Mo-LPI is a promising alternative or complementary agent to treat diabetes.
C1 [Paula, Paulo C.; Sousa, Daniele O. B.; Oliveira, Jose T. A.; Alves, Bella G. T.; Pereira, Mirella L.; Farias, Davi F.; Viana, Martonio P.; Vasconcelos, Ilka M.] Univ Fed Ceara, Dept Biochem & Mol Biol, BR-60440900 Fortaleza, Ceara, Brazil.
   [Carvalho, Ana F. U.] Univ Fed Ceara, Dept Biol, BR-60440900 Fortaleza, Ceara, Brazil.
   [Farias, Davi F.] Univ Fed Paraiba, Dept Mol Biol, BR-58051900 Joao Pessoa, Paraiba, Brazil.
   [Santos, Flavia A.; Morais, Talita C.] Univ Fed Ceara, Dept Physiol & Pharmacol, BR-60430160 Fortaleza, Ceara, Brazil.
RP Sousa, DOB; Vasconcelos, IM (corresponding author), Univ Fed Ceara, Dept Biochem & Mol Biol, BR-60440900 Fortaleza, Ceara, Brazil.
EM paulolevemir@gmail.com; danisilas@yahoo.com.br; jtaolive@ufc.br;
   aurano@ufc.br; bellaagiselly@gmail.com; mirellasally@gmail.com;
   davi@dbm.ufpb.br; vianamp@hotmail.com; flavia@ufc.br;
   talita.cm@hotmail.com; imvasco@ufc.br
RI Viana, Martonio/AAZ-4218-2020; Santos, Flavia A/S-5321-2016; Farias,
   Davi Felipe/AAH-1868-2020
OI Santos, Flavia A/0000-0003-3625-8540; Felipe Farias,
   Davi/0000-0001-5438-1919
FU National Council for Scientific and Technological Development (CNPq,
   Brasilia, Brazil)National Council for Scientific and Technological
   Development (CNPq); Coordination for the Improvement of Higher Education
   Personnel (CAPES, Brasilia, Brazil)CAPES
FX This work was supported by National Council for Scientific and
   Technological Development (CNPq, Brasilia, Brazil) and Coordination for
   the Improvement of Higher Education Personnel (CAPES, Brasilia, Brazil).
CR Adedapo AA, 2009, J MED PLANTS RES, V3, P586
   AEBI H, 1984, METHOD ENZYMOL, V105, P121
   Agar E, 1999, NEUROREPORT, V10, P1799, DOI 10.1097/00001756-199906030-00032
   Aletor O., 2012, ARCH ZOOTECHNICA, V15, P5
   [Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005
   Awodele O, 2012, J ETHNOPHARMACOL, V139, P330, DOI 10.1016/j.jep.2011.10.008
   Azevedo CR, 2006, BRAZ J MED BIOL RES, V39, P1435, DOI 10.1590/S0100-879X2006001100007
   BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8
   BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Cencioni C, 2014, INT J BIOCHEM CELL B, V51, P155, DOI 10.1016/j.biocel.2014.04.014
   Cryer PE, 2003, DIABETES CARE, V26, P1902, DOI 10.2337/diacare.26.6.1902
   Cui J, 2013, LIFE SCI, V92, P131, DOI 10.1016/j.lfs.2012.11.014
   Lima VBD, 2011, ARQ BRAS ENDOCRINOL, V55, P701, DOI 10.1590/S0004-27302011000900006
   DEAZEVEDOMOREIRA R, 1977, PLANT PHYSIOL, V59, P783, DOI 10.1104/pp.59.5.783
   Del Rio D, 2005, NUTR METAB CARDIOVAS, V15, P316, DOI 10.1016/j.numecd.2005.05.003
   Djomeni P. D. D., 2006, African Journal of Traditional, Complementary and Alternative Medicines, V3, P129
   FISCHER LJ, 1985, TRENDS PHARMACOL SCI, V6, P72, DOI 10.1016/0165-6147(85)90031-8
   Francis JA, 2004, HELV CHIM ACTA, V87, P317, DOI 10.1002/hlca.200490029
   Gifoni JM, 2012, BIOPOLYMERS, V98, P406, DOI 10.1002/bip.22068
   Gualandi-Signorini A M, 2001, Eur Rev Med Pharmacol Sci, V5, P73
   Gupta R, 2012, J DIABETES, V4, P164, DOI 10.1111/j.1753-0407.2011.00173.x
   HALLASMOLLER K, 1952, SCIENCE, V116, P394, DOI 10.1126/science.116.3015.394
   Huang DD, 2015, J ETHNOPHARMACOL, V163, P256, DOI 10.1016/j.jep.2015.01.014
   Jaiswal D, 2009, J ETHNOPHARMACOL, V123, P392, DOI 10.1016/j.jep.2009.03.036
   Kar A, 2003, J ETHNOPHARMACOL, V84, P105, DOI 10.1016/S0378-8741(02)00144-7
   Katre UV, 2008, INT J BIOL MACROMOL, V42, P203, DOI 10.1016/j.ijbiomac.2007.10.024
   Kavalali G, 2003, J ETHNOPHARMACOL, V84, P241, DOI 10.1016/S0378-8741(02)00315-X
   KHANNA P, 1981, J NAT PROD, V44, P648, DOI 10.1021/np50018a002
   Kudaravalli J., 2013, APOLLO MED, V10, p165 168, DOI [10.1016/j.apme.2013.05.002, DOI 10.1016/J.APME.2013.05.002]
   Kumar D, 2011, ASIAN PAC J TROP MED, V4, P900, DOI 10.1016/S1995-7645(11)60215-0
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Li Qiong, 2012, Zhong Yao Cai, V35, P475
   Li WL, 2004, J ETHNOPHARMACOL, V92, P1, DOI 10.1016/j.jep.2003.12.031
   LIS N., 1972, METHOD ENZYMOL, V28, P360, DOI 10.1016/0076-6879(72)28046-6.
   Mbikay M, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00024
   McCrimmon RJ, 2010, DIABETES, V59, P2333, DOI 10.2337/db10-0103
   Mehta LK, 2003, J ETHNOPHARMACOL, V86, P191, DOI 10.1016/S0378-8741(03)00075-8
   Mentreddy SR, 2007, J SCI FOOD AGR, V87, P743, DOI 10.1002/jsfa.2811
   Nishikawa T, 2000, NATURE, V404, P787
   Oliveira AEA, 1999, PROTEIN PEPTIDE LETT, V6, P15
   Oliveira JTA, 2002, PHYTOCHEMISTRY, V61, P301, DOI 10.1016/S0031-9422(02)00239-X
   Paula PC, 2017, NEW BIOTECHNOL, V39, P99, DOI 10.1016/j.nbt.2016.10.005
   Pereira ML, 2011, PROTEIN PEPTIDE LETT, V18, P1078
   Rajasekhar MD, 2010, J ETHNOPHARMACOL, V128, P58, DOI 10.1016/j.jep.2009.12.025
   Ramachandran Subramaniam, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P262, DOI 10.1016/S2221-1691(12)60020-3
   Ramachandran S, 2011, ASIAN PAC J TROP MED, V4, P624, DOI 10.1016/S1995-7645(11)60160-0
   Raman B. V., 2012, International Journal of Research in Ayurveda and Pharmacy (IJRAP), V3, P255
   Rocha A. A., 2013, ALTERN MED, V2013, DOI [10.1155/2013/86930524324521, DOI 10.1155/2013/86930524324521]
   Saio Valrielyn, 2012, J Basic Clin Pharm, V3, P249
   Sathe SK, 1997, J AGR FOOD CHEM, V45, P2854, DOI 10.1021/jf970153e
   Sheng Qingkai, 2004, Zhong Yao Cai, V27, P414
   Sinha M, 2011, J MED FOOD, V14, P1167, DOI 10.1089/jmf.2010.1506
   Tende J. A., 2011, BR J PHARM TOXICOL, V3, p1 4
   Teugwa CM, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-63
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   Venancio TM, 2003, BRAZ J MED BIOL RES, V36, P1167, DOI 10.1590/S0100-879X2003000900004
   Xavier-Filho José, 2003, Braz. J. Plant Physiol., V15, P67, DOI 10.1590/S1677-04202003000200002
   Yibchok-Anun S, 2006, BIOL PHARM BULL, V29, P1126, DOI 10.1248/bpb.29.1126
   Zhang L, 2010, J ETHNOPHARMACOL, V132, P518, DOI 10.1016/j.jep.2010.08.053
NR 60
TC 21
Z9 24
U1 0
U2 17
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1420-3049
J9 MOLECULES
JI Molecules
PD FEB
PY 2017
VL 22
IS 2
AR 271
DI 10.3390/molecules22020271
PG 15
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA EM8HP
UT WOS:000395552400085
PM 28208654
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Almeida, LCP
   de Souza, TM
   Tabosa, PMS
   Soares, NG
   Rocha-Bezerra, LCB
   Vasconcelos, IM
   Carvalho, AFU
AF Almeida Filho, Luiz C. P.
   de Souza, Terezinha M.
   Tabosa, Pedro M. S.
   Soares, Nayana G.
   Rocha-Bezerra, Lady C. B.
   Vasconcelos, Ilka M.
   Carvalho, Ana F. U.
TI Trypsin inhibitor from Leucaena leucocephala seeds delays and disrupts
   the development of Aedes aegypti, a multiple-disease vector
SO PEST MANAGEMENT SCIENCE
LA English
DT Article
DE protease inhibitors; Leucaena; legume seeds; dengue; zika; midgut
   enzymes
ID SERINE PROTEINASE-INHIBITOR; LARVAL DEVELOPMENT; BIOINSECTICIDAL
   ACTIVITY; DIPTERA-CULICIDAE; DIGESTIVE ENZYMES; SUSCEPTIBILITY;
   ALBOPICTUS; SURVIVAL; EXTRACTS; MOSQUITO
AB BACKGROUNDNowadays, the Aedes aegypti mosquito represents a serious public health issue in view of the large outbreaks of the arboviral diseases zika, dengue, chikungunya and yellow fever. This holometabolous insect has midgut digestive enzymes that are trypsin- and chymotrypsin-like proteins. Protease inhibitors are able to bind to proteolytic enzymes and promote a blockage in digestion and nutrition, leading to death. Thus, we investigated the effect of trypsin inhibitor of Leucaena leucocephala (LTI) seeds on egg hatching, larval development and digestive midgut proteases.
   RESULTSLTI was obtained by trichloroacetic acid precipitation followed by a single chromatography step on anhydrous trypsin sepharose. Polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulphate showed a single protein band with a molecular mass close to 20 kDa. After exposure of Ae. aegypti eggs to LTI (0.3mg mL(-1)), egg hatching was reduced (50%). LTI did not show acute toxicity on newly hatched larvae incubated under the same conditions, but after 10 days of exposure a high mortality rate (86%) was observed and the surviving larvae had a 25% delay in development. LTI was able to inhibit in vitro the midgut enzymatic activity (70%), and when larvae were incubated with LTI solution we observed an inhibition of 56%.
   CONCLUSIONSLTI is a promising new tool to control critical points of Ae. aegypti development. (c) 2016 Society of Chemical Industry
C1 [Tabosa, Pedro M. S.; Soares, Nayana G.; Carvalho, Ana F. U.] Univ Fed Ceara, Dept Biol, BR-60440900 Fortaleza, Ceara, Brazil.
   [Almeida Filho, Luiz C. P.; de Souza, Terezinha M.; Rocha-Bezerra, Lady C. B.; Vasconcelos, Ilka M.] Univ Fed Ceara, Biochem & Mol Biol Dept, Fortaleza, Ceara, Brazil.
RP Carvalho, AFU (corresponding author), Univ Fed Ceara, Dept Biol, BR-60440900 Fortaleza, Ceara, Brazil.
EM aurano@ufc.br
RI Carvalho, Ana/K-7344-2018; Almeida Filho, Luiz/K-7313-2018; de Souza,
   Terezinha/L-8727-2015
OI Carvalho, Ana/0000-0001-5293-9317; Almeida Filho,
   Luiz/0000-0001-6234-2418; de Souza, Terezinha/0000-0002-9580-3310
FU MCT-INSA/CNPq/CT, through Hidro/AcAo Tranversal [35/2010]; CoordenacAo
   de Aperfeicoamento de Pessoal do Ensino Superior (CAPES)CAPES
FX The authors thank MCT-INSA/CNPq/CT, through Hidro/AcAo Tranversal No.
   35/2010 - Desenvolvimento Sustentavel do Semiarido Brasileiro and
   CoordenacAo de Aperfeicoamento de Pessoal do Ensino Superior (CAPES),
   for financial support of this research.
CR Agra-Neto AC, 2014, PARASITOL RES, V113, P175, DOI 10.1007/s00436-013-3640-8
   Barbosa PBBM, 2014, PARASITOL RES, V113, P3565, DOI 10.1007/s00436-014-4022-6
   Barros LC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039138
   Bhattacharyya A, 2007, COMP BIOCHEM PHYS C, V145, P669, DOI 10.1016/j.cbpc.2007.03.003
   Bhavani P, 2007, ARTHROPOD-PLANT INTE, V1, P255, DOI 10.1007/s11829-007-9020-5
   Bosire CM, 2014, J ASIA-PAC ENTOMOL, V17, P531, DOI 10.1016/j.aspen.2014.05.003
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Carlini CR, 2002, TOXICON, V40, P1515, DOI 10.1016/S0041-0101(02)00240-4
   Chen TH, 2015, J FORMOS MED ASSOC, V114, P546, DOI 10.1016/j.jfma.2014.12.002
   Cruz ACB, 2013, PLANT PHYSIOL BIOCH, V70, P61, DOI 10.1016/j.plaphy.2013.04.023
   Dantzger M, 2015, PHYTOCHEMISTRY, V118, P224, DOI 10.1016/j.phytochem.2015.08.013
   de Arruda EJ, 2011, BRAZ ARCH BIOL TECHN, V54, P503, DOI 10.1590/S1516-89132011000300010
   Gatehouse LN, 1997, INSECT BIOCHEM MOLEC, V27, P929, DOI 10.1016/S0965-1748(97)00074-X
   Hernandez-Morales A, 2015, J ASIA-PAC ENTOMOL, V18, P227, DOI 10.1016/j.aspen.2014.09.004
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kim Lien PT, 2015, ASIAN PAC J TROP MED, V8, P543
   KUNZ PA, 1978, INSECT BIOCHEM, V8, P43, DOI 10.1016/0020-1790(78)90009-4
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Macedo MLR, 2009, PROTEIN PEPTIDE LETT, V16, P1459, DOI 10.2174/092986609789839395
   Maestre-Serrano R, 2014, PESTIC BIOCHEM PHYS, V116, P63, DOI 10.1016/j.pestbp.2014.09.014
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Oddepally R, 2013, PHYTOCHEMISTRY, V96, P26, DOI 10.1016/j.phytochem.2013.09.010
   Oliva MLV, 2000, BBA-PROTEIN STRUCT M, V1477, P64, DOI 10.1016/S0167-4838(99)00285-X
   Paiva PMG, 2013, LECTINS TRYPSIN INHI, P29
   Pardo-Lopez L, 2009, PEPTIDES, V30, P589, DOI 10.1016/j.peptides.2008.07.027
   Pilon AM, 2006, PESTIC BIOCHEM PHYS, V86, P23, DOI 10.1016/j.pestbp.2005.11.005
   Pontual EV, 2014, PARASITOL RES, V113, P727, DOI 10.1007/s00436-013-3702-y
   Pontual EV, 2012, ARCH INSECT BIOCHEM, V79, P135, DOI 10.1002/arch.21012
   Pradeep FS, 2015, PROCESS BIOCHEM, V50, P1479, DOI 10.1016/j.procbio.2015.05.022
   Prasad ER, 2010, PESTIC BIOCHEM PHYS, V98, P80, DOI 10.1016/j.pestbp.2010.05.003
   de Oliveira CFR, 2012, PROCESS BIOCHEM, V47, P929, DOI 10.1016/j.procbio.2012.02.022
   Ramos MV, 2009, MEM I OSWALDO CRUZ, V104, P805, DOI 10.1590/S0074-02762009000600001
   Ramos VD, 2009, COMP BIOCHEM PHYS A, V152, P255, DOI 10.1016/j.cbpa.2008.10.013
   Rocha HDR, 2015, ACTA TROP, V152, P66, DOI 10.1016/j.actatropica.2015.08.013
   Rufino FPS, 2013, PLANT PHYSIOL BIOCH, V63, P70, DOI 10.1016/j.plaphy.2012.11.013
   Saboia-Vahia L, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-50
   Sasaki NY, 2015, BIOCHIMIE, V112, P172, DOI 10.1016/j.biochi.2015.03.011
   Silva RGG, 2015, IND CROP PROD, V70, P48, DOI 10.1016/j.indcrop.2015.02.058
   Simoy MI, 2015, ECOL MODEL, V314, P100, DOI 10.1016/j.ecolmodel.2015.07.007
   Singh MK, 2014, J MOL CATAL B-ENZYM, V110, P92, DOI 10.1016/j.molcatb.2014.10.010
   Soares TS, 2013, INSECT BIOCHEM MOLEC, V43, P9, DOI 10.1016/j.ibmb.2012.10.007
   Souza TM, 2011, J MED ENTOMOL, V48, P846, DOI 10.1603/ME10205
   SouzaPinto JC, 1996, IMMUNOPHARMACOLOGY, V33, P330, DOI 10.1016/0162-3109(96)00056-2
   Suman DS, 2011, ARTHROPOD STRUCT DEV, V40, P479, DOI 10.1016/j.asd.2011.04.003
   Venancio TM, 2009, INSECT MOL BIOL, V18, P33, DOI 10.1111/j.1365-2583.2008.00845.x
   Wu YR, 1997, MOL BREEDING, V3, P371, DOI 10.1023/A:1009681323131
NR 48
TC 4
Z9 5
U1 0
U2 11
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 1526-498X
EI 1526-4998
J9 PEST MANAG SCI
JI Pest Manag. Sci.
PD JAN
PY 2017
VL 73
IS 1
BP 181
EP 187
DI 10.1002/ps.4284
PG 7
WC Agronomy; Entomology
SC Agriculture; Entomology
GA EE2IT
UT WOS:000389408100024
PM 27040615
DA 2020-12-08
ER

PT J
AU Pessoa, IP
   Neto, JJL
   de Almeida, TS
   Farias, DF
   Vieira, LR
   de Medeiros, JL
   Boligon, AA
   Peijnenburg, A
   Castelar, I
   Carvalho, AFU
AF Pessoa, Igor Parra
   Lopes Neto, Jose Joaquim
   de Almeida, Thiago Silva
   Farias, Davi Felipe
   Vieira, Leonardo Rogerio
   de Medeiros, Jackeline Lima
   Boligon, Aline Augusti
   Peijnenburg, Ad
   Castelar, Ivan
   Urano Carvalho, Ana Fontenele
TI Polyphenol Composition, Antioxidant Activity and Cytotoxicity of Seeds
   from Two Underexploited Wild Licania Species: L. rigida and L. tomentosa
SO MOLECULES
LA English
DT Article
DE MCF-7; Caco-2; DPPH; TBARS; phenolic compound; cytotoxicity
ID SCUTIA-BUXIFOLIA REISSEK; BIOACTIVE COMPOUNDS; FLAVONOIDS; MECHANISMS;
   EXTRACT; CELLS; CONSTITUENTS; DERIVATIVES; DAMAGE
AB Studies have shown the benefit of antioxidants in the prevention or treatment of human diseases and promoted a growing interest in new sources of plant antioxidants for pharmacological use. This study aimed to add value to two underexploited wild plant species (Licania rigida) and L. tomentosa) from Brazilian flora. Thus, the phenolic compounds profile of their seed ethanol extract and derived fractions were elucidated by HPLC, the antioxidant capacity was assessed by in vitro chemical tests and the cytotoxicity determined using the human carcinoma cell lines MCF-7 and Caco-2. Eleven phenolic compounds were identified in the extracts of each species. The extracts and fractions showed excellent antioxidant activity in the DPPH assay (SC50, ranging from 9.15 to 248.8 mu g/mL). The aqueous fraction of L. rigida seeds was most effective in preventing lipid peroxidation under basal conditions (IC50 60.80 mu g/mL) whereas, in the presence of stress inducer, the methanolic fraction of L. tomentosa performed best (IC50 8.55 mu g/mL). None of the samples showed iron chelating capacity. Ethanolic seed extracts of both species did not reveal any cytotoxicity against MCF-7 and Caco-2 cells. Both plant species showed a promising phenolic profile with potent antioxidant capacity and deserve attention to be sustainably explored.
C1 [Pessoa, Igor Parra; Lopes Neto, Jose Joaquim; de Almeida, Thiago Silva; Vieira, Leonardo Rogerio; de Medeiros, Jackeline Lima; Urano Carvalho, Ana Fontenele] Univ Fed Ceara, Dept Biochem & Mol Biol, BR-60020181 Fortaleza, CE, Brazil.
   [Farias, Davi Felipe] Univ Fed Paraiba, Dept Mol Biol, BR-58051900 Joao Pessoa, PB, Brazil.
   [Boligon, Aline Augusti] Univ Fed Santa Maria, Hlth Sci Ctr, BR-97105900 Santa Maria, RS, Brazil.
   [Peijnenburg, Ad] Wageningen Univ & Res, RIKILT, POB 230, NL-6700 AE Wageningen, Netherlands.
   [Castelar, Ivan] Univ Fed Ceara, Dept Finance, BR-60020181 Fortaleza, CE, Brazil.
RP Carvalho, AFU (corresponding author), Univ Fed Ceara, Dept Biochem & Mol Biol, BR-60020181 Fortaleza, CE, Brazil.
EM igorppessoa@gmail.com; lopes.joaquimm@hotmail.com;
   thiago.urca@gmail.com; davi@dbm.ufpb.br; leorv2005@hotmail.com;
   jackelinemedeiros@hotmail.com; alineboligon@hotmail.com;
   ad.peijnenburg@wur.nl; lume1250@yahoo.com.br; aurano@ufc.br
RI Lopes Neto, Jose Joaquim/M-1979-2018; Almeida, Thiago S./L-9833-2013;
   Farias, Davi Felipe/AAH-1868-2020; Carvalho, Ana/K-7344-2018
OI Almeida, Thiago S./0000-0002-7401-0637; Carvalho,
   Ana/0000-0001-5293-9317; Felipe Farias, Davi/0000-0001-5438-1919
FU Fundacao Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES [PVE-A006_2013]
FX Thanks to Fundacao Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES) for supporting grants (PVE-A006_2013). In memoriam of
   Margareth Linde Athayde who made a significant scientific contribution
   to this manuscript.
CR Agra MF, 2007, J ETHNOPHARMACOL, V111, P383, DOI 10.1016/j.jep.2006.12.007
   Ahmed SI, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1443-z
   Anderson T.W., 2003, INTRO MULTIVARIATE S, P1
   Atta-ur-Rahman F.R.S., 2016, STUDIES NATURAL PROD, P1
   Badisa RB, 2000, CANCER LETT, V149, P61, DOI 10.1016/S0304-3835(99)00347-X
   Boligon AA, 2013, ACTA PHYSIOL PLANT, V35, P2229, DOI 10.1007/s11738-013-1259-0
   Boligon AA, 2012, MOLECULES, V17, P5757, DOI 10.3390/molecules17055757
   Braca A, 2002, BIOCHEM SYST ECOL, V30, P271, DOI 10.1016/S0305-1978(01)00089-8
   Braca A, 2002, J ETHNOPHARMACOL, V79, P379, DOI 10.1016/S0378-8741(01)00413-5
   Brewer MS, 2011, COMPR REV FOOD SCI F, V10, P221, DOI 10.1111/j.1541-4337.2011.00156.x
   Castilho RO, 2008, QUIM NOVA, V31, P66, DOI 10.1590/S0100-40422008000100014
   Castilho RO, 2005, FITOTERAPIA, V76, P562, DOI 10.1016/j.fitote.2005.04.018
   Castilho RO, 2000, AN BRAZ ACAD SCI, V72, P292
   Chang CC, 2002, J FOOD DRUG ANAL, V10, P178
   Chang H, 2008, ARCH PHARM RES, V31, P1137, DOI 10.1007/s12272-001-1280-8
   Craft BD, 2012, COMPR REV FOOD SCI F, V11, P148, DOI 10.1111/j.1541-4337.2011.00173.x
   Farias DF, 2013, BIOMED RES INT, V2013, DOI [10.1155/2013/605831, 10.1155/2013/510736, 10.1155/2013/340605, 10.1155/2013/263509]
   Fernandes J, 2003, CANCER LETT, V190, P165, DOI 10.1016/S0304-3835(02)00593-1
   Giampieri F, 2014, J AGR FOOD CHEM, V62, P3867, DOI 10.1021/jf405455n
   HAGERMAN AE, 1987, J CHEM ECOL, V13, P437, DOI 10.1007/BF01880091
   Hagerman AE, 1998, J AGR FOOD CHEM, V46, P1887, DOI 10.1021/jf970975b
   Heim KE, 2002, J NUTR BIOCHEM, V13, P572, DOI 10.1016/S0955-2863(02)00208-5
   Hendrich AB, 2006, ACTA PHARMACOL SIN, V27, P27, DOI 10.1111/j.1745-7254.2006.00238.x
   Hunyadi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050619
   Kumar S, 2013, SCI WORLD J, DOI 10.1155/2013/162750
   Leal I.R., 2003, ECOLOGIA CONSERVACAO, P1, DOI Recife, Brazil
   Lesjak MM, 2014, J FUNCT FOODS, V7, P257, DOI 10.1016/j.jff.2014.02.003
   Liu ChangJin, 2014, Food and Nutrition Sciences, V5, P293
   Lof D, 2011, J FOOD SCI, V76, pN35, DOI 10.1111/j.1750-3841.2011.02103.x
   Lu Y., 2014, Pharmacology and Pharmacy, V5, P395, DOI 10.4236/pp.2014.54047
   Lu JM, 2010, J CELL MOL MED, V14, P840, DOI 10.1111/j.1582-4934.2009.00897.x
   Mandimika T, 2007, FOOD CHEM TOXICOL, V45, P1918, DOI 10.1016/j.fct.2007.04.009
   Mashabela MN, 2015, J FOOD SCI, V80, pH2612, DOI 10.1111/1750-3841.13103
   Matos F.J.A., 1998, INTRO FITOQUIMICA EX, P1
   Miranda MMFS, 2002, PHYTOMEDICINE, V9, P641, DOI 10.1078/094471102321616463
   Perez-Jimenez J, 2006, FOOD RES INT, V39, P791, DOI 10.1016/j.foodres.2006.02.003
   Perron NR, 2009, CELL BIOCHEM BIOPHYS, V53, P75, DOI 10.1007/s12013-009-9043-x
   Phan HTT, 2014, BBA-BIOMEMBRANES, V1838, P2670, DOI 10.1016/j.bbamem.2014.07.001
   Piazzon A, 2012, J AGR FOOD CHEM, V60, P12312, DOI 10.1021/jf304076z
   Pietta PG, 2000, J NAT PROD, V63, P1035, DOI 10.1021/np9904509
   Pistollato F, 2015, FOOD CHEM TOXICOL, V75, P58, DOI 10.1016/j.fct.2014.11.004
   Pratheeshkumar P, 2012, ANTI-CANCER AGENT ME, V12, P1159, DOI 10.2174/187152012803833035
   Puntel RL, 2005, NEUROCHEM RES, V30, P225, DOI 10.1007/s11064-004-2445-7
   Sabir SM, 2008, J ETHNOPHARMACOL, V120, P226, DOI 10.1016/j.jep.2008.08.017
   Sak Katrin, 2014, Pharmacogn Rev, V8, P122, DOI 10.4103/0973-7847.134247
   Sanderson JT, 2013, BIOORGAN MED CHEM, V21, P7182, DOI 10.1016/j.bmc.2013.08.057
   SChuck A.G., 2013, OXID ANTIOXID MED SC, V2, P265, DOI DOI 10.5455/OAMS.220713.0R.051
   Silva JBNF, 2012, ARCH BIOL SCI, V64, P459, DOI [10.2298/ABS12024597S, 10.2298/ABS1202459S]
   Singleton VL, 1999, METHOD ENZYMOL, V299, P152
   Sreeramulu D, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/369479
   Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009
   van der Zande M, 2016, NANOTOXICOLOGY, V10, P1431, DOI 10.1080/17435390.2016.1225132
   Yang JX, 2008, LWT-FOOD SCI TECHNOL, V41, P1060, DOI 10.1016/j.lwt.2007.06.010
   Zhang M, 2011, ADV EXP MED BIOL, V701, P283, DOI 10.1007/978-1-4419-7756-4_38
   Zhang XL, 2014, FOOD CHEM, V152, P300, DOI 10.1016/j.foodchem.2013.11.153
NR 55
TC 3
Z9 3
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1420-3049
J9 MOLECULES
JI Molecules
PD DEC
PY 2016
VL 21
IS 12
AR 1755
DI 10.3390/molecules21121755
PG 16
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA EI0CQ
UT WOS:000392140100149
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Miskowiak, KW
   Kjrstad, HL
   Stottrup, MM
   Vinberg, M
   Carvalho, AF
   Vieta, E
   Hoffding, LK
   Werge, TM
   Kessing, LV
   Macoveanu, J
AF Miskowiak, K. W.
   Kjrstad, H. L.
   Stottrup, M. M.
   Vinberg, M.
   Carvalho, A. F.
   Vieta, E.
   Hoffding, L. K.
   Werge, T. M.
   Kessing, L. V.
   Macoveanu, J.
TI The effect of COMT Val158Met genotype on neural response and performance
   during spatial working memory in remitted patients with bipolar disorder
SO EUROPEAN NEUROPSYCHOPHARMACOLOGY
LA English
DT Meeting Abstract
CT 29th Congress of the European-College-of-Neuropsychopharmacology (ECNP)
CY SEP 17-20, 2016
CL Vienna, AUSTRIA
SP European Coll Neuropsychopharmacol
C1 [Miskowiak, K. W.; Kjrstad, H. L.; Stottrup, M. M.; Vinberg, M.; Kessing, L. V.; Macoveanu, J.] Psychiat Ctr Copenhagen, Dept 6233, Copenhagen, Denmark.
   [Carvalho, A. F.] Univ Fed Ceara, Translat Psychiat Res Grp, Fortaleza, Ceara, Brazil.
   [Carvalho, A. F.] Univ Fed Ceara, Dept Clin Med, Fortaleza, Ceara, Brazil.
   [Vieta, E.] Univ Barcelona, Hosp Clin, Bipolar Disorders Unit, Inst Neurosci,IDIBAPS,CIBERSAM, Barcelona, Spain.
   [Hoffding, L. K.; Werge, T. M.] Mental Hlth Ctr Sct Hans, Inst Biol Psychiat, Copenhagen, Denmark.
   [Hoffding, L. K.; Werge, T. M.] iPSYCH, Lundbeck Fdn Initiat Integrat Psychiat Res, Aarhus, Denmark.
   [Werge, T. M.] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark.
RI Macoveanu, Julian/H-4256-2019; Vieta, Eduard/Y-2919-2019
OI Macoveanu, Julian/0000-0001-6148-9477; Vieta,
   Eduard/0000-0002-0548-0053; Miskowiak, Kamilla/0000-0003-2572-1384
CR Goldberg TE, 2003, ARCH GEN PSYCHIAT, V60, P889, DOI 10.1001/archpsyc.60.9.889
   Mier D, 2010, MOL PSYCHIATR, V15, P918, DOI 10.1038/mp.2009.36
NR 2
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0924-977X
EI 1873-7862
J9 EUR NEUROPSYCHOPHARM
JI Eur. Neuropsychopharmacol.
PD OCT
PY 2016
VL 26
SU 2
MA P.2.d.035
BP S440
EP S440
DI 10.1016/S0924-977X(16)31422-5
PG 1
WC Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry
SC Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry
GA ER1QT
UT WOS:000398568302001
DA 2020-12-08
ER

PT J
AU Veronezi, BP
   Moffa, AH
   Carvalho, AF
   Galhardoni, R
   Simis, M
   Bensenor, IM
   Lotufo, PA
   Machado-Vieira, R
   Daskalakis, ZJ
   Brunoni, AR
AF Veronezi, B. P.
   Moffa, A. H.
   Carvalho, A. F.
   Galhardoni, R.
   Simis, M.
   Bensenor, I. M.
   Lotufo, P. A.
   Machado-Vieira, R.
   Daskalakis, Z. J.
   Brunoni, A. R.
TI Evidence for increased motor cortical facilitation and decreased
   inhibition in atypical depression
SO ACTA PSYCHIATRICA SCANDINAVICA
LA English
DT Article
DE major depressive disorder; glutamate; gamma-aminobutyric acid; motor
   cortex excitability; transcranial magnetic stimulation
ID TRANSCRANIAL MAGNETIC STIMULATION; MAJOR DEPRESSION; CORTEX
   EXCITABILITY; PREFRONTAL CORTEX; MOOD DISORDERS; DSM-IV; FEATURES;
   ORGANIZATION; ADOLESCENTS; RELIABILITY
AB Objective: Major depressive disorder (MDD) is a clinically heterogeneous condition. However, the role of cortical glutamate and gamma-aminobutyric acid (GABA) receptor-mediated activity, implicated in MDD pathophysiology, has not been explored in different MDD subtypes. Our aim was to assess the atypical and melancholic depression subtypes regarding potential differences in GABA and glutamate receptor-mediated activity through established transcranial magnetic stimulation (TMS) neurophysiological measures from the motor cortex.
   Method: We evaluated 81 subjects free of antidepressant medication, including 21 healthy controls and 20 patients with atypical, 20 with melancholic, and 20 with undifferentiated MDD. Single and paired-pulse TMS paradigms were used to evaluate intracortical facilitation (ICF), cortical silent period (CSP), and short intracortical inhibition (SICI), which index glutamate, GABA(B) receptor-, and GABA(A) receptor-mediated activity respectively.
   Results: Patients with MDD demonstrated significantly decreased mean CSP values than healthy controls (Cohen's d = 0.22-0.3, P < 0.01 for all comparisons). Atypical depression presented a distinct cortical excitability pattern of decreased cortical inhibition and increased cortical facilitation, that is, an increased mean ICF and SICI ratios than other depression subtypes (d = 0.22-0.33, P < 0.01 for all comparisons).
   Conclusion: Different MDD subtypes may demonstrate different neurophysiology in relation to GABA(A) and glutamatergic activity. TMS as an investigational tool might be useful to distinguish between different MDD subtypes.
C1 [Veronezi, B. P.; Moffa, A. H.; Bensenor, I. M.; Lotufo, P. A.; Brunoni, A. R.] Univ Sao Paulo, Univ Hosp, Interdisciplinary Ctr Appl Neuromodulat, Sao Paulo, Brazil.
   [Carvalho, A. F.] Univ Fed Ceara, Dept Psychiat, Fortaleza, Ceara, Brazil.
   [Moffa, A. H.] Univ Fed Ceara, Fac Med, Translat Psychiat Res Grp, Fortaleza, Ceara, Brazil.
   [Galhardoni, R.; Brunoni, A. R.] Univ Sao Paulo, Dept & Inst Psychiat, Lab Neurosci LIM 27, Serv Interdisciplinary Neuromodulat, Sao Paulo, Brazil.
   [Galhardoni, R.] Univ Sao Paulo, Sch Arts Sci & Humanities, Sao Paulo, Brazil.
   [Galhardoni, R.] Univ Sao Paulo, Dept Neurol, Pain Ctr, Sao Paulo, Brazil.
   [Galhardoni, R.] Univ City Sao Paulo UNICID, Med Sch, Sao Paulo, Brazil.
   [Simis, M.] Univ Sao Paulo, Sch Med, Clin Hosp, Inst Phys Med & Rehabil, Sao Paulo, Brazil.
   [Machado-Vieira, R.] NIMH, Expt Therapeut & Pathophysiol Branch, NIH, Bethesda, MD 20892 USA.
   [Daskalakis, Z. J.] Univ Toronto, Temerty Ctr Therapeut Brain Intervent, Toronto, ON, Canada.
   [Daskalakis, Z. J.] Univ Toronto, Campbell Family Res Inst, Ctr Addict & Mental Hlth, Dept Psychiat, Toronto, ON, Canada.
RP Brunoni, AR (corresponding author), Interdisciplinary Ctr Appl Neuromodulat, Av Prof Lineu Prestes 2565,3o andar, BR-05508000 Sao Paulo, Brazil.
EM brunoni@usp.br
RI Brunoni, Andre R./H-8394-2012; Lotufo, Paulo/A-9843-2008;
   Machado-Vieira, Rodrigo/D-8293-2012; Galhardoni, Ricardo/H-2371-2014; de
   Matos Moffa, Adriano Henrique/AAA-8600-2019
OI Brunoni, Andre R./0000-0002-6310-3571; Lotufo,
   Paulo/0000-0002-4856-8450; Machado-Vieira, Rodrigo/0000-0002-4830-1190;
   Galhardoni, Ricardo/0000-0002-8947-2770; 
FU NARSAD Young Investigator from Brain & Behavior Research Foundation
   [20493]; Sao Paulo State FoundationFundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [12/20911-5]; National Council for
   Scientific and Technological Development (CNPq)National Council for
   Scientific and Technological Development (CNPq) [470904]; CNPq
   scholarship grant; FAPESP scholarship grant [13/19759-7]; National
   Council for Scientific and Technological Development (CNPq; level II;
   Brazil)
FX ARB is supported by the following grants: 2013 NARSAD Young Investigator
   from the Brain & Behavior Research Foundation (Grant Number 20493), 2012
   FAPESP Young Researcher from the Sao Paulo State Foundation (Grant
   Number 12/20911-5), and National Council for Scientific and
   Technological Development (CNPq, Grant Number 470904). ARB also received
   equipment from the Soterix Company. AHM receives a CNPq scholarship
   grant. BPV receives a FAPESP scholarship grant (13/19759-7). AFC is the
   recipient of a research fellowship award from the National Council for
   Scientific and Technological Development (CNPq; level II; Brazil).
CR Bajbouj M, 2006, BIOL PSYCHIAT, V59, P395, DOI 10.1016/j.biopsych.2005.07.036
   Bruder GE, 2002, J ABNORM PSYCHOL, V111, P446, DOI 10.1037//0021-843X.111.3.446
   Brunoni AR, 2015, SAO PAULO MED J, V133, P252, DOI 10.1590/1516-3180.2014.00351712
   Bunse T, 2014, BRAIN STIMUL, V7, P158, DOI 10.1016/j.brs.2013.08.009
   Cohen J., 1988, STAT POWER ANAL BEHA
   Croarkin PE, 2013, JAMA PSYCHIAT, V70, P291, DOI 10.1001/2013.jamapsychiatry.24
   Dantzer R, 2014, J NEURAL TRANSM, V121, P925, DOI 10.1007/s00702-014-1187-1
   Daskalakis ZJ, 2008, CLIN EEG NEUROSCI, V39, P150, DOI 10.1177/155005940803900310
   Davies CH, 1990, J PHYSL, V424, P513
   Di Lazzaro V, 2006, J NEUROPHYSIOL, V96, P1765, DOI 10.1152/jn.00360.2006
   Di Lazzaro V, 2003, J PHYSIOL-LONDON, V547, P485, DOI 10.1113/jphysiol.2002.030486
   Farzan F, 2010, J NEUROPHYSIOL, V104, P1339, DOI 10.1152/jn.00279.2010
   Fountoulakis KN, 2004, PROG NEURO-PSYCHOPH, V28, P537, DOI 10.1016/j.pnpbp.2004.01.006
   Gold PW, 2015, MOL PSYCHIATR, V20, P32, DOI 10.1038/mp.2014.163
   Gorenstein C., 2000, ESCALAS AVALIACAO CL
   Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322
   Hasler G, 2011, MOL PSYCHIATR, V16, P604, DOI 10.1038/mp.2011.23
   Hickman RJ, 2014, J BEHAV MED, V37, P621, DOI 10.1007/s10865-013-9510-0
   Hoffken O, 2013, EXP BRAIN RES, V225, P47, DOI 10.1007/s00221-012-3347-6
   Karolewicz B, 2010, INT J NEUROPSYCHOPH, V13, P411, DOI 10.1017/S1461145709990587
   KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912
   Lamers F, 2013, MOL PSYCHIATR, V18, P692, DOI 10.1038/mp.2012.144
   Lamers F, 2012, BRIT J PSYCHIAT, V201, P143, DOI 10.1192/bjp.bp.111.098079
   Lasserre AM, 2014, JAMA PSYCHIAT, V71, P880, DOI 10.1001/jamapsychiatry.2014.411
   Lefaucheur JP, 2008, J PSYCHIATR RES, V42, P389, DOI 10.1016/j.jpsychires.2007.03.001
   Lefaucheur JP, 2006, NEUROPHYSIOL CLIN, V36, P117, DOI 10.1016/j.neucli.2006.08.002
   Levinson AJ, 2007, J CLIN PSYCHOPHARM, V27, P493, DOI 10.1097/jcp.0b013e31814ce524
   Levinson AJ, 2010, BIOL PSYCHIAT, V67, P458, DOI 10.1016/j.biopsych.2009.09.025
   Lichtenberg P, 2010, PSYCHOTHER PSYCHOSOM, V79, P131, DOI 10.1159/000286957
   Maeda F, 2000, BRIT J PSYCHIAT, V177, P169, DOI 10.1192/bjp.177.2.169
   Matza LS, 2003, ARCH GEN PSYCHIAT, V60, P817, DOI 10.1001/archpsyc.60.8.817
   Mhalla A, 2010, PAIN, V149, P495, DOI 10.1016/j.pain.2010.03.009
   Nemeroff Charles B, 2003, Psychopharmacol Bull, V37, P133
   Ngomo S, 2012, J NEUROSCI METH, V205, P65, DOI 10.1016/j.jneumeth.2011.12.012
   Novick JS, 2005, J CLIN PSYCHIAT, V66, P1002, DOI 10.4088/JCP.v66n0807
   O'Keane V, 2012, PSYCHONEUROENDOCRINO, V37, P1589, DOI 10.1016/j.psyneuen.2012.03.009
   Pae CU, 2009, CNS DRUGS, V23, P1023, DOI 10.2165/11310990-000000000-00000
   Perugi G, 2011, WORLD PSYCHIATRY, V10, P45
   Petersen T, 2005, J CLIN PSYCHOPHARM, V25, P336, DOI 10.1097/01.jcp.0000169036.40755.16
   Radhu N, 2013, CLIN NEUROPHYSIOL, V124, P1309, DOI 10.1016/j.clinph.2013.01.014
   ROICK H, 1993, EXP BRAIN RES, V94, P489, DOI 10.1007/BF00230207
   Rossini PM, 2015, CLIN NEUROPHYSIOL, V126, P1071, DOI 10.1016/j.clinph.2015.02.001
   Sanacora Gerard, 2007, CNS & Neurological Disorders-Drug Targets, V6, P127, DOI 10.2174/187152707780363294
   Sanacora G, 2012, NEUROPHARMACOLOGY, V62, P63, DOI 10.1016/j.neuropharm.2011.07.036
   Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi
   Sheehan DV, 1998, J CLIN PSYCHIAT S20, V59, P4
   Shen QY, 2010, BIOL PSYCHIAT, V68, P512, DOI 10.1016/j.biopsych.2010.04.024
   Stewart JW, 2009, NEUROPSYCHOPHARMACOL, V34, P2625, DOI 10.1038/npp.2009.99
   Todd KG, 2008, J PHARM PHARM SCI, V11, P14, DOI 10.18433/J34S38
   Yuksel C, 2010, BIOL PSYCHIAT, V68, P785, DOI 10.1016/j.biopsych.2010.06.016
   Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856
   Ziemann U, 1996, J PHYSIOL-LONDON, V496, P873, DOI 10.1113/jphysiol.1996.sp021734
   Ziemann U, 2015, CLIN NEUROPHYSIOL, V126, P1847, DOI 10.1016/j.clinph.2014.08.028
NR 53
TC 8
Z9 8
U1 1
U2 11
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0001-690X
EI 1600-0447
J9 ACTA PSYCHIAT SCAND
JI Acta Psychiatr. Scand.
PD AUG
PY 2016
VL 134
IS 2
BP 172
EP 182
DI 10.1111/acps.12565
PG 11
WC Psychiatry
SC Psychiatry
GA DT7SY
UT WOS:000381688700009
PM 27028276
DA 2020-12-08
ER

PT J
AU Fernandes, BS
   Carvalho, AF
   Berk, M
AF Fernandes, B. S.
   Carvalho, A. F.
   Berk, M.
TI C-reactive protein is increased in bipolar disorder across the mood
   spectrum: a systematic review and meta-analysis
SO BIPOLAR DISORDERS
LA English
DT Meeting Abstract
CT 18th Annual Conference of the
   International-Society-for-Bipolar-Disorders / 8th Biennial Conference of
   the International-Society-for-Affective-Disorders
CY JUL 13-16, 2016
CL Amsterdam, NETHERLANDS
SP Int Soc Bipolar Disorders, Int Soc Affect Disorders
C1 [Fernandes, B. S.; Berk, M.] Deakin Univ, Dept Psychiat, Geelong, Vic, Australia.
   [Fernandes, B. S.; Berk, M.] Barwon Hlth, Geelong, Vic, Australia.
   [Carvalho, A. F.] Univ Fed Ceara, Translat Med Unit, Fotaleza, Brazil.
RI Fernandes, Brisa/B-6614-2009; Berk, Michael/M-7891-2013; Berk,
   Michael/M-3585-2019
OI Fernandes, Brisa/0000-0002-3797-7582; Berk, Michael/0000-0002-5554-6946;
   Berk, Michael/0000-0002-5554-6946
NR 0
TC 1
Z9 1
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1398-5647
EI 1399-5618
J9 BIPOLAR DISORD
JI Bipolar Disord.
PD JUL
PY 2016
VL 18
SU 1
SI SI
MA P-233
BP 142
EP 143
PG 2
WC Clinical Neurology; Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA DR5KI
UT WOS:000379941500397
DA 2020-12-08
ER

PT J
AU Fernandes, BS
   Carvalho, AF
   Berk, M
AF Fernandes, B. S.
   Carvalho, A. F.
   Berk, M.
TI The quest for a biosignature in psychiatric disorders: a predictive
   systems biology analysis of proteomic studies in peripheral blood
SO BIPOLAR DISORDERS
LA English
DT Meeting Abstract
CT 18th Annual Conference of the
   International-Society-for-Bipolar-Disorders / 8th Biennial Conference of
   the International-Society-for-Affective-Disorders
CY JUL 13-16, 2016
CL Amsterdam, NETHERLANDS
SP Int Soc Bipolar Disorders, Int Soc Affect Disorders
C1 [Fernandes, B. S.; Berk, M.] Deakin Univ, Dept Psychiat, Geelong, Vic, Australia.
   [Fernandes, B. S.; Berk, M.] Barwon Hlth, Geelong, Vic, Australia.
   [Carvalho, A. F.] Univ Fed Ceara, Translat Med Unit, Fortaleza, Ceara, Brazil.
RI Berk, Michael/M-7891-2013; Berk, Michael/M-3585-2019; Fernandes,
   Brisa/B-6614-2009
OI Berk, Michael/0000-0002-5554-6946; Berk, Michael/0000-0002-5554-6946;
   Fernandes, Brisa/0000-0002-3797-7582
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1398-5647
EI 1399-5618
J9 BIPOLAR DISORD
JI Bipolar Disord.
PD JUL
PY 2016
VL 18
SU 1
SI SI
MA P-234
BP 143
EP 143
PG 1
WC Clinical Neurology; Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA DR5KI
UT WOS:000379941500398
DA 2020-12-08
ER

PT J
AU Fernandes, BS
   Dash, S
   Jacka, F
   Dodd, S
   Carvalho, AF
   Kohler, CA
   Steiner, J
   da Graca, M
   Nardin, P
   Goncalves, CA
   Berk, M
AF Fernandes, B. S.
   Dash, S.
   Jacka, F.
   Dodd, S.
   Carvalho, A. F.
   Kohler, C. A.
   Steiner, J.
   da Graca, M.
   Nardin, P.
   Goncalves, C. -A.
   Berk, M.
TI Leptin in bipolar disorder: A systematic review and meta-analysis
SO EUROPEAN PSYCHIATRY
LA English
DT Review
DE Biomarker; Leptin; Bipolar disorder; Mania; Depression; Meta-analysis
ID NEUROTROPHIC FACTOR; METABOLIC ABNORMALITIES; CHOLESTEROL LEVELS;
   PUBLICATION BIAS; SERUM LEPTIN; TNF-ALPHA; SCHIZOPHRENIA; INFLAMMATION;
   EPISODES; INSULIN
AB Background: Bipolar disorder (BD) is a psychiatric disorder associated with increased rates of obesity and inflammation. Leptin is an adipokine that is mainly produced by the white adipose tissue in response to insulin. It stimulates the immune system, increasing the production of pro-inflammatory cytokines. There is currently uncertainty regarding possible alterations in peripheral leptin levels across the mood states in BD.
   Methods: This study comprises a between-group meta-analysis comparing serum and plasma leptin levels in people with BD in mania, depression or euthymia and healthy controls. We conducted a systematic search for all possibly eligible-English and non-English peer-reviewed articles. We calculated the effect size (ES) utilizing Hedges' adjusted g using random effects.
   Results: Eleven studies were included in the meta-analyses, providing data on 1118 participants. Serum and plasma leptin levels were not altered in subjects with BD when compared to healthy controls in mania (g = -0.99, 95% CI -2.43 to 0.43, P = 0.171), in depression (g = 0.17, 95% CI -0.45 to 0.79, P = 0.584), or in euthymia (g = 0.03, 95% CI -0.39 to 0.46, P = 0.882). However, we did observe a stronger association between leptin levels and both age and BMI in patients with BD in euthymia compared to healthy controls, such that the greater the age of the individuals, the greater the difference in leptin levels between BD and controls; and the higher the BMI, the greater the difference in leptin levels between BD and controls.
   Conclusions: Our meta-analysis provides evidence that leptin levels are not altered in BD across the mood spectrum compared to healthy controls. The disproportionate increase of leptin levels with increase in BMI in BD speaks in favour of a potential inflammatory role of white adipose tissue in BD and a disproportionate increase of leptin levels with increase in age. (C) 2016 Elsevier Masson SAS. All rights reserved.
C1 [Fernandes, B. S.; Dash, S.; Jacka, F.; Dodd, S.; Berk, M.] Deakin Univ, IMPACT Strateg Res Ctr, Sch Med, Geelong, Vic 3217, Australia.
   [Fernandes, B. S.; Dash, S.; Jacka, F.; Dodd, S.; Berk, M.] Barwon Hlth, Geelong, Vic, Australia.
   [Fernandes, B. S.; da Graca, M.; Nardin, P.; Goncalves, C. -A.] Univ Fed Rio Grande do Sul, Dept Biochem, Lab Calcium Binding Prot Cent Nervous Syst, Porto Alegre, RS, Brazil.
   [Carvalho, A. F.; Kohler, C. A.] Univ Fed Ceara, Fac Med, Translat Psychiat Res Grp, Fortaleza, CE, Brazil.
   [Carvalho, A. F.; Kohler, C. A.] Univ Fed Ceara, Fac Med, Dept Clin Med, Fortaleza, CE, Brazil.
   [Steiner, J.] Univ Magdeburg, Dept Psychiat, D-39106 Magdeburg, Germany.
   [Berk, M.] Univ Melbourne, Natl Ctr Excellence Youth Mental Hlth, Dept Psychiat & Orygen, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia.
   [Dodd, S.] Univ Melbourne, Dept Psychiat, Parkville, Vic 3052, Australia.
RP Fernandes, BS (corresponding author), Deakin Univ, Sch Med, Barwon Hlth, Geelong, Vic 3217, Australia.
EM brisasf@gmail.com
RI Berk, Michael/M-3585-2019; Fernandes, Brisa/B-6614-2009; Berk,
   Michael/M-7891-2013
OI Berk, Michael/0000-0002-5554-6946; Fernandes, Brisa/0000-0002-3797-7582;
   Berk, Michael/0000-0002-5554-6946; Dash, Sarah/0000-0002-7694-3027;
   Steiner, Johann/0000-0002-2611-2268; Dodd, Seetal/0000-0002-7918-4636
FU CNPq, BrazilNational Council for Scientific and Technological
   Development (CNPq) [MCTI/CNPQ/Universal 14/2014461833/2014-0]; CAPES,
   BrazilCAPES; CNPq (Brazil)National Council for Scientific and
   Technological Development (CNPq); NHMRCNational Health and Medical
   Research Council of Australia [1059660]
FX BSF is supported by a postdoctoral scholarship and by a research grant
   MCTI/CNPQ/Universal 14/2014461833/2014-0, both from CNPq, Brazil. CAK is
   a recipient of a postdoctoral fellowship from CAPES, Brazil. AFC is the
   recipient of a research fellowship from CNPq (Brazil, level II). MB is
   supported by a NHMRC Senior Principal Research Fellowship 1059660.
CR Atmaca M, 2002, NEUROPSYCHOBIOLOGY, V46, P176, DOI 10.1159/000067809
   Barbosa IG, 2012, J PSYCHIATR RES, V46, P389, DOI 10.1016/j.jpsychires.2011.11.010
   Berk M, 2011, NEUROSCI BIOBEHAV R, V35, P804, DOI 10.1016/j.neubiorev.2010.10.001
   Bowden J, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-41
   Brietzke E, 2009, J AFFECT DISORDERS, V116, P214, DOI 10.1016/j.jad.2008.12.001
   Cantarelli MD, 2015, J AFFECT DISORDERS, V172, P403, DOI 10.1016/j.jad.2014.10.033
   Chang HH, 2010, J CLIN PSYCHOPHARM, V30, P512, DOI 10.1097/JCP.0b013e3181f03f50
   Cordas G, 2015, NEUROENDOCRINOLOGY, V101, P82, DOI 10.1159/000371803
   Debnath M, 2015, OBES RES CLIN PRACT
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger E, 1997, LANCET, V350, P326, DOI 10.1016/S0140-6736(97)02419-7
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Fernandes BS, 2016, MOL PSYCHIATR, V21, P554, DOI 10.1038/mp.2015.87
   Fernandes BS, 2015, MOL PSYCHIATR, V20, P1108, DOI 10.1038/mp.2014.117
   Fernandes BS, 2014, MOL PSYCHIATR, V19, P749, DOI 10.1038/mp.2013.172
   Fernandes BS, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0529-7
   Fernandes BS, 2011, J PSYCHIATR RES, V45, P995, DOI 10.1016/j.jpsychires.2011.03.002
   Gergerlioglu HS, 2006, NEUROPSYCHOBIOLOGY, V53, P108, DOI 10.1159/000092219
   Girshkin L, 2014, PSYCHONEUROENDOCRINO, V49, P187, DOI 10.1016/j.psyneuen.2014.07.013
   Grande I, 2015, LANCET
   Guler O, 2007, NEUROL PSYCHIAT BRIA, V14, P4
   HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Kapczinski F, 2009, ACTA NEUROPSYCHIATR, V21, P272, DOI 10.1111/j.1601-5215.2009.00410.x
   Knutson KL, 2007, SLEEP MED REV, V11, P163, DOI 10.1016/j.smrv.2007.01.002
   Kolaczynski JW, 1996, DIABETES, V45, P1511, DOI 10.2337/diabetes.45.11.1511
   Kunz M, 2011, REV BRAS PSIQUIATR, V33, P268, DOI [10.1590/S1516-44462011005000009, 10.1590/S1516-44462011000300010]
   Kurt E, 2007, NEUROSCI LETT, V426, P49, DOI 10.1016/j.neulet.2007.08.018
   Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008
   Lee HJ, 2014, NEUROPSYCHOBIOLOGY, V70, P203, DOI 10.1159/000366488
   McElroy SL, 2014, J CLIN PSYCHIAT, V75, P46, DOI [10.4088/JCP.13010tx4c, 10.4088/JCP.13r08634]
   Minocci A, 2000, INT J OBESITY, V24, P1139, DOI 10.1038/sj.ijo.0801385
   Pasco JA, 2014, OBESITY, V22, P863, DOI 10.1002/oby.20496
   Rosso G, 2015, J AFFECT DISORDERS, V184, P293, DOI 10.1016/j.jad.2015.06.006
   Santoro A, 2015, LIFE SCI, V140, P64, DOI 10.1016/j.lfs.2015.05.012
   Sistrom CL, 2000, AM J ROENTGENOL, V174, P1241, DOI 10.2214/ajr.174.5.1741241
   Soeiro-de-Souza MG, 2014, NEUROSCI LETT, V564, P111, DOI 10.1016/j.neulet.2014.02.005
   Soeken KL, 2003, NURS RES, V52, P57, DOI 10.1097/00006199-200301000-00009
   Steiner J, 2014, PROG NEURO-PSYCHOPH, V48, P287, DOI 10.1016/j.pnpbp.2012.09.016
   Stubbs B, 2016, PSYCHONEUROENDOCRINO, V63, P144, DOI 10.1016/j.psyneuen.2015.09.026
   Tsai SY, 2014, BIPOLAR DISORD, V16, P800, DOI 10.1111/bdi.12240
   Tsai SY, 2012, J AFFECT DISORDERS, V136, P110, DOI 10.1016/j.jad.2011.08.022
   Vancampfort D, 2013, AM J PSYCHIAT, V170, P265, DOI 10.1176/appi.ajp.2012.12050620
   Williams LJ, 2009, J AFFECT DISORDERS, V118, P173, DOI 10.1016/j.jad.2009.02.001
NR 44
TC 17
Z9 17
U1 0
U2 8
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0924-9338
EI 1778-3585
J9 EUR PSYCHIAT
JI Eur. Psychiat.
PD MAY
PY 2016
VL 35
BP 1
EP 7
DI 10.1016/j.eurpsy.2016.02.003
PG 7
WC Psychiatry
SC Psychiatry
GA DN8TC
UT WOS:000377351400001
PM 27065008
DA 2020-12-08
ER

PT J
AU Cha, DS
   Vahtra, M
   Ahmed, J
   Kudlow, PA
   Mansur, RB
   Carvalho, AF
   McIntyre, RS
AF Cha, D. S.
   Vahtra, M.
   Ahmed, J.
   Kudlow, P. A.
   Mansur, R. B.
   Carvalho, A. F.
   McIntyre, R. S.
TI Repurposing of Anti-Diabetic Agents for the Treatment of Cognitive
   Impairment and Mood Disorders
SO CURRENT MOLECULAR MEDICINE
LA English
DT Article
DE Depression; bipolar; diabetes; dementia; Alzheimer's disease; insulin;
   insulin resistance; GLP-1; incretin; thiazolidinedione; metformin;
   cognition
ID MAJOR DEPRESSIVE DISORDER; GLUCAGON-LIKE PEPTIDE-1; BLOOD-BRAIN-BARRIER;
   HIGH-FAT-DIET; ACTIVATED PROTEIN-KINASE; CENTRAL-NERVOUS-SYSTEM;
   PPAR-GAMMA LIGANDS; INSULIN-RESISTANCE; SYNAPTIC PLASTICITY; INTRANASAL
   INSULIN
AB Impairments in cognitive function represent a consistent, non-specific, and clinically significant feature in metabolic, mood, and dementing disorders. The foregoing observation is instantiated by evidence demonstrating that these disorders share pathophysiological mechanisms including, but not limited to, aberrant insulin signaling, inflammation, and glucocorticoid activity. Moreover, these mechanisms have been consistently reported to increase vulnerability to and/or exacerbate impairments in cognitive function. Notwithstanding evidence suggesting a bidirectional relationship between disturbances in the metabolic milieu, mood, and increased risk for dementia, efficacious treatments that target cognitive impairments in these populations do not presently exist. Taken together, it is proposed that anti-diabetic agents may aid the management of mood disorders and future risk for dementia through disease modification by targeting underlying pathophysiological mechanisms (e.g., aberrant metabolic function) rather than focusing solely on symptom mitigation. The current aim is to provide a brief narrative review of extant studies that report on the potential neurotherapeutic effects of anti-diabetic agents on disturbances in mood and impairments in cognitive function.
C1 [Cha, D. S.; Vahtra, M.; Ahmed, J.; Kudlow, P. A.; McIntyre, R. S.] Univ Hlth Network, Mood Disorders Psychopharmacol Unit, Toronto, ON, Canada.
   [Cha, D. S.; Kudlow, P. A.; McIntyre, R. S.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada.
   [Vahtra, M.] Univ Toronto, Arts & Sci, Toronto, ON, Canada.
   [Kudlow, P. A.] Univ Toronto, Dept Psychiat, Clinician Scientist Program, Psychiat Resident, Toronto, ON, Canada.
   [Mansur, R. B.] Univ Fed Sao Paulo, Dept Psychiat, LINC, Sao Paulo, Brazil.
   [Mansur, R. B.] Univ Fed Sao Paulo, Dept Psychiat, Program Recognit & Intervent Individuals Risk Men, Sao Paulo, Brazil.
   [Carvalho, A. F.] Univ Fed Ceara, Dept Clin Med, Fac Med, Fortaleza, Ceara, Brazil.
   [Carvalho, A. F.] Univ Fed Ceara, Translat Psychiat Res Grp, Fac Med, Fortaleza, Ceara, Brazil.
   [McIntyre, R. S.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada.
   [McIntyre, R. S.] Univ Toronto, Dept Pharmacol, Toronto, ON, Canada.
   Univ Hlth Network, Toronto, ON M5T 2S8, Canada.
RP McIntyre, RS (corresponding author), Univ Toronto, Dept Psychiat, Mood Disorders Psychopharmacol Unit, Univ Hlth Network, 399 Bathurst St, Toronto, ON M5T 2S8, Canada.; McIntyre, RS (corresponding author), Univ Toronto, Dept Pharmacol, Mood Disorders Psychopharmacol Unit, Univ Hlth Network, 399 Bathurst St, Toronto, ON M5T 2S8, Canada.
EM Roger.McIntyre@uhn.ca
RI McIntyre, Roger/AAU-1000-2020; Mansur, Rodrigo/N-7131-2019; Mansur,
   Rodrigo/R-5383-2017
OI McIntyre, Roger/0000-0003-4733-2523; Mansur,
   Rodrigo/0000-0002-3968-3297; Mansur, Rodrigo/0000-0002-3968-3297
CR Abu-Hamdah R, 2009, J CLIN ENDOCR METAB, V94, P1843, DOI 10.1210/jc.2008-1296
   American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS5, DOI 10.2337/diacare.27.2007.S5
   Angst J, 2003, EUR ARCH PSY CLIN N, V253, P236, DOI 10.1007/s00406-003-0437-2
   Aoun P, 2003, INVEST OPHTH VIS SCI, V44, P2999, DOI 10.1167/iovs.02-1060
   Awad N, 2004, J CLIN EXP NEUROPSYC, V26, P1044, DOI 10.1080/13803390490514875
   Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054
   Bandaru SS, 2010, PHYSIOL BEHAV, V100, P239, DOI 10.1016/j.physbeh.2009.10.019
   Banks WA, 1997, PEPTIDES, V18, P1423, DOI 10.1016/S0196-9781(97)00231-3
   Banks WA, 1998, PEPTIDES, V19, P883, DOI 10.1016/S0196-9781(98)00018-7
   Baura GD, 1996, DIABETES, V45, P86, DOI 10.2337/diabetes.45.1.86
   Benedict C, 2007, NEUROPSYCHOPHARMACOL, V32, P239, DOI 10.1038/sj.npp.1301193
   Biessels GJ, 2008, LANCET NEUROL, V7, P184, DOI 10.1016/S1474-4422(08)70021-8
   Biswas SC, 2008, NEUROCHEM RES, V33, P1845, DOI 10.1007/s11064-008-9646-4
   Bjorntorp P, 1997, NUTRITION, V13, P795, DOI 10.1016/s0899-9007(97)00191-3
   Bora E, 2011, ACTA PSYCHIAT SCAND, V123, P165, DOI 10.1111/j.1600-0447.2010.01638.x
   Born J, 2002, NAT NEUROSCI, V5, P514, DOI 10.1038/nn849
   Bowie CR, 2005, PSYCHIAT CLIN N AM, V28, P613, DOI 10.1016/j.psc.2005.05.004
   Brands AMA, 2007, J INT NEUROPSYCH SOC, V13, P288, DOI 10.1017/S1355617707070312
   Brietzke E, 2011, EXPERT REV NEUROTHER, V11, P1017, DOI [10.1586/ERN.10.185, 10.1586/ern.10.185]
   Bruffaerts R, 2008, CAN J PSYCHIAT, V53, P679, DOI 10.1177/070674370805301007
   Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011
   Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005
   Butters Meryl A, 2008, Dialogues Clin Neurosci, V10, P345
   Camp HS, 1997, J BIOL CHEM, V272, P10811
   Carlson Paul J, 2006, NeuroRx, V3, P22, DOI 10.1016/j.nurx.2005.12.009
   Casey Daniel E, 2005, Am J Med, V118 Suppl 2, p15S
   Cernea S, 2011, DIABETES CARE, V34, pS264, DOI 10.2337/dc11-s223
   Cha DS, 2014, CNS NEUROL DISORD-DR, V13, P1740
   Chapman CD, 2013, PHARM RES-DORDR, V30, P2475, DOI 10.1007/s11095-012-0915-1
   Cheng G, 2012, INTERN MED J, V42, P484, DOI 10.1111/j.1445-5994.2012.02758.x
   Cheng Y, 2015, MOL PSYCHIATR, V20, P744, DOI 10.1038/mp.2014.136
   Colca JR, 2006, BIOCHEM PHARMACOL, V72, P125, DOI 10.1016/j.bcp.2006.01.002
   Collins PY, 2011, NATURE, V475, P27, DOI 10.1038/475027a
   Cosway R, 2001, DIABETIC MED, V18, P803, DOI 10.1046/j.1464-5491.2001.00577.x
   Craft S, 2007, CURR ALZHEIMER RES, V4, P147, DOI 10.2174/156720507780362137
   Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233
   CRAMOND WA, 1987, AUST NZ J PSYCHIAT, V21, P320, DOI 10.3109/00048678709160928
   Della-Morte D, 2014, PHARMACOGENOMICS, V15, P2063, DOI [10.2217/PGS.14.162, 10.2217/pgs.14.162]
   Dello Russo C, 2003, J BIOL CHEM, V278, P5828, DOI 10.1074/jbc.M208132200
   den Heijer T, 2003, DIABETOLOGIA, V46, P1604, DOI 10.1007/s00125-003-1235-0
   Denner LA, 2012, J NEUROSCI, V32, P16725, DOI 10.1523/JNEUROSCI.2153-12.2012
   Deschenes SS, 2015, J PSYCHOSOM RES, V78, P137, DOI 10.1016/j.jpsychores.2014.11.023
   Dotson VM, 2010, NEUROLOGY, V75, P27, DOI 10.1212/WNL.0b013e3181e62124
   Faivre E, 2011, J NEUROPHYSIOL, V105, P1574, DOI 10.1152/jn.00866.2010
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Forti P, 2010, J AM GERIATR SOC, V58, P487, DOI 10.1111/j.1532-5415.2010.02731.x
   Gault VA, 2008, EUR J PHARMACOL, V587, P112, DOI 10.1016/j.ejphar.2008.03.025
   Ghasemi R, 2013, MOL NEUROBIOL, V47, P1045, DOI 10.1007/s12035-013-8404-z
   Gispen WH, 2000, TRENDS NEUROSCI, V23, P542, DOI 10.1016/S0166-2236(00)01656-8
   Gold SM, 2007, DIABETOLOGIA, V50, P711, DOI 10.1007/s00125-007-0602-7
   Guo M, 2014, CLIN EXP PHARMACOL P, V41, P650, DOI 10.1111/1440-1681.12265
   Hallschmid M, 2008, INT J OBESITY, V32, P275, DOI 10.1038/sj.ijo.0803722
   Harada M, 2012, CIRC-ARRHYTHMIA ELEC, V5, P860, DOI 10.1161/CIRCEP.112.972265
   Hasan SS, 2013, ASIAN J PSYCHIATR, V6, P460, DOI 10.1016/j.ajp.2013.09.008
   Heneka MT, 2015, ANN NEUROL, V78, P284, DOI 10.1002/ana.24439
   Ho N, 2013, NEUROSCI BIOBEHAV R, V37, P1346, DOI 10.1016/j.neubiorev.2013.03.010
   Holden RJ, 1999, MED HYPOTHESES, V52, P193, DOI 10.1054/mehy.1997.0642
   Horrobin DF, 1999, PROSTAG LEUKOTR ESS, V60, P217, DOI 10.1054/plef.1999.0037
   Huang Chiung-Chun, 2010, Chang Gung Med J, V33, P115
   Hunter K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-33
   Illum L, 2002, DRUG DISCOV TODAY, V7, P1184, DOI 10.1016/S1359-6446(02)02529-1
   Kaidanovich-Beilin Oksana, 2012, F1000 Biol Rep, V4, P14, DOI 10.3410/B4-14
   Kaiyala KJ, 2000, DIABETES, V49, P1525, DOI 10.2337/diabetes.49.9.1525
   Kariharan T, 2015, NEUROBIOL AGING, V36, P1451, DOI 10.1016/j.neurobiolaging.2014.09.028
   Katon W, 2012, ARCH GEN PSYCHIAT, V69, P410, DOI 10.1001/archgenpsychiatry.2011.154
   Kemp DE, 2014, CNS DRUGS, V28, P571, DOI 10.1007/s40263-014-0158-2
   Kemp DE, 2010, BIPOLAR DISORD, V12, P404, DOI 10.1111/j.1399-5618.2010.00823.x
   Ketterer C, 2011, DIABETES RES CLIN PR, V93, pS47, DOI 10.1016/S0168-8227(11)70013-4
   Kim EJ, 2003, J PHARMACOL EXP THER, V307, P505, DOI 10.1124/jpet.103.053876
   Kitamura Y, 1999, NEUROSCI LETT, V262, P129, DOI 10.1016/S0304-3940(99)00055-5
   Kosaraju J, 2013, J PHARM PHARMACOL, V65, P1773, DOI 10.1111/jphp.12148
   Laaksonen DE, 2002, AM J EPIDEMIOL, V156, P1070, DOI 10.1093/aje/kwf145
   Lannert H, 1998, BEHAV NEUROSCI, V112, P1199, DOI 10.1037/0735-7044.112.5.1199
   Lee AL, 2002, BIPOLAR DISORD, V4, P117, DOI 10.1034/j.1399-5618.2002.01144.x
   Liu JH, 2009, ACTA PHARMACOL SIN, V30, P159, DOI 10.1038/aps.2008.25
   Mansur RB, 2015, NEUROSCI BIOBEHAV R, V52, P89, DOI 10.1016/j.neubiorev.2014.12.017
   Marfella R, 2010, J DIABETES COMPLICAT, V24, P79, DOI 10.1016/j.jdiacomp.2009.01.004
   McClean PL, 2011, J NEUROSCI, V31, P6587, DOI 10.1523/JNEUROSCI.0529-11.2011
   McClean PL, 2010, EUR J PHARMACOL, V630, P158, DOI 10.1016/j.ejphar.2009.12.023
   McEwen BS, 2002, J PSYCHOSOM RES, V53, P883, DOI 10.1016/S0022-3999(02)00307-0
   McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105
   McIntyre Roger S, 2006, Expert Opin Pharmacother, V7, P1305, DOI 10.1517/14656566.7.10.1305
   McIntyre Roger S, 2007, Ann Clin Psychiatry, V19, P257, DOI 10.1080/10401230701653377
   McIntyre RS, 2007, EXPERT OPIN PHARMACO, V8, P1615, DOI 10.1517/14656566.8.11.1615
   McIntyre RS, 2013, DEPRESS ANXIETY, V30, P515, DOI 10.1002/da.22063
   McNeilly AD, 2012, DIABETOLOGIA, V55, P3061, DOI 10.1007/s00125-012-2686-y
   Moore EM, 2013, DIABETES CARE, V36, P2981, DOI 10.2337/dc13-0229
   Naranjo DM, 2011, ANN FAM MED, V9, P115, DOI 10.1370/afm.1212
   National Institute of Mental Health, 2015, FAST FAST FAIL TRIAL
   Ng TP, 2014, J ALZHEIMERS DIS, V41, P61, DOI 10.3233/JAD-131901
   Novak V, 2014, DIABETES CARE, V37, P751, DOI 10.2337/dc13-1672
   Ott V, 2015, DIABETES, V64, P760, DOI 10.2337/db14-0931
   Owens DR, 2003, DIABETIC MED, V20, P886, DOI 10.1046/j.1464-5491.2003.01076.x
   Papageorgiou E, 2007, EXPERT OPIN THER TAR, V11, P1071, DOI 10.1517/14728222.11.8.1071
   Park CR, 2001, NEUROSCI BIOBEHAV R, V25, P311, DOI 10.1016/S0149-7634(01)00016-1
   Parker HE, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S146239940900132X
   Patel SS, 2016, HORM BEHAV, V78, P200, DOI 10.1016/j.yhbeh.2015.11.010
   Pintana H, 2013, J ENDOCRINOL, V218, P1, DOI 10.1530/JOE-12-0521
   Pipatpiboon N, 2013, EUR J NEUROSCI, V37, P839, DOI 10.1111/ejn.12088
   Plum L, 2005, TRENDS ENDOCRIN MET, V16, P59, DOI 10.1016/j.tem.2005.01.008
   Porter DW, 2010, DIABETES OBES METAB, V12, P891, DOI 10.1111/j.1463-1326.2010.01259.x
   Porter DW, 2011, EUR J PHARMACOL, V650, P688, DOI 10.1016/j.ejphar.2010.10.059
   Porter RJ, 2003, BRIT J PSYCHIAT, V182, P214, DOI 10.1192/bjp.182.3.214
   Potter WZ, 2015, EXPERT REV CLIN PHAR, V8, P155, DOI 10.1586/17512433.2015.991715
   Rasgon N, 2004, J GERONTOL A-BIOL, V59, P178
   Rasgon NL, 2010, THESCIENTIFICWORLDJO, V10, P321, DOI 10.1100/tsw.2010.32
   Reagan LP, 2001, P NATL ACAD SCI USA, V98, P2820, DOI 10.1073/pnas.051629798
   Reger MA, 2006, NEUROBIOL AGING, V27, P451, DOI 10.1016/j.neurobiolaging.2005.03.016
   Reynolds Kathryn, 2006, Treat Endocrinol, V5, P25, DOI 10.2165/00024677-200605010-00004
   Rizzo MR, 2014, J GERONTOL A-BIOL, V69, P1122, DOI 10.1093/gerona/glu032
   Rosenblat JD, 2014, PROG NEURO-PSYCHOPH, V53, P23, DOI 10.1016/j.pnpbp.2014.01.013
   Ryan CM, 2006, DIABETES CARE, V29, P345, DOI 10.2337/diacare.29.02.06.dc05-1626
   Sanusi Himawan, 2009, Acta Med Indones, V41, P205
   Scacchi R, 2007, BRAIN RES, V1139, P1, DOI 10.1016/j.brainres.2006.12.078
   Schroeter H, 2007, J NEUROCHEM, V101, P1596, DOI 10.1111/j.1471-4159.2006.04434.x
   Schulingkamp RJ, 2000, NEUROSCI BIOBEHAV R, V24, P855, DOI 10.1016/S0149-7634(00)00040-3
   Sharma MK, 2014, J NEUROCHEM, V128, P459, DOI 10.1111/jnc.12469
   Sheline YI, 2002, EUR PSYCHIAT, V17, p300S
   Silva N, 2012, CURR PSYCHIAT REP, V14, P8, DOI 10.1007/s11920-011-0245-8
   Stewart R, 1999, DIABETIC MED, V16, P93, DOI 10.1046/j.1464-5491.1999.00027.x
   Stockhorst U, 2004, PHYSIOL BEHAV, V83, P47, DOI 10.1016/j.physbeh.2004.07.022
   STRUBBE JH, 1988, PHYSIOL BEHAV, V44, P205, DOI 10.1016/0031-9384(88)90139-4
   Thompson JM, 2005, BRIT J PSYCHIAT, V186, P32, DOI 10.1192/bjp.186.1.32
   Unger JW, 1998, HISTOL HISTOPATHOL, V13, P1215, DOI 10.14670/HH-13.1215
   Wahlqvist ML, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-150
   Wasem J, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-47
   Watari K, 2006, ARCH CLIN NEUROPSYCH, V21, P787, DOI 10.1016/j.acn.2006.06.014
   Watson GS, 2005, AM J GERIAT PSYCHIAT, V13, P950, DOI 10.1176/appi.ajgp.13.11.950
   Ying MA, 2014, CNS NEUROL DISORD-DR, V13, P1836
   Zhang HL, 2011, NEUROSCIENCE, V176, P381, DOI 10.1016/j.neuroscience.2010.12.029
   Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505
NR 131
TC 5
Z9 5
U1 0
U2 13
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1566-5240
EI 1875-5666
J9 CURR MOL MED
JI Curr. Mol. Med.
PY 2016
VL 16
IS 5
BP 465
EP 473
DI 10.2174/1566524016666160429121737
PG 9
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DV0VW
UT WOS:000382639700004
PM 27132792
DA 2020-12-08
ER

PT J
AU Barichello, T
   Badawy, M
   Pitcher, MR
   Saigal, P
   Generoso, JS
   Goularte, JA
   Simoes, LR
   Quevedo, J
   Carvalho, AF
AF Barichello, T.
   Badawy, M.
   Pitcher, M. R.
   Saigal, P.
   Generoso, J. S.
   Goularte, J. A.
   Simoes, L. R.
   Quevedo, J.
   Carvalho, A. F.
TI Exposure to Perinatal Infections and Bipolar Disorder: A Systematic
   Review
SO CURRENT MOLECULAR MEDICINE
LA English
DT Article
DE Bipolar disorder; maternal infection; herpes; influenza; Toxoplasma
   gondii; systematic review
ID HERPES-SIMPLEX ENCEPHALITIS; TOXOPLASMA-GONDII INFECTION;
   PSYCHIATRIC-PATIENTS; COGNITIVE IMPAIRMENT; CEREBROSPINAL-FLUID;
   SCHIZOPHRENIA; METAANALYSIS; CYTOMEGALOVIRUS; INDIVIDUALS; ANTIBODIES
AB Bipolar disorder (BD) is a debilitating psychiatric disorder and a growing global public health issue. Notwithstanding BD has been conceptualized as a neuroprogressive illness, there are some evidences to suggest a role for neurodevelopmental pathways in the patho-etiology of this disorder. Evidences on the associations between perinatal infections and risk for bipolar disorder have been inconsistent across studies. Here, we performed a systematic review of observational studies on the relationship between exposure to perinatal pathogens and bipolar disorder. A computerized literature search of the PubMed, Embase, and PsyINFO databases till January 31st, 2015 was performed. Twenty-three studies ultimately met inclusion criteria. Studies investigated exposure to several pathogens namely Cytomegalovirus (CMV), Epstein-Barr Virus (EBV), Herpes simplex virus-1 (HSV-1), Herpes simplex virus-2 (HSV-2), Human herpesvirus 6 (HHV-6), Toxoplasma gondii, Influenza, and Varicella zoster virus (VZV). Overall, studies provided mixed evidences. Thus, contrary to schizophrenia, the role of perinatal infections as risk factors for BD remain inconclusive. Larger studies with a prospective design would be necessary to elucidate the role of previous exposure to infectious agents as a potential risk factor for BD.
C1 [Barichello, T.; Generoso, J. S.; Goularte, J. A.; Simoes, L. R.] Univ Southern Santa Catarina UNESC, Hlth Sci Unit, Grad Program Hlth Sci, Lab Expt Microbiol, Criciuma, SC, Brazil.
   [Quevedo, J.] Univ Southern Santa Catarina UNESC, Hlth Sci Unit, Grad Program Hlth Sci, Neurosci Lab, Criciuma, SC, Brazil.
   [Barichello, T.; Badawy, M.; Pitcher, M. R.; Saigal, P.; Quevedo, J.] Univ Texas Hlth Sci Ctr Houston, UTHlth, McGovern Med Sch, Dept Psychiat & Behav Sci,Translat Psychiat Progr, Houston, TX 77054 USA.
   [Barichello, T.; Quevedo, J.] Univ Texas Hlth Sci Ctr Houston, UTHlth, McGovern Med Sch, Dept Psychiat & Behav Sci,Ctr Excellence Mood Dis, Houston, TX 77054 USA.
   [Barichello, T.; Quevedo, J.] Univ Texas Houston, Grad Sch Biomed Sci Houston, Grad Program Neurosci, Houston, TX USA.
   [Carvalho, A. F.] Univ Fed Ceara, Dept Clin Med, Translat Psychiat Res Grp, BR-60430140 Fortaleza, CE, Brazil.
RP Barichello, T (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Psychiat & Behav Sci, Houston, TX 77054 USA.
EM Tatiana.Barichello@uth.tmc.edu
RI Generoso, Jaqueline S/N-3142-2013; de Quevedo, Joao Luciano/E-5491-2013
OI Generoso, Jaqueline S/0000-0003-0571-6764; de Quevedo, Joao
   Luciano/0000-0003-3114-6611; Barichello, Tatiana/0000-0001-7776-8454
FU Department of Psychiatry and Behavioral Sciences, McGovern Medical
   School, The University of Texas Health Science Center at Houston
   (UTHealth); CNPqNational Council for Scientific and Technological
   Development (CNPq); FAPESC; Instituto Cerebro e Mente; UNESC
FX The Translational Psychiatry Program (USA) is funded by the Department
   of Psychiatry and Behavioral Sciences, McGovern Medical School, The
   University of Texas Health Science Center at Houston (UTHealth).
   Laboratory of Experimental Microbiology and Neurosciences (Brazil) are
   one of the centers of the National Institute for Molecular Medicine
   (INCT-MM) and one of the members of the Center of Excellence in Applied
   Neurosciences of Santa Catarina (NENASC). Its research is supported by
   grants from CNPq (JQ and TB), FAPESC (JQ and TB); Instituto Cerebro e
   Mente (JQ and TB) and UNESC (JQ and TB).
CR Arango C, 2014, SCHIZOPHRENIA BULL, V40, pS138, DOI 10.1093/schbul/sbt198
   Berk M, 2011, NEUROSCI BIOBEHAV R, V35, P804, DOI 10.1016/j.neubiorev.2010.10.001
   Bourne C, 2013, ACTA PSYCHIAT SCAND, V128, P149, DOI 10.1111/acps.12133
   Canetta SE, 2014, AM J PSYCHIAT, V171, P557, DOI 10.1176/appi.ajp.2013.13070943
   Debnath M, 2015, NEUROSCI BIOBEHAV R, V49, P90, DOI 10.1016/j.neubiorev.2014.12.003
   Dickerson F, 2014, J NERV MENT DIS, V202, P589, DOI 10.1097/NMD.0000000000000166
   Dickerson F, 2014, BIPOLAR DISORD, V16, P129, DOI 10.1111/bdi.12123
   Dickerson FB, 2004, BIOL PSYCHIAT, V55, P588, DOI 10.1016/j.biopsych.2003.10.008
   Dong XH, 2015, CNS NEUROSCI THER, V21, P393, DOI 10.1111/cns.12390
   Egger M, 2001, SYSTEMATIC REV HLTH, V2, P3, DOI DOI 10.1002/9780470693926
   Fusar-Poli P, 2012, J PSYCHIATR NEUROSCI, V37, P170, DOI 10.1503/jpn.110061
   Gerber SI, 2012, PROG NEURO-PSYCHOPH, V36, P110, DOI 10.1016/j.pnpbp.2011.09.003
   Gubert C, 2016, MOL NEUROBIOL, V53, P611, DOI 10.1007/s12035-014-9031-z
   Hamdani N, 2015, J AFFECT DISORDERS, V179, P161, DOI 10.1016/j.jad.2015.03.038
   Hamdani N, 2013, J AFFECT DISORDERS, V148, P444, DOI 10.1016/j.jad.2012.11.034
   Hinze-Selch D, 2010, FOLIA PARASIT, V57, P129, DOI 10.14411/fp.2010.016
   Hornig M, 2012, MOL PSYCHIATR, V17, P486, DOI 10.1038/mp.2011.179
   Houenou J, 2014, PROG NEURO-PSYCHOPH, V48, P142, DOI 10.1016/j.pnpbp.2013.09.003
   Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021
   KAPUR N, 1994, J NEUROL NEUROSUR PS, V57, P1334, DOI 10.1136/jnnp.57.11.1334
   Khademvatan S., 2013, Journal of Medical Sciences (Pakistan), V13, P215
   Khandaker GM, 2012, SCHIZOPHR RES, V139, P161, DOI 10.1016/j.schres.2012.05.023
   Kilcher S, 2015, VIROLOGY, V479, P578, DOI 10.1016/j.virol.2015.01.024
   Kodjikian L, 2010, J FR OPHTALMOL, V33, P362, DOI 10.1016/j.jfo.2010.03.002
   KOEHLER K, 1979, BIOL PSYCHIAT, V14, P405
   Lu B, 2014, EXPERT REV CLIN IMMU, V10, P713, DOI 10.1586/1744666X.2014.909730
   LYCKE E, 1974, BRIT J PSYCHIAT, V124, P273, DOI 10.1192/bjp.124.3.273
   Machado-Vieira R, 2002, EUR NEUROPSYCHOPHARM, V12, P269, DOI 10.1016/S0924-977X(02)00029-9
   Mazaheri-Tehrani E, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-161
   Merikangas KR, 2011, ARCH GEN PSYCHIAT, V68, P241, DOI 10.1001/archgenpsychiatry.2011.12
   Meyer U, 2014, AM J PSYCHIAT, V171, P485, DOI 10.1176/appi.ajp.2014.14010095
   Mirza Raul A, 2012, MSMR, V19, P10
   Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005
   Mook-Kanamori BB, 2011, CLIN MICROBIOL REV, V24, P557, DOI 10.1128/CMR.00008-11
   Mortensen PB, 2011, BIPOLAR DISORD, V13, P624, DOI 10.1111/j.1399-5618.2011.00962.x
   Munkholm K, 2013, J AFFECT DISORDERS, V144, P16, DOI 10.1016/j.jad.2012.06.010
   Otten M, 2015, J AFFECT DISORDERS, V174, P113, DOI 10.1016/j.jad.2014.11.001
   Parboosing R, 2013, JAMA PSYCHIAT, V70, P677, DOI 10.1001/jamapsychiatry.2013.896
   Pearce BD, 2012, BIOL PSYCHIAT, V72, P290, DOI 10.1016/j.biopsych.2012.01.003
   Phillips ML, 2013, LANCET, V381, P1663, DOI 10.1016/S0140-6736(13)60989-7
   Prossin AR, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/939780
   Prossin AR, 2013, BRAIN BEHAV IMMUN, V32, pe37
   Rackova S, 2009, NEUROENDOCRINOL LETT, V30, P414
   Rizzo LB, 2013, BIPOLAR DISORD, V15, P832, DOI 10.1111/bdi.12121
   Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303
   Savitz JB, 2014, NEUROSCI BIOBEHAV R, V42, P132, DOI 10.1016/j.neubiorev.2014.02.008
   SCHLITT M, 1985, SOUTHERN MED J, V78, P1347, DOI 10.1097/00007611-198511000-00021
   Sellner Johann, 2010, Handb Clin Neurol, V96, P1, DOI 10.1016/S0072-9752(09)96001-8
   Severance EG, 2011, SCHIZOPHRENIA BULL, V37, P101, DOI 10.1093/schbul/sbp052
   Soderlund J, 2011, J PSYCHIATR NEUROSCI, V36, P114, DOI 10.1503/jpn.100080
   Stich O, 2015, BIPOLAR DISORD, V17, P291, DOI 10.1111/bdi.12244
   Tedla Yared, 2011, Ethiop Med J, V49, P211
   TORREY EF, 1982, SCIENCE, V216, P892, DOI 10.1126/science.6281883
   Wang XY, 2014, IEEE T COMP PACK MAN, V4, P4, DOI 10.1109/TCPMT.2013.2280922
   Wiersinga WJ, 2014, VIRULENCE, V5, P36, DOI 10.4161/viru.25436
   Yolken RH, 2008, MOL PSYCHIATR, V13, P470, DOI 10.1038/mp.2008.5
   Yolken RH, 2011, SCHIZOPHRENIA BULL, V37, P235
NR 57
TC 13
Z9 13
U1 2
U2 12
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1566-5240
EI 1875-5666
J9 CURR MOL MED
JI Curr. Mol. Med.
PY 2016
VL 16
IS 2
BP 106
EP 118
DI 10.2174/1566524016666160126143741
PG 13
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DH1MY
UT WOS:000372550000002
PM 26812921
DA 2020-12-08
ER

PT J
AU Rosenblat, JD
   Gregory, JM
   Carvalho, AF
   McIntyre, RS
AF Rosenblat, J. D.
   Gregory, J. M.
   Carvalho, A. F.
   McIntyre, R. S.
TI Depression and Disturbed Bone Metabolism: A Narrative Review of the
   Epidemiological Findings and Postulated Mechanisms
SO CURRENT MOLECULAR MEDICINE
LA English
DT Article
DE Osteoporosis; bone mineral density (BMD); fractures; major depressive
   disorder (MDD); antidepressants; cytokines; vitamin D; serotonin
ID TASK-FORCE RECOMMENDATIONS; PITUITARY-ADRENAL AXIS; QUALITY-OF-LIFE;
   MINERAL DENSITY; DIABETES-MELLITUS; MOOD DISORDERS; RISK-FACTOR;
   SEROTONIN RECEPTORS; REUPTAKE INHIBITORS; LEPTIN REGULATION
AB Major depressive disorder (MDD) is a pervasive chronic condition that contributes substantially to the global burden of disease and disability. Adding to the complexity of this disorder are numerous associated medical comorbidities with a bidirectional impact on morbidity and mortality. In recent years, osteoporosis has been increasingly identified as a significant comorbidity of MDD. This narrative review examines the literature to summarize key epidemiological studies and discuss postulated mechanisms of interaction. Epidemiological studies have repeatedly shown an increased co-prevalence of fractures and decreased bone mineral density (BMD) in MDD. The pathophysiological mechanism underlying this interaction is undoubtedly complex and multifactorial, and proposed pathways have varying levels of evidence from preclinical and clinical models. Conceptually, the mechanisms by which depression might influence bone metabolism can be categorized into biological, behavioral, iatrogenic, and comorbidity-related factors. Biological factors include the inflammatory-mood pathway, hypothalamic-pituitary-adrenal (HPA) axis dysregulation, metabolic dysfunction, and serotonin's direct and indirect effects on bone cells. Behavioral factors incorporate lifestyle choices typical in depressed patients, such as increased tobacco use or limited exercise. The prominent iatrogenic factor is the independent effects of anti-depressants on bone metabolism. Psychiatric and medical comorbidities common to both osteoporosis and MDD are also important to consider. Physical activity promotion, vitamin D supplementation, and routine BMD screening of MDD patients are simple interventions that might lead to improved outcomes for both conditions. An improved understanding of the underlying mechanisms may yield insights into novel prevention and treatment strategies to target osteoporosis and fractures in the MDD population.
C1 [Rosenblat, J. D.; McIntyre, R. S.] Univ Toronto, Dept Psychiat, Univ Hlth Network, Mood Disorder Psychopharmacol Unit, Toronto, ON M5T 2S8, Canada.
   [Rosenblat, J. D.; McIntyre, R. S.] Univ Toronto, Dept Psychiat, 399 Bathurst St, Toronto, ON M5T 2S8, Canada.
   [Rosenblat, J. D.; McIntyre, R. S.] Univ Toronto, Dept Pharmacol, Toronto, ON M5T 2S8, Canada.
   [Gregory, J. M.] Univ Western Ontario, Dept Psychiat, London, ON N6A 3K7, Canada.
   [Carvalho, A. F.] Univ Fed Ceara, Fac Med, Translat Psychiat Res Grp, Fortaleza, CE, Brazil.
   [Carvalho, A. F.] Univ Fed Ceara, Fac Med, Dept Clin Med, Fortaleza, CE, Brazil.
RP McIntyre, RS (corresponding author), Univ Toronto, Dept Psychiat, 399 Bathurst St, Toronto, ON M5T 2S8, Canada.
EM Roger.McIntyre@uhn.on
RI McIntyre, Roger/AAU-1000-2020
OI McIntyre, Roger/0000-0003-4733-2523
FU AstraZenecaAstraZeneca; Bristol-Myers SquibbBristol-Myers Squibb;
   Janssen-Ortho; Eli Lily; Forest; LundbeckLundbeck Corporation;
   PfizerPfizer; Shire; MerckMerck & Company; Sepracor; OtsukaOtsuka
   Pharmaceutical
FX JDR, AFC and JG have no conflicts of interest to declare. RSM declares
   that he has been on advisory boards and/or received honoraria for
   educational activities and/or research grants from AstraZeneca,
   Bristol-Myers Squibb, Janssen-Ortho, Eli Lily, Forest, Lundbeck, Pfizer,
   Shire, Merck, Sepracor and Otsuka.
CR ALEXEEVA L, 1994, WHO TECH REP SER, V843, P1
   Aloumanis K, 2013, HORM-INT J ENDOCRINO, V12, P350, DOI 10.1007/BF03401301
   American Psychiatric Association (APA), 2013, DIAGN STAT MAN MENT
   ANDA RF, 1990, JAMA-J AM MED ASSOC, V264, P1541, DOI 10.1001/jama.264.12.1541
   Anderson G, 2014, CNS DRUGS, V28, P1, DOI 10.1007/s40263-013-0119-1
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Andrade L, 2003, INT J METH PSYCH RES, V12, P3, DOI 10.1002/mpr.138
   Baldwin RC, 2010, INT PSYCHOGERIATR, V22, P1216, DOI 10.1017/S1041610210000864
   Banfi G, 2008, CLIN CHEM LAB MED, V46, P1550, DOI 10.1515/CCLM.2008.302
   Banks WA, 2012, PHARMACOL THERAPEUT, V136, P82, DOI 10.1016/j.pharmthera.2012.07.006
   Baskaran A, 2014, CNS NEUROL DISORD-DR, V13, P1667
   Beishuizen A, 2003, J ENDOTOXIN RES, V9, P3, DOI 10.1179/096805103125001298
   Berk M, 2014, J CLIN PSYCHIAT, V75, P628, DOI 10.4088/JCP.13m08454
   Berk M, 2013, TRENDS PHARMACOL SCI, V34, P167, DOI 10.1016/j.tips.2013.01.001
   Bingham EM, 2002, DIABETES, V51, P3384, DOI 10.2337/diabetes.51.12.3384
   Bliziotes MM, 2001, BONE, V29, P477, DOI 10.1016/S8756-3282(01)00593-2
   Calarge CA, 2014, J BONE MINER RES, V29, P2230, DOI 10.1002/jbmr.2249
   Carek PJ, 2011, INT J PSYCHIAT MED, V41, P15, DOI 10.2190/PM.41.1.c
   Carnahan RM, 2004, DRUG AGING, V21, P361, DOI 10.2165/00002512-200421060-00002
   Carpintero P, 2014, WORLD J ORTHOP, V5, P402, DOI 10.5312/wjo.v5.i4.402
   Carter Melissa I, 2014, Mo Med, V111, P59
   Chang CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089867
   Chau K, 2012, J OSTEOPOROS, V2012, DOI 10.1155/2012/323061
   Cizza G, 2010, HORM METAB RES, V42, P467, DOI 10.1055/s-0030-1252020
   Cizza G, 2001, TRENDS ENDOCRIN MET, V12, P198, DOI 10.1016/S1043-2760(01)00407-6
   Cizza G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040894
   Cizza Giovanni, 2011, Dialogues Clin Neurosci, V13, P73
   Cizza G, 2010, J CLIN PSYCHIAT, V71, P1079, DOI 10.4088/JCP.09m05314blu
   Cizza G, 2009, TRENDS ENDOCRIN MET, V20, P367, DOI 10.1016/j.tem.2009.05.003
   Clemens TL, 2011, J BONE MINER RES, V26, P677, DOI 10.1002/jbmr.321
   Cohen Jacob, 1977, STAT POWER ANAL BEHA
   Colon-Emeric C, 2011, MT SINAI J MED, V78, P515, DOI 10.1002/msj.20269
   Conn VS, 2010, ANN BEHAV MED, V39, P128, DOI 10.1007/s12160-010-9172-x
   Coryell W, 2013, MERK MANUAL MOOD DIS
   Craft S, 2004, LANCET NEUROL, V3, P169, DOI 10.1016/S1474-4422(04)00681-7
   CUMMINGS SR, 1989, J GERONTOL, V44, pM107
   Deandrea S, 2010, EPIDEMIOLOGY, V21, P658, DOI 10.1097/EDE.0b013e3181e89905
   Dempster David W, 2011, Am J Manag Care, V17 Suppl 6, pS164
   Diem SJ, 2013, OSTEOPOROSIS INT, V24, P111, DOI 10.1007/s00198-012-1975-0
   Diem SJ, 2007, J AM GERIATR SOC, V55, P824, DOI 10.1111/j.1532-5415.2007.01194.x
   Diem SJ, 2007, ARCH INTERN MED, V167, P1240, DOI 10.1001/archinte.167.12.1240
   Diem SJ, 2013, J CLIN ENDOCR METAB, V98, P4355, DOI 10.1210/jc.2013-1971
   DiVasta AD, 2013, METABOLISM, V62, P1714, DOI 10.1016/j.metabol.2013.09.016
   Dorn LD, 2013, J ADOLESCENT HEALTH, V52, P393, DOI 10.1016/j.jadohealth.2012.10.005
   Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033
   Dunn AJ, 2005, NEUROSCI BIOBEHAV R, V29, P891, DOI 10.1016/j.neubiorev.2005.03.023
   Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398
   Eom CS, 2012, J BONE MINER RES, V27, P1186, DOI 10.1002/jbmr.1554
   Fazeli PK, 2013, PSYCHOSOM MED, V75, P117, DOI 10.1097/PSY.0b013e3182821e91
   Felger JC, 2013, NEUROSCIENCE, V246, P199, DOI 10.1016/j.neuroscience.2013.04.060
   Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547
   Ferrari AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069637
   Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003
   Fulzele K, 2010, CELL, V142, P309, DOI 10.1016/j.cell.2010.06.002
   Gans ROB, 2006, MED CLIN N AM, V90, P573, DOI 10.1016/j.mcna.2006.05.002
   Gebara MA, 2014, J AM GERIATR SOC, V62, P1434, DOI 10.1111/jgs.12945
   Gimble JM, 2011, J BONE MINER RES, V26, P1694, DOI 10.1002/jbmr.445
   Graff LA, 2009, INFLAMM BOWEL DIS, V15, P1105, DOI 10.1002/ibd.20873
   GRANT BF, 1995, DRUG ALCOHOL DEPEN, V39, P197, DOI 10.1016/0376-8716(95)01160-4
   Grinevich V, 2001, J NEUROENDOCRINOL, V13, P711, DOI 10.1046/j.1365-2826.2001.00684.x
   Guideline for the prevention of falls in older persons, 2001, J AM GERIATR SOC, V49, P664, DOI DOI 10.1046/J.1532-5415.2001.49115.X
   Gustafsson BI, 2006, J CELL BIOCHEM, V98, P139, DOI 10.1002/jcb.20734
   Hoang MT, 2011, MAYO CLIN PROC, V86, P1050, DOI 10.4065/mcp.2011.0208
   HONKANEN R, 1976, ANN CHIR GYNAECOL FE, V65, P287
   Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4
   Johnell O, 2005, OSTEOPOROSIS INT, V16, pS3, DOI 10.1007/s00198-004-1702-6
   Kahl KG, 2006, PSYCHOSOM MED, V68, P669, DOI 10.1097/01.psy.0000237858.76880.3d
   Kahl KG, 2005, AM J PSYCHIAT, V162, P168, DOI 10.1176/appi.ajp.162.1.168
   Kaidanovich-Beilin Oksana, 2012, F1000 Biol Rep, V4, P14, DOI 10.3410/B4-14
   Kallala R, 2013, EXPERT OPIN DRUG SAF, V12, P209, DOI 10.1517/14740338.2013.770471
   Kapoor D, 2005, EUR J ENDOCRINOL, V152, P491, DOI 10.1530/eje.1.01867
   Karsenty G, 2012, NATURE, V481, P314, DOI 10.1038/nature10763
   Khosla S, 1998, J CLIN ENDOCR METAB, V83, P2266, DOI 10.1210/jc.83.7.2266
   Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785
   LAITINEN K, 1991, CALCIFIED TISSUE INT, V49, pS70, DOI 10.1007/BF02555094
   Lee CWS, 2015, MAYO CLIN PROC, V90, P63, DOI 10.1016/j.mayocp.2014.11.009
   Lenze EJ, 2007, J AM GERIATR SOC, V55, P81, DOI 10.1111/j.1532-5415.2006.01017.x
   Lips P, 2005, OSTEOPOROSIS INT, V16, P447, DOI 10.1007/s00198-004-1762-7
   Lourenco S, 2014, ARCH OSTEOPOROS, V9, DOI 10.1007/s11657-014-0173-4
   Isidro ML, 2010, CURR DIABETES REV, V6, P144, DOI 10.2174/157339910791162970
   Malik P, 2013, PROG NEURO-PSYCHOPH, V44, P58, DOI 10.1016/j.pnpbp.2013.01.019
   Mansur RB, 2015, NEUROSCI BIOBEHAV R, V52, P89, DOI 10.1016/j.neubiorev.2014.12.017
   Mansur RB, 2014, NEUROMOL MED, V16, P658, DOI 10.1007/s12017-014-8316-8
   Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254
   Mattar L, 2011, J AFFECT DISORDERS, V132, P311, DOI 10.1016/j.jad.2010.09.014
   McNamara RK, 2012, EXPERT REV NEUROTHER, V12, P1143, DOI [10.1586/ern.12.98, 10.1586/ERN.12.98]
   Mead GE, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004366.pub3
   Mezuk B, 2008, OSTEOPOROSIS INT, V19, P1, DOI 10.1007/s00198-007-0449-2
   Mezuk B, 2008, CLIN REV BONE MINER, V6, P101, DOI 10.1007/s12018-009-9025-y
   Misra M, 2014, J ENDOCRINOL, V221, pR163, DOI 10.1530/JOE-14-0039
   Moylan S, 2014, NEUROSCI BIOBEHAV R, V45, P46, DOI 10.1016/j.neubiorev.2014.05.007
   MURPHY BEP, 1991, J STEROID BIOCHEM, V38, P537
   National Osteoprosis Foundation, 2013, NAT OST FDN NOF CLIN
   Oh SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069929
   Oh SM, 2012, MATURITAS, V71, P142, DOI 10.1016/j.maturitas.2011.11.007
   Oikonen M, 2014, INT J BEHAV MED, V21, P464, DOI 10.1007/s12529-013-9327-9
   Olfson M, 2009, ARCH GEN PSYCHIAT, V66, P848, DOI 10.1001/archgenpsychiatry.2009.81
   Pace TWW, 2009, ANN NY ACAD SCI, V1179, P86, DOI 10.1111/j.1749-6632.2009.04984.x
   Papaioannou A, 2009, OSTEOPOROSIS INT, V20, P703, DOI 10.1007/s00198-008-0743-7
   Pirraglia Paul A., 2003, Prim Care Companion J Clin Psychiatry, V5, P153
   Rabenda V, 2013, OSTEOPOROSIS INT, V24, P121, DOI 10.1007/s00198-012-2015-9
   Raisz LG, 1999, CLIN CHEM, V45, P1353
   Ramasubbu R, 2012, ANN CLIN PSYCHIATRY, V24, P91
   Ramasubbu R, 2012, ANN CLIN PSYCHIATRY, V24, P82
   Rauma PH, 2015, AUST NZ J PSYCHIAT, V49, P437, DOI 10.1177/0004867414565475
   Rauma PH, 2014, PSYCHOSOM MED, V76, P709, DOI 10.1097/PSY.0000000000000114
   Rizzoli R, 2012, BONE, V51, P606, DOI 10.1016/j.bone.2012.05.018
   Rosen CJ, 2010, CELL, V142, P198, DOI 10.1016/j.cell.2010.07.001
   Rosenblat JD, 2014, PROG NEURO-PSYCHOPH, V53, P23, DOI 10.1016/j.pnpbp.2014.01.013
   Rothem DE, 2009, J BONE MINER METAB, V27, P555, DOI 10.1007/s00774-009-0075-5
   Sampson HW, 1997, ALCOHOL CLIN EXP RES, V21, P400
   Sanchez-Riera L, 2014, ANN RHEUM DIS, V73, P1635, DOI 10.1136/annrheumdis-2013-204320
   Schwan S, 2009, EUR NEUROPSYCHOPHARM, V19, P683, DOI 10.1016/j.euroneuro.2009.05.001
   Schwartz AV, 2003, CALCIFIED TISSUE INT, V73, P515, DOI 10.1007/s00223-003-0023-7
   SCHWEIGER U, 1994, AM J PSYCHIAT, V151, P1691
   Sharma Sudhaa, 2014, J Midlife Health, V5, P6, DOI 10.4103/0976-7800.127782
   Silverman MN, 2004, ENDOCRINOLOGY, V145, P3580, DOI 10.1210/en.2003-1421
   Soczynska JK, 2012, BEHAV BRAIN RES, V235, P302, DOI 10.1016/j.bbr.2012.07.026
   Stahl SM, 1998, J AFFECT DISORDERS, V51, P215, DOI 10.1016/S0165-0327(98)00221-3
   Stahl SM, 2013, CURR DRUG TARGETS, V14, P578
   Tsapakis EM, 2012, EUR PSYCHIAT, V27, P156, DOI 10.1016/j.eurpsy.2010.10.006
   Turnbull AV, 1999, PHYSIOL REV, V79, P1, DOI 10.1152/physrev.1999.79.1.1
   Vrkljan M, 2001, COLLEGIUM ANTROPOL, V25, P485
   Warden SJ, 2005, MOL CELL ENDOCRINOL, V242, P1, DOI 10.1016/j.mce.2005.06.005
   Weber T, 2013, JAMA SURG, V148, P109, DOI 10.1001/2013.jamasurg.316
   Westbroek I, 2001, J BIOL CHEM, V276, P28961, DOI 10.1074/jbc.M101824200
   Whooley MA, 1999, ARCH INTERN MED, V159, P484, DOI 10.1001/archinte.159.5.484
   WINOKUR A, 1988, AM J PSYCHIAT, V145, P325
   World Health Organisation, 1992, ICD 10 CLASS MENT BE
   Wu Q, 2012, OSTEOPOROSIS INT, V23, P365, DOI 10.1007/s00198-011-1778-8
   Wu Q, 2010, OSTEOPOROSIS INT, V21, P1627, DOI 10.1007/s00198-010-1181-x
   Wu Q, 2009, OSTEOPOROSIS INT, V20, P1309, DOI 10.1007/s00198-009-0918-x
   Yadav VK, 2009, CELL, V138, P976, DOI 10.1016/j.cell.2009.06.051
   Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059
   Yirmiya R, 2009, BIOL PSYCHIAT, V66, P423, DOI 10.1016/j.biopsych.2009.03.016
   Yoon V, 2012, OSTEOPOROSIS INT, V23, P2081, DOI 10.1007/s00198-012-1940-y
   Zhang Q, 2015, J INTERN MED, V277, P681, DOI 10.1111/joim.12348
NR 137
TC 9
Z9 11
U1 1
U2 22
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1566-5240
EI 1875-5666
J9 CURR MOL MED
JI Curr. Mol. Med.
PY 2016
VL 16
IS 2
BP 165
EP 178
DI 10.2174/1566524016666160126144303
PG 14
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DH1MY
UT WOS:000372550000005
PM 26812918
DA 2020-12-08
ER

PT J
AU Slyepchenko, A
   Brunoni, AR
   McIntyre, RS
   Quevedo, J
   Carvalho, AF
AF Slyepchenko, A.
   Brunoni, A. R.
   McIntyre, R. S.
   Quevedo, J.
   Carvalho, A. F.
TI The Adverse Effects of Smoking on Health Outcomes in Bipolar Disorder: A
   Review and Synthesis of Biological Mechanisms
SO CURRENT MOLECULAR MEDICINE
LA English
DT Article
DE Biomarkers; bipolar disorder; nicotine; oxidative stress; smoking
ID SUBSTANCE USE DISORDERS; C-REACTIVE PROTEIN; SEROTONIN TRANSPORTER GENE;
   MAJOR DEPRESSIVE DISORDER; ANTERIOR CINGULATE CORTEX; MESSENGER-RNA
   EXPRESSION; OXIDATIVE STRESS; CIGARETTE-SMOKING; NEUROTROPHIC FACTOR;
   NICOTINE DEPENDENCE
AB Several biological systems are implicated in the neuroprogression of bipolar disorder including but not limited to cytokine levels, oxidative stress markers, monoamine levels, tryptophan catabolite and glutamate-mediated excitotoxicity, microglial activation as well as structural and functional changes. The high rate of smoking behaviour in individuals with bipolar disorder provides the impetus for exploring shared and discrete pathogenetic mechanisms. In addition to contributing to increased mortality, smoking activates several neurobiological effector systems implicated in the progression of bipolar disorder. Here, a narrative review provides evidence and putative mechanisms of comorbid effects of BD, cigarette use, and nicotine dependence, and discusses the clinical implications of these interactions.
C1 [Slyepchenko, A.] McMaster Univ, McMaster Integrat Neurosci Discovery & Study, Hamilton, ON, Canada.
   [Brunoni, A. R.] Univ Sao Paulo, Univ Hosp, Interdisciplinary Ctr Appl Neuromodulat CINA, Sao Paulo, Brazil.
   [Brunoni, A. R.] Univ Sao Paulo, Dept & Inst Psychiat, Lab Neurosci LIM27, SIN, Sao Paulo, Brazil.
   [McIntyre, R. S.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada.
   [McIntyre, R. S.] Univ Toronto, Dept Pharmacol, Toronto, ON, Canada.
   [McIntyre, R. S.] Univ Toronto, Mood Disorders Psychopharmacol Unit, Toronto, ON, Canada.
   [Quevedo, J.] Univ Texas Houston, Med Sch Houston, Dept Psychiat & Behav Sci, Ctr Expt Models Psychiat, Houston, TX USA.
   [Quevedo, J.] Univ Southern Santa Catarina, Hlth Sci Unit, Grad Program Hlth Sci, Neurosci Lab, Criciuma, SC, Brazil.
   [Carvalho, A. F.] Univ Fed Ceara, Fac Med, Dept Clin Med, Rua Prof Costa Mendes,1608,4o Andar, BR-60430040 Fortaleza, CE, Brazil.
   [Carvalho, A. F.] Univ Fed Ceara, Fac Med, Translat Psychiat Res Grp, BR-60430040 Fortaleza, CE, Brazil.
RP Carvalho, AF (corresponding author), Univ Fed Ceara, Fac Med, Dept Clin Med, Rua Prof Costa Mendes,1608,4o Andar, BR-60430040 Fortaleza, CE, Brazil.
EM andrefc7@terra.com.br
RI Brunoni, Andre R./H-8394-2012; de Quevedo, Joao Luciano/E-5491-2013;
   McIntyre, Roger/AAU-1000-2020
OI Brunoni, Andre R./0000-0002-6310-3571; de Quevedo, Joao
   Luciano/0000-0003-3114-6611; McIntyre, Roger/0000-0003-4733-2523;
   Slyepchenko, Anastasiya/0000-0003-0179-2129
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq,
   Brazil)National Council for Scientific and Technological Development
   (CNPq); Department of Psychiatry and Behavioral Sciences, The University
   of Texas Medical School at Houston; NARSADNARSAD [YI 2013/20493];
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [2013/470904]; Sao Paulo Research State Foundation (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/20911-5]
FX AFC and JQ are supported by research fellowship awards from the Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil).
   Laboratory of Neurosciences (Brazil) is one of the centers of the
   National Institute for Molecular Medicine (INCT-MM) and one of the
   members of the Center of Excellence in Applied Neurosciences of Santa
   Catarina (NENASC). Center for Experimental Models in Psychiatry (USA) is
   funded by Department of Psychiatry and Behavioral Sciences, The
   University of Texas Medical School at Houston. ARB is awarded by NARSAD
   (YI 2013/20493), CNPq (2013/470904) and Sao Paulo Research State
   Foundation (FAPESP, 2012/20911-5) grants.
CR AAGAARD J, 1988, PHARMACOPSYCHIATRY, V21, P166, DOI 10.1055/s-2007-1014670
   Ahmed AIA, 2013, J CLIN PSYCHOPHARM, V33, P55, DOI 10.1097/JCP.0b013e31827c0117
   Alhatem F, 2009, CLIN NEUROPHARMACOL, V32, P117, DOI 10.1097/WNF.0b013e31816f75bc
   Anderson G, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-014-0541-1
   Anderson G, 2014, CNS NEUROL DISORD-DR, V13, P817, DOI 10.2174/1871527313666140711091400
   Andreazza AC, 2008, J AFFECT DISORDERS, V111, P135, DOI 10.1016/j.jad.2008.04.013
   Andreazza AC, 2013, J NEUROCHEM, V127, P552, DOI 10.1111/jnc.12316
   Andreazza AC, 2010, ARCH GEN PSYCHIAT, V67, P360, DOI 10.1001/archgenpsychiatry.2010.22
   Andreazza AC, 2007, PSYCHIAT RES, V153, P27, DOI 10.1016/j.psychres.2006.03.025
   Arinami T, 2000, EUR J PHARMACOL, V410, P215, DOI 10.1016/S0014-2999(00)00816-5
   Bai YM, 2015, BIPOLAR DISORD, V17, P269, DOI 10.1111/bdi.12259
   BALLDIN J, 1982, PSYCHOPHARMACOLOGY, V76, P371, DOI 10.1007/BF00449127
   Barnett JH, 2011, PSYCHOL MED, V41, P1593, DOI 10.1017/S0033291710002333
   BAXTER LR, 1985, ARCH GEN PSYCHIAT, V42, P441
   Beal MF, 2002, FREE RADICAL BIO MED, V32, P797, DOI 10.1016/S0891-5849(02)00780-3
   Bengesser SA, 2015, J AFFECT DISORDERS, V172, P367, DOI 10.1016/j.jad.2014.10.014
   Berk M, 2007, ACTA PSYCHIAT SCAND, V116, P41, DOI 10.1111/j.1600-0447.2007.01058.x
   Berk M, 2011, NEUROSCI BIOBEHAV R, V35, P804, DOI 10.1016/j.neubiorev.2010.10.001
   Berk M, 2008, J AFFECT DISORDERS, V110, P126, DOI 10.1016/j.jad.2008.01.018
   Berk M, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-200
   Berlin I, 2001, INT J NEUROPSYCHOPH, V4, P33, DOI 10.1017/S1461145701002188
   Berman SB, 1999, J NEUROCHEM, V73, P1127, DOI 10.1046/j.1471-4159.1999.0731127.x
   Beyer JL, 2009, INT REV PSYCHIATR, V21, P394, DOI 10.1080/09540260902962198
   Bhang SY, 2010, NEUROSCI LETT, V468, P7, DOI 10.1016/j.neulet.2009.10.046
   Bora E, 2010, BIOL PSYCHIAT, V67, P1097, DOI 10.1016/j.biopsych.2010.01.020
   Bortolasci CC, 2014, J AFFECT DISORDERS, V159, P23, DOI 10.1016/j.jad.2014.02.018
   Bosetti F, 2002, MOL PSYCHIATR, V7, P845, DOI 10.1038/sj.mp.4001111
   Boufidou F, 2004, J AFFECT DISORDERS, V82, P309, DOI 10.1016/j.jad.2004.01.007
   Brietzke E, 2009, BRAIN BEHAV IMMUN, V23, P1079, DOI 10.1016/j.bbi.2009.04.008
   Brown NC, 2014, PSYCHIAT RES, V218, P61, DOI 10.1016/j.psychres.2014.04.005
   Bustamante AC, 2013, COMPR PSYCHIAT, V54, pe17
   Caldirola D, 2013, J CLIN PSYCHIAT, V74, pE130, DOI 10.4088/JCP.12m07985
   Callaghan RC, 2014, J PSYCHIATR RES, V48, P102, DOI 10.1016/j.jpsychires.2013.09.014
   Chen C, 2014, BIPOLAR DISORD, V16, P790, DOI 10.1111/bdi.12255
   Chengappa KNR, 2014, J CLIN PSYCHIAT, V75, P765, DOI 10.4088/JCP.13m08756
   Cherlyn SYT, 2010, NEUROSCI BIOBEHAV R, V34, P958, DOI 10.1016/j.neubiorev.2010.01.002
   Chitty KM, 2014, J PSYCHIATR RES, V55, P59, DOI 10.1016/j.jpsychires.2014.03.024
   Cho HJ, 2005, MOL PSYCHIATR, V10, P771, DOI 10.1038/sj.mp.4001663
   Clay HB, 2011, INT J DEV NEUROSCI, V29, P311, DOI 10.1016/j.ijdevneu.2010.08.007
   Colombo G, 2014, MASS SPECTROM REV, V33, P183, DOI 10.1002/mas.21392
   Corvin A, 2001, BRIT J PSYCHIAT, V179, P35, DOI 10.1192/bjp.179.1.35
   Cunha AB, 2008, EUR ARCH PSY CLIN N, V258, P300, DOI 10.1007/s00406-007-0797-0
   Czubak A, 2009, PHARMACOL REP, V61, P1017, DOI 10.1016/S1734-1140(09)70163-X
   Czuczwar M, 2003, POL J PHARMACOL, V55, P799
   D'Addario C, 2012, NEUROPSYCHOPHARMACOL, V37, P1647, DOI 10.1038/npp.2012.10
   Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214
   David SP, 2007, NICOTINE TOB RES, V9, P225, DOI 10.1080/14622200601078566
   Depp CA, 2015, ACTA PSYCHIAT SCAND, V131, P333, DOI 10.1111/acps.12380
   Deshauer D, 2006, BIPOLAR DISORD, V8, P345, DOI 10.1111/j.1399-5618.2006.00338.x
   Dickerson F, 2007, PROG NEURO-PSYCHOPH, V31, P952, DOI 10.1016/j.pnpbp.2007.02.018
   Dodd S, 2010, COMPR PSYCHIAT, V51, P504, DOI 10.1016/j.comppsych.2009.12.001
   Eastwood SL, 2010, BIOL PSYCHIAT, V67, P1010, DOI 10.1016/j.biopsych.2009.12.004
   Edmondson DE, 2004, CURR MED CHEM, V11, P1983, DOI 10.2174/0929867043364784
   El-Mallakh RS, 2002, PSYCHIAT SERV, V53, P580, DOI 10.1176/appi.ps.53.5.580
   Ezquiaga E, 2014, PSYCHIAT QUART, V85, P467, DOI 10.1007/s11126-014-9303-9
   Fattal O, 2006, PSYCHOSOMATICS, V47, P1, DOI 10.1176/appi.psy.47.1.1
   Fernandes BS, 2011, J PSYCHIATR RES, V45, P995, DOI 10.1016/j.jpsychires.2011.03.002
   Filia SL, 2014, PSYCHIAT RES, V215, P586, DOI 10.1016/j.psychres.2014.01.002
   Flatscher-Bader T, 2008, HUM MOL GENET, V17, P38, DOI 10.1093/hmg/ddm283
   Fornito A, 2007, ACTA PSYCHIAT SCAND, V116, P467, DOI 10.1111/j.1600-0447.2007.01069.x
   Fowler JS, 2003, NEUROTOXICOLOGY, V24, P75, DOI 10.1016/S0161-813X(02)00109-2
   Franchini L, 1999, EUR ARCH PSY CLIN N, V249, P227, DOI 10.1007/s004060050091
   Frey BN, 2007, PROG NEURO-PSYCHOPH, V31, P283, DOI 10.1016/j.pnpbp.2006.06.011
   FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0
   Gan WQ, 2005, CHEST, V127, P558, DOI 10.1378/chest.127.2.558
   Garcia YJ, 2005, J NEUROSCI METH, V144, P127, DOI 10.1016/j.jneumeth.2004.10.018
   Garno JL, 2005, BRIT J PSYCHIAT, V186, P121, DOI 10.1192/bjp.186.2.121
   Geller B, 2004, AM J PSYCHIAT, V161, P1698, DOI 10.1176/appi.ajp.161.9.1698
   Girshkin L, 2014, PSYCHONEUROENDOCRINO, V49, P187, DOI 10.1016/j.psyneuen.2014.07.013
   Goldstein BI, 2009, J CLIN PSYCHIAT, V70, P1078, DOI 10.4088/JCP.08r04505
   Gonzales D, 2006, JAMA-J AM MED ASSOC, V296, P47, DOI 10.1001/jama.296.1.47
   Gonzalez-Estecha M, 2011, J TRACE ELEM MED BIO, V25, pS78, DOI 10.1016/j.jtemb.2010.10.015
   Goodwin RD, 2012, AM J ADDICTION, V21, P416, DOI 10.1111/j.1521-0391.2012.00263.x
   Graff FS, 2008, DRUG ALCOHOL DEPEN, V94, P272, DOI 10.1016/j.drugalcdep.2007.11.002
   Gutierrez-Rojas L, 2008, BIPOLAR DISORD, V10, P625, DOI 10.1111/j.1399-5618.2008.00604.x
   Hallahan B, 2011, BIOL PSYCHIAT, V69, P326, DOI 10.1016/j.biopsych.2010.08.029
   Hartz SM, 2011, PSYCHIAT GENET, V21, P77, DOI 10.1097/YPG.0b013e32834135eb
   Hashioka S, 2007, EXP NEUROL, V206, P33, DOI 10.1016/j.expneurol.2007.03.022
   Hastings TG, 1996, P NATL ACAD SCI USA, V93, P1956, DOI 10.1073/pnas.93.5.1956
   HEATH AC, 1995, BEHAV GENET, V25, P103, DOI 10.1007/BF02196921
   Heffner JL, 2012, BIPOLAR DISORD, V14, P735, DOI 10.1111/bdi.12010
   Heffner JL, 2011, BIPOLAR DISORD, V13, P439, DOI 10.1111/j.1399-5618.2011.00943.x
   Heffner JL, 2008, BIPOLAR DISORD, V10, P838, DOI 10.1111/j.1399-5618.2008.00630.x
   Heim C, 2008, PSYCHONEUROENDOCRINO, V33, P693, DOI 10.1016/j.psyneuen.2008.03.008
   Hong CJ, 2004, NEUROSCI LETT, V355, P69, DOI 10.1016/j.neulet.2003.10.043
   Hope S, 2011, J PSYCHIATR RES, V45, P1608, DOI 10.1016/j.jpsychires.2011.08.003
   Horton WJ, 2015, PSYCHOPHARMACOLOGY, V232, P2519, DOI 10.1007/s00213-015-3886-1
   Hossain M, 2009, BRAIN RES, V1287, P192, DOI 10.1016/j.brainres.2009.06.033
   Hu MC, 2006, AM J PUBLIC HEALTH, V96, P299, DOI 10.2105/AJPH.2004.057232
   Jamal M, 2015, NICOTINE TOB RES, V17, P323, DOI 10.1093/ntr/ntu151
   Kamali M, 2012, J AFFECT DISORDERS, V136, P350, DOI 10.1016/j.jad.2011.11.027
   Kapczinski F, 2008, NEUROSCI BIOBEHAV R, V32, P675, DOI 10.1016/j.neubiorev.2007.10.005
   Kato T, 2007, CNS DRUGS, V21, P1, DOI 10.2165/00023210-200721010-00001
   Kauer-Sant'Anna M, 2007, BIPOLAR DISORD, V9, P128, DOI 10.1111/j.1399-5618.2007.00478.x
   Kenna GA, 2012, PHARMACOGN PERS MED, V5, P19, DOI 10.2147/PGPM.S23462
   Kessing LV, 1998, PSYCHOL MED, V28, P1027, DOI 10.1017/S0033291798006862
   Khantzian EJ, 1997, HARVARD REV PSYCHIAT, V4, P231, DOI 10.3109/10673229709030550
   Kim B, 2008, NEUROPSYCHOBIOLOGY, V58, P97, DOI 10.1159/000162356
   Kim HW, 2011, MOL PSYCHIATR, V16, P419, DOI 10.1038/mp.2009.137
   Kim SH, 2012, NEUROL SCI, V33, P45, DOI 10.1007/s10072-011-0617-1
   KIRSCHBAUM C, 1993, PHARMACOL BIOCHEM BE, V44, P527, DOI 10.1016/0091-3057(93)90162-M
   Kohen I, 2007, AM J PSYCHIAT, V164, P1269, DOI 10.1176/appi.ajp.2007.07010173
   Konradi C, 2004, ARCH GEN PSYCHIAT, V61, P300, DOI 10.1001/archpsyc.61.3.300
   Kremer I, 2005, AM J PSYCHIAT, V162, P924, DOI 10.1176/appi.ajp.162.5.924
   Krystal JH, 2002, MOL PSYCHIATR, V7, pS71, DOI 10.1038/sj.mp.4001021
   Kunz M, 2008, PROG NEURO-PSYCHOPH, V32, P1677, DOI 10.1016/j.pnpbp.2008.07.001
   Lang UE, 2007, PSYCHOPHARMACOLOGY, V190, P433, DOI 10.1007/s00213-006-0647-1
   Lasser K, 2000, JAMA-J AM MED ASSOC, V284, P2606, DOI 10.1001/jama.284.20.2606
   Law CWY, 2009, PHARMACOL BIOCHEM BE, V92, P12, DOI 10.1016/j.pbb.2008.10.002
   Leventhal AM, 2010, PSYCHOL ADDICT BEHAV, V24, P360, DOI 10.1037/a0019217
   Liao YH, 2012, ADDICT BIOL, V17, P977, DOI 10.1111/j.1369-1600.2010.00250.x
   Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6
   Liechti ME, 2008, CNS DRUGS, V22, P705, DOI 10.2165/00023210-200822090-00001
   Lowe EJ, 2010, ANN PHARMACOTHER, V44, P727, DOI 10.1345/aph.1M398
   Lyoo IK, 2006, BIPOLAR DISORD, V8, P65, DOI 10.1111/j.1399-5618.2006.00284.x
   Macedo DS, 2013, PROG NEURO-PSYCHOPH, V43, P230, DOI 10.1016/j.pnpbp.2013.01.007
   MacQueen GM, 2001, ACTA PSYCHIAT SCAND, V103, P163, DOI 10.1034/j.1600-0447.2001.00059.x
   Maes Michael, 2012, Inflammopharmacology, V20, P127, DOI 10.1007/s10787-011-0111-7
   Malouff JM, 2006, J DRUG EDUC, V36, P47, DOI 10.2190/9EP8-17P8-EKG7-66AD
   Manji H K, 2001, Psychopharmacol Bull, V35, P5
   Markus RP, 2003, J PHARMACOL EXP THER, V305, P525, DOI 10.1124/jpet.102.045625
   Martinez-Ortega JM, 2013, J PSYCHIATR RES, V47, P858, DOI 10.1016/j.jpsychires.2013.03.012
   Masubuchi T, 1998, AM J PATHOL, V153, P1903, DOI 10.1016/S0002-9440(10)65704-5
   Matovic V, 2011, ARH HIG RADA TOKSIKO, V62, P65, DOI 10.2478/10004-1254-62-2011-2075
   Mattson MP, 2002, NEUROMOL MED, V2, P215, DOI 10.1385/NMM:2:2:215
   McEachin RC, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-14
   McGuffin P, 2003, ARCH GEN PSYCHIAT, V60, P497, DOI 10.1001/archpsyc.60.5.497
   McIntyre RS, 2007, CURR OPIN PSYCHIATR, V20, P406, DOI 10.1097/YCO.0b013e3281938102
   Mercan S, 2013, TOXICOL IND HEALTH, V29, P888, DOI 10.1177/0748233712446725
   Miller CL, 2006, BRAIN RES, V1073, P25, DOI 10.1016/j.brainres.2005.12.056
   Mills CD, 2012, CRIT REV IMMUNOL, V32, P463, DOI 10.1615/CritRevImmunol.v32.i6.10
   Minassian A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024185
   Mitchell AJ, 2015, GEN HOSP PSYCHIAT, V37, P14, DOI 10.1016/j.genhosppsych.2014.11.006
   Modabbernia A, 2013, BIOL PSYCHIAT, V74, P15, DOI 10.1016/j.biopsych.2013.01.007
   Monick MM, 2012, AM J MED GENET B, V159B, P141, DOI 10.1002/ajmg.b.32021
   Montag C, 2009, PSYCHOL MED, V39, P1831, DOI 10.1017/S0033291709005509
   Moon E, 2014, PSYCHIAT RES, V218, P69, DOI 10.1016/j.psychres.2014.03.047
   Morisano D, 2013, AM J ADDICTION, V22, P46, DOI 10.1111/j.1521-0391.2013.00313.x
   Morstad AE, 2008, ANN PHARMACOTHER, V42, P288, DOI 10.1345/aph.1K511
   Munkholm K, 2013, J PSYCHIATR RES, V47, P1119, DOI 10.1016/j.jpsychires.2013.05.018
   Neves FS, 2011, J AFFECT DISORDERS, V131, P307, DOI 10.1016/j.jad.2010.11.022
   Neves-Pereira M, 2002, AM J HUM GENET, V71, P651, DOI 10.1086/342288
   Niles LP, 2012, INT J NEUROPSYCHOPH, V15, P1343, DOI 10.1017/S1461145711001969
   NORDSTROM P, 1994, SUICIDE LIFE-THREAT, V24, P1
   Novak G, 2010, GENES BRAIN BEHAV, V9, P910, DOI 10.1111/j.1601-183X.2010.00631.x
   Obata T, 2006, J NEURAL TRANSM, V113, P1131, DOI 10.1007/s00702-005-0415-0
   Ostacher MJ, 2006, J CLIN PSYCHIAT, V67, P1907, DOI 10.4088/JCP.v67n1210
   Ozguner F, 2005, TOXICOL IND HEALTH, V21, P21, DOI 10.1191/0748233705th211oa
   Padmos RC, 2008, ARCH GEN PSYCHIAT, V65, P395, DOI 10.1001/archpsyc.65.4.395
   Pan PL, 2013, NEUROL SCI, V34, P813, DOI 10.1007/s10072-012-1256-x
   Parikh SV, 2010, CAN J PSYCHIAT, V55, P136, DOI 10.1177/070674371005500304
   Perroud N, 2014, BRIT J PSYCHIAT, V204, P30, DOI 10.1192/bjp.bp.112.120055
   Pertovaara M, 2006, CLIN EXP IMMUNOL, V145, P469, DOI 10.1111/j.1365-2249.2006.03166.x
   de Castro MRP, 2015, J AFFECT DISORDERS, V172, P347, DOI 10.1016/j.jad.2014.10.023
   Post RM, 2007, J PSYCHIATR RES, V41, P979, DOI 10.1016/j.jpsychires.2006.09.009
   Rapaport MH, 2001, BIOL PSYCHIAT, V50, P217, DOI 10.1016/S0006-3223(01)01144-1
   Ray MT, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.26
   Reininghaus EZ, 2014, BIPOLAR DISORD, V16, P432, DOI 10.1111/bdi.12166
   Reinsberger C, 2008, SEIZURE-EUR J EPILEP, V17, P651, DOI 10.1016/j.seizure.2008.05.009
   REYNOLDS IJ, 1995, J NEUROSCI, V15, P3318, DOI 10.1523/jneurosci.15-05-03318.1995
   RIBEIRO SCM, 1993, AM J PSYCHIAT, V150, P1618
   Robillard R, 2013, EUR PSYCHIAT, V28, P412, DOI 10.1016/j.eurpsy.2013.04.001
   Robinson LJ, 2006, BIPOLAR DISORD, V8, P103, DOI 10.1111/j.1399-5618.2006.00277.x
   Rodella LF, 2010, J PINEAL RES, V48, P126, DOI 10.1111/j.1600-079X.2009.00735.x
   Rohleder N, 2006, INT J PSYCHOPHYSIOL, V59, P236, DOI 10.1016/j.ijpsycho.2005.10.012
   Rosenblat JD, 2014, PROG NEURO-PSYCHOPH, V53, P23, DOI 10.1016/j.pnpbp.2014.01.013
   Rybakowski JK, 1999, J PSYCHIAT RES, V33, P363, DOI 10.1016/S0022-3956(99)00014-X
   Saiyad M, 2012, ANN CLIN PSYCHIATRY, V24, P305
   Sala R, 2014, J AFFECT DISORDERS, V165, P74, DOI 10.1016/j.jad.2014.04.035
   Savas HA, 2002, NEUROPSYCHOBIOLOGY, V45, P57, DOI 10.1159/000048677
   Schmider J, 1995, BIOL PSYCHIAT, V38, P797, DOI 10.1016/0006-3223(95)00064-X
   Scott J, 2006, BRIT J PSYCHIAT, V188, P313, DOI 10.1192/bjp.188.4.313
   Scott J, 2014, BRIT J PSYCHIAT, V205, P362, DOI 10.1192/bjp.bp.113.134262
   Sklar P, 2002, MOL PSYCHIATR, V7, P579, DOI 10.1038/sj.mp.4001058
   Stahl Stephen M., 2004, Prim Care Companion J Clin Psychiatry, V6, P159
   Stertz L, 2013, CURR OPIN PSYCHIATR, V26, P19, DOI 10.1097/YCO.0b013e32835aa4b4
   Sun XJ, 2006, J PSYCHIATR NEUROSCI, V31, P189
   Sunyer J, 2009, NICOTINE TOB RES, V11, P1347, DOI 10.1093/ntr/ntp144
   Szulinska M, 2013, EUR REV MED PHARMACO, V17, P1916
   Taha F, 2014, CHILD ABUSE NEGLECT, V38, P1995, DOI 10.1016/j.chiabu.2014.10.022
   Takuma K, 2004, PROG NEUROBIOL, V72, P111, DOI 10.1016/j.pneurobio.2004.02.001
   Talhout R, 2007, EUR NEUROPSYCHOPHARM, V17, P627, DOI 10.1016/j.euroneuro.2007.02.013
   Tohen M, 2012, J CLIN PSYCHIAT, V73, P1426, DOI [10.4088/JCP.10m06737, 10.4088/JCP.12com08119]
   Tonstad S, 2009, INT J CLIN PRACT, V63, P1634, DOI 10.1111/j.1742-1241.2009.02179.x
   Tsai SY, 2012, J AFFECT DISORDERS, V136, P110, DOI 10.1016/j.jad.2011.08.022
   Uezato A, 2009, BIPOLAR DISORD, V11, P711, DOI 10.1111/j.1399-5618.2009.00752.x
   Valavanidis A, 2009, INT J ENV RES PUB HE, V6, P445, DOI 10.3390/ijerph6020445
   van der Werf-Eldering MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037119
   Nunes SOV, 2014, PSYCHIAT GENET, V24, P87, DOI 10.1097/YPG.0000000000000023
   Nunes SOV, 2013, NEUROSCI BIOBEHAV R, V37, P1336, DOI 10.1016/j.neubiorev.2013.04.014
   Verma S, 2002, CIRCULATION, V106, P913, DOI 10.1161/01.CIR.0000029802.88087.5E
   Versace A, 2014, MOL PSYCHIATR, V19, P200, DOI 10.1038/mp.2012.188
   Vieta E, 1997, ACTA PSYCHIAT SCAND, V95, P205, DOI 10.1111/j.1600-0447.1997.tb09621.x
   VONKNORRING L, 1986, J NEURAL TRANSM, V66, P37
   Wadee AA, 2002, HUM PSYCHOPHARM CLIN, V17, P175, DOI 10.1002/hup.390
   Watson S, 2005, AUST NZ J PSYCHIAT, V39, P244, DOI 10.1111/j.1440-1614.2005.01560.x
   Watson S, 2004, BRIT J PSYCHIAT, V184, P496, DOI 10.1192/bjp.184.6.496
   Waxmonsky JA, 2005, GEN HOSP PSYCHIAT, V27, P321, DOI 10.1016/j.genhosppsych.2005.05.003
   Whitfield JB, 2000, PSYCHOL MED, V30, P443, DOI 10.1017/S0033291799001798
   Wilens TE, 2008, DRUG ALCOHOL DEPEN, V95, P188, DOI 10.1016/j.drugalcdep.2007.12.016
   Wilens TE, 2013, DRUG ALCOHOL DEPEN, V132, P114, DOI 10.1016/j.drugalcdep.2013.01.015
   Williams JM, 2012, BIPOLAR DISORD, V14, P618, DOI 10.1111/j.1399-5618.2012.01047.x
   Williams JM, 2010, CANCER EPIDEM BIOMAR, V19, P2582, DOI 10.1158/1055-9965.EPI-10-0384
   Wilson GM, 2006, HUM MOL GENET, V15, P743, DOI 10.1093/hmg/ddi489
   Yanbaeva DG, 2007, CHEST, V131, P1557, DOI 10.1378/chest.06-2179
   Yatham LN, 2013, BIPOLAR DISORD, V15, P1, DOI 10.1111/bdi.12025
   Yatham LN, 2005, J CLIN PSYCHIAT, V66, P40
   Youdim MBH, 2006, NAT REV NEUROSCI, V7, P295, DOI 10.1038/nrn1883
   Zhang XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053295
   Zhdanova IV, 2000, PHARMACOL BIOCHEM BE, V67, P131, DOI 10.1016/S0091-3057(00)00302-6
   Zuo DY, 2007, PHARMACOL BIOCHEM BE, V86, P1, DOI 10.1016/j.pbb.2006.05.010
NR 211
TC 6
Z9 6
U1 0
U2 7
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1566-5240
EI 1875-5666
J9 CURR MOL MED
JI Curr. Mol. Med.
PY 2016
VL 16
IS 2
BP 187
EP 205
DI 10.2174/1566524016666160126144601
PG 19
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DH1MY
UT WOS:000372550000007
PM 26812916
DA 2020-12-08
ER

PT J
AU Kudlow, P
   Cha, DS
   Carvalho, AF
   McIntyre, RS
AF Kudlow, P.
   Cha, D. S.
   Carvalho, A. F.
   McIntyre, R. S.
TI Nitric Oxide and Major Depressive Disorder: Pathophysiology and
   Treatment Implications
SO CURRENT MOLECULAR MEDICINE
LA English
DT Article
DE Major depressive disorder; nitric oxide; inflammation; oxidative stress;
   nitric oxide synthase; endophenotypes; review
ID GUANOSINE-MONOPHOSPHATE PATHWAY; NMDA RECEPTORS; ASSOCIATION ANALYSIS;
   SYNTHASE INHIBITORS; INVOLVEMENT; ANTIDEPRESSANTS; POLYMORPHISMS;
   CYTOKINES; NEURONS; STRESS
AB Major depressive disorder (MDD) is a multi-factorial and heterogeneous disease. Robust evidence suggests that inflammation is involved in the pathogenesis of MDD for a subpopulation of individuals. However, it remains unclear what traits and/or states precede the onset of inflammation in this subpopulation of individuals with MDD. Several recent studies have implicated nitric oxide (NO) as a critical regulator of neuroinflammation, thus suggesting a possible role in the pathophysiology of MDD. The aim of this review is to evaluate the evidentiary base supporting the hypothesis that the increased hazard for developing MDD in certain subpopulations may be mediated, in part, by inflammogenic trait and/or state variations in NO signaling pathways. We conducted a non-systematic literature search for English language studies via PubMed and Google Scholar, from 1985 to October 2014. Replicated evidence suggests that NO has contrasting effects in the central nervous system (CNS). Low concentrations of NO are neuroprotective and mediate physiological signaling whereas higher concentrations mediate neuroinflammatory actions and are neurotoxic. Certain polymorphisms in the neuronal nitric oxide synthase gene (NOS1) are associated MDD. Furthermore, state variations (e.g. decreased levels of essential co-factor, 5,6,7,8-tetrahydrobiopterin [BH4], enhanced microglial cell activity) in the NO signaling pathway are associated with an increased risk of developing MDD. Increased concentrations of NO enhance the production of reactive nitrogen species (RNS) and reactive oxygen species (ROS), which are associated with an increase in pro-inflammatory cytokines. Taken together, evidences suggest that abnormalities in NO signaling may constitute a trait-marker related to MDD pathophysiology, which could be explored for novel therapeutic targets.
C1 [Kudlow, P.] Univ Toronto, Dept Psychiat, Clinician Scientist Program, Toronto, ON, Canada.
   [Kudlow, P.; Cha, D. S.; McIntyre, R. S.] Univ Hlth Network, Mood Disorders Psychopharmacol Unit, 399 Bathurst St,MP 9-325, Toronto, ON M5T 2S8, Canada.
   [Kudlow, P.; Cha, D. S.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada.
   [Carvalho, A. F.] Univ Fed Ceara, Fac Med, Dept Clin Med, Fortaleza, Ceara, Brazil.
   [Carvalho, A. F.] Univ Fed Ceara, Fac Med, Translat Psychiat Res Grp, Fortaleza, Ceara, Brazil.
   [McIntyre, R. S.] Univ Toronto, Dept Pharmacol & Psychiat, Toronto, ON, Canada.
RP Kudlow, P (corresponding author), Univ Hlth Network, Mood Disorders Psychopharmacol Unit, 399 Bathurst St,MP 9-325, Toronto, ON M5T 2S8, Canada.
EM paul.kudlow@gmail.com
RI McIntyre, Roger/AAU-1000-2020
OI McIntyre, Roger/0000-0003-4733-2523
FU AstraZenecaAstraZeneca; GlaxoSmithKlineGlaxoSmithKline; MerckMerck &
   Company; ServierServier; WyethWyeth
FX Dr. McIntyre has received research funding from AstraZeneca,
   GlaxoSmithKline, Merck, Servier, and Wyeth and has served as a
   consultant to, and on the speaker's boards for, AstraZeneca, Eli Lilly,
   GlaxoSmithKline, Lundbeck, Organon, Ortho-McNeil-Janssen, Oryx, Pfizer,
   Prestwick, and Wyeth. None of these interests had relevance to this
   review. All other authors declare no conflicts of interest. No funding
   was obtained for the writing of this review.
CR Abbasi SH, 2012, J AFFECT DISORDERS, V141, P308, DOI 10.1016/j.jad.2012.03.033
   Anderson G, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-014-0541-1
   Anderson G, 2014, CNS NEUROL DISORD-DR, V13, P817, DOI 10.2174/1871527313666140711091400
   Anderson IM, 2008, J PSYCHOPHARMACOL, V22, P343, DOI 10.1177/0269881107088441
   Arslan A, 2008, EUR REV MED PHARMACO, V12, P309
   Bao AM, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.26521
   Bufalino C, 2013, BRAIN BEHAV IMMUN, V31, P31, DOI 10.1016/j.bbi.2012.04.009
   Chrapko WE, 2004, BIOL PSYCHIAT, V56, P129, DOI 10.1016/j.biopsych.2004.03.003
   Cooke JP, 1997, ANNU REV MED, V48, P489, DOI 10.1146/annurev.med.48.1.489
   Cunha MP, 2015, AMINO ACIDS, V47, P795, DOI 10.1007/s00726-014-1910-0
   da Silva GD, 2000, NEUROREPORT, V11, P3699
   Dhir A, 2007, EUR J PHARMACOL, V568, P177, DOI 10.1016/j.ejphar.2007.04.028
   Dhir A, 2007, PROG NEURO-PSYCHOPH, V31, P921, DOI 10.1016/j.pnpbp.2007.02.008
   Dhir A, 2011, NITRIC OXIDE-BIOL CH, V24, P125, DOI 10.1016/j.niox.2011.02.002
   Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033
   Esplugues JV, 2002, BRIT J PHARMACOL, V135, P1079, DOI 10.1038/sj.bjp.0704569
   Finkel MS, 1996, PSYCHOPHARMACOL BULL, V32, P653
   Fonseka TM, 2015, EXPERT OPIN INV DRUG, V24, P459, DOI 10.1517/13543784.2014.998334
   FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0
   Galecki P, 2011, J AFFECT DISORDERS, V129, P175, DOI 10.1016/j.jad.2010.09.005
   Galecki P, 2010, NEUROSCI LETT, V486, P184, DOI 10.1016/j.neulet.2010.09.048
   Gao SF, 2013, CEREB CORTEX, V23, P2956, DOI 10.1093/cercor/bhs285
   Garthwaite G, 2006, J NEUROSCI, V26, P7730, DOI 10.1523/JNEUROSCI.1528-06.2006
   Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636
   HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56
   Hasler G, 2006, BIOL PSYCHIAT, V60, P93, DOI 10.1016/j.biopsych.2005.11.006
   Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b
   Hu Y, 2012, P NATL ACAD SCI USA, V109, P14224, DOI 10.1073/pnas.1207461109
   Ikenouchi-Sugita A, 2009, N-S ARCH PHARMACOL, V380, P479, DOI 10.1007/s00210-009-0467-z
   JOHNSON MD, 1993, J COMP NEUROL, V332, P391, DOI 10.1002/cne.903320402
   Karolewicz B, 2004, J NEUROCHEM, V91, P1057, DOI 10.1111/j.1471-4159.2004.02792.x
   Karolewicz B, 2001, POL J PHARMACOL, V53, P587
   Kim YK, 2006, PROG NEURO-PSYCHOPH, V30, P1091, DOI 10.1016/j.pnpbp.2006.04.008
   Kohler O, 2014, JAMA PSYCHIAT, V71, P1381, DOI 10.1001/jamapsychiatry.2014.1611
   Krishnadas R, 2012, J NEUROL NEUROSUR PS, V83, P495, DOI 10.1136/jnnp-2011-301779
   Kudlow PA, 2013, SLEEP MED, V14, P943, DOI 10.1016/j.sleep.2013.04.017
   Le Melledo JM, 2004, J PSYCHIATR NEUROSCI, V29, P414
   Lee BH, 2006, NEUROPSYCHOBIOLOGY, V53, P127, DOI 10.1159/000092542
   Leon J, 2006, J NEUROCHEM, V98, P2023, DOI 10.1111/j.1471-4159.2006.04029.x
   Liebenberg N, 2015, ACTA NEUROPSYCHIATR, V27, P90, DOI 10.1017/neu.2014.39
   Liu DX, 2011, NEUROPHARMACOLOGY, V61, P592, DOI 10.1016/j.neuropharm.2011.04.033
   Loftis JM, 2010, NEUROBIOL DIS, V37, P519, DOI 10.1016/j.nbd.2009.11.015
   Lu DY, 2013, INT J NEUROPSYCHOPH, V16, P433, DOI 10.1017/S1461145712000338
   Lu YR, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-123
   Maes M, 2011, PROG NEURO-PSYCHOPH, V35, P702, DOI 10.1016/j.pnpbp.2010.12.017
   McLeod T M, 2001, Psychopharmacol Bull, V35, P24
   Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029
   Na KS, 2014, PROG NEURO-PSYCHOPH, V48, P79, DOI 10.1016/j.pnpbp.2013.09.006
   Najjar S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-43
   Okumura T, 2010, NEUROPSYCHOBIOLOGY, V61, P57, DOI 10.1159/000265130
   Peng YL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-75
   Reichenberg A, 2001, ARCH GEN PSYCHIAT, V58, P445, DOI 10.1001/archpsyc.58.5.445
   Reierson GW, 2011, CURR NEUROPHARMACOL, V9, P715, DOI 10.2174/157015911798376271
   Sarginson JE, 2014, NEUROPSYCHOPHARMACOL, V39, P2857, DOI 10.1038/npp.2014.137
   Scapagnini G, 2012, CNS DRUGS, V26, P477, DOI 10.2165/11633190-000000000-00000
   SCOTTBURDEN T, 1995, CIRCULATION, V91, P248, DOI 10.1161/01.CIR.91.1.248
   Simonian SX, 1996, BRAIN RES, V732, P247, DOI 10.1016/0006-8993(96)00687-7
   Sperner-Unterweger B, 2014, PROG NEURO-PSYCHOPH, V48, P268, DOI 10.1016/j.pnpbp.2012.10.006
   Steinert JR, 2010, NEUROSCIENTIST, V16, P435, DOI 10.1177/1073858410366481
   Suzuki E, 2001, J AFFECT DISORDERS, V63, P221, DOI 10.1016/S0165-0327(00)00164-6
   Tobe EH, 2013, NEUROPSYCH DIS TREAT, V9, P567, DOI 10.2147/NDT.S44282
   Tomaz VS, 2014, NEUROSCIENCE, V268, P236, DOI 10.1016/j.neuroscience.2014.03.025
   Trivedi MH, 2006, AM J PSYCHIAT, V163, P28, DOI 10.1176/appi.ajp.163.1.28
   Tynan RJ, 2012, BRAIN BEHAV IMMUN, V26, P469, DOI 10.1016/j.bbi.2011.12.011
   VALTSCHANOFF JG, 1993, NEUROSCI LETT, V157, P157, DOI 10.1016/0304-3940(93)90726-2
   Wegener G, 2010, PHARMACEUTICALS, V3, P273, DOI 10.3390/ph3010273
   Wong ML, 2006, P NATL ACAD SCI USA, V103, P15124, DOI 10.1073/pnas.0602795103
   Yu YWY, 2003, NEUROPSYCHOBIOLOGY, V47, P137, DOI 10.1159/000070582
   Zielasek J, 1996, ADV NEUROIMMUNOL, V6, P191, DOI 10.1016/0960-5428(96)00017-4
   Zomkowski ADE, 2012, PHARMACOL BIOCHEM BE, V103, P408, DOI 10.1016/j.pbb.2012.09.011
   Zomkowski ADE, 2010, EUR NEUROPSYCHOPHARM, V20, P793, DOI 10.1016/j.euroneuro.2010.07.011
NR 71
TC 29
Z9 29
U1 1
U2 10
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1566-5240
EI 1875-5666
J9 CURR MOL MED
JI Curr. Mol. Med.
PY 2016
VL 16
IS 2
BP 206
EP 215
DI 10.2174/1566524016666160126144722
PG 10
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DH1MY
UT WOS:000372550000008
PM 26812915
DA 2020-12-08
ER

PT J
AU Bortolato, B
   Berk, M
   Maes, M
   McIntyre, RS
   Carvalho, AF
AF Bortolato, B.
   Berk, M.
   Maes, M.
   McIntyre, R. S.
   Carvalho, A. F.
TI Fibromyalgia and Bipolar Disorder: Emerging Epidemiological Associations
   and Shared Pathophysiology
SO CURRENT MOLECULAR MEDICINE
LA English
DT Article
DE Bipolar disorder; fibromyalgia; inflammation; oxidative stress;
   brain-derived neurotrophic factor; hypothalamic-pituitary adrenal axis;
   neuroimaging; pathophysiology; psychiatry; neurology
ID SEROTONIN TRANSPORTER GENE; CHRONIC-FATIGUE-SYNDROME; PITUITARY-ADRENAL
   AXIS; QUALITY-OF-LIFE; C-REACTIVE PROTEIN; ANTERIOR CINGULATE CORTEX;
   PLACEBO-CONTROLLED TRIAL; CHRONIC WIDESPREAD PAIN; VITAMIN-D DEFICIENCY;
   NEUROTROPHIC FACTOR
AB Fibromyalgia (FM) is a prevalent disorder defined by the presence of chronic widespread pain in association with fatigue, sleep disturbances and cognitive dysfunction. Recent studies indicate that bipolar spectrum disorders frequently co-occur in individuals with FM. Furthermore, shared pathophysiological mechanisms anticipate remarkable phenomenological similarities between FM and BD. A comprehensive search of the English literature was carried out in the Pubmed/MEDLINE database through May 10th, 2015 to identify unique references pertaining to the epidemiology and shared pathophysiology between FM and bipolar disorder (BD). Overlapping neural circuits may underpin parallel clinical manifestations of both disorders. Fibromyalgia and BD are both characterized by functional abnormalities in the hypothalamic-pituitary-adrenal axis, higher levels of inflammatory mediators, oxidative and nitrosative stress as well as mitochondrial dysfunction. An over-activation of the kynurenine pathway in both illnesses drives tryptophan away from the production of serotonin and melatonin, leading to affective symptoms, circadian rhythm disturbances and abnormalities in pain processing. In addition, both disorders are associated with impaired neuroplasticity (e.g., altered brain-derived neurotrophic factor signaling). The recognition of the symptomatic and pathophysiological overlaping between FM and bipolar spectrum disorders has relevant etiological, clinical and therapeutic implications that deserve future research consideration.
C1 [Bortolato, B.] ULSS 10 Veneto Orientale VE, Dept Mental Hlth, Rome, Italy.
   [Berk, M.; Maes, M.] Deakin Univ, Sch Med, IMPACT Strateg Res Ctr, Geelong, Vic 3217, Australia.
   [Berk, M.; Maes, M.] Barwon Hlth, Geelong, Vic 3217, Australia.
   [Berk, M.] Orygen, Dept Psychiat, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia.
   [McIntyre, R. S.] Univ Toronto, Dept Pharmacol, Toronto, ON, Canada.
   [McIntyre, R. S.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada.
   [McIntyre, R. S.] Univ Hlth Network, MDPU, Toronto, ON, Canada.
   [Carvalho, A. F.] Univ Fed Ceara, Fac Med, Dept Clin Med, Translat Psychiat Res Grp, BR-60430040 Fortaleza, CE, Brazil.
RP Carvalho, AF (corresponding author), Univ Fed Ceara, Fac Med, Dept Clin Med, Rua Prof Costa Mendes 1608,4 Andar, BR-60430040 Fortaleza, CE, Brazil.
EM andrefc7@terra.com.br
RI Berk, Michael/M-7891-2013; Maes, Michael/B-8546-2011; Berk,
   Michael/M-3585-2019; McIntyre, Roger/AAU-1000-2020
OI Berk, Michael/0000-0002-5554-6946; Maes, Michael/0000-0002-2012-871X;
   Berk, Michael/0000-0002-5554-6946; McIntyre, Roger/0000-0003-4733-2523
FU NHMRC Senior Principal Research FellowshipNational Health and Medical
   Research Council of Australia [1059660]; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil)National Council
   for Scientific and Technological Development (CNPq)
FX This review was not supported by any funding source. MB is supported by
   a NHMRC Senior Principal Research Fellowship 1059660. Andre F. Carvalho
   is supported by a research fellowship award from the Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil, Level II).
CR Aaron LA, 1996, ARTHRITIS RHEUM-US, V39, P436, DOI 10.1002/art.1780390311
   Aas M, 2013, PROG NEURO-PSYCHOPH, V46, P181, DOI 10.1016/j.pnpbp.2013.07.008
   Abeles AM, 2007, ANN INTERN MED, V146, P726, DOI 10.7326/0003-4819-146-10-200705150-00006
   Ablin JN, 2006, NAT CLIN PRACT RHEUM, V2, P671, DOI 10.1038/ncprheum0349
   Aguglia A, 2011, J AFFECT DISORDERS, V128, P262, DOI 10.1016/j.jad.2010.07.004
   Ahmadi S, 2012, MINERVA MED, V103, P383
   Akkus S, 2009, CELL BIOCHEM FUNCT, V27, P181, DOI 10.1002/cbf.1548
   Alciati A, 2012, CLIN EXP RHEUMATOL, V30, pS122
   Anderson G, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-014-0541-1
   Anderson G, 2014, CNS NEUROL DISORD-DR, V13, P817, DOI 10.2174/1871527313666140711091400
   Andreazza AC, 2008, J AFFECT DISORDERS, V111, P135, DOI 10.1016/j.jad.2008.04.013
   Andreazza AC, 2013, J NEUROCHEM, V127, P552, DOI 10.1111/jnc.12316
   Andreazza AC, 2015, AM J GERIAT PSYCHIAT, V23, P314, DOI 10.1016/j.jagp.2014.05.008
   Aoki Y, 2013, PSYCHIAT RES-NEUROIM, V213, P242, DOI 10.1016/j.pscychresns.2013.03.008
   Arnold LM, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1971
   Arnold LM, 2006, J CLIN PSYCHIAT, V67, P1219, DOI 10.4088/JCP.v67n0807
   Banerjee U, 2012, PROG NEURO-PSYCHOPH, V37, P56, DOI 10.1016/j.pnpbp.2011.12.006
   Barbosa IG, 2013, EUR ARCH PSY CLIN N, V263, P159, DOI 10.1007/s00406-012-0327-6
   Bazzichi L, 2007, CLIN EXP RHEUMATOL, V25, P225
   BEHAN WMH, 1991, ACTA NEUROPATHOL, V83, P61, DOI 10.1007/BF00294431
   Belsky J, 2014, WORLD PSYCHIATRY, V13, P87, DOI 10.1002/wps.20092
   Benedetti F, 2011, BIPOLAR DISORD, V13, P414, DOI 10.1111/j.1399-5618.2011.00938.x
   Bengesser SA, 2015, J AFFECT DISORDERS, V172, P367, DOI 10.1016/j.jad.2014.10.014
   Berk M, 2011, NEUROSCI BIOBEHAV R, V35, P804, DOI 10.1016/j.neubiorev.2010.10.001
   Bierhaus A, 2003, P NATL ACAD SCI USA, V100, P1920, DOI 10.1073/pnas.0438019100
   Blankfield A, 2013, INT J TRYPTOPHAN RES, P39, DOI 10.4137/IJTR.S11193
   Blond BN, 2012, BIPOLAR DISORD, V14, P340, DOI 10.1111/j.1399-5618.2012.01015.x
   Blumberg HP, 2006, BIOL PSYCHIAT, V59, P611, DOI 10.1016/j.biopsych.2005.08.031
   Blumberg HP, 2005, BIPOLAR DISORD, V7, P570, DOI 10.1111/j.1399-5618.2005.00264.x
   Bonifazi M, 2006, PSYCHONEUROENDOCRINO, V31, P1076, DOI 10.1016/j.psyneuen.2006.06.008
   Booth NE, 2012, INT J CLIN EXP MED, V5, P208
   Bourne C, 2013, ACTA PSYCHIAT SCAND, V128, P149, DOI 10.1111/acps.12133
   Bozkurt M, 2014, REDOX REP, V19, P148, DOI 10.1179/1351000213Y.0000000079
   Bradley LA, 2008, J CLIN PSYCHIAT, V69, P6
   Brietzke E, 2012, PROG NEURO-PSYCHOPH, V39, P1, DOI 10.1016/j.pnpbp.2012.05.004
   Brietzke E, 2009, BRAIN BEHAV IMMUN, V23, P1079, DOI 10.1016/j.bbi.2009.04.008
   Brooks JO, 2008, J PSYCHIATR RES, V43, P181, DOI 10.1016/j.jpsychires.2008.04.015
   Brown NC, 2014, PSYCHIAT RES, V218, P61, DOI 10.1016/j.psychres.2014.04.005
   Bruno A, 2013, J CLIN PSYCHOPHARM, V33, P507, DOI 10.1097/JCP.0b013e31829057ae
   Burgmer M, 2009, PSYCHOSOM MED, V71, P566, DOI 10.1097/PSY.0b013e3181a32da0
   Buskila D, 2004, MOL PSYCHIATR, V9, P973, DOI 10.1038/sj.mp.4001568
   Buskila D, 2007, PHARMACOGENOMICS, V8, P67, DOI 10.2217/14622416.8.1.67
   Cagnie B, 2014, SEMIN ARTHRITIS RHEU, V44, P68, DOI 10.1016/j.semarthrit.2014.01.001
   Calandre EP, 2014, PHARMACOPSYCHIATRY, V47, P67, DOI 10.1055/s-0033-1363659
   Caliyurt O, 2009, BIPOLAR DISORD, V11, P102, DOI 10.1111/j.1399-5618.2008.00649.x
   Callaly E, 2015, MINI-REV MED CHEM, V15, P355, DOI 10.2174/1389557515666150324122026
   Cao H, 2008, NEUROSCI BIOBEHAV R, V32, P972, DOI 10.1016/j.neubiorev.2008.03.009
   Carta Mauro Giovanni, 2006, Clin Pract Epidemiol Ment Health, V2, P2, DOI 10.1186/1745-0179-2-2
   Carta Mauro Giovanni, 2005, Clin Pract Epidemiol Ment Health, V1, P4, DOI 10.1186/1745-0179-1-4
   Carta Mg, 2013, Clin Pract Epidemiol Ment Health, V9, P120, DOI 10.2174/1745017901309010120
   Carvalho AF, 2015, J AFFECT DISORDERS, V172, P337, DOI 10.1016/j.jad.2014.10.024
   Castro-Marrero J, 2013, ANTIOXID REDOX SIGN, V19, P1855, DOI 10.1089/ars.2013.5346
   Cervantes P, 2001, J PSYCHIATR NEUROSCI, V26, P411
   Cherniack EP, 2009, CURR PSYCHIAT REP, V11, P12
   Chung KH, 2013, NEUROPSYCHOBIOLOGY, V68, P168, DOI 10.1159/000353613
   Cifre I, 2012, PSYCHOSOM MED, V74, P55, DOI 10.1097/PSY.0b013e3182408f04
   Cimen OB, 2009, PAIN MED, V10, P813, DOI 10.1111/j.1526-4637.2009.00642.x
   Clauw DJ, 2014, JAMA-J AM MED ASSOC, V311, P1547, DOI 10.1001/jama.2014.3266
   Cohen H, 2002, SEMIN ARTHRITIS RHEU, V32, P38, DOI 10.1053/sarh.2002.33719
   Collado A, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0513-5
   Cook DB, 2004, J RHEUMATOL, V31, P364
   Cordero MD, 2014, RHEUMATOL INT, V34, P419, DOI 10.1007/s00296-012-2647-2
   Cordero MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035677
   Cunha ABM, 2006, NEUROSCI LETT, V398, P215, DOI 10.1016/j.neulet.2005.12.085
   Daban C, 2005, PSYCHIAT CLIN N AM, V28, P469, DOI 10.1016/j.psc.2005.01.005
   Danese A, 2014, MOL PSYCHIATR, V19, P544, DOI 10.1038/mp.2013.54
   de Sousa RT, 2014, J PSYCHIATR RES, V50, P36, DOI 10.1016/j.jpsychires.2013.11.011
   de Zanette SA, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-40
   Dell'Osso L, 2009, CLIN EXP RHEUMATOL, V27, pS57
   Dickerson F, 2007, PROG NEURO-PSYCHOPH, V31, P952, DOI 10.1016/j.pnpbp.2007.02.018
   Dickerson F, 2013, J AFFECT DISORDERS, V150, P456, DOI 10.1016/j.jad.2013.04.039
   Drevets WC, 2000, BIOL PSYCHIAT, V48, P813, DOI 10.1016/S0006-3223(00)01020-9
   Drevets WC, 1998, MOL PSYCHIATR, V3, P220, DOI 10.1038/sj.mp.4000370
   Drexhage RC, 2011, BRAIN BEHAV IMMUN, V25, P1206, DOI 10.1016/j.bbi.2011.03.013
   Dvir Y, 2014, HARVARD REV PSYCHIAT, V22, P149, DOI 10.1097/HRP.0000000000000014
   Eide PK, 2000, EUR J PAIN, V4, P5, DOI 10.1053/eujp.1999.0154
   Epstein SA, 1999, PSYCHOSOMATICS, V40, P57, DOI 10.1016/S0033-3182(99)71272-7
   Fagundes CP, 2013, BRAIN BEHAV IMMUN, V27, P8, DOI 10.1016/j.bbi.2012.06.014
   Failde I, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-112
   Fernandes BS, 2011, J PSYCHIATR RES, V45, P995, DOI 10.1016/j.jpsychires.2011.03.002
   Fernandez-de-las-Penas C, 2014, CLIN J PAIN, V30, P199, DOI 10.1097/AJP.0b013e3182928da0
   Fietta Pierluigi, 2007, Acta Biomed, V78, P88
   Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263
   Fornaro M, 2013, NEUROPSYCH DIS TREAT, V9, P243, DOI 10.2147/NDT.S41557
   Fries E, 2005, PSYCHONEUROENDOCRINO, V30, P1010, DOI 10.1016/j.psyneuen.2005.04.006
   Fries GR, 2014, INT J NEUROPSYCHOPHA, V18
   Geiss A, 2012, PSYCHONEUROENDOCRINO, V37, P671, DOI 10.1016/j.psyneuen.2011.07.021
   Ghaemi SN, 2003, BIPOLAR DISORD, V5, P421, DOI 10.1046/j.1399-5618.2003.00074.x
   Gilman SE, 2015, MOL PSYCHIATR, V20, P329, DOI 10.1038/mp.2014.36
   Giordano James, 2005, Pain Physician, V8, P277
   Goldstein BI, 2009, J AFFECT DISORDERS, V117, P151, DOI 10.1016/j.jad.2009.01.011
   Gonzalez R, 2014, J CLIN PSYCHIAT, V75, pE323, DOI 10.4088/JCP.13r08507
   Goshen I, 2008, MOL PSYCHIATR, V13, P717, DOI 10.1038/sj.mp.4002055
   Grande I, 2012, J PSYCHIATR RES, V46, P1511, DOI 10.1016/j.jpsychires.2012.08.017
   Gruber SA, 2004, J AFFECT DISORDERS, V82, P191, DOI 10.1016/j.jad.2003.10.010
   Haas L, 2010, NEUROCHEM RES, V35, P830, DOI 10.1007/s11064-010-0129-z
   Hafeman DM, 2012, BIPOLAR DISORD, V14, P375, DOI 10.1111/j.1399-5618.2012.01023.x
   Hakamata Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075526
   Harris RE, 2008, ARTHRITIS RHEUM, V58, P903, DOI 10.1002/art.23223
   Harris RE, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3136
   Haviland MG, 2011, CLIN EXP RHEUMATOL, V29, pS79
   Heidari B, 2010, INT J RHEUM DIS, V13, P340, DOI 10.1111/j.1756-185X.2010.01561.x
   HUDSON JI, 1992, AM J MED, V92, P363, DOI 10.1016/0002-9343(92)90265-D
   Hulvershorn LA, 2012, BIOL PSYCHIAT, V71, P603, DOI 10.1016/j.biopsych.2011.10.038
   Ikeda M, 2006, J NEURAL TRANSM, V113, P899, DOI 10.1007/s00702-005-0349-6
   Iqbal R, 2011, RHEUMATOL INT, V31, P149, DOI 10.1007/s00296-010-1470-x
   Jensen KB, 2013, ARTHRITIS RHEUM-US, V65, P3293, DOI 10.1002/art.38170
   Jiao J, 2015, RHEUMATOL INT, V35, P547, DOI 10.1007/s00296-014-3113-0
   Jorge LL, 2012, CURR PAIN HEADACHE R, V16, P388, DOI 10.1007/s11916-012-0284-9
   Kapczinski F, 2011, J PSYCHIATR RES, V45, P156, DOI 10.1016/j.jpsychires.2010.05.015
   Kauer-Sant'Anna M, 2009, INT J NEUROPSYCHOPH, V12, P447, DOI 10.1017/S1461145708009310
   Ketter TA, 2001, BIOL PSYCHIAT, V49, P97, DOI 10.1016/S0006-3223(00)00975-6
   Klingmann PO, 2008, ANN NY ACAD SCI, V1148, P446, DOI 10.1196/annals.1410.020
   Knochel C, 2014, NEUROIMAGE-CLIN, V6, P134, DOI 10.1016/j.nicl.2014.08.015
   Koo JW, 2008, P NATL ACAD SCI USA, V105, P751, DOI 10.1073/pnas.0708092105
   Korszun A, 2000, Curr Rheumatol Rep, V2, P124, DOI 10.1007/s11926-000-0052-4
   Kuchinad A, 2007, J NEUROSCI, V27, P4004, DOI 10.1523/JNEUROSCI.0098-07.2007
   Kuningas M, 2009, NEUROBIOL AGING, V30, P466, DOI 10.1016/j.neurobiolaging.2007.07.001
   La Rubia M, 2013, CLIN EXP RHEUMATOL, V31, pS121
   Laske C, 2007, J PSYCHIATR RES, V41, P600, DOI 10.1016/j.jpsychires.2006.02.007
   Lasky-Su JA, 2005, AM J MED GENET B, V133B, P110, DOI 10.1016/j.ajmg.b.30104
   Lentjes EGWM, 1997, PSYCHONEUROENDOCRINO, V22, P603, DOI 10.1016/S0306-4530(97)00061-9
   Leonard B, 2012, NEUROSCI BIOBEHAV R, V36, P764, DOI 10.1016/j.neubiorev.2011.12.005
   Lotsch J, 2007, PAIN, V132, P18, DOI 10.1016/j.pain.2007.06.024
   Luerding R, 2008, BRAIN, V131, P3222, DOI 10.1093/brain/awn229
   Lyon P, 2011, PAIN MED, V12, P1167, DOI 10.1111/j.1526-4637.2011.01168.x
   Macedo JA, 2008, PSYCHONEUROENDOCRINO, V33, P799, DOI 10.1016/j.psyneuen.2008.03.012
   Machado-Vieira R, 2007, NEUROSCI LETT, V421, P33, DOI 10.1016/j.neulet.2007.05.016
   MAES M, 1995, J PSYCHIAT RES, V29, P141, DOI 10.1016/0022-3956(94)00049-W
   Maes M, 1999, PSYCHONEUROENDOCRINO, V24, P371, DOI 10.1016/S0306-4530(98)00087-0
   Maes M, 2011, PROG NEURO-PSYCHOPH, V35, P702, DOI 10.1016/j.pnpbp.2010.12.017
   Magalhaes PVS, 2012, INT J NEUROPSYCHOPH, V15, P1043, DOI 10.1017/S1461145711001532
   Mahon K, 2010, NEUROSCI BIOBEHAV R, V34, P533, DOI 10.1016/j.neubiorev.2009.10.012
   Maletic V, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00098
   Maletic V, 2009, FRONT BIOSCI-LANDMRK, V14, P5291, DOI 10.2741/3598
   Mandelli L, 2007, INT J NEUROPSYCHOPH, V10, P437, DOI 10.1017/S1461145706006882
   Manji HK, 2001, NAT MED, V7, P541, DOI 10.1038/87865
   Mansour HA, 2005, ANN MED, V37, P590, DOI 10.1080/07853890500357428
   McBeth J, 2010, ANN RHEUM DIS, V69, P1448, DOI 10.1136/ard.2009.116053
   Menon V, 2011, TRENDS COGN SCI, V15, P483, DOI 10.1016/j.tics.2011.08.003
   Menzies V, 2010, BIOL RES NURS, V11, P387, DOI 10.1177/1099800409348328
   Mergener M, 2011, REV BRAS REUMATOL, V51, P587
   Merikangas KR, 2011, ARCH GEN PSYCHIAT, V68, P241, DOI 10.1001/archgenpsychiatry.2011.12
   Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029
   Miller CJ, 2013, J AFFECT DISORDERS, V146, P100, DOI 10.1016/j.jad.2012.08.045
   Miller S, 2013, J PSYCHIATR RES, V47, P252, DOI 10.1016/j.jpsychires.2012.10.015
   Miyamae T, 2013, REDOX REP, V18, P12, DOI 10.1179/1351000212Y.0000000036
   Modabbernia A, 2013, BIOL PSYCHIAT, V74, P15, DOI 10.1016/j.biopsych.2013.01.007
   Moldofsky H, 2008, CNS SPECTRUMS, V13, P22, DOI 10.1017/S1092852900026808
   Morris G, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0310-y
   Morris G, 2013, MOL NEUROBIOL, V48, P883, DOI 10.1007/s12035-013-8477-8
   Muller DJ, 2006, BRIT J PSYCHIAT, V189, P317, DOI 10.1192/bjp.bp.105.010587
   Munkholm K, 2014, PSYCHONEUROENDOCRINO, V47, P199, DOI 10.1016/j.psyneuen.2014.05.011
   Munkholm K, 2013, J PSYCHIATR RES, V47, P1119, DOI 10.1016/j.jpsychires.2013.05.018
   Murphy VE, 2001, AM J MED GENET, V105, P422, DOI 10.1002/ajmg.1435.abs
   Neugebauer V, 2004, NEUROSCIENTIST, V10, P221, DOI 10.1177/1073858403261077
   Neyal M, 2013, CLIN NEUROL NEUROSUR, V115, P736, DOI 10.1016/j.clineuro.2012.08.028
   Ng F, 2008, INT J NEUROPSYCHOPH, V11, P851, DOI 10.1017/S1461145707008401
   Nicholl BI, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0350-4
   Nicolson NA, 2010, PSYCHOSOM MED, V72, P471, DOI 10.1097/PSY.0b013e3181d9a104
   Nijs J, 2015, EXPERT OPIN THER TAR, V19, P565, DOI 10.1517/14728222.2014.994506
   Nortje G, 2013, J AFFECT DISORDERS, V150, P192, DOI 10.1016/j.jad.2013.05.034
   Nugraha B, 2013, NEUROCHEM INT, V62, P281, DOI 10.1016/j.neuint.2013.01.001
   Oertel-Knochel V, 2015, J AFFECT DISORDERS, V174, P627, DOI 10.1016/j.jad.2014.10.060
   Offenbaecher M, 1999, ARTHRITIS RHEUM-US, V42, P2482, DOI 10.1002/1529-0131(199911)42:11<2482::AID-ANR27>3.0.CO;2-B
   Ohayon MM, 2004, J CLIN PSYCHIAT, V65, P5
   Okumus M, 2013, PAIN MANAG NURS, V14, pE156, DOI 10.1016/j.pmn.2011.09.006
   Pacchiarotti I, 2013, AM J PSYCHIAT, V170, P1249, DOI 10.1176/appi.ajp.2013.13020185
   Padmos RC, 2008, ARCH GEN PSYCHIAT, V65, P395, DOI 10.1001/archpsyc.65.4.395
   Park MH, 2015, J PSYCHIATR RES, V61, P81, DOI 10.1016/j.jpsychires.2014.11.013
   Park S, 2012, PSYCHIAT RES, V198, P509, DOI 10.1016/j.psychres.2012.01.028
   Pernambuco AP, 2015, CLIN EXP RHEUMATOL, V33, pS14
   Petersel DL, 2011, J NEUROSCI RES, V89, P29, DOI 10.1002/jnr.22512
   Phillips ML, 2014, AM J PSYCHIAT, V171, P829, DOI 10.1176/appi.ajp.2014.13081008
   Polyakova M, 2015, J AFFECT DISORDERS, V174, P432, DOI 10.1016/j.jad.2014.11.044
   Post RM, 2013, J AFFECT DISORDERS, V147, P288, DOI 10.1016/j.jad.2012.11.020
   Queiroz LP, 2013, CURR PAIN HEADACHE R, V17, DOI 10.1007/s11916-013-0356-5
   Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968
   Rege S, 2013, AUST NZ J PSYCHIAT, V47, P1136, DOI 10.1177/0004867413499077
   Riva R, 2012, PSYCHONEUROENDOCRINO, V37, P299, DOI 10.1016/j.psyneuen.2011.06.014
   Robillard R, 2013, EUR PSYCHIAT, V28, P412, DOI 10.1016/j.eurpsy.2013.04.001
   Romo-Nava F, 2014, BIPOLAR DISORD, V16, P410, DOI 10.1111/bdi.12196
   Rybakowski JK, 2013, J AFFECT DISORDERS, V146, P286, DOI 10.1016/j.jad.2012.07.019
   Sanders KM, 2011, BRIT J PSYCHIAT, V198, P357, DOI 10.1192/bjp.bp.110.087544
   Sarchielli P, 2007, J PAIN, V8, P737, DOI 10.1016/j.jpain.2007.05.002
   Sawamoto N, 2000, J NEUROSCI, V20, P7438
   Schmechel DE, 2012, NEUROTOXICOLOGY, V33, P1454, DOI 10.1016/j.neuro.2012.03.001
   Schur EA, 2007, J GEN INTERN MED, V22, P818, DOI 10.1007/s11606-007-0140-5
   Scola G, 2015, PROG NEURO-PSYCHOPH, V56, P122, DOI 10.1016/j.pnpbp.2014.08.013
   Scola G, 2013, BIOL PSYCHIAT, V73, pE4, DOI 10.1016/j.biopsych.2012.06.028
   Sendur OF, 2009, RHEUMATOL INT, V29, P629, DOI 10.1007/s00296-008-0738-x
   Serretti A, 2006, NEUROPSYCHOBIOLOGY, V53, P9, DOI 10.1159/000089916
   Sharma V, 2001, CAN J PSYCHIAT, V46, P452, DOI 10.1177/070674370104600521
   Shelton Richard C, 2008, Curr Psychiatry Rep, V10, P520
   Smith DJ, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-263
   Smits B, 2011, MITOCHONDRION, V11, P735, DOI 10.1016/j.mito.2011.05.005
   Soeiro-de-Souza MG, 2013, INT J NEUROPSYCHOPH, V16, P1505, DOI 10.1017/S1461145713000047
   Soeiro-de-Souza MG, 2012, BIPOLAR DISORD, V14, P554, DOI 10.1111/j.1399-5618.2012.01030.x
   Stahl SM, 2009, HUM PSYCHOPHARM CLIN, V24, pS11, DOI 10.1002/hup.1029
   Staud R, 2011, CLIN EXP RHEUMATOL, V29, pS109
   Strakowski SM, 2002, AM J PSYCHIAT, V159, P1841, DOI 10.1176/appi.ajp.159.11.1841
   Strakowski SM, 2012, BIPOLAR DISORD, V14, P313, DOI 10.1111/j.1399-5618.2012.01022.x
   Stubbs B, 2015, ACTA PSYCHIAT SCAND, V131, P75, DOI 10.1111/acps.12325
   Subramaniam M, 2013, J AFFECT DISORDERS, V146, P189, DOI 10.1016/j.jad.2012.09.002
   Suk JH, 2012, EXP CLIN ENDOCR DIAB, V120, P401, DOI 10.1055/s-0032-1309008
   Tak LM, 2011, BIOL PSYCHOL, V87, P183, DOI 10.1016/j.biopsycho.2011.02.002
   Tang JH, 2008, NEUROSCI LETT, V433, P98, DOI 10.1016/j.neulet.2008.01.001
   Tanriverdi F, 2007, STRESS, V10, P13, DOI 10.1080/10253890601130823
   Topbas M, 2005, SCAND J RHEUMATOL, V34, P140, DOI 10.1080/03009740510026337
   Townsend J, 2012, BIPOLAR DISORD, V14, P326, DOI 10.1111/j.1399-5618.2012.01021.x
   Trinanes Y, 2015, PAIN PRACT, V15, P323, DOI 10.1111/papr.12186
   Tsai MC, 2015, J AFFECT DISORDERS, V173, P22, DOI 10.1016/j.jad.2014.10.045
   Ubbenhorst A, 2011, PSYCHOPHARMACOLOGY, V215, P733, DOI 10.1007/s00213-011-2175-x
   Uceyler N, 2006, ARTHRITIS RHEUM-US, V54, P2656, DOI 10.1002/art.22026
   Uceyler N, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-245
   van IJzendoorn MH, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.73
   Vederine FE, 2011, PROG NEURO-PSYCHOPH, V35, P1820, DOI 10.1016/j.pnpbp.2011.05.009
   Vincent A, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4395
   Vincent JB, 1999, AM J PSYCHIAT, V156, P136, DOI 10.1176/ajp.156.1.136
   von Kanel R, 2014, PAIN MED, V15, P1609, DOI 10.1111/pme.12454
   Wallace DJ, 2008, SEMIN ARTHRITIS RHEU, V37, P256, DOI 10.1016/j.semarthrit.2007.04.008
   Wallace DJ, 2001, RHEUMATOLOGY, V40, P743, DOI 10.1093/rheumatology/40.7.743
   Wang HL, 2008, J RHEUMATOL, V35, P1366
   Watkins CC, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.119
   Watson S, 2004, BRIT J PSYCHIAT, V184, P496, DOI 10.1192/bjp.184.6.496
   Watson S, 2014, AUST NZ J PSYCHIAT, V48, P564, DOI 10.1177/0004867413516681
   Weissbecker I, 2006, PSYCHONEUROENDOCRINO, V31, P312, DOI 10.1016/j.psyneuen.2005.08.009
   Wepner F, 2014, PAIN, V155, P261, DOI 10.1016/j.pain.2013.10.002
   Werle E, 2001, J RHEUMATOL, V28, P595
   White KP, 1999, J RHEUMATOL, V26, P1570
   Wieck A, 2013, BRAIN BEHAV IMMUN, V34, P47, DOI 10.1016/j.bbi.2013.07.005
   Wilke WS, 2010, BIPOLAR DISORD, V12, P514, DOI 10.1111/j.1399-5618.2010.00848.x
   Wingenfeld K, 2008, PSYCHOSOM MED, V70, P65, DOI 10.1097/PSY.0b013e31815ff3ce
   Wingenfeld K, 2007, J PSYCHOSOM RES, V62, P85, DOI 10.1016/j.jpsychores.2006.06.006
   Wingenfeld K, 2010, J PAIN, V11, P1195, DOI 10.1016/j.jpain.2010.02.011
   WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203
   Wolfe F, 2013, NAT REV RHEUMATOL, V9, P751, DOI 10.1038/nrrheum.2013.96
   Wolfe F, 2011, J RHEUMATOL, V38, P1113, DOI 10.3899/jrheum.100594
   Wolfe F, 2010, J RHEUMATOL, V37, P305, DOI 10.3899/jrheum.090781
   Xiao YM, 2012, RHEUMATOL INT, V32, P2479, DOI 10.1007/s00296-011-1990-z
   Yasui M, 2014, GLIA, V62, P1407, DOI 10.1002/glia.22687
   Yatham LN, 2016, BRIT J PSYCHIAT, V208, P78, DOI 10.1192/bjp.bp.114.147587
   Zanette SA, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-46
   Zubieta JK, 2003, SCIENCE, V299, P1240, DOI 10.1126/science.1078546
NR 244
TC 19
Z9 19
U1 0
U2 10
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1566-5240
EI 1875-5666
J9 CURR MOL MED
JI Curr. Mol. Med.
PY 2016
VL 16
IS 2
BP 119
EP 136
DI 10.2174/1566524016666160126144027
PG 18
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DH1MY
UT WOS:000372550000003
PM 26812920
DA 2020-12-08
ER

PT J
AU Souza, TM
   Menezes, ESB
   Oliveira, RV
   Filho, LCPA
   Martins, JM
   Moreno, FB
   Monteiro-Moreira, ACO
   Moura, AAA
   Carvalho, AFU
AF Souza, Terezinha M.
   Bezerra Menezes, Erika S.
   Oliveira, Rodrigo V.
   Filho, Luiz Carlos P. Almeida
   Martins, Jorge M.
   Moreno, Frederico B.
   Monteiro-Moreira, Ana Cristina O.
   Araripe Moura, Arlindo A.
   Urano Carvalho, Ana F.
TI Further evidences for the mode of action of the larvicidal
   m-pentadecadienyl-phenol isolated from Myracrodruon urundeuva seeds
   against Aedes aegypti
SO ACTA TROPICA
LA English
DT Article
DE Comparative proteomics; Detoxification; Natural insecticide;
   m-Pentadecadienyl-phenol
ID YELLOW-FEVER MOSQUITO; INSECTICIDE RESISTANCE; DROSOPHILA-MELANOGASTER;
   S-TRANSFERASES; DAIRY BULLS; PROTEINS; POLYAMINES; INFECTION; GENES;
   PROTEOME
AB Nowadays, dengue fever is considered the most important arbovirosis worldwide and its control is still based upon combating the vector Aedes aegypti. Besides monitoring of mosquito populations resistant to conventional insecticides, the search for new environmentally safe insecticides and conduction of molecular studies focusing on the elucidation of mode of action and possible resistance mechanisms are considered the key for a sustainable management of the mosquito vector. Thus, the present work aimed to assess changes in protein expression of 3rd-instar larvae of Ae. aegypti after exposure to the natural insecticide m-pentadecadienyl-phenol. Bidimensional electrophoresis followed by mass spectrometry resulted in identification of 12 proteins differentially expressed between control and treated groups. Larvae exposed to the toxic compound for 24 h showed elevated detoxification response (glutathione-S-transferase), increased levels of stress-related proteins (HSP70) as well as evidence of lysosome stabilization to enable survival. Furthermore, expression of proteins involved in protection of peritrophic membrane and metabolism of lipids indicated systemic effect of toxic effects in treated larvae. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Souza, Terezinha M.; Filho, Luiz Carlos P. Almeida] Univ Fed Ceara, Dept Biochem & Mol Biol, BR-60440900 Fortaleza, Ceara, Brazil.
   [Bezerra Menezes, Erika S.; Oliveira, Rodrigo V.; Martins, Jorge M.; Araripe Moura, Arlindo A.] Univ Fed Ceara, Dept Anim Sci, BR-60455760 Fortaleza, Ceara, Brazil.
   [Moreno, Frederico B.; Monteiro-Moreira, Ana Cristina O.] Univ Fortaleza, Sch Pharm, BR-60810431 Fortaleza, Ceara, Brazil.
   [Urano Carvalho, Ana F.] Univ Fed Ceara, Dept Biol, BR-60455760 Fortaleza, Ceara, Brazil.
RP Carvalho, AFU (corresponding author), Univ Fed Ceara, Dept Biol, Campus Pici, BR-60455760 Fortaleza, Ceara, Brazil.
EM aurano@ufc.br
RI Almeida Filho, Luiz/K-7313-2018; Monteiro-Moreira, Ana Cristina
   O/F-3685-2014; Carvalho, Ana/K-7344-2018; MOURA, ARLINDO A/P-6697-2018;
   Souza, Terezinha/L-8727-2015
OI Almeida Filho, Luiz/0000-0001-6234-2418; Monteiro-Moreira, Ana Cristina
   O/0000-0002-3606-6808; Carvalho, Ana/0000-0001-5293-9317; MOURA, ARLINDO
   A/0000-0002-8271-5733; Souza, Terezinha/0000-0002-9580-3310; Vasconcelos
   de Oliveira, Rodrigo/0000-0002-7420-1097
FU Ministerio da Saude, through Departamento de Ciencia e Tecnologia
   (DECIT); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao Cearense de Apoio Cientifico e Tecnologico (FUNCAP);
   Secretaria de Ciencia, Tecnologia e Insumos Estrategicos (SCTIE)
FX The authors thank Ministerio da Saude, through Departamento de Ciencia e
   Tecnologia (DECIT), Secretaria de Ciencia, Tecnologia e Insumos
   Estrategicos (SCTIE), Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq) and Fundacao Cearense de Apoio Cientifico e
   Tecnologico (FUNCAP) for financial support of this research.
CR [Anonymous], 1981, INSTR DET SUSC RES M
   ASADA N, 1993, INSECT BIOCHEM MOLEC, V23, P515, DOI 10.1016/0965-1748(93)90060-6
   Behura SK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001385
   Biron DG, 2005, INT J PARASITOL, V35, P1385, DOI 10.1016/j.ijpara.2005.05.015
   BOYLAND E, 1969, ADV ENZYMOL RAMB, V32, P173
   Bryant B, 2008, INSECT BIOCHEM MOLEC, V38, P331, DOI 10.1016/j.ibmb.2007.11.012
   Camara FP, 2007, REV SOC BRAS MED TRO, V40, P192, DOI 10.1590/S0037-86822007000200009
   Cancino-Rodezno A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037034
   Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844
   CHAPUS C, 1988, BIOCHIMIE, V70, P1223, DOI 10.1016/0300-9084(88)90188-5
   Chuo CP, 2005, FISH SHELLFISH IMMUN, V18, P149, DOI 10.1016/j.fsi.2004.06.009
   Oliveira MSC, 2011, ACTA TROP, V117, P165, DOI 10.1016/j.actatropica.2010.08.003
   Costa SGVAO, 2006, PROCESS BIOCHEM, V41, P483, DOI 10.1016/j.procbio.2005.07.002
   Duncan AB, 2012, ECOL EVOL, V2, P681, DOI 10.1002/ece3.199
   Fonseca-Gonzalez I, 2011, PEST MANAG SCI, V67, P430, DOI 10.1002/ps.2081
   GARRETT WD, 1977, MOSQ NEWS, V37, P344
   Glockzin S, 2003, MOL CELL BIOL, V23, P8960, DOI 10.1128/MCB.23.24.8960-8969.2003
   Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0
   Hemingway J, 2000, INSECT BIOCHEM MOLEC, V30, P1009, DOI 10.1016/S0965-1748(00)00079-5
   Hemingway J, 2002, SCIENCE, V298, P96, DOI 10.1126/science.1078052
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Khush RS, 2000, TRENDS GENET, V16, P442, DOI 10.1016/S0168-9525(00)02095-3
   Kirkegaard T, 2010, NATURE, V463, P549, DOI 10.1038/nature08710
   Kogan PH, 2000, J INSECT PHYSIOL, V46, P1079, DOI 10.1016/S0022-1910(99)00084-0
   Lawson D, 2009, NUCLEIC ACIDS RES, V37, pD583, DOI 10.1093/nar/gkn857
   Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104
   LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443
   Longnecker MP, 1997, ANNU REV PUBL HEALTH, V18, P211, DOI 10.1146/annurev.publhealth.18.1.211
   Marcombe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030989
   Maritsi D, 2006, HIPPOKRATIA, V10, P116
   MARRS TC, 1993, PHARMACOL THERAPEUT, V58, P51, DOI 10.1016/0163-7258(93)90066-M
   MATSUKURA U, 1981, BIOCHIM BIOPHYS ACTA, V662, P41, DOI 10.1016/0005-2744(81)90221-7
   MATTHEWS HR, 1993, BIOESSAYS, V15, P561, DOI 10.1002/bies.950150811
   Moura AA, 2006, J ANDROL, V27, P201, DOI 10.2164/jandrol.05089
   Moura AA, 2006, J ANDROL, V27, P534, DOI 10.2164/jandrol.05201
   Nylandsted J, 2004, J EXP MED, V200, P425, DOI 10.1084/jem.20040531
   Onstad DW, 2013, INSECT RESISTANCE MA
   PEGG AE, 1986, BIOCHEM J, V234, P249, DOI 10.1042/bj2340249
   Poupardin R, 2008, INSECT BIOCHEM MOLEC, V38, P540, DOI 10.1016/j.ibmb.2008.01.004
   Ray DE, 2000, J TOXICOL-CLIN TOXIC, V38, P95, DOI 10.1081/CLT-100100922
   Shen S, 2003, ARCH INSECT BIOCHEM, V53, P80, DOI 10.1002/arch.10087
   SJOHOLM A, 1993, AM J PHYSIOL, V264, pC501
   Souza CEA, 2012, J PROTEOMICS, V75, P4436, DOI 10.1016/j.jprot.2012.05.039
   Souza TM, 2011, J MED ENTOMOL, V48, P846, DOI 10.1603/ME10205
   Souza TM, 2012, PEST MANAG SCI, V68, P1380, DOI 10.1002/ps.3316
   Sritunyalucksana K, 2000, AQUACULTURE, V191, P53, DOI 10.1016/S0044-8486(00)00411-7
   Turk B, 2009, J BIOL CHEM, V284, P21783, DOI 10.1074/jbc.R109.023820
   WELCH WJ, 1992, PHYSIOL REV, V72, P1063
   Wijffels G, 2001, J BIOL CHEM, V276, P15527, DOI 10.1074/jbc.M009393200
NR 49
TC 2
Z9 3
U1 0
U2 26
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD DEC
PY 2015
VL 152
BP 49
EP 55
DI 10.1016/j.actatropica.2015.08.010
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA CW5SW
UT WOS:000365057900006
PM 26299195
DA 2020-12-08
ER

PT J
AU Farias, DF
   Peijnenburg, AACM
   Grossi-de-Sa, MF
   Carvalho, AFU
AF Farias, Davi F.
   Peijnenburg, Ad A. C. M.
   Grossi-de-Sa, Maria F.
   Carvalho, Ana F. U.
TI Food safety knowledge on the Bt mutant protein Cry8Ka5 employed in the
   development of coleopteran-resistant transgenic cotton plants
SO BIOENGINEERED
LA English
DT Editorial Material
DE Anthonomus grandis; Bacillus thuringiensis; Bt crops; cytotoxicity;
   gastrointestinal microbiota; recombinant protein; risk assessment;
   toxicogenomics
ID ANTHONOMUS-GRANDIS BOHEMAN; BACILLUS-THURINGIENSIS CRY; LEPIDOPTERA
   CRAMBIDAE; INSECTICIDAL ACTIVITY; CROPS; MODE; PEST; SUSCEPTIBILITY;
   CURCULIONIDAE; POPULATIONS
AB Insecticidal Cry proteins from Bacillus thuringiensis (Bt) have been exploited in the development of genetically modified (GM) crops for pest control. However, several pests are still difficult to control such as the coleopteran boll weevil Anthonomus grandis. By applying in vitro molecular evolution to the cry8Ka1 gene sequence, variants were generated with improved activity against A. grandis. Among them, Cry8Ka5 mutant protein showed coleoptericidal activity 3-fold higher (LC50 2.83 mu g/mL) than that of the original protein (Cry8Ka1). Cry8Ka5 has been used in breeding programs in order to obtain coleopteran-resistant cotton plants. Nevertheless, there is some concern in relation to the food safety of transgenic crops, especially to the heterologously expressed proteins. In this context, our research group has performed risk assessment studies on Cry8Ka5, using the tests recommended by Codex as well as tests that we proposed as alternative and/or complementary approaches. Our results on the risk analysis of Cry8Ka5 taken together with those of other Cry proteins, point out that there is a high degree of certainty on their food safety. It is reasonable to emphasize that most safety studies on Cry proteins have essentially used the Codex approach. However, other methodologies would potentially provide additional information such as studies on the effects of Cry proteins and derived peptides on the indigenous gastrointestinal microbiota and on intestinal epithelial cells of humans. Additionally, emerging technologies such as toxicogenomics potentially will offer sensitive alternatives for some current approaches or methods.
C1 [Farias, Davi F.; Carvalho, Ana F. U.] Univ Fed Ceara, Grad Program Biochem, Fortaleza, Ceara, Brazil.
   [Peijnenburg, Ad A. C. M.] Wageningen Univ & Res Ctr, RIKILT Inst Food Safety, NL-6700 AP Wageningen, Netherlands.
   [Grossi-de-Sa, Maria F.] Natl Ctr Genet Resources Embrapa Cenargen, Parque Estacao Biol PqEB, Brasilia, DF, Brazil.
   [Grossi-de-Sa, Maria F.] Univ Catolica Brasilia, Grad Program Genom Sci & Biotechnol, Brasilia, DF, Brazil.
RP Farias, DF (corresponding author), Univ Fed Ceara, Grad Program Biochem, Campus Pici, Fortaleza, Ceara, Brazil.
EM daviffarias@yahoo.com.br; aurano@ufc.br
RI Grossi-de-Sa, Maria Fatima/N-7856-2017; Farias, Davi
   Felipe/AAH-1868-2020
OI GROSSI-DE-SA, MARIA FATIMA/0000-0001-8184-9599; Felipe Farias,
   Davi/0000-0001-5438-1919
CR Alcantara E, 2011, CROP PROT, V30, P554, DOI 10.1016/j.cropro.2010.12.019
   An JJ, 2010, J ECON ENTOMOL, V103, P2169, DOI 10.1603/EC10105
   Bagla P., 2010, SCIENCE, V327, P14
   Bravo A, 2007, TOXICON, V49, P423, DOI 10.1016/j.toxicon.2006.11.022
   Brevault T, 2009, J ECON ENTOMOL, V102, P2301, DOI 10.1603/029.102.0636
   Cao SS, 2010, REGUL TOXICOL PHARM, V58, P474, DOI 10.1016/j.yrtph.2010.08.018
   Carriere Y, 2010, EVOL APPL, V3, P561, DOI 10.1111/j.1752-4571.2010.00129.x
   Codex Alimentarius, 2009, FOODS DER MOD BIOT
   Delaney B, 2008, FOOD CHEM TOXICOL, V46, pS71, DOI 10.1016/j.fct.2008.01.045
   EPA, 2010, BIOP REG ACT DOC BAC
   Farias DF, 2015, FOOD CHEM TOXICOL, V81, P81, DOI 10.1016/j.fct.2015.04.008
   Farias DF, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/810490
   Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629
   Gatehouse AMR, 2011, PHILOS T R SOC B, V366, P1438, DOI 10.1098/rstb.2010.0330
   Goodman RE, 2005, INT ARCH ALLERGY IMM, V137, P153, DOI 10.1159/000086314
   Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701
   Grisolia CK, 2009, MUTAT RES-GEN TOX EN, V672, P119, DOI 10.1016/j.mrgentox.2008.10.017
   Grossi-De-Sa MF, 2007, J BIOCHEM MOL BIOL, V40, P773
   Koch MS, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00283
   Koch MS, 2012, REV FOOD SAFETY BT C, P305
   Kumar S, 2008, J ENVIRON BIOL, V29, P641
   Lira J, 2013, APPL ENVIRON MICROB, V79, P7590, DOI 10.1128/AEM.01979-13
   Lucena WA, 2014, TOXINS, V6, P2393, DOI 10.3390/toxins6082393
   Marquez AM, 2000, MICROBIOL RES, V154, P355, DOI 10.1016/S0944-5013(00)80010-5
   Martins ES, 2008, J APPL MICROBIOL, V104, P1363, DOI 10.1111/j.1365-2672.2007.03665.x
   Martins ES, 2007, BIOL CONTROL, V40, P65, DOI 10.1016/j.biocontrol.2006.09.009
   Martins WFS, 2007, GENET MOL RES, V6, P23
   Mendelsohn M, 2003, NAT BIOTECHNOL, V21, P1003, DOI 10.1038/nbt0903-1003
   Nakasu EYT, 2010, J INVERTEBR PATHOL, V104, P227, DOI 10.1016/j.jip.2010.01.012
   Oliveira GR., 2008, THESIS
   Oliveira GR, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-85
   Palma L, 2014, TOXINS, V6, P3144, DOI 10.3390/toxins6113144
   Sanahuja G, 2011, PLANT BIOTECHNOL J, V9, P283, DOI 10.1111/j.1467-7652.2011.00595.x
   Soberon M, 2007, TOXICON, V49, P597, DOI 10.1016/j.toxicon.2006.11.008
   Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040
   TABASHNIK BE, 1994, ANNU REV ENTOMOL, V39, P47, DOI 10.1146/annurev.en.39.010194.000403
   Tabashnik BE, 2012, J INVERTEBR PATHOL, V110, P301, DOI 10.1016/j.jip.2012.04.008
   Vachon V, 2012, J INVERTEBR PATHOL, V111, P1, DOI 10.1016/j.jip.2012.05.001
   Wan P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029975
   Xu WT, 2009, FOOD CHEM TOXICOL, V47, P1459, DOI 10.1016/j.fct.2009.03.029
   Yudina TG, 2007, ANAEROBE, V13, P6, DOI 10.1016/j.anaerobe.2006.09.006
   Zhang HN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022874
   Zhao C, 2015, APPL ENVIRON MICROB, V81, P3699, DOI 10.1128/AEM.00379-15
NR 43
TC 1
Z9 1
U1 0
U2 19
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 2165-5979
EI 2165-5987
J9 BIOENGINEERED
JI Bioengineered
PD NOV-DEC
PY 2015
VL 6
IS 6
BP 323
EP 327
DI 10.1080/21655979.2015.1109755
PG 5
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA CY4ZR
UT WOS:000366418000003
PM 26513483
OA Bronze, Green Published
DA 2020-12-08
ER

PT J
AU Pinto, CEM
   Farias, DF
   Carvalho, AFU
   Oliveira, JTA
   Pereira, ML
   Grangeiro, TB
   Freire, JEC
   Viana, DA
   Vasconcelos, IM
AF Pinto, Clidia E. M.
   Farias, Davi F.
   Carvalho, Ana F. U.
   Oliveira, Jose T. A.
   Pereira, Mirella L.
   Grangeiro, Thalles B.
   Freire, Jose E. C.
   Viana, Daniel A.
   Vasconcelos, Ilka M.
TI Food safety assessment of an antifungal protein from Moringa oleifera
   seeds in an agricultural biotechnology perspective
SO FOOD AND CHEMICAL TOXICOLOGY
LA English
DT Article
DE Mo-CBP3; Chitin-binding protein; Risk assessment; Allergen; Weight of
   evidence; Transgenic crops
ID GENETICALLY-MODIFIED CROPS; ALLERGENICITY ASSESSMENT; PLANT;
   GLYCOSYLATION; PATHOGENS; EXTRACT; PROFILE; GROWTH
AB Mo-CBP3 is an antifungal protein produced by Moringa oleifera which has been investigated as potential candidate for developing transgenic crops. Before the use of novel proteins, food safety tests must be conducted. This work represents an early food safety assessment of Mo-CBP3, using the two-tiered approach proposed by ILSI. The history of safe use, mode of action and results for amino acid sequence homology using the full-length and short contiguous amino acids sequences indicate low risk associated to this protein. Mo-CBP3 isoforms presented a reasonable number of alignments (>35% identity) with allergens in a window of 80 amino acids. This protein was resistant to pepsin degradation up to 2 h, but it was susceptible to digestion using pancreatin. Many positive attributes were presented for Mo-CBP3. However, this protein showed high sequence homology with allergens and resistance to pepsin digestion that indicates that further hypothesis-based testing on its potential allergenicity must be done. Additionally, animal toxicity evaluations (e.g. acute and repeated dose oral exposure assays) must be performed to meet the mandatory requirements of several regulatory agencies. Finally, the approach adopted here exemplified the importance of performing an early risk assessment of candidate proteins for use in plant transformation programs. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Pinto, Clidia E. M.; Farias, Davi F.; Oliveira, Jose T. A.; Pereira, Mirella L.; Freire, Jose E. C.; Vasconcelos, Ilka M.] Univ Fed Ceara, Dept Biochem & Mol Biol, BR-60440900 Fortaleza, Ceara, Brazil.
   [Carvalho, Ana F. U.; Grangeiro, Thalles B.] Univ Fed Ceara, Dept Biol, BR-60440900 Fortaleza, Ceara, Brazil.
   [Viana, Daniel A.] Univ Estadual Ceara, BR-60740903 Fortaleza, Ceara, Brazil.
RP Farias, DF (corresponding author), Univ Fed Ceara, Dept Biochem & Mol Biol, Campus Pici, BR-60440900 Fortaleza, Ceara, Brazil.
EM daviffarias@yahoo.com.br; imvasco@ufc.br
RI Grangeiro, Thalles Barbosa/E-9606-2010; da Cruz Freire, Jose
   Ednesio/D-8645-2016; Farias, Davi Felipe/AAH-1868-2020
OI Grangeiro, Thalles Barbosa/0000-0001-8276-3092; da Cruz Freire, Jose
   Ednesio/0000-0002-0660-0459; Felipe Farias, Davi/0000-0001-5438-1919
FU Brazilian National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [479358/2012-5]; Coordination for the Improvement of Higher
   Education Personnel (CAPES, Brazilian Ministry of Education)CAPES
   [A006_2013, 1213/2011]
FX This work was supported by the Brazilian National Council for Scientific
   and Technological Development (CNPq) (grant number 479358/2012-5) and
   Coordination for the Improvement of Higher Education Personnel (CAPES,
   Brazilian Ministry of Education) (grant numbers A006_2013 and 1213/2011)
   for financial support of this research.
CR Aalberse RC, 2000, J ALLERGY CLIN IMMUN, V106, P228, DOI 10.1067/mai.2000.108434
   Altmann F, 2007, INT ARCH ALLERGY IMM, V142, P99, DOI 10.1159/000096114
   Anwar F, 2007, PHYTOTHER RES, V21, P17, DOI 10.1002/ptr.2023
   Asare GA, 2012, J ETHNOPHARMACOL, V139, P265, DOI 10.1016/j.jep.2011.11.009
   Astwood JD, 1996, MONOGR ALLERGY, V32, P105
   Batista AB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111427
   Ben Salem H, 2009, ANIM FEED SCI TECH, V150, P27, DOI 10.1016/j.anifeedsci.2008.07.007
   Ben-Josef AM, 2000, INT J ANTIMICROB AG, V13, P287, DOI 10.1016/S0924-8579(99)00140-5
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Codex Alimentarius, 2009, FOODS DER MOD BIOT
   Constable A, 2007, FOOD CHEM TOXICOL, V45, P2513, DOI 10.1016/j.fct.2007.05.028
   Araujo LCC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081973
   Cressman RF, 2009, REGUL TOXICOL PHARM, V54, pS20, DOI 10.1016/j.yrtph.2008.11.006
   Delaney B, 2008, FOOD CHEM TOXICOL, V46, pS71, DOI 10.1016/j.fct.2008.01.045
   Fahey J. W., 2005, TREES LIFE J, V1, P1, DOI DOI 10.12691/JBET-2-1-2
   FAIZI S, 1994, J NAT PROD, V57, P1256, DOI 10.1021/np50111a011
   Faizi S, 1998, PLANTA MED, V64, P225, DOI 10.1055/s-2006-957414
   FAO/WHO (Food and Agriculture Organization of the United Nations/World Health Organization), 2001, EV ALL GEN MOD FOODS
   Fotisch K, 2001, GLYCOCONJUGATE J, V18, P373, DOI 10.1023/A:1014860030380
   Freire JEC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119871
   Gifoni JM, 2012, BIOPOLYMERS, V98, P406, DOI 10.1002/bip.22068
   Gong CY, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00041
   Goodman RE, 2005, INT ARCH ALLERGY IMM, V137, P153, DOI 10.1159/000086314
   Goodman RE, 2008, NAT BIOTECHNOL, V26, P73, DOI 10.1038/nbt1343
   Goyal B. R., 2007, NAT PROD RAD, V6, P347
   Hammond B, 2013, CRIT REV TOXICOL, V43, P25, DOI 10.3109/10408444.2013.842956
   Herouet-Guicheney C, 2009, REGUL TOXICOL PHARM, V54, P143, DOI 10.1016/j.yrtph.2009.03.005
   Hileman RE, 2002, INT ARCH ALLERGY IMM, V128, P280, DOI 10.1159/000063861
   Huby RDJ, 2000, TOXICOL SCI, V55, P235, DOI 10.1093/toxsci/55.2.235
   Igwilo I O, 2014, Pak J Biol Sci, V17, P114, DOI 10.3923/pjbs.2014.114.117
   Igwilo I O, 2013, Pak J Biol Sci, V16, P48, DOI 10.3923/pjbs.2013.48.50
   *ILSI HESI, 2001, ALL ASS FOODS DER GE
   Jenkins N, 1996, NAT BIOTECHNOL, V14, P975, DOI 10.1038/nbt0896-975
   Katayon S, 2006, BIORESOURCE TECHNOL, V97, P1455, DOI 10.1016/j.biortech.2005.07.031
   Konig A, 2004, FOOD CHEM TOXICOL, V42, P1047, DOI 10.1016/j.fct.2004.02.019
   Kumar P. S., 2010, INT J PHYTOMED, V2, P210, DOI DOI 10.5138/ijpm.2010.0975.0185.02031
   Labandeira CC, 2014, INT J PALEOPATHOL, V4, P1, DOI 10.1016/j.ijpp.2013.10.002
   Lacerda AF, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00116
   Ladics GS, 2008, FOOD CHEM TOXICOL, V46, pS20, DOI 10.1016/j.fct.2008.07.021
   Ladics GS, 2011, REGUL TOXICOL PHARM, V60, P46, DOI 10.1016/j.yrtph.2011.02.004
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Madduri KM, 2012, FOOD CHEM TOXICOL, V50, P3776, DOI 10.1016/j.fct.2012.07.013
   Mandal SM, 2013, BIOCHIMIE, V95, P1939, DOI 10.1016/j.biochi.2013.06.027
   Mangale S.M., 2012, RES J RECENT SCI, V1, P31
   Marei GIK, 2012, PESTIC BIOCHEM PHYS, V103, P56, DOI 10.1016/j.pestbp.2012.03.004
   Mbikay M, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00024
   Mehta LK, 2003, J ETHNOPHARMACOL, V86, P191, DOI 10.1016/S0378-8741(03)00075-8
   Mello EO, 2011, CURR MICROBIOL, V62, P1209, DOI 10.1007/s00284-010-9847-3
   Meng XH, 2010, CARBOHYD POLYM, V81, P70, DOI 10.1016/j.carbpol.2010.01.057
   MONK BC, 1994, CRIT REV MICROBIOL, V20, P209, DOI 10.3109/10408419409114555
   Morais JKS, 2010, J AGR FOOD CHEM, V58, P10356, DOI 10.1021/jf101688k
   *OECD, 1996, FOOD SAF EV
   Omabe M, 2014, J TOXICOL-US, V2014, DOI 10.1155/2014/406242
   Oyagbemi A.A., 2013, J BASIC CLIN PHYSL P, V18, P1
   Parrott W, 2010, FOOD CHEM TOXICOL, V48, P1773, DOI 10.1016/j.fct.2010.04.017
   PRAKASH A O, 1987, Acta Europaea Fertilitatis, V18, P129
   Qaim M, 2010, NEW BIOTECHNOL, V27, P552, DOI 10.1016/j.nbt.2010.07.009
   RAMACHANDRAN C, 1980, ECON BOT, V34, P276, DOI 10.1007/BF02858648
   Randhawa GJ, 2011, FOOD CHEM TOXICOL, V49, P356, DOI 10.1016/j.fct.2010.11.008
   Rice E.A., 2007, FOOD SAFETY PROTEINS, P237
   Roesler KR, 2001, J AGR FOOD CHEM, V49, P3443, DOI 10.1021/jf010209b
   Rolim LADMM, 2011, J FOOD SCI, V76, pT53, DOI 10.1111/j.1750-3841.2010.01990.x
   Vieira AMS, 2010, WATER AIR SOIL POLL, V206, P273, DOI 10.1007/s11270-009-0104-y
   Sethi N, 1988, Anc Sci Life, V7, P172
   SHUKLA S, 1988, J ETHNOPHARMACOL, V22, P51, DOI 10.1016/0378-8741(88)90230-9
   Stohs SJ, 2015, PHYTOTHER RES, V29, P796, DOI 10.1002/ptr.5325
   Thomas K, 2009, FOOD CHEM TOXICOL, V47, P1041, DOI 10.1016/j.fct.2009.02.001
   Thurber MD, 2009, ECOL FOOD NUTR, V48, P212, DOI 10.1080/03670240902794598
   VILLASENOR IM, 1989, MUTAT RES, V224, P209, DOI 10.1016/0165-1218(89)90157-2
   Wang B, 2014, BIOTECHNOL ADV, V32, P583, DOI 10.1016/j.biotechadv.2014.03.003
   Yadav S, 2013, RES J ENV SCI, V2, P91
   Zhang ZB, 2010, PLANT OMICS, V3, P183
NR 72
TC 9
Z9 9
U1 0
U2 51
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0278-6915
EI 1873-6351
J9 FOOD CHEM TOXICOL
JI Food Chem. Toxicol.
PD SEP
PY 2015
VL 83
BP 1
EP 9
DI 10.1016/j.fct.2015.05.012
PG 9
WC Food Science & Technology; Toxicology
SC Food Science & Technology; Toxicology
GA CR1IQ
UT WOS:000361078800001
PM 26032632
OA Bronze
DA 2020-12-08
ER

PT J
AU Silva, RGG
   Vasconcelos, IM
   Filho, AJUB
   Carvalho, AFU
   Souza, TM
   Gondim, DMF
   Varela, ALN
   Oliveira, JTA
AF Silva, Rodolpho G. G.
   Vasconcelos, Ilka M.
   Filho, Acrisio J. U. B.
   Carvalho, Ana F. U.
   Souza, Terezinha M.
   Gondim, Darcy M. F.
   Varela, Anna L. N.
   Oliveira, Jose T. A.
TI Castor bean cake contains a trypsin inhibitor that displays antifungal
   activity against Colletotrichum gloeosporioides and inhibits the midgut
   proteases of the dengue mosquito larvae
SO INDUSTRIAL CROPS AND PRODUCTS
LA English
DT Article
DE Ricinus communis; Trypsin inhibitor; Aedes aegypti; Colletotrichum
   gloeosporioides
ID PROTEINASE-INHIBITOR; PURIFICATION; SEEDS; CYSTEINE; EXTRACTION;
   RESOLUTION
AB A novel trypsin inhibitor, named RcTI, was purified from castor bean cake (Ricinus communis L.) by heat treatment followed by chromatography on anhydrotrypsin-Sepharose 4B and Resource Q, RcTI is a 14 kDa competitive inhibitor with pI 5.2 and a dissociation constant (Xi) of 1.9 x 10(-5) mM. The amino-terminal sequence showed similarity with a 2S sulfur-rich seed storage protein (83%) and napin-like protein (48%). RcTI was stable over a broad pH range and is exceptionally resistant to heating as it retained high inhibitory activity toward trypsin after incubation at 100 degrees C for 2 h. RcTI (13 mu g) inhibited the spore germination of the phytopatogenic fungus Colletotri chum gloeosporioides and promoted 91% inhibition of the proteases from the midgut of Aedes aegypti larvae. The results of the present study indicate that RcTI has biotechnological potential as an alternative agent to combat the important phytopathogen C. gloeosporioides and the larvae of A. aegypti. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Silva, Rodolpho G. G.; Vasconcelos, Ilka M.; Filho, Acrisio J. U. B.; Gondim, Darcy M. F.; Varela, Anna L. N.; Oliveira, Jose T. A.] Univ Fed Ceara, Biochem & Mol Biol Dept, Fortaleza, CE, Brazil.
   [Carvalho, Ana F. U.; Souza, Terezinha M.] Univ Fed Ceara, Dept Biol, Fortaleza, CE, Brazil.
RP Oliveira, JTA (corresponding author), Univ Fed Ceara, Biochem & Mol Biol Dept, Lab Plant Def Prot, Av Mister Hull,POB 60451, Fortaleza, CE, Brazil.
EM jtaolive@ufc.br
RI Carvalho, Ana/K-7344-2018; de Souza, Terezinha/L-8727-2015
OI Carvalho, Ana/0000-0001-5293-9317; de Souza,
   Terezinha/0000-0002-9580-3310
FU CAPESCAPES; CNPqNational Council for Scientific and Technological
   Development (CNPq); FUNCAP
FX Silva, R.G.G. acknowledges a Master grant from CAPES. The authors
   acknowledge the financial support by CNPq, CAPES, and FUNCAP. The
   authors declare no conflict of interest.
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Bhattacharyya A, 2006, PHYTOCHEMISTRY, V67, P232, DOI 10.1016/j.phytochem.2005.11.010
   Bhattacharyya A, 2009, PHYTOCHEMISTRY, V70, P703, DOI 10.1016/j.phytochem.2009.04.001
   Bijina B, 2011, PROCESS BIOCHEM, V46, P2291, DOI 10.1016/j.procbio.2011.09.008
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844
   Carrillo L, 2011, PLANT PHYSIOL BIOCH, V49, P1191, DOI 10.1016/j.plaphy.2011.03.012
   Chaudhary NS, 2008, PHYTOCHEMISTRY, V69, P2120, DOI 10.1016/j.phytochem.2008.05.002
   Chen ZY, 1998, PHYTOPATHOLOGY, V88, P276, DOI 10.1094/PHYTO.1998.88.4.276
   Chen ZY, 1999, APPL ENVIRON MICROB, V65, P1320
   Cruz ACB, 2013, PLANT PHYSIOL BIOCH, V70, P61, DOI 10.1016/j.plaphy.2013.04.023
   DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170
   Dubois JL, 2013, IND CROP PROD, V43, P194, DOI 10.1016/j.indcrop.2012.07.012
   Ee KY, 2011, FOOD CHEM, V129, P1224, DOI 10.1016/j.foodchem.2011.05.026
   ERLANGER BF, 1961, ARCH BIOCHEM BIOPHYS, V95, P271, DOI 10.1016/0003-9861(61)90145-X
   Fan SG, 2005, BOT BULL ACAD SINICA, V46, P273
   Fang EF, 2010, J BIOSCI BIOENG, V109, P211, DOI 10.1016/j.jbiosc.2009.08.483
   Franco OL, 2000, RUSS J PLANT PHYSL+, V47, P137
   Garcia VA, 2004, PROTEIN J, V23, P343, DOI 10.1023/B:JOPC.0000032654.67733.d5
   Garcia-Olmedo F., 1987, OXFORD SURVEYS PLANT, V4, P275
   Giudici AM, 2000, PLANT PHYSIOL BIOCH, V38, P881, DOI 10.1016/S0981-9428(00)01191-8
   Ishihara M, 2006, J BIOSCI BIOENG, V101, P166, DOI 10.1263/jbb.101.166
   KAPITANY RA, 1973, ANAL BIOCHEM, V56, P361, DOI 10.1016/0003-2697(73)90202-9
   Katunuma N, 2003, BIOL CHEM, V384, P883, DOI 10.1515/BC.2003.099
   Klomklao S, 2011, FOOD CHEM, V129, P1348, DOI 10.1016/j.foodchem.2011.05.029
   Klomklao S, 2010, INT J FOOD SCI TECH, V45, P163, DOI 10.1111/j.1365-2621.2009.02117.x
   KUNZ PA, 1978, INSECT BIOCHEM, V8, P43, DOI 10.1016/0020-1790(78)90009-4
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113
   Macedo MLR, 2003, BBA-GEN SUBJECTS, V1621, P170, DOI 10.1016/S0304-4165(03)00055-2
   Macedo MLR, 2000, PHYTOCHEMISTRY, V54, P553, DOI 10.1016/S0031-9422(00)00155-2
   Maleki SJ, 2003, J ALLERGY CLIN IMMUN, V112, P190, DOI 10.1067/mai.2003.1551
   Mandal S, 2002, J BIOL CHEM, V277, P37161, DOI 10.1074/jbc.M205280200
   Oliveira AS, 2007, J AGR FOOD CHEM, V55, P7342, DOI 10.1021/jf071107+
   Paiva PMG, 2003, BIORESOURCE TECHNOL, V88, P75, DOI 10.1016/S0960-8524(02)00272-9
   PAUL GC, 1993, BIOTECHNOL BIOENG, V42, P11, DOI 10.1002/bit.260420103
   de Oliveira CFR, 2012, PROCESS BIOCHEM, V47, P929, DOI 10.1016/j.procbio.2012.02.022
   Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971
   Richardson M., 1991, METHODS PLANT BIOCH, V5, P259
   Ryan CA, 2000, BBA-PROTEIN STRUCT M, V1477, P112, DOI 10.1016/S0167-4838(99)00269-1
   Shee C, 2007, INT J BIOL MACROMOL, V41, P410, DOI 10.1016/j.ijbiomac.2007.05.011
   Shee C, 2007, J ENZYM INHIB MED CH, V22, P115, DOI 10.1080/14756360601027332
   Shee C, 2007, ACTA CRYSTALLOGR F, V63, P318, DOI 10.1107/S1744309107011414
   Solomon M, 1999, PLANT CELL, V11, P431, DOI 10.1105/tpc.11.3.431
   Sritanyarat W, 2006, PHYTOCHEMISTRY, V67, P1644, DOI 10.1016/j.phytochem.2005.12.016
   Vasconcelos IM, 1997, J SCI FOOD AGR, V75, P419, DOI [10.1002/(SICI)1097-0010(199712)75:4&lt;419::AID-JSFA886&gt;3.0.CO;2-D, 10.1002/(SICI)1097-0010(199712)75:4<419::AID-JSFA886>3.3.CO;2-4]
   Xavier-filho J., 1989, TOXICANTS PLANT ORIG, P1
   Yoshizaki L, 2007, PHYTOCHEMISTRY, V68, P2625, DOI 10.1016/j.phytochem.2007.06.003
NR 48
TC 14
Z9 14
U1 1
U2 16
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0926-6690
EI 1872-633X
J9 IND CROP PROD
JI Ind. Crop. Prod.
PD AUG
PY 2015
VL 70
BP 48
EP 55
DI 10.1016/j.indcrop.2015.02.058
PG 8
WC Agricultural Engineering; Agronomy
SC Agriculture
GA CJ7VS
UT WOS:000355709100007
DA 2020-12-08
ER

PT J
AU Sousa, DOB
   Carvalho, AFU
   Oliveira, JTA
   Farias, DF
   Castelar, I
   Oliveira, HP
   Vasconcelos, IM
AF Sousa, Daniele O. B.
   Carvalho, Ana F. U.
   Oliveira, Jose Tadeu A.
   Farias, Davi F.
   Castelar, Ivan
   Oliveira, Henrique P.
   Vasconcelos, Ilka M.
TI Increased Levels of Antinutritional and/or Defense Proteins Reduced the
   Protein Quality of a Disease-Resistant Soybean Cultivar
SO NUTRIENTS
LA English
DT Article
DE Serido-RCH; unintended traits; conventional breeding; nutritional value;
   plant protein
ID KUNITZ TRYPSIN-INHIBITOR; ANTIFUNGAL ACTIVITY; PLANT-LECTINS; IN-VITRO;
   RADIATION; LACKING; FOOD
AB The biochemical and nutritional attributes of two soybean (Glycine max (L.) Merr.) cultivars, one susceptible (Serido) and the other resistant (Serido-RCH) to stem canker, were examined to assess whether the resistance to pathogens was related to levels of antinutritional and/or defense proteins in the plant and subsequently affected the nutritional quality. Lectin, urease, trypsin inhibitor, peroxidase and chitinase activities were higher in the resistant cultivar. Growing rats were fed with isocaloric and isoproteic diets prepared with defatted raw soybean meals. Those on the Serido-RCH diet showed the worst performance in terms of protein quality indicators. Based on regression analysis, lectin, trypsin inhibitor, peroxidase and chitinase appear to be involved in the resistance trait but also in the poorer nutritional quality of Serido-RCH. Thus, the development of cultivars for disease resistance may lead to higher concentrations of antinutritional compounds, affecting the quality of soybean seeds. Further research that includes the assessment of more cultivars/genotypes is needed.
C1 [Sousa, Daniele O. B.; Oliveira, Jose Tadeu A.; Farias, Davi F.; Oliveira, Henrique P.; Vasconcelos, Ilka M.] Univ Fed Ceara, Dept Biochem & Mol Biol, BR-60444090 Fortaleza, Ceara, Brazil.
   [Carvalho, Ana F. U.] Univ Fed Ceara, Dept Biol, BR-60440900 Fortaleza, Ceara, Brazil.
   [Castelar, Ivan] Univ Fed Ceara, Dept Finance, BR-60020180 Fortaleza, Ceara, Brazil.
RP Carvalho, AFU (corresponding author), Univ Fed Ceara, Dept Biol, Campus Pici, BR-60440900 Fortaleza, Ceara, Brazil.
EM danisilas@yahoo.com.br; aurano@ufc.br; jtaolive@ufc.br;
   daviffarias@yahoo.com.br; lume1250@yahoo.com.br; henriquebio@gmail.com;
   imvasco@ufc.br
RI Farias, Davi Felipe/AAH-1868-2020
OI Felipe Farias, Davi/0000-0001-5438-1919
FU Brazilian Federal Agency for the Support and Evaluation of Graduate
   Education (CAPES, Brasilia, Brazil); Brazilian National Council for
   Scientific and Technological Development (CNPq, Brasilia,
   Brazil)National Council for Scientific and Technological Development
   (CNPq); Ceara State Research Foundation (FUNCAP, Fortaleza, Brazil)
FX This work was supported by the Brazilian Federal Agency for the Support
   and Evaluation of Graduate Education (CAPES, Brasilia, Brazil), the
   Brazilian National Council for Scientific and Technological Development
   (CNPq, Brasilia, Brazil) and Ceara State Research Foundation (FUNCAP,
   Fortaleza, Brazil).
CR Afify AMR, 2011, NOT BOT HORTI AGROBO, V39, P90
   BAETHGEN WE, 1989, COMMUN SOIL SCI PLAN, V20, P961, DOI 10.1080/00103628909368129
   Becker-Ritt AB, 2007, TOXICON, V50, P971, DOI 10.1016/j.toxicon.2007.07.008
   Boller T, 1993, MOL PLANT PATHOL, P23
   Campelo G.J.A., CARACTERISTICAS AGRO
   Carrillo L, 2011, PLANT PHYSIOL BIOCH, V49, P1191, DOI 10.1016/j.plaphy.2011.03.012
   Charungchitrak S, 2011, FOOD CHEM, V126, P1025, DOI 10.1016/j.foodchem.2010.11.114
   Cipollini D, 2011, J CHEM ECOL, V37, P450, DOI 10.1007/s10886-011-9954-z
   Coates M.E., 1969, LABORATORY ANIMAL HD, P13
   Collinge DB, 2010, ANNU REV PHYTOPATHOL, V48, P269, DOI 10.1146/annurev-phyto-073009-114430
   De Hoff PL, 2009, MOL GENET GENOMICS, V282, P1, DOI 10.1007/s00438-009-0460-8
   El-Niely HFG, 2007, RADIAT PHYS CHEM, V76, P1050, DOI 10.1016/j.radphyschem.2006.10.006
   FRIEDMAN M, 1991, J AGR FOOD CHEM, V39, P327, DOI 10.1021/jf00002a022
   Gilani GS, 2005, J AOAC INT, V88, P967
   GRANT G, 1989, PROG FOOD NUTR SCI, V13, P317
   Haq SK, 2004, ARCH BIOCHEM BIOPHYS, V431, P145, DOI 10.1016/j.abb.2004.07.022
   Huma Habib, 2007, Biotechnology and Molecular Biology Reviews, V2, P068
   Iqbal A, 2006, FOOD CHEM, V97, P331, DOI 10.1016/j.foodchem.2005.05.011
   KAKADE ML, 1969, CEREAL CHEM, V46, P518
   KAPLAN A, 1969, Methods of Biochemical Analysis, V17:, P311, DOI 10.1002/9780470110355.ch7
   Kim JY, 2009, INT J MOL SCI, V10, P2860, DOI 10.3390/ijms10062860
   Kumar S, 2013, NUTRITION, V29, P821, DOI 10.1016/j.nut.2012.11.010
   KUMTA US, 1961, NATURE, V191, P1304, DOI 10.1038/1911304a0
   LIENER IE, 1994, CRIT REV FOOD SCI, V34, P31, DOI 10.1080/10408399409527649
   Maity JP, 2009, FOOD CHEM, V114, P1237, DOI 10.1016/j.foodchem.2008.11.001
   Milhome MAL, 2014, FOOD CONTROL, V42, P34, DOI 10.1016/j.foodcont.2014.01.033
   MILLER DS, 1955, BRIT J NUTR, V9, P382, DOI 10.1079/BJN19550055
   MORRISON DF, 1978, MULTIVARIATE STAT ME
   MUNDLAK Y, 1981, J ECONOMETRICS, V16, P139, DOI 10.1016/0304-4076(81)90081-6
   Muzquiz M, 2012, PHYTOCHEM REV, V11, P227, DOI 10.1007/s11101-012-9233-9
   Paparini Andrea, 2004, Biotechnol Annu Rev, V10, P85, DOI 10.1016/S1387-2656(04)10004-5
   PINTERSZAKACS M, 1990, J AGR FOOD CHEM, V38, P720, DOI 10.1021/jf00093a028
   Raboy V., 2013, SABRAO Journal of Breeding and Genetics, V45, P100
   Rao V. R., 2002, PLANT CELL TISSUE OR, V68, P1, DOI DOI 10.1023/A:1013359015812
   Real-Guerra R, 2013, COMPREHENSIVE SURVEY OF INTERNATIONAL SOYBEAN RESEARCH - GENETICS, PHYSIOLOGY, AGRONOMY AND NITROGEN RELATIONSHIPS, P317, DOI 10.5772/52106
   Rischer H, 2006, TRENDS BIOTECHNOL, V24, P102, DOI 10.1016/j.tibtech.2006.01.009
   Schultze M, 1998, PLANT J, V16, P571, DOI 10.1046/j.1365-313x.1998.00326.x
   Brune MFSS, 2010, CIENCIA TECNOL ALIME, V30, P657, DOI 10.1590/S0101-20612010000300014
   Stam JM, 2014, ANNU REV PLANT BIOL, V65, P689, DOI 10.1146/annurev-arplant-050213-035937
   Tome D, 2012, BRIT J NUTR, V108, pS222, DOI 10.1017/S0007114512002565
   Triebold H.O., 1946, QUANTITATIVE ANAL AP
   URBANEK H, 1991, ACTA PHYSIOL PLANT, V13, P43
   Vandenborre G, 2011, PHYTOCHEMISTRY, V72, P1538, DOI 10.1016/j.phytochem.2011.02.024
   Vasconcelos IM, 1997, J SCI FOOD AGR, V75, P419, DOI [10.1002/(SICI)1097-0010(199712)75:4&lt;419::AID-JSFA886&gt;3.0.CO;2-D, 10.1002/(SICI)1097-0010(199712)75:4<419::AID-JSFA886>3.3.CO;2-4]
   Vasconcelos IM, 2001, J NUTR BIOCHEM, V12, P55, DOI 10.1016/S0955-2863(00)00148-0
   Vega K., 2012, INT J MICROBIOL
   Wang SY, 2012, FOOD RES INT, V45, P116, DOI 10.1016/j.foodres.2011.10.010
   Wang S, 2011, J FOOD BIOCHEM, V35, P1206, DOI 10.1111/j.1745-4514.2010.00445.x
   WHO, 2007, WHO TECH REP SER, V935, P1
   Wiebke-Strohm B, 2012, PLANT MOL BIOL, V79, P75, DOI 10.1007/s11103-012-9894-1
NR 50
TC 3
Z9 3
U1 0
U2 15
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD JUL
PY 2015
VL 7
IS 7
BP 6038
EP 6054
DI 10.3390/nu7075269
PG 17
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA CO7OQ
UT WOS:000359349800059
PM 26205163
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Farias, DF
   Viana, MP
   Oliveira, GR
   Santos, VO
   Pinto, CEM
   Viana, DA
   Vasconcelos, IM
   Grossi-de-Sa, MF
   Carvalho, AFU
AF Farias, Davi Felipe
   Viana, Martonio Ponte
   Oliveira, Gustavo Ramos
   Santos, Vanessa Olinto
   Moreira Pinto, Clidia Eduarda
   Viana, Daniel Araujo
   Vasconcelos, Ilka Maria
   Grossi-de-Sa, Maria Fatima
   Urano Carvalho, Ana Fontenele
TI Food safety assessment of Cry8Ka5 mutant protein using Cry1Ac as a
   control Bt protein
SO FOOD AND CHEMICAL TOXICOLOGY
LA English
DT Article
DE delta-endotoxin; Bacillus thuringiensis; GMO; Risk assessment;
   Two-tiered approach
ID BACILLUS-THURINGIENSIS; ALLERGENICITY ASSESSMENT; POTENTIAL
   ALLERGENICITY; PLANTS; CROPS
AB Cry8Ka5 is a mutant protein from Bacillus thuringiensis (Bt) that has been proposed for developing transgenic plants due to promising activity against coleopterans, like Anthonomus grandis (the major pest of Brazilian cotton culture). Thus, an early food safety assessment of Cry8Ka5 protein could provide valuable information to support its use as a harmless biotechnological tool. This study aimed to evaluate the food safety of Cry8Ka5 protein following the two-tiered approach, based on weights of evidence, proposed by ILSI. Cry1Ac protein was used as a control Bt protein. The history of safe use revealed no convincing hazard reports for Bt pesticides and three-domain Cry proteins. The bioinformatics analysis with the primary amino acids sequence of Cry8Ka5 showed no similarity to any known toxic, antinutritional or allergenic proteins. The mode of action of Cry proteins is well understood and their fine specificity is restricted to insects. Cry8Ka5 and Cry1Ac proteins were rapidly degraded in simulated gastric fluid, but were resistant to simulated intestinal fluid and heat treatment. The LD50 for Cry8Ka5 and Cry1Ac was >5000 mg/kg body weight when administered by gavage in mice. Thus, no expected relevant risks are associated with the consumption of Cry8Ka5 protein. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Farias, Davi Felipe; Viana, Martonio Ponte; Moreira Pinto, Clidia Eduarda; Vasconcelos, Ilka Maria; Urano Carvalho, Ana Fontenele] Univ Fed Ceara, Grad Program Biochem, BR-60440900 Fortaleza, Ceara, Brazil.
   [Oliveira, Gustavo Ramos] Univ Fed Parana, Grad Program Bioproc Engn & Biotechnol, BR-8153198 Curitiba, Parana, Brazil.
   [Oliveira, Gustavo Ramos; Santos, Vanessa Olinto; Grossi-de-Sa, Maria Fatima] Natl Ctr Genet Resources Embrapa Cenargen, Parque Estacao Biol, BR-70770917 Brasilia, DF, Brazil.
   [Viana, Daniel Araujo] Univ Estadual Ceara, Grad Program Biotechnol, BR-60740903 Fortaleza, Ceara, Brazil.
   [Grossi-de-Sa, Maria Fatima] Univ Catolica Brasilia, Grad Program Gemon Sci & Biotechnol, BR-70790160 Brasilia, DF, Brazil.
RP Carvalho, AFU (corresponding author), Univ Fed Ceara, Grad Program Biochem, BR-60440900 Fortaleza, Ceara, Brazil.
EM aurano@ufc.br
RI Farias, Davi Felipe/AAH-1868-2020; Grossi-de-Sa, Maria
   Fatima/N-7856-2017; Viana, Martonio/AAZ-4218-2020; Carvalho,
   Ana/K-7344-2018
OI GROSSI-DE-SA, MARIA FATIMA/0000-0001-8184-9599; Felipe Farias,
   Davi/0000-0001-5438-1919; Vasconcelos, Ilka/0000-0002-7207-8734;
   Carvalho, Ana/0000-0001-5293-9317
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [43/2009]; Bicudo and Coordenacao de Aperfeicoamento de Pessoal
   do Ensino Superior (CAPES) [71/2013]
FX The authors thank Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq) (Edital MCT/CNPq/CT-AGRO no 43/2009 - Bicudo and
   Coordenacao de Aperfeicoamento de Pessoal do Ensino Superior (CAPES)
   (Edital no71/2013 Programa Ciencias Sem Fronteiras - Pesquisador
   Visitante Especial - Linha 1) for financial support to this research.
CR Aalberse RC, 2000, J ALLERGY CLIN IMMUN, V106, P228, DOI 10.1067/mai.2000.108434
   Betz FS, 2000, REGUL TOXICOL PHARM, V32, P156, DOI 10.1006/rtph.2000.1426
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Bravo A, 1998, APPL ENVIRON MICROB, V64, P4965
   Brazilian National Biosafety Technical Commission (CTNBio), 2012, COMM APPR CROPS COTT
   Cao SS, 2010, REGUL TOXICOL PHARM, V58, P474, DOI 10.1016/j.yrtph.2010.08.018
   Codex Alimentarius Commission, 2009, FOODS DER MOD BIOT, P1
   Constable A, 2007, FOOD CHEM TOXICOL, V45, P2513, DOI 10.1016/j.fct.2007.05.028
   Delaney B, 2008, FOOD CHEM TOXICOL, V46, pS71, DOI 10.1016/j.fct.2008.01.045
   DUNCAN JR, 1982, PATOLOGIA CLIN VET
   Edman P., 1964, THROMB DIATH HAEMO, P17
   Farias D.F., 2014, BIOMED RES INT, V2014, P1
   Federici B, 2008, FOOD SAFETY PROTEINS, P45
   Foster ES, 2013, TOXICOLOGY, V309, P30, DOI 10.1016/j.tox.2013.04.011
   Goodman RE, 2008, NAT BIOTECHNOL, V26, P73, DOI 10.1038/nbt1343
   Goodman RE, 2011, CURR ALLERGY ASTHM R, V11, P317, DOI 10.1007/s11882-011-0195-6
   Grossi-De-Sa MF, 2007, J BIOCHEM MOL BIOL, V40, P773
   Hammond BG, 2012, BACILLUS THURINGIENS, P305
   Hedrich HJ, 2012, LABORATORY MOUSE, P1
   Herouet C, 2005, REGUL TOXICOL PHARM, V41, P134, DOI 10.1016/j.yrtph.2004.11.002
   Juberg DR, 2009, REGUL TOXICOL PHARM, V54, P154, DOI 10.1016/j.yrtph.2009.03.008
   Kumar S, 2008, J ENVIRON BIOL, V29, P641
   Ladics GS, 2011, REGUL TOXICOL PHARM, V60, P46, DOI 10.1016/j.yrtph.2011.02.004
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Liu PF, 2012, FOOD CHEM TOXICOL, V50, P3215, DOI 10.1016/j.fct.2012.06.009
   Mishra A, 2012, FOOD CHEM TOXICOL, V50, P1334, DOI 10.1016/j.fct.2012.02.005
   Moran DL, 2014, REGUL TOXICOL PHARM, V69, P243, DOI 10.1016/j.yrtph.2014.04.004
   Nakasu EYT, 2010, J INVERTEBR PATHOL, V104, P227, DOI 10.1016/j.jip.2010.01.012
   OECD, 2001, OECD GUID TEST CHEM
   Oliveira GR, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-85
   Privalle L, 2011, REGUL TOXICOL PHARM, V61, P292, DOI 10.1016/j.yrtph.2011.08.009
   Randhawa GJ, 2011, FOOD CHEM TOXICOL, V49, P356, DOI 10.1016/j.fct.2010.11.008
   Roesler KR, 2001, J AGR FOOD CHEM, V49, P3443, DOI 10.1021/jf010209b
   Sanahuja G, 2011, PLANT BIOTECHNOL J, V9, P283, DOI 10.1111/j.1467-7652.2011.00595.x
   SILVIE P, 2001, MANUAL IDENTIFICACAO
   Soberon M, 2010, ADV EXP MED BIOL, V677, P127
   Carvalho AFU, 2011, J FOOD COMPOS ANAL, V24, P487, DOI 10.1016/j.jfca.2011.01.013
   Xu WT, 2009, FOOD CHEM TOXICOL, V47, P1459, DOI 10.1016/j.fct.2009.03.029
   Yu HL, 2011, J INTEGR PLANT BIOL, V53, P520, DOI 10.1111/j.1744-7909.2011.01047.x
NR 39
TC 8
Z9 8
U1 1
U2 59
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0278-6915
EI 1873-6351
J9 FOOD CHEM TOXICOL
JI Food Chem. Toxicol.
PD JUL
PY 2015
VL 81
BP 81
EP 91
DI 10.1016/j.fct.2015.04.008
PG 11
WC Food Science & Technology; Toxicology
SC Food Science & Technology; Toxicology
GA CL1YJ
UT WOS:000356740500010
PM 25890087
DA 2020-12-08
ER

PT J
AU Farias, DF
   Viana, MP
   de Oliveira, GR
   Beneventi, MA
   Soares, BM
   Pessoa, C
   Pessoa, IP
   Silva, LP
   Vasconcelos, IM
   de Sa, MFG
   Carvalho, AFU
AF Farias, Davi Felipe
   Viana, Martonio Ponte
   de Oliveira, Gustavo Ramos
   Beneventi, Magda Aparecida
   Soares, Bruno Marques
   Pessoa, Claudia
   Pessoa, Igor Parra
   Silva, Luciano Paulino
   Vasconcelos, Ilka Maria
   Grossi de Sa, Maria Fatima
   Urano Carvalho, Ana Fontenele
TI Evaluation of Cytotoxic and Antimicrobial Effects of Two Bt Cry Proteins
   on a GMO Safety Perspective
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID COTTON BOLL-WEEVIL; BACILLUS-THURINGIENSIS; IN-VITRO; CRY3BB1 PROTEIN;
   ARTEMIA-SALINA; TOXIN; TOXICITY; CROPS; CELLS; CRYSTALS
AB Studies have contested the innocuousness of Bacillus thuringiensis (Bt) Cry proteins to mammalian cells as well as to mammals microbiota. Thus, this study aimed to evaluate the cytotoxic and antimicrobial effects of two Cry proteins, Cry8Ka5 (a novel mutant protein) and Cry1Ac (a widely distributed protein in GM crops). Evaluation of cyto- and genotoxicity in human lymphocytes was performed as well as hemolytic activity coupled with cellular membrane topography analysis in mammal erythrocytes. Effects of Cry8Ka5 and Cry1Ac upon Artemia sp. nauplii and upon bacteria and yeast growth were assessed. The toxins caused no significant effects on the viability (IC50 > 1,000 mu g/mL) or to the cellular DNA integrity of lymphocytes (no effects at 1,000 mu g/mL). The Cry8Ka5 and Cry1Ac proteins did not cause severe damage to erythrocytes, neither with hemolysis (IC50 > 1,000 mu g/mL) nor with alterations in the membrane. Likewise, the Cry8Ka5 and Cry1Ac proteins presented high LC50 (755.11 and > 1,000 mu g/mL, resp.) on the brine shrimp lethality assay and showed no growth inhibition of the microorganisms tested (MIC > 1,000 mu g/mL). This study contributed with valuable information on the effects of Cry8Ka5 and Cry1Ac proteins on nontarget organisms, which reinforce their potential for safe biotechnological applications.
C1 [Farias, Davi Felipe; Viana, Martonio Ponte; Pessoa, Igor Parra; Vasconcelos, Ilka Maria; Urano Carvalho, Ana Fontenele] Univ Fed Ceara, Grad Program Biochem, BR-60440900 Fortaleza, Ceara, Brazil.
   [de Oliveira, Gustavo Ramos] Univ Fed Parana, Grad Program Bioproc Engn & Biotechnol, BR-8153198 Curitiba, Parana, Brazil.
   [de Oliveira, Gustavo Ramos; Beneventi, Magda Aparecida; Silva, Luciano Paulino; Grossi de Sa, Maria Fatima] Embrapa Cenargen, Natl Ctr Genet Resources, BR-70770917 Brasilia, DF, Brazil.
   [Soares, Bruno Marques; Pessoa, Claudia] Univ Fed Ceara, Grad Program Pharmacol, BR-60430270 Fortaleza, Ceara, Brazil.
   [Grossi de Sa, Maria Fatima] Univ Catolica Brasilia, Grad Program Gemon Sci & Biotechnol, BR-70790160 Brasilia, DF, Brazil.
RP Carvalho, AFU (corresponding author), Univ Fed Ceara, Grad Program Biochem, BR-60440900 Fortaleza, Ceara, Brazil.
EM aurano@ufc.br
RI Silva, Luciano Paulino/G-4915-2012; Grossi-de-Sa, Maria
   Fatima/N-7856-2017; Fapesp, Biota/F-8655-2017; Viana,
   Martonio/AAZ-4218-2020; Farias, Davi Felipe/AAH-1868-2020
OI Silva, Luciano Paulino/0000-0001-9075-7725; Fapesp,
   Biota/0000-0002-9887-8449; GROSSI-DE-SA, MARIA
   FATIMA/0000-0001-8184-9599; Felipe Farias, Davi/0000-0001-5438-1919
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)
   (Edital MCT/CNPq/CTAGRO)National Council for Scientific and
   Technological Development (CNPq) [43/2009-Bicudo]; Coordenacao de
   Aperfeicoamento de Pessoal do Ensino Superior (CAPES) (Edital Programa
   Ciencias Sem Fronteiras-Pesquisador Visitante Especial-Linha 1)CAPES
   [71/2013]
FX The authors thank Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq) (Edital MCT/CNPq/CTAGRO No. 43/2009-Bicudo) and
   Coordenacao de Aperfeicoamento de Pessoal do Ensino Superior (CAPES)
   (Edital No. 71/2013 Programa Ciencias Sem Fronteiras-Pesquisador
   Visitante Especial-Linha 1) for financial support of this research.
CR Acey RA, 2002, BIOCHEM BIOPH RES CO, V299, P659, DOI 10.1016/S0006-291X(02)02716-X
   BERNHEIMER AW, 1988, METHOD ENZYMOL, V165, P213
   Bondzio A, 2008, FOOD CHEM TOXICOL, V46, P1976, DOI 10.1016/j.fct.2008.01.038
   Bondzio A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067079
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Brand GD, 2002, J BIOL CHEM, V277, P49332, DOI 10.1074/jbc.M209289200
   Bravo A, 2007, TOXICON, V49, P423, DOI 10.1016/j.toxicon.2006.11.022
   Broderick NA, 2006, P NATL ACAD SCI USA, V103, P15196, DOI 10.1073/pnas.0604865103
   Burim RV, 2001, TERATOGEN CARCIN MUT, V21, P383, DOI 10.1002/tcm.1026
   Costa-Lotufo LV, 2005, J ETHNOPHARMACOL, V99, P21, DOI 10.1016/j.jep.2005.01.041
   Delaney B, 2008, FOOD CHEM TOXICOL, V46, pS71, DOI 10.1016/j.fct.2008.01.045
   Edman P., 1964, THROMB DIATH HAEMO, P17
   Favilla M, 2006, FOOD CHEM TOXICOL, V44, P1922, DOI 10.1016/j.fct.2006.06.024
   Finney D. J., 1971, PROBIT ANAL
   Gatehouse AMR, 2011, PHILOS T R SOC B, V366, P1438, DOI 10.1098/rstb.2010.0330
   Gill M, 2002, INSECT MOL BIOL, V11, P619, DOI 10.1046/j.1365-2583.2002.00373.x
   Grisolia CK, 2009, MUTAT RES-GEN TOX EN, V672, P119, DOI 10.1016/j.mrgentox.2008.10.017
   Grossi-De-Sa MF, 2007, J BIOCHEM MOL BIOL, V40, P773
   Hissa DC, 2008, J EXP BIOL, V211, P2707, DOI 10.1242/jeb.019315
   Kim HS, 2000, J APPL MICROBIOL, V89, P16, DOI 10.1046/j.1365-2672.2000.01087.x
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lima PDL, 2007, FOOD CHEM TOXICOL, V45, P1154, DOI 10.1016/j.fct.2006.12.022
   Mendelsohn J, 2003, J CLIN ONCOL, V21, P2787, DOI 10.1200/JCO.2003.01.504
   MERKER MP, 1986, TOXICON, V24, P451, DOI 10.1016/0041-0101(86)90077-2
   Mesnage R, 2013, J APPL TOXICOL, V33, P695, DOI 10.1002/jat.2712
   Militao GCG, 2012, PHARM BIOL, V50, P1479, DOI 10.3109/13880209.2012.684691
   Mohamed ZA, 2007, FEMS MICROBIOL ECOL, V59, P749, DOI 10.1111/j.1574-6941.2006.00226.x
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Noteborn H. P. J. M., 1996, GENETICALLY MODIFIED, P23
   O'Callaghan M, 2005, ANNU REV ENTOMOL, V50, P271, DOI 10.1146/annurev.ento.50.071803.130352
   Oliveira GR, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-85
   PrietoSamsonov DL, 1997, J IND MICROBIOL BIOT, V19, P202, DOI 10.1038/sj.jim.2900460
   Prihoda KR, 2008, CHEMOSPHERE, V73, P1102, DOI 10.1016/j.chemosphere.2008.07.025
   Prihoda KR, 2008, ENVIRON TOXICOL CHEM, V27, P793, DOI 10.1897/07-300.1
   Revina LP, 2005, CAN J MICROBIOL, V51, P141, DOI 10.1139/w04-121
   Ribeiro SFF, 2007, SCI HORTIC-AMSTERDAM, V111, P399, DOI 10.1016/j.scienta.2006.11.004
   Romeis J, 2006, NAT BIOTECHNOL, V24, P63, DOI 10.1038/nbt1180
   Sanahuja G, 2011, PLANT BIOTECHNOL J, V9, P283, DOI 10.1111/j.1467-7652.2011.00595.x
   Shimada N, 2003, J VET MED SCI, V65, P187, DOI 10.1292/jvms.65.187
   Souza TM, 2011, J MED ENTOMOL, V48, P846, DOI 10.1603/ME10205
   Correa RFT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046121
   Yu HL, 2011, J INTEGR PLANT BIOL, V53, P520, DOI 10.1111/j.1744-7909.2011.01047.x
   Yudina TG, 2007, ANAEROBE, V13, P6, DOI 10.1016/j.anaerobe.2006.09.006
   Yudina TG, 2003, CAN J MICROBIOL, V49, P37, DOI 10.1139/W03-007
NR 44
TC 3
Z9 3
U1 3
U2 54
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2014
VL 2014
AR 810490
DI 10.1155/2014/810490
PG 14
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA AN7DD
UT WOS:000340758000001
PM 25165717
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Custodio, C
   Mello, BSF
   Costa, AMN
   Gomes, PXL
   Oliveira, GV
   Araujo, FYR
   Sousa, FCF
   Carvalho, AF
   Macedo, DS
AF Custodio, C.
   Mello, B. S. F.
   Costa, A. M. N.
   Gomes, P. X. L.
   Oliveira, G. V.
   Araujo, F. Y. R.
   Sousa, F. C. F.
   Carvalho, A. F.
   Macedo, D. S.
TI Prevention of nicotine-induced kindling in female periadolescent rats by
   the repeated administration of N-acetylcysteine
SO EUROPEAN NEUROPSYCHOPHARMACOLOGY
LA English
DT Meeting Abstract
C1 [Custodio, C.; Mello, B. S. F.] Univ Fed Ceara, Dept Microbiol Med, Fortaleza, Ceara, Brazil.
   [Costa, A. M. N.; Gomes, P. X. L.; Oliveira, G. V.; Araujo, F. Y. R.; Sousa, F. C. F.; Macedo, D. S.] Univ Fed Ceara, Dept Fisiol & Farmacol, Fortaleza, Ceara, Brazil.
   [Carvalho, A. F.] Univ Fed Ceara, Dept Med Clin, Fortaleza, Ceara, Brazil.
RI de Sousa, Francisca Clea Florenco/ABA-5683-2020; Macedo,
   Danielle/E-3424-2014
OI Macedo, Danielle/0000-0001-8980-9970
CR Gomes PXL, 2013, PSYCHOPHARMACOLOGY, V225, P115, DOI 10.1007/s00213-012-2799-5
   Racine RJ, 1972, CLIN NEUROPHYSIOL, V32, P281, DOI DOI 10.1016/0013-4694(72)90177-0
NR 2
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0924-977X
EI 1873-7862
J9 EUR NEUROPSYCHOPHARM
JI Eur. Neuropsychopharmacol.
PD OCT
PY 2013
VL 23
SU 2
MA P.1.g.084
BP S239
EP S240
DI 10.1016/S0924-977X(13)70371-7
PG 2
WC Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry
SC Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry
GA V40HR
UT WOS:000209470200257
DA 2020-12-08
ER

PT J
AU Mello, BSF
   Custodio, CS
   Ribeiro, BMM
   Cordeiro, RC
   Santos, JV
   Gomes, PXL
   Sousa, FCF
   Nobre, HV
   Carvalho, AF
   Macedo, DS
AF Mello, B. S. F.
   Custodio, C. S.
   Ribeiro, B. M. M.
   Cordeiro, R. C.
   Santos, J. V.
   Gomes, P. X. L.
   Sousa, F. C. F.
   Nobre Junior, H. V.
   Carvalho, A. F.
   Macedo, D. S.
TI Determination of the alterations in prepulse inhibition in mice treated
   with doxycycline in an animal model of depression
SO EUROPEAN NEUROPSYCHOPHARMACOLOGY
LA English
DT Meeting Abstract
C1 [Mello, B. S. F.; Custodio, C. S.] Univ Fed Ceara, Dept Microbiol Med, Fortaleza, Ceara, Brazil.
   [Ribeiro, B. M. M.; Santos, J. V.; Gomes, P. X. L.; Sousa, F. C. F.; Macedo, D. S.] Univ Fed Ceara, Dept Fisiol & Farmacol, Fortaleza, Ceara, Brazil.
   [Cordeiro, R. C.; Nobre Junior, H. V.; Carvalho, A. F.] Univ Fed Ceara, Dept Med Clin, Fortaleza, Ceara, Brazil.
RI de Sousa, Francisca Clea Florenco/ABA-5683-2020; Macedo,
   Danielle/E-3424-2014
OI Macedo, Danielle/0000-0001-8980-9970
CR Levin R, 2011, PROG NEURO-PSYCHOPH, V35, P1748, DOI 10.1016/j.pnpbp.2011.06.003
   Ohgi Y, 2013, PHARMACOL BIOCHEM BE, V103, P853, DOI 10.1016/j.pbb.2012.12.003
   Perez-Trallero E, 2003, ENFERM INFEC MICR CL, V21, P520, DOI 10.1157/13052338
NR 3
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0924-977X
EI 1873-7862
J9 EUR NEUROPSYCHOPHARM
JI Eur. Neuropsychopharmacol.
PD OCT
PY 2013
VL 23
SU 2
MA P.1.g.083
BP S238
EP S239
DI 10.1016/S0924-977X(13)70370-5
PG 2
WC Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry
SC Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry
GA V40HR
UT WOS:000209470200256
DA 2020-12-08
ER

PT J
AU Ribeiro, BMM
   Custodio, CS
   Mello, BSF
   Cordeiro, RC
   Santos, JV
   Menezes, AT
   Vale, ML
   Vasconcelos, SMM
   Carvalho, AF
   Macedo, DS
AF Ribeiro, B. M. M.
   Custodio, C. S.
   Mello, B. S. F.
   Cordeiro, R. C.
   Santos, J. V.
   Menezes, A. T.
   Vale, M. L.
   Vasconcelos, S. M. M.
   Carvalho, A. F.
   Macedo, D. S.
TI Effects of clozapine on the prepulse inhibition of rats submitted to the
   model of schizophrenia induced by neonatal immune challenge
SO EUROPEAN NEUROPSYCHOPHARMACOLOGY
LA English
DT Meeting Abstract
C1 [Ribeiro, B. M. M.; Santos, J. V.; Menezes, A. T.; Vale, M. L.; Vasconcelos, S. M. M.; Macedo, D. S.] Univ Fed Ceara, Dept Fisiol & Farmacol, Fortaleza, Ceara, Brazil.
   [Custodio, C. S.; Mello, B. S. F.] Univ Fed Ceara, Dept Microbiol Med, Fortaleza, Ceara, Brazil.
   [Cordeiro, R. C.; Carvalho, A. F.] Univ Fed Ceara, Dept Med Clin, Fortaleza, Ceara, Brazil.
RI Macedo, Danielle/E-3424-2014
OI Macedo, Danielle/0000-0001-8980-9970
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0924-977X
EI 1873-7862
J9 EUR NEUROPSYCHOPHARM
JI Eur. Neuropsychopharmacol.
PD OCT
PY 2013
VL 23
SU 2
MA P.1.g.077
BP S235
EP S235
DI 10.1016/S0924-977X(13)70364-X
PG 1
WC Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry
SC Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry
GA V40HR
UT WOS:000209470200250
DA 2020-12-08
ER

PT J
AU Ribeiro, BMM
   Souza, GC
   Queiroz, AIG
   Gomes, JAS
   Cavalcante, LM
   Machado, MJS
   Araujo, MM
   Cordeiro, RC
   Carvalho, AF
   Macedo, DS
AF Ribeiro, B. M. M.
   Souza, G. C.
   Queiroz, A. I. G.
   Gomes, J. A. S.
   Cavalcante, L. M.
   Machado, M. J. S.
   Araujo, M. M.
   Cordeiro, R. C.
   Carvalho, A. F.
   Macedo, D. S.
TI Effects of carvedilol on the social behavior of rats submitted to an
   animal model of mania
SO EUROPEAN NEUROPSYCHOPHARMACOLOGY
LA English
DT Meeting Abstract
C1 [Ribeiro, B. M. M.; Souza, G. C.; Queiroz, A. I. G.; Gomes, J. A. S.; Cavalcante, L. M.; Machado, M. J. S.; Araujo, M. M.; Macedo, D. S.] Univ Fed Ceara, Dept Fisiol & Farmacol, Fortaleza, Ceara, Brazil.
   [Cordeiro, R. C.; Carvalho, A. F.] Univ Fed Ceara, Dept Med Clin, Fortaleza, Ceara, Brazil.
RI Macedo, Danielle/E-3424-2014
OI Macedo, Danielle/0000-0001-8980-9970
CR Kumar A, 2009, N-S ARCH PHARMACOL, V380, P431, DOI 10.1007/s00210-009-0442-8
   Macedo DS, 2013, PROG NEURO-PSYCHOPH, V43, P230, DOI 10.1016/j.pnpbp.2013.01.007
NR 2
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0924-977X
EI 1873-7862
J9 EUR NEUROPSYCHOPHARM
JI Eur. Neuropsychopharmacol.
PD OCT
PY 2013
VL 23
SU 2
MA P.1.g.001
BP S189
EP S189
DI 10.1016/S0924-977X(13)70289-X
PG 1
WC Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry
SC Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry
GA V40HR
UT WOS:000209470200175
DA 2020-12-08
ER

PT J
AU Hyphantis, T
   Goulia, P
   Carvalho, AF
AF Hyphantis, T.
   Goulia, P.
   Carvalho, A. F.
TI Personality traits, defense mechanisms and hostility features associated
   with somatic symptom severity in health and disease
SO JOURNAL OF PSYCHOSOMATIC RESEARCH
LA English
DT Meeting Abstract
C1 [Hyphantis, T.; Goulia, P.] Univ Ioannina, Dept Psychiat, Sch Med, GR-45110 Ioannina, Greece.
   [Carvalho, A. F.] Univ Fed Ceara, Psychiat Res Grp, Fortaleza, Ceara, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0022-3999
EI 1879-1360
J9 J PSYCHOSOM RES
JI J. Psychosomat. Res.
PD JUN
PY 2013
VL 74
IS 6
MA 29
BP 547
EP 547
DI 10.1016/j.jpsychores.2013.03.043
PG 1
WC Psychiatry
SC Psychiatry
GA 162WX
UT WOS:000320297800042
DA 2020-12-08
ER

PT J
AU Hyphantis, T
   Kotsis, K
   Tsifetaki, N
   Creed, F
   Drosos, AA
   Carvalho, AF
   Voulgari, PV
AF Hyphantis, T.
   Kotsis, K.
   Tsifetaki, N.
   Creed, F.
   Drosos, A. A.
   Carvalho, A. F.
   Voulgari, P. V.
TI Depressive and anxiety symptoms and illness perceptions associated with
   physical health-related quality of life in rheumatologic disorders
SO JOURNAL OF PSYCHOSOMATIC RESEARCH
LA English
DT Meeting Abstract
C1 [Hyphantis, T.; Kotsis, K.] Univ Ioannina, Dept Psychiat, Sch Med, GR-45110 Ioannina, Greece.
   [Tsifetaki, N.; Drosos, A. A.; Voulgari, P. V.] Univ Ioannina, Rheumatol Clin, Dept Internal Med, Sch Med, GR-45110 Ioannina, Greece.
   [Creed, F.] Univ Manchester, Psychiat Res Grp, Sch Med, Manchester, Lancs, England.
   [Carvalho, A. F.] Univ Fed Ceara, Psychiat Res Grp, Fac Med, Fortaleza, Ceara, Brazil.
RI Drosos, Alexandros A./AAK-1115-2020
NR 0
TC 2
Z9 2
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0022-3999
EI 1879-1360
J9 J PSYCHOSOM RES
JI J. Psychosomat. Res.
PD JUN
PY 2013
VL 74
IS 6
MA 30
BP 548
EP 548
DI 10.1016/j.jpsychores.2013.03.044
PG 1
WC Psychiatry
SC Psychiatry
GA 162WX
UT WOS:000320297800043
DA 2020-12-08
ER

PT J
AU de Lima, GPG
   de Souza, TM
   Freire, GD
   Farias, DF
   Cunha, AP
   Ricardo, NMPS
   de Morais, SM
   Carvalho, AFU
AF Gomes de Lima, Glauber Pacelli
   de Souza, Terezinha Maria
   Freire, Gabrielle de Paula
   Farias, Davi Felipe
   Cunha, Arcelina Pacheco
   Pontes Silva Ricardo, Nagila Maria
   de Morais, Selene Maia
   Urano Carvalho, Ana Fontenele
TI Further insecticidal activities of essential oils from Lippia sidoides
   and Croton species against Aedes aegypti L.
SO PARASITOLOGY RESEARCH
LA English
DT Article
ID LARVICIDAL ACTIVITY; OCIMUM-BASILICUM; REPELLENT; TOXICITY; EXTRACT;
   DIPTERA; SEEDS
AB This study assessed new insecticidal activities of essential oils from Lippia sidoides and Croton species (Croton zehntneri, Croton nepetaefolius, Croton argyrophylloides, and Croton sonderianus) against Aedes aegypti mosquito. In addition, the acute toxicity upon mice was determined. All essential oils showed inhibition of egg hatching, with IC50 values ranging from 66.4 to 143.2 mu g mL(-1), larvicidal activity with LC50 ranging from 25.5 to 94.6 mu g mL(-1), and pupicidal action with PC50 ranging from 276.8 to over 500 mu g mL(-1). Only L. sidoides, C. zehntneri, and C. argyrophylloides essential oils were able to inhibit the oviposition of female gravid mosquitoes with OD50 values of 35.3, 45.3, and 45.8 mu g mL(-1), respectively. Oral acute toxicity in mice showed that C. sonderianus and C. argyrophylloides oils are nontoxic (LD50 > 6,000 mg.kg(-1)) while C. nepetaefolius, C. zehntneri, and L. sidoides oils are moderately toxic (LD50 3,840; 3,464, and 2,624 mg.kg(-1), respectively). The results indicate that these oils are promising sources of bioactive compounds, showing low or no toxicity to mammals.
C1 [Gomes de Lima, Glauber Pacelli; de Souza, Terezinha Maria; Farias, Davi Felipe] Univ Fed Ceara, Dept Biochem & Mol Biol, BR-60455760 Fortaleza, Ceara, Brazil.
   [Freire, Gabrielle de Paula; Urano Carvalho, Ana Fontenele] Univ Fed Ceara, Dept Biol, BR-60455760 Fortaleza, Ceara, Brazil.
   [Cunha, Arcelina Pacheco; Pontes Silva Ricardo, Nagila Maria] Univ Fed Ceara, Dept Organ & Inorgan Chem, BR-60455760 Fortaleza, Ceara, Brazil.
   [de Morais, Selene Maia] Univ Estadual Ceara, Course Chem, BR-60740000 Fortaleza, Ceara, Brazil.
RP Carvalho, AFU (corresponding author), Univ Fed Ceara, Dept Biol, Campus Pici, BR-60455760 Fortaleza, Ceara, Brazil.
EM aurano@ufc.br
RI Ricardo, Nagila Maria Pontes Silva/C-3630-2015; de Souza,
   Terezinha/L-8727-2015; Farias, Davi Felipe/AAH-1868-2020; Carvalho,
   Ana/K-7344-2018
OI Ricardo, Nagila Maria Pontes Silva/0000-0003-1849-5403; de Souza,
   Terezinha/0000-0002-9580-3310; Carvalho, Ana/0000-0001-5293-9317; Gomes
   de Lima, Glauber Pacelli/0000-0002-5366-4551; Felipe Farias,
   Davi/0000-0001-5438-1919
CR Adams R., 2001, IDENTIFICATION ESSEN
   Ansari MA, 2000, BIORESOURCE TECHNOL, V73, P207, DOI 10.1016/S0960-8524(99)00180-7
   Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106
   Camurca-Vasconcelos ALE, 2008, VET PARASITOL, V154, P167, DOI 10.1016/j.vetpar.2008.02.023
   Carvalho AFU, 2003, MEM I OSWALDO CRUZ, V98, P569, DOI 10.1590/S0074-02762003000400027
   Cavalheiro MG, 2009, REV BRAS FARMACOGN, V19, P586, DOI 10.1590/S0102-695X2009000400014
   CRAVEIRO AA, 1976, J CHEM EDUC, V53, P652, DOI 10.1021/ed053p652
   Dharmagadda VSS, 2005, BIORESOURCE TECHNOL, V96, P1235, DOI 10.1016/j.biortech.2004.10.020
   Fandohan P, 2008, FOOD CHEM TOXICOL, V46, P2493, DOI 10.1016/j.fct.2008.04.006
   Farias DF, 2009, J AM MOSQUITO CONTR, V25, P386, DOI 10.2987/08-5851.1
   Ferreira PMP, 2009, AN ACAD BRAS CIENC, V81, P207, DOI 10.1590/S0001-37652009000200007
   Finney D. J., 1971, PROBIT ANAL
   HODGE H C, 1949, Am Ind Hyg Assoc Q, V10, P93
   Hoskins WM, 1943, HILGARDIA, V13, P307
   Koodalingam A, 2009, PARASITOL RES, V105, P1425, DOI 10.1007/s00436-009-1574-y
   Lembe DM, 2009, ANDROLOGIA, V41, P341, DOI 10.1111/j.1439-0272.2009.00934.x
   Matos F. J. A., 2000, PLANTAS MED GUIA SEL
   Morais SM, 2006, J AM MOSQUITO CONTR, V22, P161, DOI 10.2987/8756-971X(2006)22[161:LAOEOF]2.0.CO;2
   Murugan K, 2007, BIORESOURCE TECHNOL, V98, P198, DOI 10.1016/j.biortech.2005.12.009
   Prajapati V, 2005, BIORESOURCE TECHNOL, V96, P1749, DOI 10.1016/j.biortech.2005.01.007
   Silva CGV, 2008, J ESSENT OIL RES, V20, P179, DOI 10.1080/10412905.2008.9699985
   Souza TM, 2011, J MED ENTOMOL, V48, P846, DOI 10.1603/ME10205
   Tauil Pedro Luiz, 2002, Cad. Saúde Pública, V18, P867, DOI 10.1590/S0102-311X2002000300030
   Valente ROH, 2009, REV BRAS FARMACOGN, V19, P557, DOI 10.1590/S0102-695X2009000400008
   Zhu JJ, 2009, MED VET ENTOMOL, V23, P209, DOI 10.1111/j.1365-2915.2009.00809.x
NR 25
TC 36
Z9 39
U1 1
U2 34
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0932-0113
EI 1432-1955
J9 PARASITOL RES
JI Parasitol. Res.
PD MAY
PY 2013
VL 112
IS 5
BP 1953
EP 1958
DI 10.1007/s00436-013-3351-1
PG 6
WC Parasitology
SC Parasitology
GA 127EH
UT WOS:000317678700016
PM 23435925
DA 2020-12-08
ER

PT J
AU Todaro, AR
   Nascimento, VX
   Souza, NCC
   Silva, PP
   Santos, JM
   Ramalho, EAVF
   Melo, TVC
   Silva, ISM
   Lins, GS
   Bastos, MLA
   Farias, DF
   Souza, PCV
   Carvalho, AFU
   Silva, MCS
   Almeida, RMRG
   Neto, ER
AF Todaro, A. R.
   Nascimento, V. X.
   Souza, N. C. C.
   Silva, P. P.
   Santos, J. M.
   Ramalho, E. A. V. F.
   Melo, T. V. C.
   Silva, I. S. M.
   Lins Junior, G. S.
   Bastos, M. L. A.
   Farias, D. F.
   Souza, P. C. V.
   Carvalho, A. F. U.
   Silva, M. C. S.
   Almeida, R. M. R. G.
   Ramalho Neto, E.
TI Genetic variability in the ITS and IGS regions of the ribosomal DNA of
   Acremonium cavaraeanum exhibiting antimicrobial activity
SO GENETICS AND MOLECULAR RESEARCH
LA English
DT Article
DE PCR; ITS; IGS; Acremonium fungal endophy; Antimicrobial activity
ID GRADIENT GEL-ELECTROPHORESIS; AEDES-AEGYPTI; FUNGAL COMMUNITIES;
   IDENTIFICATION; PLANTS; PCR; RNA; SEQUENCES; EXTRACTS; SEEDS
AB Endophytic microorganisms represent promising alternatives for obtaining new drugs of biotechnological importance. In this study, the endophytic species Acremonium cavaraeanum (A1a) isolated from Cocos nucifera was cultivated for the production of secondary metabolites, and its extracts and fractions were evaluated by the dilution method (MIC). The EtOAc extracts and MeOH fractions were tested against Gram-positive and -negative bacteria, and had an MIC of 125 mu g/mL when evaluated in the EtOAc extract (EBI). The EtOAc extract (EBII) had an MIC of 62.25 mu g/mL for Staphylococcus aureus and an MIC between 125 and 250 mu g/mL for Gram-negative bacteria. The methanolic fractions showed activity with MIC between 125 and 250 mu g/mL for all bacteria tested. The IGS region of the rDNA repeat unit of genomic DNA was analyzed by PCR/RFLPs, including endonucleases PstI, BamHII, HinfI, and EcoRI. The physical maps showed different restriction sites for the 6 Acremonium sp isolates, and revealed 5 RFLP patterns. The results showed that isolates of the same Acremonium species exhibited variation in this specific region. The sequences of ITS1-5.8S-ITS2 regions were aligned by Clustal W using the neighbor joining method, which grouped the isolates into 5 distinct clusters. This study aimed to evaluate the genetic diversity of A. cavaraeanum crops exhibiting antibacterial activity. The results of this study indicate that different fungal genetic isolates have biotechnological potential for the production of active bio-compounds against several human pathogens.
C1 [Todaro, A. R.; Nascimento, V. X.; Souza, N. C. C.; Silva, P. P.; Santos, J. M.; Ramalho, E. A. V. F.; Ramalho Neto, E.] Univ Fed Alagoas, Ctr Ciencias Agr, Lab Genet Mol Genom & Prote, Rio Largo, AL, Brazil.
   [Melo, T. V. C.; Silva, I. S. M.; Lins Junior, G. S.; Bastos, M. L. A.] Univ Fed Alagoas, Escola Enfermagem & Farm, Lab Cuidado Saude, Maceio, AL, Brazil.
   [Farias, D. F.; Souza, P. C. V.; Carvalho, A. F. U.] Univ Fed Ceara, Dept Bioquim & Biol Mol, Fortaleza, Ceara, Brazil.
   [Farias, D. F.; Souza, P. C. V.; Carvalho, A. F. U.] Univ Fed Ceara, Dept Biol, Fortaleza, Ceara, Brazil.
   [Silva, M. C. S.; Almeida, R. M. R. G.] Univ Fed Alagoas, Lab Gestao Alimentos & Bebidas, Maceio, AL, Brazil.
RP Todaro, AR (corresponding author), Univ Fed Alagoas, Ctr Ciencias Agr, Lab Genet Mol Genom & Prote, Campus Delza Gitai, Rio Largo, AL, Brazil.
EM a.todaro@gmail.com
RI Silva, Iandara Schettert/L-8525-2018; de Assis Bastos, Maria
   Lysete/F-6446-2016; Farias, Davi Felipe/AAH-1868-2020; Almeida, Renata
   Maria Rosas Garcia/AAE-6638-2019
OI Silva, Iandara Schettert/0000-0001-9431-098X; de Assis Bastos, Maria
   Lysete/0000-0003-1752-7645; Almeida, Renata Maria Rosas
   Garcia/0000-0003-1331-8619; Felipe Farias, Davi/0000-0001-5438-1919
CR Abd-Elsalam Kamel A., 2003, African Journal of Biotechnology, V2, P82
   Abliz P, 2004, FEMS IMMUNOL MED MIC, V40, P41, DOI 10.1016/S0928-8244(03)00275-X
   Ahmad A, 2012, CURR PROTEIN PEPT SC, V13, P211, DOI 10.2174/138920312800785076
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Brookman JL, 2000, MICROBIOL-UK, V146, P393, DOI 10.1099/00221287-146-2-393
   CARVALHO AFU, 1988, CIENC CULT, V40, P1109
   Costa-Lotufo LV, 2005, J ETHNOPHARMACOL, V99, P21, DOI 10.1016/j.jep.2005.01.041
   Farias DF, 2010, AN ACAD BRAS CIENC, V82, P585, DOI 10.1590/S0001-37652010000300006
   Farias DF, 2009, J AM MOSQUITO CONTR, V25, P386, DOI 10.2987/08-5851.1
   Ferreira PMP, 2009, AN ACAD BRAS CIENC, V81, P207, DOI 10.1590/S0001-37652009000200007
   Ferreira PMP, 2011, AN ACAD BRAS CIENC, V83, P1045, DOI 10.1590/S0001-37652011005000017
   Finney D. J., 1971, PROBIT ANAL
   Gams W, 1971, CEPHALOSPORIUM ARTIG
   Huang YJ, 2001, FEMS IMMUNOL MED MIC, V31, P163, DOI 10.1111/j.1574-695X.2001.tb00513.x
   Kang SJ, 2012, ARCH PHARM RES, V35, P791, DOI 10.1007/s12272-012-0505-0
   KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581
   LOBUGLIO KF, 1995, J CLIN MICROBIOL, V33, P85, DOI 10.1128/JCM.33.1.85-89.1995
   National Committee for Clinical Laboratory Standards, 2003, M7A6 NCCLS
   Nunes BS, 2006, ENVIRON POLLUT, V144, P453, DOI 10.1016/j.envpol.2005.12.037
   Peintner U, 2003, MYCOL RES, V107, P485, DOI 10.1017/S0953756203007585
   RAEDER U, 1985, LETT APPL MICROBIOL, V1, P17, DOI 10.1111/j.1472-765X.1985.tb01479.x
   Redecker D, 2000, MYCORRHIZA, V10, P73, DOI 10.1007/s005720000061
   Schabereiter-Gurtner C, 2001, J MICROBIOL METH, V45, P77, DOI 10.1016/S0167-7012(01)00227-5
   Sette LD, 2005, ANTON LEEUW INT J G, V87, P81, DOI 10.1007/s10482-004-1129-2
   Smit E, 1999, APPL ENVIRON MICROB, V65, P2614
   Sterflinger K, 2001, ANTON LEEUW INT J G, V80, P275, DOI 10.1023/A:1013060308809
   Strobel G, 2003, MICROBIOL MOL BIOL R, V67, P491, DOI 10.1128/MMBR.67.4.491-502.2003
   Sutar R, 2004, J MED MICROBIOL, V53, P119, DOI 10.1099/jmm.0.05436-0
   Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   van Elsas JD, 2000, J MICROBIOL METH, V43, P133, DOI 10.1016/S0167-7012(00)00212-8
   White TJ, 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1
   Wu ZH, 2003, APPL ENVIRON MICROB, V69, P5389, DOI 10.1128/AEM.69.9.5389-5397.2003
NR 33
TC 1
Z9 1
U1 0
U2 17
PU FUNPEC-EDITORA
PI RIBEIRAO PRETO
PA RUA FLORIANO PEIXOTO 2444, ALTO DA BOA VISTA, RIBEIRAO PRETO, SP 00000,
   BRAZIL
SN 1676-5680
J9 GENET MOL RES
JI Genet. Mol. Res.
PY 2013
VL 12
IS 4
BP 6983
EP 6995
DI 10.4238/2013.December.20.1
PG 13
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA AB2FG
UT WOS:000331608000288
PM 24391056
OA Bronze
DA 2020-12-08
ER

PT J
AU Teixeira, DC
   Farias, DF
   Carvalho, AFU
   Arantes, MR
   Oliveira, JTA
   Sousa, DOB
   Pereira, ML
   Oliveira, HD
   Andrade-Neto, M
   Vasconcelos, IM
AF Teixeira, Daniel Camara
   Farias, Davi Felipe
   Urano Carvalho, Ana Fontenele
   Arantes, Mariana Reis
   Abreu Oliveira, Jose Tadeu
   Bezerra Sousa, Daniele Oliveira
   Pereira, Mirella Leite
   Oliveira, Hermogenes David
   Andrade-Neto, Manoel
   Vasconcelos, Ilka Maria
TI Chemical Composition, Nutritive Value, and Toxicological Evaluation of
   Bauhinia cheilantha Seeds: A Legume from Semiarid Regions Widely Used in
   Folk Medicine
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID PROTEIN; FOOD
AB Among the Bauhinia species, B. cheilantha stands out for its seed protein content. However, there is no record of its nutritional value, being used in a nonsustainable way in the folk medicine and for large-scale extraction of timber. The aim of this study was to investigate the food potential of B. cheilantha seeds with emphasis on its protein quality to provide support for flora conservation and use as raw material or as prototype for the development of bioproducts with high added socioeconomic value. B. cheilantha seeds show high protein content (35.9%), reasonable essential amino acids profile, low levels of antinutritional compounds, and nutritional parameters comparable to those of legumes widely used such as soybean and cowpea. The heat treatment of the seeds as well as the protein extraction process (to obtain the protein concentrate) increased the acceptance of diets by about 100% when compared to that of raw Bc diet. These wild legume seeds can be promising alternative source of food to overcome the malnutrition problem faced by low income people adding socioeconomic value to the species.
C1 [Teixeira, Daniel Camara; Farias, Davi Felipe; Arantes, Mariana Reis; Abreu Oliveira, Jose Tadeu; Bezerra Sousa, Daniele Oliveira; Pereira, Mirella Leite; Oliveira, Hermogenes David; Vasconcelos, Ilka Maria] Univ Fed Ceara, Dept Bioquim & Biol Mol, BR-60455970 Fortaleza, CE, Brazil.
   [Urano Carvalho, Ana Fontenele] Univ Fed Ceara, Dept Biol, BR-60455970 Fortaleza, CE, Brazil.
   [Andrade-Neto, Manoel] Univ Fed Ceara, Dept Quim Organ & Inorgan, BR-60455970 Fortaleza, CE, Brazil.
RP Vasconcelos, IM (corresponding author), Univ Fed Ceara, Dept Bioquim & Biol Mol, BR-60455970 Fortaleza, CE, Brazil.
EM imvasco@ufc.br
RI De Oliveira, Hermogenes David/M-1372-2018; Farias, Davi
   Felipe/AAH-1868-2020
OI De Oliveira, Hermogenes David/0000-0003-4633-5597; Felipe Farias,
   Davi/0000-0001-5438-1919
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; FUNCAP
FX This work was supported by CNPq, CAPES, and FUNCAP.
CR AOAC, 1997, OFFICIAL METHODS ANA
   BAETHGEN WE, 1989, COMMUN SOIL SCI PLAN, V20, P961, DOI 10.1080/00103628909368129
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BRAGA R, 1960, PLANTAS NORDESTE ESP
   Cartaxo SL, 2010, J ETHNOPHARMACOL, V131, P326, DOI 10.1016/j.jep.2010.07.003
   Coates M. E., 1969, LAB ANIMAL HDB, V2
   DEAZEVEDOMOREIRA R, 1977, PLANT PHYSIOL, V59, P783, DOI 10.1104/pp.59.5.783
   FAO, 2003, FOOD EN METH AN CONV
   *FAO WHO UNU, 1985, TECHN REP SER WHO, V724
   Food and Agriculture Organization, 2012, STAT FOOD INS WORLD
   Gallardo K, 2008, CR BIOL, V331, P755, DOI 10.1016/j.crvi.2008.07.017
   Giami SY, 2005, J FOOD COMPOS ANAL, V18, P665, DOI 10.1016/j.jfca.2004.06.007
   HAMERSTRAND GE, 1981, CEREAL CHEM, V58, P42
   KAPLAN A, 1969, Methods of Biochemical Analysis, V17:, P311, DOI 10.1002/9780470110355.ch7
   Maia FMM, 2000, J SCI FOOD AGR, V80, P453, DOI 10.1002/(SICI)1097-0010(200003)80:4&lt;453::AID-JSFA548&gt;3.0.CO;2-X
   Martinez-Villaluenga C, 2007, FOOD CHEM, V103, P944, DOI 10.1016/j.foodchem.2006.09.048
   Matos F. J. A., 1999, INTRO FITOQUIMICA EX
   PINTERSZAKACS M, 1990, J AGR FOOD CHEM, V38, P720, DOI 10.1021/jf00093a028
   RAJARAM N, 1991, J SCI FOOD AGR, V55, P423, DOI 10.1002/jsfa.2740550310
   Rangel A, 2004, FOOD CHEM, V87, P491, DOI 10.1016/j.foodchem.2003.12.023
   READ NW, 1992, DIETARY FIBRE COMPON, P103
   REEVES PG, 1993, J NUTR, V123, P1939
   RUBIO LA, 1991, BRIT J NUTR, V66, P533, DOI 10.1079/BJN19910053
   Ruiz-Roso B, 2010, PLANT FOOD HUM NUTR, V65, P50, DOI 10.1007/s11130-009-0153-9
   Trugo LC, 2000, J AGR FOOD CHEM, V48, P2082, DOI 10.1021/jf9913920
   Carvalho AFU, 2011, J FOOD COMPOS ANAL, V24, P487, DOI 10.1016/j.jfca.2011.01.013
   Vadivel V, 2011, PLANT FOOD HUM NUTR, V66, P245, DOI 10.1007/s11130-011-0237-1
   Vasconcelos Ilka M., 2006, Braz. J. Bot., V29, P617, DOI 10.1590/S0100-84042006000400012
   Vasconcelos IM, 2001, J NUTR BIOCHEM, V12, P55, DOI 10.1016/S0955-2863(00)00148-0
NR 29
TC 3
Z9 3
U1 0
U2 11
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2013
VL 2013
AR 578781
DI 10.1155/2013/578781
PG 7
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA 133NL
UT WOS:000318145000001
PM 23691507
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Farias, DF
   Souza, TM
   Viana, MP
   Soares, BM
   Cunha, AP
   Vasconcelos, IM
   Ricardo, NMPS
   Ferreira, PMP
   Melo, VMM
   Carvalho, AFU
AF Farias, Davi Felipe
   Souza, Terezinha Maria
   Viana, Martonio Ponte
   Soares, Bruno Marques
   Cunha, Arcelina Pacheco
   Vasconcelos, Ilka Maria
   Pontes Silva Ricardo, Nagila Maria
   Pinheiro Ferreira, Paulo Michel
   Maciel Melo, Vania Maria
   Urano Carvalho, Ana Fontenele
TI Antibacterial, Antioxidant, and Anticholinesterase Activities of Plant
   Seed Extracts from Brazilian Semiarid Region
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID MEDICINAL-PLANTS; ANTIMICROBIAL ACTIVITY; ALZHEIMERS-DISEASE; ALKALOIDS;
   DEFENSE
AB The antimicrobial, antioxidant, and anticholinesterase activities of ethanolic seed extracts of twenty-one plant species from Brazilian semiarid region were investigated. The extracts were tested for antimicrobial activity against six bacteria strains and three yeasts. Six extracts presented activity against the Gram (-) organism Salmonella choleraesuis and the Gram (+) organisms Staphylococcus aureus and Bacillus subtilis. The MIC values ranged from 4.96 to 37.32mg/mL. The Triplaris gardneriana extract presented activity against the three species, with MIC values 18.8, 13.76, and 11.15 mg/mL, respectively. Five extracts presented antioxidant activity, with EC50 values ranging from 69.73 mu g/mL (T. gardneriana) to 487.51 mu g/mL (Licania rigida). For the anticholinesterase activity, eleven extracts were capable of inhibiting the enzyme activity. From those, T. gardneriana, Parkia platycephala and Connarus detersus presented the best activities, with inhibition values of 76.7, 71.5, and 91.9%, respectively. The extracts that presented antimicrobial activity were tested for hemolytic assay against human A, B, and O blood types and rabbit blood. From those, only the Myracrodruon urundeuva extract presented activity (about 20% of hemolysis at the lowest tested concentration, 1.9 mu g/mL). Infrared spectroscopy of six representative extracts attested the presence of tannins, polyphenols, and flavonoids, which was confirmed by a qualitative phytochemical assay.
C1 [Farias, Davi Felipe; Viana, Martonio Ponte; Vasconcelos, Ilka Maria] Univ Fed Ceara, Dept Bioquim & Biol Mol, BR-60440970 Fortaleza, Ceara, Brazil.
   [Souza, Terezinha Maria] Maastricht Univ, Netherlands Toxicogenom Ctr, NL-6229 ER Maastricht, Netherlands.
   [Soares, Bruno Marques] Univ Fed Ceara, Fac Med, Dept Fisiol & Farmacol, BR-60430270 Fortaleza, Ceara, Brazil.
   [Cunha, Arcelina Pacheco; Pontes Silva Ricardo, Nagila Maria] Univ Fed Ceara, Dept Quim Organ & Inorgan, BR-60440970 Fortaleza, Ceara, Brazil.
   [Pinheiro Ferreira, Paulo Michel] Univ Fed Piaui, Dept Ciencias Biol, BR-64600000 Picos, PI, Brazil.
   [Pinheiro Ferreira, Paulo Michel] Univ Fed Piaui, Programa Posgrad Ciencias Farmaceut, BR-64049550 Teresina, PI, Brazil.
   [Maciel Melo, Vania Maria; Urano Carvalho, Ana Fontenele] Univ Fed Ceara, Dept Biol, BR-60451970 Fortaleza, Ceara, Brazil.
RP Carvalho, AFU (corresponding author), Univ Fed Ceara, Dept Biol, Campus Pici, BR-60451970 Fortaleza, Ceara, Brazil.
EM aurano@ufc.br
RI da Silva, Pedro Almeida/B-6926-2012; Ahmad, Iqbal/I-1271-2019; Nunez,
   Cecilia V/I-9681-2016; Barison, Andersson/F-7134-2012; Carvalho,
   Ana/K-7344-2018; Osek, Jacek/ABD-3337-2020; Husain, Fohad M/D-3674-2014;
   Farias, Davi Felipe/AAH-1868-2020; de Souza, Terezinha/L-8727-2015;
   Ferreira, Paulo Michel Pinheiro/J-6783-2012; Ricardo, Nagila Maria
   Pontes Silva/C-3630-2015; Viana, Martonio/AAZ-4218-2020; Ramos,
   Daniela/AAN-1971-2020; Ramos, Daniela/AAK-4716-2020; Pilotto,
   Andrea/J-6852-2018; Melo, Vania/E-2377-2015
OI da Silva, Pedro Almeida/0000-0003-1666-1295; Nunez, Cecilia
   V/0000-0003-3400-9508; Barison, Andersson/0000-0001-9381-8239; Carvalho,
   Ana/0000-0001-5293-9317; Husain, Fohad M/0000-0001-6598-4328; de Souza,
   Terezinha/0000-0002-9580-3310; Ferreira, Paulo Michel
   Pinheiro/0000-0001-6862-6497; Ricardo, Nagila Maria Pontes
   Silva/0000-0003-1849-5403; Ramos, Daniela/0000-0001-6888-9553;
   Wieczorek, Kinga/0000-0001-8268-3885; Ahmad, Iqbal/0000-0001-8447-4497;
   Pilotto, Andrea/0000-0003-2029-6606; Melo, Vania/0000-0002-3302-8857;
   Kayal, Rayyan/0000-0003-3887-7775; Felipe Farias,
   Davi/0000-0001-5438-1919
FU Ministerio da Saude, Departamento de Ciencias e Tecnologia (DECIT);
   Secretaria de Ciencias, Tecnologia e Insumos estrategicos (SCTIE);
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao Cearense de Apoio Cientifico e Tecnologico (FUN-CAP)
FX The authors thank the Ministerio da Saude, Departamento de Ciencias e
   Tecnologia (DECIT), Secretaria de Ciencias, Tecnologia e Insumos
   estrategicos (SCTIE), Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq), and Fundacao Cearense de Apoio Cientifico e
   Tecnologico (FUN-CAP) for financial support of this research.
CR BENNETT RN, 1994, NEW PHYTOL, V127, P617, DOI 10.1111/j.1469-8137.1994.tb02968.x
   BERNHEIMER AW, 1988, METHOD ENZYMOL, V165, P213
   Cardoso-Lopes EM, 2010, MOLECULES, V15, P9205, DOI 10.3390/molecules15129205
   Chandrasekaran M, 2004, J ETHNOPHARMACOL, V91, P105, DOI 10.1016/j.jep.2003.12.012
   Cotelle N, 1996, FREE RADICAL BIO MED, V20, P35, DOI 10.1016/0891-5849(95)02014-4
   Cowan MM, 1999, CLIN MICROBIOL REV, V12, P564, DOI 10.1128/CMR.12.4.564
   de Albuquerque UP, 2008, B LATINOAM CARIBE PL, V7, P156
   De Albuquerque UP, 2007, J ETHNOPHARMACOL, V114, P325, DOI 10.1016/j.jep.2007.08.017
   de Almeida CFCBR, 2005, J ARID ENVIRON, V62, P127, DOI 10.1016/j.jaridenv.2004.09.020
   Edris AE, 2009, CURR CLIN PHARMACOL, V4, P43, DOI 10.2174/157488409787236137
   ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9
   Fernandez K, 2007, J AGR FOOD CHEM, V55, P7294, DOI 10.1021/jf071193d
   Ferreira PMP, 2011, AN ACAD BRAS CIENC, V83, P1045, DOI 10.1590/S0001-37652011005000017
   Fleischer TC, 2003, FITOTERAPIA, V74, P136, DOI 10.1016/S0367-326X(02)00289-7
   GRAYER RJ, 1994, PHYTOCHEMISTRY, V37, P19, DOI 10.1016/0031-9422(94)85005-4
   Hillhouse BJ, 2004, PHARM BIOL, V42, P68, DOI 10.1080/13880200490505636
   Howes MJR, 2003, PHYTOTHER RES, V17, P1, DOI 10.1002/ptr.1280
   Ji HF, 2008, ACTA PHARMACOL SIN, V29, P143, DOI 10.1111/j.1745-7254.2008.00752.x
   Katiyar Chandrakant, 2012, Ayu, V33, P10, DOI 10.4103/0974-8520.100295
   Lopez S, 2002, LIFE SCI, V71, P2521, DOI 10.1016/S0024-3205(02)02034-9
   Luize Patrícia Shima, 2005, Rev. Bras. Cienc. Farm., V41, P85, DOI 10.1590/S1516-93322005000100010
   MAIA G.N., 2004, CAATINGA ARVORES ARB
   Majhenic L, 2007, FOOD CHEM, V104, P1258, DOI 10.1016/j.foodchem.2007.01.074
   Matos F. J. A., 2000, PLANTAS MED GUIA SEL
   Matos F. J. A., 2004, CONSTITUINTES QUIMIC
   Matos F.J.A, 2009, INTRO FITOQUIMICA EX
   Mosquera OM, 2007, MEM I OSWALDO CRUZ, V102, P631, DOI 10.1590/S0074-02762007005000066
   Oh H, 2004, J ETHNOPHARMACOL, V95, P421, DOI 10.1016/j.jep.2004.08.015
   Ortega MG, 2004, PHYTOMEDICINE, V11, P539, DOI 10.1016/j.phymed.2003.07.006
   Osbourn AE, 1996, PLANT CELL, V8, P1821, DOI 10.1105/tpc.8.10.1821
   Rafat A, 2010, J MED PLANTS RES, V4, P197
   Sampaio E. V. S. B., 2000, VEGETACAO FLORA CAAT
   Sawasdee P, 2009, PHYTOTHER RES, V23, P1792, DOI 10.1002/ptr.2858
   Souza TM, 2011, J MED ENTOMOL, V48, P846, DOI 10.1603/ME10205
   Xavier-Filho J., 1993, SEMENTES SUAS DEFESA, P1
   Yepez B, 2002, FLUID PHASE EQUILIBR, V194, P879, DOI 10.1016/S0378-3812(01)00707-5
NR 36
TC 132
Z9 144
U1 0
U2 1
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2013
VL 2013
AR 510736
DI 10.1155/2013/510736
PG 9
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA 277QB
UT WOS:000328833200001
PM 23509750
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Borella, VM
   Custodio, CS
   Mello, BSF
   Cordeiro, RC
   Chaves, JH
   Queiroz, AIG
   Araujo, MM
   Nobre, HV
   Carvalho, AF
   Macedo, DS
AF Borella, V. M.
   Custodio, C. S.
   Mello, B. S. F.
   Cordeiro, R. C.
   Chaves, J. H.
   Queiroz, A. I. G.
   Araujo, M. M.
   Nobre, H. V.
   Carvalho, A. F.
   Macedo, D. S.
TI Systemic lipopolysaccharide administration causes time- and dose-related
   alterations in mouse behaviour
SO EUROPEAN NEUROPSYCHOPHARMACOLOGY
LA English
DT Meeting Abstract
CT 25th Congress of the European-College-of-Neuropsychopharmacology (ECNP)
CY OCT 13-17, 2012
CL Vienna, AUSTRIA
SP European Coll Neuropsychopharmacol (ECNP)
C1 [Borella, V. M.; Chaves, J. H.; Queiroz, A. I. G.; Araujo, M. M.; Macedo, D. S.] Univ Fed Ceara, Dept Fisiol & Farmacol, Fortaleza, Ceara, Brazil.
   [Custodio, C. S.; Mello, B. S. F.; Nobre, H. V.] Univ Fed Ceara, Dept Patol & Med Legal, Fortaleza, Ceara, Brazil.
   [Cordeiro, R. C.; Carvalho, A. F.] Univ Fed Ceara, Dept Med Clin, Fortaleza, Ceara, Brazil.
RI Macedo, Danielle/E-3424-2014
OI Macedo, Danielle/0000-0001-8980-9970
CR Bay-Richter C, 2011, BEHAV BRAIN RES, V222, P193, DOI 10.1016/j.bbr.2011.03.060
   Haruhiko S.A.B., 2009, PROGR NEUROPSYCHOPHA, V33, P303
NR 2
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0924-977X
J9 EUR NEUROPSYCHOPHARM
JI Eur. Neuropsychopharmacol.
PD OCT
PY 2012
VL 22
SU 2
BP S187
EP S187
DI 10.1016/S0924-977X(12)70268-7
PG 1
WC Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry
SC Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry
GA 130VQ
UT WOS:000317948600159
DA 2020-12-08
ER

PT J
AU Borella, VM
   Belchior, LD
   Dos Santos, JV
   Nascimento, NL
   De Souza, MRM
   Monte, AS
   Medeiros, CD
   Cordeiro, RC
   Carvalho, AF
   Macedo, DS
AF Borella, V. M.
   Belchior, L. D.
   Dos Santos, J. V.
   Nascimento, N. L.
   De Souza, M. R. M.
   Monte, A. S.
   Medeiros, C. D.
   Cordeiro, R. C.
   Carvalho, A. F.
   Macedo, D. S.
TI Determination of alpha-lipoic acid and acetyl-L-carnitine administration
   effects in a Parkinson animal model induced by 6-OHDA
SO EUROPEAN NEUROPSYCHOPHARMACOLOGY
LA English
DT Meeting Abstract
CT 25th Congress of the European-College-of-Neuropsychopharmacology (ECNP)
CY OCT 13-17, 2012
CL Vienna, AUSTRIA
SP European Coll Neuropsychopharmacol (ECNP)
C1 [Borella, V. M.; Belchior, L. D.; Dos Santos, J. V.; Nascimento, N. L.; De Souza, M. R. M.; Monte, A. S.; Macedo, D. S.] Univ Fed Ceara, Dept Fisiol & Farmacol, Fortaleza, Ceara, Brazil.
   [Medeiros, C. D.; Cordeiro, R. C.; Carvalho, A. F.] Univ Fed Ceara, Dept Clin Med, Fortaleza, Ceara, Brazil.
RI Macedo, Danielle/E-3424-2014
OI Macedo, Danielle/0000-0001-8980-9970; De Souza,
   Marcos/0000-0002-9365-3224
CR GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X
   Huong NTT, 1998, BIOL PHARM BULL, V21, P978, DOI 10.1248/bpb.21.978
NR 2
TC 0
Z9 0
U1 0
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0924-977X
J9 EUR NEUROPSYCHOPHARM
JI Eur. Neuropsychopharmacol.
PD OCT
PY 2012
VL 22
SU 2
BP S181
EP S182
DI 10.1016/S0924-977X(12)70259-6
PG 2
WC Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry
SC Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry
GA 130VQ
UT WOS:000317948600150
DA 2020-12-08
ER

PT J
AU Carvalho, AF
   Monte, AS
   Cordeiro, RC
   Dos Santos, JV
   Borella, VCM
   Oliveira, GV
   Araujo, FYR
   Oliveira, TQ
   Escudeiro, SS
   Macedo, DS
AF Carvalho, A. F.
   Monte, A. S.
   Cordeiro, R. C.
   Dos Santos, J. V.
   Borella, V. C. M.
   Oliveira, G. V.
   Araujo, F. Y. R.
   Oliveira, T. Q.
   Escudeiro, S. S.
   Macedo, D. S.
TI Prevention and reversal of ketamine-induced behavioural alterations by
   minocycline administration in mice
SO EUROPEAN NEUROPSYCHOPHARMACOLOGY
LA English
DT Meeting Abstract
CT 25th Congress of the European-College-of-Neuropsychopharmacology (ECNP)
CY OCT 13-17, 2012
CL Vienna, AUSTRIA
SP European Coll Neuropsychopharmacol (ECNP)
C1 [Carvalho, A. F.; Cordeiro, R. C.] Univ Fed Ceara, Dept Clin Med, Fortaleza, Ceara, Brazil.
   [Monte, A. S.; Dos Santos, J. V.; Borella, V. C. M.; Oliveira, G. V.; Araujo, F. Y. R.; Oliveira, T. Q.; Escudeiro, S. S.; Macedo, D. S.] Univ Fed Ceara, Dept Fisiol & Farmacol, Fortaleza, Ceara, Brazil.
RI Macedo, Danielle/E-3424-2014
OI Macedo, Danielle/0000-0001-8980-9970
CR Monji A., 2011, PROG NEUROPSYCHOPHAR
NR 1
TC 0
Z9 0
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0924-977X
J9 EUR NEUROPSYCHOPHARM
JI Eur. Neuropsychopharmacol.
PD OCT
PY 2012
VL 22
SU 2
BP S181
EP S181
DI 10.1016/S0924-977X(12)70258-4
PG 1
WC Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry
SC Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry
GA 130VQ
UT WOS:000317948600149
DA 2020-12-08
ER

PT J
AU Souza, TM
   Cunha, AP
   Farias, DF
   Machado, LK
   Morais, SM
   Ricardo, NMPS
   Carvalho, AFU
AF Souza, Terezinha M.
   Cunha, Arcelina P.
   Farias, Davi F.
   Machado, Lyeghyna K.
   Morais, Selene M.
   Ricardo, Nagila M. P. S.
   Carvalho, Ana F. U.
TI Insecticidal activity against Aedes aegypti of m-pentadecadienyl-phenol
   isolated from Myracrodruon urundeuva seeds
SO PEST MANAGEMENT SCIENCE
LA English
DT Article
DE Aedes aegypti; cardanol diene; larvicidal; mode of action;
   m-pentadecadienyl-phenol; Myracrodruon urundeuva
ID LARVICIDAL ACTIVITY; ESSENTIAL OILS; TOXICITY; DIPTERA; CULICIDAE;
   EXTRACTS; STRAINS; LARVAE
AB BACKGROUND: Myracrodruon urundeuva Fr. Allemao is a common tree in the Caatinga that has been widely used for various medical purposes. Previous studies showed that the ethanol seed extract of M. urundeuva has potent activity against the larval stage of the dengue vector Aedes aegypti. Given this potential insecticidal activity, bioguided separation steps were performed in order to isolate the active compound(s). RESULTS: The isolation process resulted in only one active chemical compound, identified by infrared spectroscopy and mass spectrometry as m-pentadecadienyl-phenol. This compound presented potent larvicidal and pupicidal activity (LC50 10.16 and 99.06 mu g mL-1 respectively) and great egg hatching inhibitory activity (IC50 49.79 mu g mL-1). The mode of action was investigated through observations of behavioural and morphological changes performed in third-instar larvae treated with m-pentadecadienyl-phenol solution after 1, 6, 12, 16 and 20 h of exposure. Some changes were observed as flooding of the tracheal system, alterations in siphonal valves and anal gills and lethargy, probably caused by the strong anticholinesterasic activity reported previously. CONCLUSION: The compound isolated from M. urundeuva seeds, m-pentadecadienyl-phenol, showed potent activity against immature stages of dengue vector, Ae. aegypti, being considered the main larvicidal principle. Copyright (C) 2012 Society of Chemical Industry
C1 [Carvalho, Ana F. U.] Univ Fed Ceara, Dept Biol, BR-60455760 Fortaleza, CE, Brazil.
   [Souza, Terezinha M.; Farias, Davi F.] Univ Fed Ceara, Dept Biochem & Mol Biol, BR-60455760 Fortaleza, CE, Brazil.
   [Cunha, Arcelina P.; Ricardo, Nagila M. P. S.] Univ Fed Ceara, Dept Organ & Inorgan Chem, BR-60455760 Fortaleza, CE, Brazil.
   [Machado, Lyeghyna K.; Morais, Selene M.] Univ Estadual Ceara, Dept Chem, Fortaleza, CE, Brazil.
RP Carvalho, AFU (corresponding author), Univ Fed Ceara, Dept Biol, Campus Pici, BR-60455760 Fortaleza, CE, Brazil.
EM aurano@ufc.br
RI Farias, Davi Felipe/AAH-1868-2020; Carvalho, Ana/K-7344-2018; Ricardo,
   Nagila Maria Pontes Silva/C-3630-2015; de Souza, Terezinha/L-8727-2015
OI Carvalho, Ana/0000-0001-5293-9317; Ricardo, Nagila Maria Pontes
   Silva/0000-0003-1849-5403; de Souza, Terezinha/0000-0002-9580-3310;
   Felipe Farias, Davi/0000-0001-5438-1919
FU Ministerio da Saude through Departamento de Ciencia e Tecnologia
   (DECIT); Secretaria de Ciencia, Tecnologia e Insumos Estrategicos
   (SCTIE); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao Cearense de Apoio Cientifico e Tecnologico (FUNCAP)
FX The authors thank Ministerio da Saude, through Departamento de Ciencia e
   Tecnologia (DECIT), Secretaria de Ciencia, Tecnologia e Insumos
   Estrategicos (SCTIE), Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq) and Fundacao Cearense de Apoio Cientifico e
   Tecnologico (FUNCAP) for financial support of this research.
CR Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a
   Adams R., 2001, IDENTIFICATION ESSEN
   BARBEHENN RV, 1994, J CHEM ECOL, V20, P1985, DOI 10.1007/BF02066238
   Barbehenn RV, 1996, J CHEM ECOL, V22, P1901, DOI 10.1007/BF02028511
   Becker N, 2000, ENTOMOPATHOGENIC BAC, P383
   Braga IA, 2007, EPIDEMIOL SERV SAUDE, V16, P295, DOI [10.5123/S1679-49742007000400007, DOI 10.5123/S1679-49742007000400007]
   Carvalho AFU, 2003, MEM I OSWALDO CRUZ, V98, P569, DOI 10.1590/S0074-02762003000400027
   Chaiyasit D, 2006, PARASITOL RES, V99, P715, DOI 10.1007/s00436-006-0232-x
   Cheng SS, 2009, BIORESOURCE TECHNOL, V100, P452, DOI 10.1016/j.biortech.2008.02.038
   Coelho JS, 2009, CHEMOSPHERE, V77, P934, DOI 10.1016/j.chemosphere.2009.08.022
   Consoli R.A.G.B, 1994, PRINCIPAIS MOSQUITOS
   Corbet SA, 2000, ENTOMOL EXP APPL, V94, P295, DOI 10.1023/A:1003920817649
   Oliveira MSC, 2011, ACTA TROP, V117, P165, DOI 10.1016/j.actatropica.2010.08.003
   David JP, 2000, J INVERTEBR PATHOL, V75, P9, DOI 10.1006/jipa.1999.4886
   Farias DF, 2010, AN ACAD BRAS CIENC, V82, P585, DOI 10.1590/S0001-37652010000300006
   Farias DF, 2009, J AM MOSQUITO CONTR, V25, P386, DOI 10.2987/08-5851.1
   Ferreira Barreto Cleyde, 2006, Revista de Patologia Tropical, V35, P37
   Finney D. J., 1971, PROBIT ANAL
   Gibbons RV, 2010, INT J ANTIMICROB AG, V36, pS36, DOI 10.1016/j.ijantimicag.2010.06.019
   Henn M, 1997, M D GESELL ALLG ANGE, V11, P495
   Hoskins WM, 1943, HILGARDIA, V13, P307
   Marques MMM, 2011, J AM MOSQUITO CONTR, V27, P156, DOI 10.2987/10-6056.1
   Moreira MF, 2007, INSECT BIOCHEM MOLEC, V37, P1249, DOI 10.1016/j.ibmb.2007.07.017
   Nobre-Junior HV, 2009, NEUROCHEM RES, V34, P1066, DOI 10.1007/s11064-008-9876-5
   O'Kane WC, 1934, NEW HAMPSHIRE AGR EX
   Paquot C., 1987, STAND METH AN OILS F
   Park HM, 2011, J MED ENTOMOL, V48, P405, DOI 10.1603/ME10108
   Polanczyk RA, 2003, REV SAUDE PUBL, V37, P813, DOI 10.1590/S0034-89102003000600020
   Rahuman AA, 2008, PARASITOL RES, V103, P1383, DOI 10.1007/s00436-008-1146-6
   Sa RA, 2009, INT BIODETER BIODEGR, V63, P470, DOI 10.1016/j.ibiod.2009.01.002
   Sa RA, 2009, COMP BIOCHEM PHYS C, V149, P300, DOI 10.1016/j.cbpc.2008.08.004
   Santos SRL, 2010, VECTOR-BORNE ZOONOT, V10, P1049, DOI 10.1089/vbz.2009.0158
   Satyan RS, J EC ENTOMOL, V102, P1197
   Shepard DS, 2011, AM J TROP MED HYG, V84, P200, DOI 10.4269/ajtmh.2011.10-0503
   Souza TM, 2011, J MED ENTOMOL, V48, P846, DOI 10.1603/ME10205
   Taverner P, 2001, SPRAY OILS 2000 SUST, P81
   Waliwitiya R, 2009, PEST MANAG SCI, V65, P241, DOI 10.1002/ps.1675
NR 37
TC 11
Z9 12
U1 0
U2 26
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 1526-498X
EI 1526-4998
J9 PEST MANAG SCI
JI Pest Manag. Sci.
PD OCT
PY 2012
VL 68
IS 10
BP 1380
EP 1384
DI 10.1002/ps.3316
PG 5
WC Agronomy; Entomology
SC Agriculture; Entomology
GA 003YM
UT WOS:000308647300009
PM 22689540
DA 2020-12-08
ER

PT J
AU de Lima, GPG
   da Rocha-Bezerra, LCB
   de Macedo, LLP
   Bemquerer, MP
   de Sa, MFG
   Carvalho, AFU
AF Gomes de Lima, G. P.
   Brito da Rocha-Bezerra, L. C.
   Pepino de Macedo, L. L.
   Bemquerer, M. P.
   Grossi de Sa, M. F.
   Carvalho, A. F. U.
TI Purification, partial characterization and in vitro biological activity
   against pest insects of a novel trypsin inhibitor from Sapindus
   saponaria seeds
SO FEBS JOURNAL
LA English
DT Meeting Abstract
CT 22nd IUBMB Congress/37th FEBS Congress
CY SEP 04-09, 2012
CL Seville, SPAIN
SP IUBMB, FEBS
C1 [Gomes de Lima, G. P.; Brito da Rocha-Bezerra, L. C.; Carvalho, A. F. U.] Univ Fed Ceara, Lab Bioprospeccao Recursos Regionais, Fortaleza, Ceara, Brazil.
   [Pepino de Macedo, L. L.; Grossi de Sa, M. F.] Embrapa Recursos Genet & Biotecnol, Lab Interacao Mol Planta Praga 1, Brasilia, DF, Brazil.
   [Bemquerer, M. P.] Embrapa Recursos Genet & Biotecnol, Lab Espectrometria Massa, Brasilia, DF, Brazil.
RI Carvalho, Ana/K-7344-2018; Grossi-de-Sa, Maria Fatima/N-7856-2017;
   Bemquerer, Marcelo Porto/A-9688-2013
OI Carvalho, Ana/0000-0001-5293-9317; Bemquerer, Marcelo
   Porto/0000-0002-9740-5818
NR 0
TC 0
Z9 0
U1 0
U2 8
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1742-464X
J9 FEBS J
JI FEBS J.
PD SEP
PY 2012
VL 279
SU 1
SI SI
BP 81
EP 81
PG 1
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 996XR
UT WOS:000308128601095
DA 2020-12-08
ER

PT J
AU Carvalho, AFU
   de Sousa, NM
   Farias, DF
   da Rocha-Bezerra, LCB
   da Silva, RMP
   Viana, MP
   Gouveia, ST
   Saker-Sampaio, S
   de Sousa, MB
   de Lima, GPG
   de Morais, SM
   Barros, CC
   Freire, FR
AF Urano Carvalho, Ana Fontenele
   de Sousa, Nathanna Mateus
   Farias, Davi Felipe
   Brito da Rocha-Bezerra, Lady Clarissa
   Pereira da Silva, Renata Maria
   Viana, Martonio Ponte
   Gouveia, Sandro Thomaz
   Saker-Sampaio, Silvana
   de Sousa, Marcia Barbosa
   Gomes de Lima, Glauber Pacelli
   de Morais, Selene Maia
   Barros, Caroline Costa
   Freire Filho, Francisco Rodrigues
TI Nutritional ranking of 30 Brazilian genotypes of cowpeas including
   determination of antioxidant capacity and vitamins
SO JOURNAL OF FOOD COMPOSITION AND ANALYSIS
LA English
DT Article
DE Vigna unguiculata; Cowpea; Proteins; Dietary fiber; Vitamins;
   Antioxidant capacity; Conventional genetic breeding; Unintentional
   effects; Food composition; Biodiversity
ID VIGNA-UNGUICULATA; ACID-COMPOSITION; SOY PRODUCTS; DIGESTIBILITY;
   TOCOPHEROL; PROTEINS; LINES; FOOD
AB This study aimed to establish a nutritional ranking of 30 genotypes of cowpea (Vigna unguiculata L Walp). The results showed the proximate composition vanes among genotypes in protein (20-30%) and dietary fiber contents (20-35%), in protease inhibitors (2-4 UI/mu g protein), lectin (40,000-640,000 UH/kg meal) and essential amino acid levels, in vitro protein digestibility (30-40%) and in the apparent concentration of expressed proteins. The antioxidant capacity varied from EC50 of 9.54-38.7 mg seed extract/mL DPPH and the highest values detected for alpha- and delta-tocopherol were 0.38 mg/g and 1.88 mg/g, respectively. The analysis of a nutritional quality index based on the weighted average content of total protein, dietary fiber, iron, zinc, protease inhibitors and lectins allowed ranking genotypes. In descending order the 5 best genotypes were: BRS-Cauarne > BRS-Tumucumaque > Canapuzinho > BRS-Potengi > BRS-Urubuquara. (C) 2012 Elsevier Inc. All rights reserved.
C1 [Urano Carvalho, Ana Fontenele; Pereira da Silva, Renata Maria; Viana, Martonio Ponte] Univ Fed Ceara, Dept Biol, BR-60455970 Fortaleza, Ceara, Brazil.
   [de Sousa, Nathanna Mateus; Farias, Davi Felipe; Brito da Rocha-Bezerra, Lady Clarissa; Gomes de Lima, Glauber Pacelli] Univ Fed Ceara, Dept Bioquim & Biol Mol, BR-60455970 Fortaleza, Ceara, Brazil.
   [Gouveia, Sandro Thomaz] Univ Fed Ceara, Dept Quim Analit, BR-60455970 Fortaleza, Ceara, Brazil.
   [Saker-Sampaio, Silvana; de Sousa, Marcia Barbosa] Univ Fed Ceara, Dept Engn Pesca, BR-60455460 Fortaleza, Ceara, Brazil.
   [de Morais, Selene Maia; Barros, Caroline Costa] Univ Estadual Ceara, Dept Quim, BR-60740000 Fortaleza, Ceara, Brazil.
   [Freire Filho, Francisco Rodrigues] Empresa Brasileira Pesquisa Agropecuaria, Embrapa Meio Norte, Teresina, Piaui, Brazil.
RP Carvalho, AFU (corresponding author), Univ Fed Ceara, Dept Biol, Campus Pici, BR-60455970 Fortaleza, Ceara, Brazil.
EM aurano@ufc.br
RI Farias, Davi Felipe/AAH-1868-2020; Carvalho, Ana/K-7344-2018; Sampaio,
   Alexandre H/P-5222-2019; Viana, Martonio/AAZ-4218-2020; Saker, Samir
   H/Y-4774-2018
OI Carvalho, Ana/0000-0001-5293-9317; Saker, Samir H/0000-0003-2793-0972;
   Felipe Farias, Davi/0000-0001-5438-1919; GOUVEIA,
   SANDRO/0000-0001-5494-6705; Gomes de Lima, Glauber
   Pacelli/0000-0002-5366-4551
FU Ministerio da Saude through Departamento de Ciencia e Tecnologia (DECIT)
   [090.999.98-3]; Ministerio da Saude through Secretaria de Ciencia,
   Tecnologia e Insumos Estrategicos (SCTIE) [090.999.98-3]; Ministerio da
   Saude through Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq) [090.999.98-3]; Ministerio da Saude through Fundacao
   de Amparo a Pesquisa do Estado do Ceara (FUNCAP) [090.999.98-3]
FX The authors wish to thank Ministerio da Saude, through Departamento de
   Ciencia e Tecnologia (DECIT), Secretaria de Ciencia, Tecnologia e
   Insumos Estrategicos (SCTIE), Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do
   Estado do Ceara (FUNCAP) for their financial support Project Number SPU
   No. 090.999.98-3.
CR Amarowicza R., 2011, INT J MOL SCI, V10, P5513
   AOAC, 2000, OFF METH AN
   Atherton K.T., 2002, GENETICALLY MODIFIED
   BAETHGEN WE, 1989, COMMUN SOIL SCI PLAN, V20, P961, DOI 10.1080/00103628909368129
   Boye J, 2010, FOOD RES INT, V43, P414, DOI 10.1016/j.foodres.2009.09.003
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Brownlee IA, 2011, FOOD HYDROCOLLOID, V25, P238, DOI 10.1016/j.foodhyd.2009.11.013
   de Sousa MB, 2008, CIENCIA TECNOL ALIME, V28, P953, DOI 10.1590/S0101-20612008000400030
   Duranti M, 2006, FITOTERAPIA, V77, P67, DOI 10.1016/j.fitote.2005.11.008
   Mendonca CVCE, 2003, CIENC AGROTEC, V27, P858, DOI 10.1590/S1413-70542003000400018
   ERLANGER BF, 1961, ARCH BIOCHEM BIOPHYS, V95, P271, DOI 10.1016/0003-9861(61)90145-X
   FAO/WHO/UNU, 1985, REP JOINT FAO WHO UN, V27
   FDA, 2010, NUTR LAB ED ACT NLEA
   Giami SY, 2005, J FOOD COMPOS ANAL, V18, P665, DOI 10.1016/j.jfca.2004.06.007
   Gouveia ST, 2002, J FOOD ENG, V51, P59, DOI 10.1016/S0260-8774(01)00037-1
   GRELA ER, 1995, ANIM FEED SCI TECH, V52, P325, DOI 10.1016/0377-8401(94)00733-P
   HAMERSTRAND GE, 1981, CEREAL CHEM, V58, P42
   Heimler D, 2005, J AGR FOOD CHEM, V53, P3053, DOI 10.1021/jf049001r
   Iqbal A, 2006, FOOD CHEM, V97, P331, DOI 10.1016/j.foodchem.2005.05.011
   KAKADE ML, 1974, CEREAL CHEM, V51, P376
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Maia FMM, 2000, J SCI FOOD AGR, V80, P453, DOI 10.1002/(SICI)1097-0010(200003)80:4&lt;453::AID-JSFA548&gt;3.0.CO;2-X
   Mesquita FR, 2007, CIENC AGROTEC, V31, P1114, DOI 10.1590/S1413-70542007000400026
   Onwuliri VA, 2002, FOOD CHEM, V78, P1, DOI 10.1016/S0308-8146(00)00293-4
   Otten JJ, 2006, DIETARY REFERENCE IN
   Phillips RD, 2003, FIELD CROP RES, V82, P193, DOI 10.1016/S0378-4290(03)00038-8
   PINTERSZAKACS M, 1990, J AGR FOOD CHEM, V38, P720, DOI 10.1021/jf00093a028
   SHOSHIMA AHR, 2005, BRAZ J FOOD TECHNOL, V8, P299
   Tang CH, 2009, FOOD CHEM, V113, P957, DOI 10.1016/j.foodchem.2008.08.038
   Vasconcelos IM, 2010, J FOOD COMPOS ANAL, V23, P54, DOI 10.1016/j.jfca.2009.05.008
   VASCONCELOS IM, 1994, ARCH BIOCHEM BIOPHYS, V312, P357, DOI 10.1006/abbi.1994.1320
   Wang TL, 2003, PLANT PHYSIOL, V131, P886, DOI 10.1104/pp.102.017665
   White PJ, 2009, NEW PHYTOL, V182, P49, DOI 10.1111/j.1469-8137.2008.02738.x
   Yepez B, 2002, FLUID PHASE EQUILIBR, V194, P879, DOI 10.1016/S0378-3812(01)00707-5
NR 34
TC 39
Z9 41
U1 0
U2 15
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0889-1575
EI 1096-0481
J9 J FOOD COMPOS ANAL
JI J. Food Compos. Anal.
PD MAY-JUN
PY 2012
VL 26
IS 1-2
BP 81
EP 88
DI 10.1016/j.jfca.2012.01.005
PG 8
WC Chemistry, Applied; Food Science & Technology
SC Chemistry; Food Science & Technology
GA 969HG
UT WOS:000306045700010
OA Green Published
DA 2020-12-08
ER

PT J
AU Macedo, DS
   Araujo, DP
   Sampaio, LRL
   Vasconcelos, SMM
   Sales, PMG
   Sousa, FCF
   Hallak, JE
   Crippa, JA
   Carvalho, AF
AF Macedo, D. S.
   Araujo, D. P.
   Sampaio, L. R. L.
   Vasconcelos, S. M. M.
   Sales, P. M. G.
   Sousa, F. C. F.
   Hallak, J. E.
   Crippa, J. A.
   Carvalho, A. F.
TI Animal models of prenatal immune challenge and their contribution to the
   study of schizophrenia: a systematic review
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Review
DE Schizophrenia; Animal models; Neurodevelopment; Prenatal immune
   activation; Poly-I:C
ID DISRUPTED LATENT INHIBITION; NEUROCHEMICAL ABNORMALITIES; DOPAMINERGIC
   HYPERFUNCTION; PHARMACOLOGICAL CHANGES; ACTIVATION LEADS;
   VIRAL-INFECTION; ADULT BRAIN; MICE LEADS; RATS; HIPPOCAMPUS
AB Prenatal immune challenge (PIC) in pregnant rodents produces offspring with abnormalities in behavior, histology, and gene expression that are reminiscent of schizophrenia and autism. Based on this, the goal of this article was to review the main contributions of PIC models, especially the one using the viral-mimetic particle polyriboinosinic-polyribocytidylic acid (poly-I:C), to the understanding of the etiology, biological basis and treatment of schizophrenia. This systematic review consisted of a search of available web databases (PubMed, SciELO, LILACS, PsycINFO, and ISI Web of Knowledge) for original studies published in the last 10 years (May 2001 to October 2011) concerning animal models of PIC, focusing on those using poly-I: C. The results showed that the PIC model with poly-I: C is able to mimic the prodrome and both the positive and negative/cognitive dimensions of schizophrenia, depending on the specific gestation time window of the immune challenge. The model resembles the neurobiology and etiology of schizophrenia and has good predictive value. In conclusion, this model is a robust tool for the identification of novel molecular targets during prenatal life, adolescence and adulthood that might contribute to the development of preventive and/or treatment strategies (targeting specific symptoms, i.e., positive or negative/cognitive) for this devastating mental disorder, also presenting biosafety as compared to viral infection models. One limitation of this model is the incapacity to model the full spectrum of immune responses normally induced by viral exposure.
C1 [Macedo, D. S.] Univ Fed Ceara, Dept Fisiol & Farmacol, Lab Neurofarmacol, Fac Med, BR-60431270 Fortaleza, Ceara, Brazil.
   [Sales, P. M. G.; Carvalho, A. F.] Univ Fed Ceara, Fac Med, Dept Clin Med, BR-60431270 Fortaleza, Ceara, Brazil.
   [Hallak, J. E.; Crippa, J. A.] Univ Sao Paulo, Fac Med Ribeirao Preto, Hosp Clin, Dept Neurol Psiquiatria & Psicol Med, Ribeirao Preto, SP, Brazil.
RP Macedo, DS (corresponding author), Univ Fed Ceara, Dept Fisiol & Farmacol, Lab Neurofarmacol, Fac Med, Rua Coronel Nunes de Melo 1127, BR-60431270 Fortaleza, Ceara, Brazil.
EM daniellesm2000@yahoo.com
RI Crippa, Jose Alexandre S/A-1215-2008; Macedo, Danielle/E-3424-2014;
   Hallak, Jaime E C/J-3547-2012; de Sousa, Francisca Clea
   Florenco/ABA-5683-2020; Vasconcelos, Silvania/N-4470-2017
OI Macedo, Danielle/0000-0001-8980-9970; Vasconcelos,
   Silvania/0000-0003-1478-0127; Florenco, Francisca
   Clea/0000-0002-9140-1795
CR Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560
   Amann LC, 2010, BRAIN RES BULL, V83, P147, DOI 10.1016/j.brainresbull.2010.04.008
   Andreasen NC, 1999, ARCH GEN PSYCHIAT, V56, P781, DOI 10.1001/archpsyc.56.9.781
   Bitanihirwe BKY, 2010, NEUROPSYCHOPHARMACOL, V35, P2462, DOI 10.1038/npp.2010.129
   Borrell J, 2002, NEUROPSYCHOPHARMACOL, V26, P204, DOI 10.1016/S0893-133X(01)00360-8
   Brown AS, 2010, AM J PSYCHIAT, V167, P261, DOI 10.1176/appi.ajp.2009.09030361
   Brown AS, 2002, MENT RETARD DEV D R, V8, P51, DOI 10.1002/mrdd.10004
   Cardon M, 2010, MOL PSYCHIATR, V15, P415, DOI 10.1038/mp.2009.66
   Clarke MC, 2006, SCHIZOPHRENIA BULL, V32, P3, DOI 10.1093/schbul/sbj028
   De Miranda J, 2010, MBIO, V1, DOI 10.1128/mBio.00176-10
   Dickerson DD, 2010, J NEUROSCI, V30, P12424, DOI 10.1523/JNEUROSCI.3046-10.2010
   Fatemi SH, 2009, SCHIZOPHRENIA BULL, V35, P528, DOI 10.1093/schbul/sbn187
   Fortier ME, 2007, BEHAV BRAIN RES, V181, P270, DOI 10.1016/j.bbr.2007.04.016
   Gilmore JH, 2005, J NEUROIMMUNOL, V159, P106, DOI 10.1016/j.jneuroim.2004.10.008
   Gogtay N, 2011, SCHIZOPHRENIA BULL, V37, P504, DOI 10.1093/schbul/sbr030
   Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636
   Haro JM, 2003, ACTA PSYCHIAT SCAND, V107, P16, DOI 10.1034/j.1600-0447.107.s416.5.x
   Harrison PJ, 1999, LANCET, V353, P3, DOI 10.1016/S0140-6736(05)74878-9
   Hsiao EY, 2011, BRAIN BEHAV IMMUN, V25, P604, DOI 10.1016/j.bbi.2010.12.017
   Ibi D, 2009, NEUROSCI RES, V64, P297, DOI 10.1016/j.neures.2009.03.015
   Ito HT, 2010, BRAIN BEHAV IMMUN, V24, P930, DOI 10.1016/j.bbi.2010.03.004
   Kaufman MH, 2003, ATLAS MOUSE DEV
   Kissling W, 1999, FORTSCHR NEUROL PSYC, V67, P29, DOI 10.1055/s-2007-993735
   Koshibu K, 2004, NEUROIMAGE, V22, P1636, DOI 10.1016/j.neuroimage.2004.03.051
   Lancaster K, 2007, BEHAV BRAIN RES, V176, P141, DOI 10.1016/j.bbr.2006.06.013
   Lara D, 2004, BASES BIOL TRANSTORN, P285
   Le-Niculescu H, 2007, AM J MED GENET B, V144B, P129, DOI 10.1002/ajmg.b.30481
   Li Q, 2010, NEUROIMAGE, V52, P1, DOI 10.1016/j.neuroimage.2010.04.015
   Li Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006354
   Makinodan M, 2008, J NEUROSCI RES, V86, P2190, DOI 10.1002/jnr.21673
   McGrath J, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-13
   Meyer U, 2008, MOL PSYCHIATR, V13, P208, DOI 10.1038/sj.mp.4002042
   Meyer U, 2008, NEUROSCIENCE, V154, P701, DOI 10.1016/j.neuroscience.2008.04.031
   Meyer U, 2006, J NEUROSCI, V26, P4752, DOI 10.1523/JNEUROSCI.0099-06.2006
   Meyer U, 2005, NEUROSCI BIOBEHAV R, V29, P913, DOI 10.1016/j.neubiorev.2004.10.012
   Meyer U, 2008, BRAIN BEHAV IMMUN, V22, P469, DOI 10.1016/j.bbi.2007.09.012
   Meyer U, 2006, EXP BRAIN RES, V173, P243, DOI 10.1007/s00221-006-0419-5
   Meyer U, 2006, BRAIN BEHAV IMMUN, V20, P378, DOI 10.1016/j.bbi.2005.11.003
   Meyer U, 2012, NEUROPHARMACOLOGY, V62, P1308, DOI 10.1016/j.neuropharm.2011.01.009
   Meyer U, 2011, PEDIATR RES, V69, p26R, DOI 10.1203/PDR.0b013e318212c196
   Meyer U, 2010, SCHIZOPHRENIA BULL, V36, P607, DOI 10.1093/schbul/sbn131
   Meyer U, 2009, BEHAV BRAIN RES, V204, P322, DOI 10.1016/j.bbr.2008.12.022
   Moore H, 2010, SCHIZOPHRENIA BULL, V36, P1066, DOI 10.1093/schbul/sbq106
   Moreno JL, 2011, J NEUROSCI, V31, P1863, DOI 10.1523/JNEUROSCI.4230-10.2011
   Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647
   Oh-Nishi A, 2010, BRAIN RES, V1363, P170, DOI 10.1016/j.brainres.2010.09.054
   Ozawa K, 2006, BIOL PSYCHIAT, V59, P546, DOI 10.1016/j.biopsych.2005.07.031
   Pearce BD, 2001, MOL PSYCHIATR, V6, P634, DOI 10.1038/sj.mp.4000956
   Piontkewitz Y, 2011, SCHIZOPHRENIA BULL, V37, P1257, DOI 10.1093/schbul/sbq040
   Piontkewitz Y, 2009, BIOL PSYCHIAT, V66, P1038, DOI 10.1016/j.biopsych.2009.07.005
   Richtand NM, 2011, J PSYCHIATR RES, V45, P1194, DOI 10.1016/j.jpsychires.2011.02.007
   Roenkerd NL, 2011, NEUROSCI LETT, V500, P167, DOI 10.1016/j.neulet.2011.06.011
   Saha S, 2005, PLOS MED, V2, P413, DOI 10.1371/journal.pmed.0020141
   Salgado JV, 2006, REV BRAS PSIQUIATR, V28, P135, DOI 10.1590/S1516-44462006000200012
   Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013
   Schnieder TP, 2011, BIOL PSYCHIAT, V69, P134, DOI 10.1016/j.biopsych.2010.08.027
   Shi LM, 2009, BRAIN BEHAV IMMUN, V23, P116, DOI 10.1016/j.bbi.2008.07.012
   Shi LM, 2003, J NEUROSCI, V23, P297, DOI 10.1523/jneurosci.23-01-00297.2003
   Smith SEP, 2007, J NEUROSCI, V27, P10695, DOI 10.1523/JNEUROSCI.2178-07.2007
   Soumiya H, 2011, J NEUROSCI RES, V89, P1342, DOI 10.1002/jnr.22636
   Takeuchi O, 2004, J ENDOTOXIN RES, V10, P252, DOI 10.1179/096805104225005896
   Trzesniak C, 2011, PROG NEURO-PSYCHOPH, V35, P877, DOI 10.1016/j.pnpbp.2010.12.024
   Trzesniak C, 2011, SCHIZOPHR RES, V125, P1, DOI 10.1016/j.schres.2010.09.016
   Vuillermot S, 2010, J NEUROSCI, V30, P1270, DOI 10.1523/JNEUROSCI.5408-09.2010
   Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140
   WEINBERGER DR, 1995, LANCET, V346, P552, DOI 10.1016/S0140-6736(95)91386-6
   Winter C, 2009, INT J NEUROPSYCHOPH, V12, P513, DOI 10.1017/S1461145708009206
   Wolff AR, 2008, BEHAV BRAIN RES, V190, P156, DOI 10.1016/j.bbr.2008.02.021
   Zuckerman L, 2005, J PSYCHIATR RES, V39, P311, DOI 10.1016/j.jpsychires.2004.08.008
   Zuckerman L, 2003, PSYCHOPHARMACOLOGY, V169, P308, DOI 10.1007/s00213-003-1461-7
   Zuckerman L, 2003, NEUROPSYCHOPHARMACOL, V28, P1778, DOI 10.1038/sj.npp.1300248
NR 71
TC 20
Z9 22
U1 0
U2 19
PU ASSOC BRAS DIVULG CIENTIFICA
PI RIBEIRAO PRETO
PA FACULDADE MEDICINA, CASA 10, 14049 RIBEIRAO PRETO, RIBEIRAO PRETO, SP
   14049, BRAZIL
SN 0100-879X
EI 1414-431X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PD MAR
PY 2012
VL 45
IS 3
BP 179
EP 186
DI 10.1590/S0100-879X2012007500031
PG 8
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA 922OE
UT WOS:000302556400001
PM 22392187
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Neto, OBO
   Farias, DF
   Vasconcelos, IM
   Paes, NS
   Monteiro, ACS
   da Silva, MCM
   Guimaraes, LM
   Carvalho, AFU
   Grossi-de-Sa, MF
AF Oliveira Neto, Osmundo B.
   Farias, Davi F.
   Vasconcelos, Ilka M.
   Paes, Norma S.
   Monteiro, Ana C. S.
   da Silva, Maria C. M.
   Guimaraes, Luciane M.
   Carvalho, Ana F. U.
   Grossi-de-Sa, Maria F.
TI A brief report on some health aspects of rats fed with crescent levels
   of recombinant chagasin, a potential plant defense protein
SO ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS
LA English
DT Article
DE chagasin; recombinant protein; hazard potential; short-term rat feeding
   trial
ID 90-DAY SAFETY; TOXICITY; WEEVIL; TOXIN
AB Chagasin may be considered a potential plant-incorporated protectant (PIP) protein due to its deleterious effects on insect pests. However, extensive safety studies with PIP's are necessary before introducing them into the target plant. Thus, a short-term feeding trial in rats with high doses of r-chagasin was conducted to provide evidences about its safety. Three test diets containing casein + r-chagasin (0.25, 0.5 and 1% of total protein) were offered to rats (10 days). The test diets did not show adverse effects upon the development, organ weight, hematological parameters and serum protein profiles of rats, providing preliminary information on the safety of r-chagasin.
C1 [Oliveira Neto, Osmundo B.; Paes, Norma S.; da Silva, Maria C. M.; Guimaraes, Luciane M.; Grossi-de-Sa, Maria F.] Embrapa Recursos Genet & Biotecnol, BR-70770900 Brasilia, DF, Brazil.
   [Oliveira Neto, Osmundo B.] Ctr Univ Euroamer Unieuro, SCES, BR-70201001 Brasilia, DF, Brazil.
   [Farias, Davi F.; Vasconcelos, Ilka M.] Univ Fed Ceara, Dept Bioquim & Biol Mol, BR-60455970 Fortaleza, CE, Brazil.
   [Monteiro, Ana C. S.] Inst Nacl Canc, Div Lab Oncol Expt, BR-20231050 Rio De Janeiro, RJ, Brazil.
   [Carvalho, Ana F. U.] Univ Fed Ceara, Dept Biol, BR-60455970 Fortaleza, CE, Brazil.
   [Grossi-de-Sa, Maria F.] Univ Catolica Brasilia, Posgrad Ciencias Genom & Biotecnol, BR-70790160 Brasilia, DF, Brazil.
RP Grossi-de-Sa, MF (corresponding author), Embrapa Recursos Genet & Biotecnol, Parque Estacao Biol,Final W5 Norte,Asa Norte, BR-70770900 Brasilia, DF, Brazil.
EM fatimasa@cenargen.embrapa.br
RI Grossi-de-Sa, Maria Fatima/N-7856-2017; Farias, Davi
   Felipe/AAH-1868-2020
OI GROSSI-DE-SA, MARIA FATIMA/0000-0001-8184-9599; Felipe Farias,
   Davi/0000-0001-5438-1919
FU Brazilian government; Empresa Brasileira de Pesquisa de Agropecuaria
   (EMBRAPA); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES
FX This work was supported by grants from the Brazilian government, Empresa
   Brasileira de Pesquisa de Agropecuaria (EMBRAPA), Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) and Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES). Thanks to Dr
   Magnus Abrahamson (University of Lund, Sweden) for providing the plasmid
   pHD313/Tc18 and to BIOAGRI for the conduction of animal trials.
CR Delaney B, 2008, FOOD CHEM TOXICOL, V46, pS71, DOI 10.1016/j.fct.2008.01.045
   Monteiro ACDS, 2008, PEST MANAG SCI, V64, P755, DOI 10.1002/ps.1553
   Dryzga MD, 2007, FOOD CHEM TOXICOL, V45, P1994, DOI 10.1016/j.fct.2007.04.017
   Grossi-De-Sa MF, 2007, J BIOCHEM MOL BIOL, V40, P773
   Harkness J. E., 1989, BIOL MED RABBITS ROD
   Isenman L, 1999, AM J PHYSIOL-ENDOC M, V276, pE223
   Juberg DR, 2009, REGUL TOXICOL PHARM, V54, P154, DOI 10.1016/j.yrtph.2009.03.008
   Kilic A, 2008, FOOD CHEM TOXICOL, V46, P1164, DOI 10.1016/j.fct.2007.11.016
   LEPLE JC, 1995, MOL BREEDING, V1, P319, DOI 10.1007/BF01248409
   Liener I. E., 1980, ADV LEGUME SCI, P157
   Monteiro ACS, 2001, J CELL SCI, V114, P3933
   MURDOCK LL, 1987, COMP BIOCHEM PHYS B, V87, P783, DOI 10.1016/0305-0491(87)90388-9
   Poulsen M, 2007, FOOD CHEM TOXICOL, V45, P350, DOI 10.1016/j.fct.2006.09.002
   Poulsen M, 2007, FOOD CHEM TOXICOL, V45, P364, DOI 10.1016/j.fct.2006.09.003
   Schmale I, 2006, J STORED PROD RES, V42, P31, DOI 10.1016/j.jspr.2004.10.005
   Schroder M, 2007, FOOD CHEM TOXICOL, V45, P339, DOI 10.1016/j.fct.2006.09.001
NR 16
TC 0
Z9 0
U1 0
U2 9
PU ACAD BRASILEIRA DE CIENCIAS
PI RIO JANEIRO
PA RUA ANFILOFIO DE CARVALHO, 29, 3 ANDAR, 20030-060 RIO JANEIRO, BRAZIL
SN 0001-3765
EI 1678-2690
J9 AN ACAD BRAS CIENC
JI An. Acad. Bras. Cienc.
PD MAR
PY 2012
VL 84
IS 1
BP 185
EP 190
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 914LZ
UT WOS:000301952900019
PM 22441608
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Cordeiro, RC
   Gomes, PXL
   de Araujo, FYR
   Oliveira, GV
   Carvalho, AF
   Vasconcelos, SM
   Macedo, DS
AF Cordeiro, R. C.
   Gomes, P. X. L.
   de Araujo, F. Y. R.
   Oliveira, G. V.
   Carvalho, A. F.
   Vasconcelos, S. M.
   Macedo, D. S.
TI Sex and age differences in rats susceptibility to nicotine-induced
   kindling: a possible involvement of oxidative stress
SO EUROPEAN NEUROPSYCHOPHARMACOLOGY
LA English
DT Meeting Abstract
CT 24th Congress Meeting of European-College-of-Neuropsychopharmacology
CY SEP 03-07, 2011
CL Paris, FRANCE
SP European Coll Neuropsychopharmacol
C1 [Cordeiro, R. C.; Gomes, P. X. L.; de Araujo, F. Y. R.; Oliveira, G. V.; Vasconcelos, S. M.; Macedo, D. S.] Univ Fed Ceara, Dept Physiol & Pharmacol, Fortaleza, Ceara, Brazil.
   [Carvalho, A. F.] Univ Fed Ceara, Dept Clin Med, Fortaleza, Ceara, Brazil.
RI Macedo, Danielle/E-3424-2014
OI Macedo, Danielle/0000-0001-8980-9970
CR Bastlund JF, 2005, NEUROPHARMACOLOGY, V48, P975, DOI 10.1016/j.neuropharm.2005.01.015
   Racine RJ, 1972, CLIN NEUROPHYSIOL, V32, P281, DOI DOI 10.1016/0013-4694(72)90177-0
NR 2
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0924-977X
J9 EUR NEUROPSYCHOPHARM
JI Eur. Neuropsychopharmacol.
PD SEP
PY 2011
VL 21
SU 3
BP S590
EP S591
DI 10.1016/S0924-977X(11)70966-X
PG 2
WC Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry
SC Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry
GA 852US
UT WOS:000297383600735
DA 2020-12-08
ER

PT J
AU Cordeiro, RC
   dos Santos, JV
   Medeiros, CD
   Morais, TA
   Vasconcelos, SM
   Sousa, FCF
   Macedo, DS
   Carvalho, AF
AF Cordeiro, R. C.
   dos Santos, J. V.
   Medeiros, C. D.
   Morais, T. A.
   Vasconcelos, S. M.
   Sousa, F. C. F.
   Macedo, D. S.
   Carvalho, A. F.
TI Decrease of lipid peroxidation in prefrontal cortex and hippocampus by
   alpha lipoic acid in an animal model of mania
SO EUROPEAN NEUROPSYCHOPHARMACOLOGY
LA English
DT Meeting Abstract
CT 24th Congress Meeting of European-College-of-Neuropsychopharmacology
CY SEP 03-07, 2011
CL Paris, FRANCE
SP European Coll Neuropsychopharmacol
C1 [Cordeiro, R. C.; dos Santos, J. V.; Medeiros, C. D.; Morais, T. A.; Vasconcelos, S. M.; Sousa, F. C. F.; Macedo, D. S.; Carvalho, A. F.] Univ Fed Ceara, Dept Physiol & Pharmacol, Fortaleza, Ceara, Brazil.
RI de Sousa, Francisca Clea Florenco/ABA-5683-2020; Macedo,
   Danielle/E-3424-2014
OI Macedo, Danielle/0000-0001-8980-9970
CR Huong NTT, 1998, BIOL PHARM BULL, V21, P978, DOI 10.1248/bpb.21.978
NR 1
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0924-977X
J9 EUR NEUROPSYCHOPHARM
JI Eur. Neuropsychopharmacol.
PD SEP
PY 2011
VL 21
SU 3
BP S438
EP S439
DI 10.1016/S0924-977X(11)70709-X
PG 2
WC Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry
SC Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry
GA 852US
UT WOS:000297383600478
DA 2020-12-08
ER

PT J
AU Ferreira, PMP
   Farias, DF
   Viana, MP
   Souza, TM
   Vasconcelos, IM
   Soares, BM
   Pessoa, C
   Costa-Lotufo, LV
   Moraes, MO
   Carvalho, AFU
AF Ferreira, Paulo Michel P.
   Farias, Davi F.
   Viana, Martonio P.
   Souza, Terezinha M.
   Vasconcelos, Ilka M.
   Soares, Bruno M.
   Pessoa, Claudia
   Costa-Lotufo, Leticia V.
   Moraes, Manoel O.
   Carvalho, Ana F. U.
TI Study of the antiproliferative potential of seed extracts from
   Northeastern Brazilian plants
SO ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS
LA English
DT Article
DE antiproliferative potential; Northeastern Brazilian plants; Myracrodruon
   urundeuva; sarcoma 180 tumor; seed extracts
ID MYRACRODRUON-URUNDEUVA ALLEMAO; AMBURANA-CEARENSIS SMITH,A.C; IN-VITRO;
   MEDICINAL-PLANTS; ENTEROLOBIUM-CONTORTISILIQUUM; CHEMICAL-COMPOSITION;
   ANTIFUNGAL ACTIVITY; LARVICIDAL ACTIVITY; CYTOTOXIC ACTIVITY; ANTICANCER
   AGENTS
AB This study assessed the antiproliferative and cytotoxic potential against tumor lines of ethanolic seed extracts of 21 plant species belonging to different families from Northeastern Brazil. In addition, some underlying mechanisms involved in this cytotoxicity were also investigated. Among the 21 extracts tested, the MTT assay after 72 h of incubation demonstrated that only the ethanolic extract obtained from Myracrodruon urundeuva seeds (EEMUS), which has steroids, alkaloids and phenols, showed in vitro cytotoxic activity against human cancer cells, being 2-fold more active on leukemia HL-60 line [IC(50) value of 12.5 (9.5-16.7) mu g/mL] than on glioblastoma SF-295 [IC(50) of 25.1 (17.3-36.3) mu g/mL] and Sarcoma 180 cells [IC(50) of 38.1 (33.5-43.4) mu g/mL]. After 72h exposure, flow cytometric and morphological analyses of HL-60-treated cells showed that EEMUS caused decrease in cell number, volume and viability as well as internucleosomal DNA fragmentation in a dose-dependent way, suggesting that the EEMUS triggers apoptotic pathways of cell death.
C1 [Ferreira, Paulo Michel P.] Univ Fed Piaui, Dept Ciencias Biol, BR-64600000 Picos, PI, Brazil.
   [Farias, Davi F.; Viana, Martonio P.; Souza, Terezinha M.; Carvalho, Ana F. U.] Univ Fed Ceara, Dept Biol, BR-60455970 Fortaleza, Ceara, Brazil.
   [Vasconcelos, Ilka M.] Univ Fed Ceara, Dept Bioquim & Biol Mol, BR-60455970 Fortaleza, Ceara, Brazil.
   [Soares, Bruno M.; Pessoa, Claudia; Costa-Lotufo, Leticia V.; Moraes, Manoel O.] Univ Fed Ceara, Dept Fisiol & Farmacol, Fac Med, BR-60430270 Fortaleza, Ceara, Brazil.
RP Ferreira, PMP (corresponding author), Univ Fed Piaui, Dept Ciencias Biol, Campus Senador Helvidio Nunes de Barros,Rua Cicer, BR-64600000 Picos, PI, Brazil.
EM pmifepe@yahoo.com.br
RI Ferreira, Paulo Michel Pinheiro/J-6783-2012; de Souza,
   Terezinha/L-8727-2015; Farias, Davi Felipe/AAH-1868-2020; Viana,
   Martonio/AAZ-4218-2020; Costa-Lotufo, Leticia V/D-4998-2014
OI Ferreira, Paulo Michel Pinheiro/0000-0001-6862-6497; de Souza,
   Terezinha/0000-0002-9580-3310; Costa-Lotufo, Leticia
   V/0000-0003-1861-5153; Felipe Farias, Davi/0000-0001-5438-1919
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e
   Tecnologico (FUNCAP); Financiadora de Estudos e Projetos (FINEP)Ciencia
   Tecnologia e Inovacao (FINEP); Banco do Nordeste do Brasil (BNB)
FX We wish to thank Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES), Fundacao Cearense de Apoio ao Desenvolvimento
   Cientifico e Tecnologico (FUNCAP), Financiadora de Estudos e Projetos
   (FINEP) and Banco do Nordeste do Brasil (BNB) for financial support in
   the form of grants and fellowship awards. We are grateful to Berenice
   Alves and Silvana Franca dos Santos for technical assistance.
CR Abdulla M, 2000, BIOFACTORS, V12, P45, DOI 10.1002/biof.5520120108
   Albiero ALM, 2002, J ETHNOPHARMACOL, V82, P41, DOI 10.1016/S0378-8741(02)00094-6
   Alencar NMN, 2005, J PHARM PHARMACOL, V57, P919, DOI 10.1211/0022357056352
   Alviano WS, 2008, ARCH ORAL BIOL, V53, P545, DOI 10.1016/j.archoralbio.2007.12.001
   Botelho MA, 2007, J ETHNOPHARMACOL, V113, P471, DOI 10.1016/j.jep.2007.07.010
   Braga FC, 2000, PHYTOMEDICINE, V6, P447, DOI 10.1016/S0944-7113(00)80073-2
   Buriol L, 2009, QUIM NOVA, V32, P296, DOI 10.1590/S0100-40422009000200006
   Butler MS, 2004, J NAT PROD, V67, P2141, DOI 10.1021/np040106y
   CASTROFARIA N, 1991, TOXICON, V29, P1143
   Costa-Lotufo LV, 2003, Z NATURFORSCH C, V58, P675
   Cragg GM, 2005, J ETHNOPHARMACOL, V100, P72, DOI 10.1016/j.jep.2005.05.011
   CRAGG GM, 1994, CIBA F SYMP, V185, P178
   Cruz MCS, 2007, J ETHNOPHARMACOL, V111, P409, DOI 10.1016/j.jep.2006.12.005
   Cunha GMD, 2003, PHYTOTHER RES, V17, P155, DOI 10.1002/ptr.1096
   Cury-Boaventura MF, 2004, CLIN NUTR, V23, P721, DOI 10.1016/j.clnu.2003.12.004
   da Costa PM, 2008, TOXICOL IN VITRO, V22, P854, DOI 10.1016/j.tiv.2008.01.003
   DARZYNKIEWICZ Z, 1992, CYTOMETRY, V13, P795, DOI 10.1002/cyto.990130802
   de Sousa M V, 1989, An Acad Bras Cienc, V61, P405
   Dranoff G, 2004, NAT REV CANCER, V4, P11, DOI 10.1038/nrc1252
   Fernandes J, 2003, CANCER LETT, V190, P165, DOI 10.1016/S0304-3835(02)00593-1
   Ferreira PMP, 2009, AN ACAD BRAS CIENC, V81, P207, DOI 10.1590/S0001-37652009000200007
   Goes Annya Costa Araújo de Macedo, 2005, Acta Cir. Bras., V20, P144, DOI 10.1590/S0102-86502005000200008
   Hsieh HK, 1998, PHARMACEUT RES, V15, P39, DOI 10.1023/A:1011940401754
   Kinghorn AD, 2003, PHARM BIOL, V41, P53, DOI 10.1080/1388020039051744
   Kohler I, 2002, Z NATURFORSCH C, V57, P277
   Leal LKAM, 2005, NEUROSCI LETT, V388, P86, DOI 10.1016/j.neulet.2005.06.034
   Leal LKAM, 2003, PHYTOTHER RES, V17, P335, DOI 10.1002/ptr.1139
   Leal LKAM, 2008, PLANTA MED, V74, P497, DOI 10.1055/s-2008-1074501
   Leal LKAM, 2006, LIFE SCI, V79, P98, DOI 10.1016/j.lfs.2005.12.024
   Lemos Jesus Rodrigues, 2002, Acta Bot. Bras., V16, P23, DOI 10.1590/S0102-33062002000100005
   Luna JD, 2005, J ETHNOPHARMACOL, V97, P199, DOI 10.1016/j.jep.2004.10.004
   Magalhaes HIF, 2010, AN ACAD BRAS CIENC, V82, P407, DOI 10.1590/S0001-37652010000200017
   MAIA G.N., 2004, CAATINGA ARVORES ARB
   Matos F. J. A., 2000, PLANTAS MED GUIA SEL
   Mimaki Y, 2003, BIOORG MED CHEM LETT, V13, P623, DOI 10.1016/S0960-894X(02)01044-2
   Miranda MMFS, 2002, PHYTOMEDICINE, V9, P641, DOI 10.1078/094471102321616463
   Monteiro JM, 2006, J ETHNOPHARMACOL, V105, P173, DOI 10.1016/j.jep.2005.10.016
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O
   Nunez-Selles AJ, 2005, J BRAZIL CHEM SOC, V16, P699, DOI 10.1590/S0103-50532005000500004
   Olajide Olumayokun A, 2004, Inflammopharmacology, V12, P196, DOI 10.1163/1568560041352310
   Ferreira PMP, 2010, CHEM-BIOL INTERACT, V188, P497, DOI 10.1016/j.cbi.2010.08.008
   Ferreira PMP, 2008, REV NUTR, V21, P431, DOI 10.1590/S1415-52732008000400007
   Rodrigues LV, 2002, PHYTOTHER RES, V16, P267, DOI 10.1002/ptr.841
   Sa RA, 2008, INT BIODETER BIODEGR, V62, P460, DOI 10.1016/j.ibiod.2008.04.003
   Sa RA, 2009, COMP BIOCHEM PHYS C, V149, P300, DOI 10.1016/j.cbpc.2008.08.004
   Sampaio C A, 1992, Agents Actions Suppl, V36, P191
   Sampaio EVSB, 2002, VEGETACAO FLORA CAAT, P49
   Santos JP, 2008, J ARID ENVIRON, V72, P652, DOI 10.1016/j.jaridenv.2007.08.004
   Shahat AA, 2008, J ENVIRON SCI HEAL B, V43, P519, DOI 10.1080/03601230802174714
   SOUSA MP, 2004, ONSTITUINTES QUIMICO
   Souza SMC, 2007, PHYTOTHER RES, V21, P220, DOI 10.1002/ptr.2011
   Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217
   Suffness M., 1990, METHODS PLANT BIOCH, P71
   Surh YJ, 2001, MUTAT RES-FUND MOL M, V480, P243, DOI 10.1016/S0027-5107(01)00183-X
   Torres MR, 2005, ARQ CIEN MAR, V38, P55
   Tsuzuki JK, 2007, AN ACAD BRAS CIENC, V79, P577, DOI 10.1590/S0001-37652007000400002
   Viana GSB, 2003, PHYTOMEDICINE, V10, P189, DOI 10.1078/094471103321659924
   Wang IK, 1999, EUR J CANCER, V35, P1517, DOI 10.1016/S0959-8049(99)00168-9
   Xavier-Filho J., 1993, SEMENTES SUAS DEFESA, P1
NR 60
TC 28
Z9 28
U1 0
U2 11
PU ACAD BRASILEIRA DE CIENCIAS
PI RIO JANEIRO
PA RUA ANFILOFIO DE CARVALHO, 29, 3 ANDAR, 20030-060 RIO JANEIRO, BRAZIL
SN 0001-3765
J9 AN ACAD BRAS CIENC
JI An. Acad. Bras. Cienc.
PD SEP
PY 2011
VL 83
IS 3
BP 1045
EP 1058
DI 10.1590/S0001-37652011005000017
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 810LK
UT WOS:000294126600023
PM 21779655
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Souza, TM
   Farias, DF
   Soares, BM
   Viana, MP
   Lima, GPG
   Machado, LKA
   Morais, SM
   Carvalho, AFU
AF Souza, T. M.
   Farias, D. F.
   Soares, B. M.
   Viana, M. P.
   Lima, G. P. G.
   Machado, L. K. A.
   Morais, S. M.
   Carvalho, A. F. U.
TI Toxicity of Brazilian Plant Seed Extracts to Two Strains of Aedes
   aegypti (Diptera: Culicidae) and Nontarget Animals
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE Aedes aegypti; Artemia sp.; selectivity; organophosphate resistance
   plant seed extracts
ID LARVICIDAL ACTIVITY; ESSENTIAL OILS; ANOPHELES-STEPHENSI; INSECTICIDES;
   RESISTANCE; LARVAE; REPELLENT; STATE; LINN
AB Seed ethanolic extracts of 21 Brazilian plants were evaluated for ovicidal, larvicidal, and pupicidal activities against insecticide-susceptible (SS) and field-collected (FC) strains of Aedes aegypti (L.) (Diptera: Culicidae), as well as for their effects on nontarget organisms. Myracrodruon urundeuva Fr. Allemao extract was highly toxic to both mosquito strains. Schinopsis brasiliensis Engler extract showed low toxicity and was 38-68 times less toxic to Ae. aegypti larvae than was M. urundeuva extract. The pupicidal activity (LC(50)) of 14 plant seed extracts ranged between 9 and 433 mu g/ml, and toxicities were comparable to both mosquito strains. Piptadenia moniliformis Benth. and Luetzelburgia auriculata (Allemao) Ducke extracts showed the highest activities against pupae of FC and SS strains. None of the extracts showed 100% ovicidal activity. In addition, the active extracts did not show high acute toxicity to mice (LD(50) > 1.5 g/kg), except that of Enterolobium contortisiliquum (Vell.) Morong. Most of the active extracts exhibited low toxicity against brine shrimp (Artemia sp.) nauplii. The extracts of M. urundeuva, P. moniliformis, and L. auriculata are promising sources of recognized classes of insecticidal compounds with good selectivity against immature stages of Ae. aegypti.
C1 [Souza, T. M.; Soares, B. M.; Viana, M. P.; Carvalho, A. F. U.] Univ Fed Ceara, Dept Biol, BR-60455760 Fortaleza, CE, Brazil.
   [Farias, D. F.; Lima, G. P. G.] Univ Fed Ceara, Dept Biochem & Mol Biol, BR-60455760 Fortaleza, CE, Brazil.
   [Machado, L. K. A.; Morais, S. M.] Univ Estadual Ceara, Dept Chem, BR-60740000 Fortaleza, CE, Brazil.
RP Carvalho, AFU (corresponding author), Univ Fed Ceara, Dept Biol, Campus Pici, BR-60455760 Fortaleza, CE, Brazil.
EM aurano@ufc.br
RI lima, giuseppina GPPL/C-5995-2012; de Souza, Terezinha/L-8727-2015;
   Farias, Davi Felipe/AAH-1868-2020; Viana, Martonio/AAZ-4218-2020;
   Carvalho, Ana/K-7344-2018
OI lima, giuseppina GPPL/0000-0002-1792-2605; de Souza,
   Terezinha/0000-0002-9580-3310; Carvalho, Ana/0000-0001-5293-9317; Felipe
   Farias, Davi/0000-0001-5438-1919
FU Ministerio da Saude, through Departamento de Ciencia e Tecnologia
   (DECIT); Secretaria de Ciencia, Tecnologia e Insumos estrategicos
   (SCTIE); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao Cearense de Apoio Cientifico e Tecnologico (FUNCAP)
FX We thank Ministerio da Saude, through Departamento de Ciencia e
   Tecnologia (DECIT), Secretaria de Ciencia, Tecnologia e Insumos
   estrategicos (SCTIE), Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq), and Fundacao Cearense de Apoio Cientifico e
   Tecnologico (FUNCAP) for financial support of this research.
CR ABBOTT WSA, 1925, J ECON ENTOMOL, V18, pD267
   Braga IA, 2007, EPIDEMIOL SERV SAUDE, V16, P279
   Carvalho AFU, 2003, MEM I OSWALDO CRUZ, V98, P569, DOI 10.1590/S0074-02762003000400027
   CARVALHO AFU, 1988, CIENC CULT, V40, P1109
   Charles JF, 2000, MEM I OSWALDO CRUZ, V95, P201, DOI 10.1590/S0074-02762000000700034
   COATS JR, 1994, ANNU REV ENTOMOL, V39, P489, DOI 10.1146/annurev.en.39.010194.002421
   Consoli R.A.G.B, 1994, PRINCIPAIS MOSQUITOS
   Farias DF, 2009, J AM MOSQUITO CONTR, V25, P386, DOI 10.2987/08-5851.1
   Ferreira PMP, 2009, AN ACAD BRAS CIENC, V81, P207, DOI 10.1590/S0001-37652009000200007
   Finney D. J., 1971, PROBIT ANAL
   Geetha I, 2008, BIOL CONTROL, V44, P242, DOI 10.1016/j.biocontrol.2007.10.007
   HODGE H C, 1949, Am Ind Hyg Assoc Q, V10, P93
   Kiran SR, 2006, BIORESOURCE TECHNOL, V97, P2481, DOI 10.1016/j.biortech.2005.10.003
   Lima EP, 2006, REV SOC BRAS MED TRO, V39, P259, DOI 10.1590/S0037-86822006000300006
   Macoris MD, 2003, MEM I OSWALDO CRUZ, V98, P703, DOI 10.1590/S0074-02762003000500020
   Matos F.J.A., 1988, INTRO FITOQUIMICA EX
   Mello Marcia O., 2002, Braz. J. Plant Physiol., V14, P71, DOI 10.1590/S1677-04202002000200001
   Murugan K, 2007, BIORESOURCE TECHNOL, V98, P198, DOI 10.1016/j.biortech.2005.12.009
   Polanczyk RA, 2003, REV SAUDE PUBL, V37, P813, DOI 10.1590/S0034-89102003000600020
   Prajapati V, 2005, BIORESOURCE TECHNOL, V96, P1749, DOI 10.1016/j.biortech.2005.01.007
   Promsiri Suwannee, 2006, Insect Science, V13, P179, DOI 10.1111/j.1744-7917.2006.00080.x
   Ramos MV, 2006, MEM I OSWALDO CRUZ, V101, P503, DOI 10.1590/S0074-02762006000500004
   Silva WJ, 2008, BIORESOURCE TECHNOL, V99, P3251, DOI 10.1016/j.biortech.2007.05.064
   Tare V, 2004, J ECON ENTOMOL, V97, P1734, DOI 10.1603/0022-0493-97.5.1734
   Wandscheer CB, 2004, TOXICON, V44, P829, DOI 10.1016/j.toxicon.2004.07.009
   WHO, 2005, GUID LAB FIELD TEST
   XAVIER J, 1993, PROJETO MULTINACIONA, P1
   Yang YC, 2002, J AGR FOOD CHEM, V50, P3765, DOI 10.1021/jf011708f
NR 28
TC 21
Z9 22
U1 0
U2 15
PU ENTOMOLOGICAL SOC AMER
PI LANHAM
PA 10001 DEREKWOOD LANE, STE 100, LANHAM, MD 20706-4876 USA
SN 0022-2585
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD JUL
PY 2011
VL 48
IS 4
BP 846
EP 851
DI 10.1603/ME10205
PG 6
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA 810KJ
UT WOS:000294123900015
PM 21845944
DA 2020-12-08
ER

PT J
AU Carvalho, AFU
   Farias, DF
   da Rocha-Bezerra, LCB
   de Sousa, NM
   Cavalheiro, MG
   Fernandes, GS
   Brasil, ICF
   Maia, AAB
   de Sousa, DOB
   Vasconcelos, IM
   Gouveia, ST
   Machado, OLT
AF Urano Carvalho, Ana Fontenele
   Farias, Davi Felipe
   Brito da Rocha-Bezerra, Lady Clarissa
   de Sousa, Nathanna Mateus
   Cavalheiro, Mariana Giovenardi
   Fernandes, Georgia Sampaio
   Facanha Brasil, Isabel Cristiane
   Bessa Maia, Andrea Agaciana
   Bezerra de Sousa, Daniele Oliveira
   Vasconcelos, Ilka Maria
   Gouveia, Sandro Thomaz
   Tavares Machado, Olga Lima
TI Preliminary assessment of the nutritional composition of underexploited
   wild legumes from semi-arid Caatinga and moist forest environments of
   northeastern Brazil
SO JOURNAL OF FOOD COMPOSITION AND ANALYSIS
LA English
DT Article
DE Proximate composition; Amino acids; Antinutritional factors; Toxic
   factors; Minerals; Wild legume seeds; Underutilized species; Wild foods;
   Biodiversity and horticulture; Sustainable agricultural practice; Food
   security; Indigenous foods; Biodiversity; Food analysis; Food
   composition
ID VIGNA-UNGUICULATA; CULTIVARS; QUALITY; LECTIN; SEEDS
AB The seeds of 14 wild legume species from Brazil were analyzed to assess their potential as food. The seeds showed high levels of crude protein (10.9-50.0%), dietary fiber (0.8-52.3%) and energy (905-1804 kJ 100 g(-1)), and the amino acid composition (mg g(-1) N) was comparable to that of soybeans, but with higher amounts of lysine (456-10,884) and histidine (199-918). The seeds showed lectin activity (202560 and 60-2560 HU g(-1) flour for untreated or treated erythrocytes, respectively) as well as trypsin inhibitory activity (4.06-27.35 mu g TI mg(-1) flour), urease (225-23,895 U kg(-1) flour) and toxic activities (LD50 0.22-0.12 g kg(-1) body weight). Most of the minerals, as with edible legume seeds, were present in high levels when considering reference daily intake (RDI) and the nutrient content claims of the United States Food and Drug Administration (FDA). Thus, these wild legume seeds can be promising alternatives sources of food to overcome malnutrition problems. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Urano Carvalho, Ana Fontenele] Univ Fed Ceara, Dept Biol, BR-60455970 Fortaleza, Ceara, Brazil.
   [Farias, Davi Felipe; Brito da Rocha-Bezerra, Lady Clarissa; de Sousa, Nathanna Mateus; Cavalheiro, Mariana Giovenardi; Fernandes, Georgia Sampaio; Facanha Brasil, Isabel Cristiane; Bessa Maia, Andrea Agaciana; Bezerra de Sousa, Daniele Oliveira; Vasconcelos, Ilka Maria] Univ Fed Ceara, Dept Bioquim & Biol Mol, BR-60455970 Fortaleza, Ceara, Brazil.
   [Gouveia, Sandro Thomaz] Univ Fed Ceara, Dept Quim Analit, BR-60455970 Fortaleza, Ceara, Brazil.
   [Tavares Machado, Olga Lima] Univ Estadual Norte Fluminense, BR-28013600 Rio De Janeiro, Brazil.
RP Carvalho, AFU (corresponding author), Univ Fed Ceara, Dept Biol, Campus Pici, BR-60455970 Fortaleza, Ceara, Brazil.
EM aurano@ufc.br
RI Machado, Olga/P-1944-2019; Farias, Davi Felipe/AAH-1868-2020; Machado,
   Olga/G-7461-2012; Carvalho, Ana/K-7344-2018
OI Carvalho, Ana/0000-0001-5293-9317; Felipe Farias,
   Davi/0000-0001-5438-1919
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [505.773/2004-0]; Fundacao Cearense de Apoio ao Desenvolvimento
   Cientifico e Tecnologico (FUNCAP) [09099998-3]
FX The authors are thankful to Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq) for the research grant 505.773/2004-0
   and scholarships and to Fundacao Cearense de Apoio ao Desenvolvimento
   Cientifico e Tecnologico (FUNCAP) for the research grant SPU No.:
   09099998-3.
CR Agra Maria de Fátima, 2007, Rev. bras. farmacogn., V17, P114, DOI 10.1590/S0102-695X2007000100021
   Arun A.B., 2003, PLANT FOOD HUM NUTR, V58, P1
   Association of Official Analytical Chemist (AOAC), 1998, OFF METH AN ASS OFF
   Babayemi O. J., 2004, Communications in Agricultural and Applied Biological Sciences, V69, P103
   BAETHGEN WE, 1989, COMMUN SOIL SCI PLAN, V20, P961, DOI 10.1080/00103628909368129
   Batista Filho Malaquias, 2003, Cad. Saúde Pública, V19, pS181, DOI 10.1590/S0102-311X2003000700019
   Batista IFC, 1996, PHYTOCHEMISTRY, V41, P1017, DOI 10.1016/0031-9422(95)00710-5
   Duranti M, 2006, FITOTERAPIA, V77, P67, DOI 10.1016/j.fitote.2005.11.008
   *FAO, 2003, REP TECHN WORKSH ROM
   FAO/WHO/UNU, 1985, REP JOINT FAO WHO UN, V27
   Gouveia ST, 2002, J FOOD ENG, V51, P59, DOI 10.1016/S0260-8774(01)00037-1
   HAMERSTRAND GE, 1981, CEREAL CHEM, V58, P42
   KAKADE ML, 1969, CEREAL CHEM, V46, P518
   KAPLAN A, 1969, METHOD BIOCHEM ANAL, P311
   LIENER IE, 1994, CRIT REV FOOD SCI, V34, P31, DOI 10.1080/10408399409527649
   Maia FMM, 2000, J SCI FOOD AGR, V80, P453, DOI 10.1002/(SICI)1097-0010(200003)80:4&lt;453::AID-JSFA548&gt;3.0.CO;2-X
   Maia G. N., 2004, CAATINGA ARVORES ARB, P413
   Mann K, 2001, EUR J BIOCHEM, V268, P4414, DOI 10.1046/j.1432-1327.2001.02368.x
   Moraes SMD, 1996, BRAZ J MED BIOL RES, V29, P977
   Moreira RA, 1997, PHYTOCHEMISTRY, V46, P139, DOI 10.1016/S0031-9422(97)00262-8
   Onwuliri VA, 2002, FOOD CHEM, V78, P1, DOI 10.1016/S0308-8146(00)00293-4
   PINTERSZAKACS M, 1990, J AGR FOOD CHEM, V38, P720, DOI 10.1021/jf00093a028
   Proll J, 1998, J NUTR, V128, P2014
   PUZZI D, 2000, ABASTECIMENTO ARMAZE, P666
   Ruiz MA, 2001, J AGR FOOD CHEM, V49, P5336, DOI 10.1021/jf010247v
   SAMPAIO EVS, 2000, VEGETACAO FLORA CAAT, P76
   Sridhar KR, 2006, FOOD CHEM, V99, P267, DOI 10.1016/j.foodchem.2005.07.049
   Trugo LC, 2000, J AGR FOOD CHEM, V48, P2082, DOI 10.1021/jf9913920
   Vadivel V, 2005, PLANT FOOD HUM NUTR, V60, P69, DOI 10.1007/s11130-005-5102-y
   Vasconcelos IM, 2010, J FOOD COMPOS ANAL, V23, P54, DOI 10.1016/j.jfca.2009.05.008
   Vasconcelos IM, 1997, J SCI FOOD AGR, V75, P419, DOI [10.1002/(SICI)1097-0010(199712)75:4&lt;419::AID-JSFA886&gt;3.0.CO;2-D, 10.1002/(SICI)1097-0010(199712)75:4<419::AID-JSFA886>3.3.CO;2-4]
   Vasconcelos IM, 2001, J NUTR BIOCHEM, V12, P55, DOI 10.1016/S0955-2863(00)00148-0
NR 32
TC 10
Z9 10
U1 0
U2 23
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0889-1575
EI 1096-0481
J9 J FOOD COMPOS ANAL
JI J. Food Compos. Anal.
PD JUN-AUG
PY 2011
VL 24
IS 4-5
SI SI
BP 487
EP 493
DI 10.1016/j.jfca.2011.01.013
PG 7
WC Chemistry, Applied; Food Science & Technology
SC Chemistry; Food Science & Technology
GA 791LV
UT WOS:000292667600003
DA 2020-12-08
ER

PT J
AU Oliveira, MSC
   de Morais, SM
   Magalhaes, DV
   Batista, WP
   Vieira, IGP
   Craveiro, AA
   de Manezes, JESA
   Carvalho, AFU
   de Lima, GPG
AF Costa Oliveira, Micheline Soares
   de Morais, Selene Maia
   Magalhaes, Davi Varela
   Batista, Williams Pereira
   Pinto Vieira, Icaro Gusmao
   Craveiro, Afranio Aragao
   Silva Alencar de Manezes, Jane Eire
   Urano Carvalho, Ana Fontenelle
   Gomes de Lima, Glauber Pacelli
TI Antioxidant, larvicidal and antiacetylcholinesterase activities of
   cashew nut shell liquid constituents
SO ACTA TROPICA
LA English
DT Article
DE CNSL; Antiradical; Larvicide; Acetylcholinesterase inhibition
ID AEDES-AEGYPTI; ESSENTIAL OILS; ANACARDIC ACID; RESISTANCE;
   ORGANOPHOSPHATES; COMBINATION; BIOACTIVITY; PRODUCTS; STATE
AB Anacardic acid, cardanol and cardol. the main constituents of natural cashew nut shell liquid (CNSL), were obtained by solvent extraction and assayed for antioxidant, larvicidal and antiacetylcholinesterase activity. Their relative percent composition was obtained by HPLC analysis. Antioxidant activity was assessed using the DPPH and ABTS(center dot+) tests, which showed cardanol as the most active, followed by cardol and anacardic acid. The three CNSL components demonstrated good larvicidal activity against Aedes aegypti (LC50 = 12.40 for anacardic acid, 10.22 for cardol and 14.45 for cardanol) and exhibited inhibition zones for acetylcholinesterase enzymes in the TLC test similar to carbachol, which was used as standard. Based on the results, these multipotent compounds represent promising agents in the control of Ae. aegypti, the main dengue vector in Brazil. (C) 2011 Published by Elsevier B.V.
C1 [Costa Oliveira, Micheline Soares; de Morais, Selene Maia; Batista, Williams Pereira] Doutorado Biotecnol Rede Nordeste Biotecnol, BR-70840000 Fortaleza, Ceara, Brazil.
   [de Morais, Selene Maia; Magalhaes, Davi Varela] Curso Quim, BR-70840000 Fortaleza, Ceara, Brazil.
   [Pinto Vieira, Icaro Gusmao; Craveiro, Afranio Aragao] Parque Desenvolvimento Tecnol PADETEC, Fortaleza, Ceara, Brazil.
   [Silva Alencar de Manezes, Jane Eire] UECE, FACEDI, Fac Educ Itapipoca, Itapipoca, CE, Brazil.
   [Urano Carvalho, Ana Fontenelle; Gomes de Lima, Glauber Pacelli] Univ Fed Ceara, Dept Biol, Fortaleza, Ceara, Brazil.
RP de Morais, SM (corresponding author), Doutorado Biotecnol Rede Nordeste Biotecnol, Av Paranjana 1700,Campus Itaperi, BR-70840000 Fortaleza, Ceara, Brazil.
EM selene@uece.br
RI VIEIRA, ICARO GP GUSMAO PINTO/K-5273-2016; Carvalho, Ana/K-7344-2018
OI Carvalho, Ana/0000-0001-5293-9317; Gomes de Lima, Glauber
   Pacelli/0000-0002-5366-4551
FU Ministerio da Saude; Departamento de Ciencia e Tecnologia (DECIT);
   Secretaria de Ciencia, Tecnologia e Insumos Estrategicos (SCTIE);
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Estado do Ceara (FUNCAP)
FX The authors wish to thank Ministerio da Saude, through to Departamento
   de Ciencia e Tecnologia (DECIT), Secretaria de Ciencia, Tecnologia e
   Insumos Estrategicos (SCTIE), Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do
   Estado do Ceara (FUNCAP) for their financial support. To EMBRAPA
   Agroindustrial Tropical for furnishing early dwarf cashew nut samples.
CR AGOSTINICOSTA TS, 2005, 122 EMBRAPA
   Asogwa E. U., 2007, RES J APPL SCI, V2, P939
   BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25
   Castle T, 1999, JAMAICA REV PANAM SA, V5, P100
   Cavalcanti ESB, 2004, MEM I OSWALDO CRUZ, V99, P541, DOI 10.1590/S0074-02762004000500015
   Cheng SS, 2003, BIORESOURCE TECHNOL, V89, P99, DOI 10.1016/S0960-8524(03)00008-7
   CONSOLI R A G B, 1988, Memorias do Instituto Oswaldo Cruz, V83, P87, DOI 10.1590/S0074-02761988000100012
   Diogenes MJN, 1996, CONTACT DERMATITIS, V35, P114
   Elejalde Guerra J I, 2001, An Med Interna, V18, P326
   Farias DF, 2009, J AM MOSQUITO CONTR, V25, P386, DOI 10.2987/08-5851.1
   Finkelstein BL, 2002, BIOORGAN MED CHEM, V10, P599, DOI 10.1016/S0968-0896(01)00326-1
   Kubo I, 2006, FOOD CHEM, V99, P555, DOI 10.1016/j.foodchem.2005.08.023
   Lima EP, 2006, REV SOC BRAS MED TRO, V39, P259, DOI 10.1590/S0037-86822006000300006
   Lima JBP, 2003, AM J TROP MED HYG, V68, P329, DOI 10.4269/ajtmh.2003.68.329
   Lomonaco D, 2009, GREEN CHEM, V11, P31, DOI 10.1039/b811504d
   Macoris MD, 2003, MEM I OSWALDO CRUZ, V98, P703, DOI 10.1590/S0074-02762003000500020
   MAIA D, 1978, ESBOCO ECOLOGIA AGRI, P372
   Mazzetto SE, 2009, QUIM NOVA, V32, P732, DOI 10.1590/S0100-40422009000300017
   MENON ARR, 1985, J SCI IND RES INDIA, V44, P324
   MEYER BN, 1982, PLANTA MED, V45, P31, DOI 10.1055/s-2007-971236
   Morais SM, 2006, J AM MOSQUITO CONTR, V22, P161, DOI 10.2987/8756-971X(2006)22[161:LAOEOF]2.0.CO;2
   Munn M.J., 2006, 20065148 US GEOL SUR
   Muroi H, 1996, J APPL BACTERIOL, V80, P387, DOI 10.1111/j.1365-2672.1996.tb03233.x
   Paramashivappa R, 2001, J AGR FOOD CHEM, V49, P2548, DOI 10.1021/jf001222j
   Pimentel M. R., 2009, PAN AM J AQUATIC SCI, V4, P363
   RAWLINS SC, 1995, J AM MOSQUITO CONTR, V11, P59
   Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3
   Rhee IK, 2001, J CHROMATOGR A, V915, P217, DOI 10.1016/S0021-9673(01)00624-0
   Rosenberry TL, 2008, CHEM-BIOL INTERACT, V175, P235, DOI 10.1016/j.cbi.2008.06.002
   SANDES ARR, 2000, BIOTECNOL CIENC DESE, V13, P28
   SANTOS RP, 2008, QUIM NOVA, V31, P53
   Sung B, 2008, BLOOD, V111, P4880, DOI 10.1182/blood-2007-10-117994
   Tocco G, 2009, BIOORG MED CHEM LETT, V19, P36, DOI 10.1016/j.bmcl.2008.11.020
   Trevisan MTS, 2006, FOOD CHEM TOXICOL, V44, P188, DOI 10.1016/j.fct.2005.06.012
   Wirth MC, 1999, J AM MOSQUITO CONTR, V15, P315
   Yepez B, 2002, FLUID PHASE EQUILIBR, V194, P879, DOI 10.1016/S0378-3812(01)00707-5
NR 36
TC 43
Z9 45
U1 0
U2 38
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD MAR
PY 2011
VL 117
IS 3
BP 165
EP 170
DI 10.1016/j.actatropica.2010.08.003
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 733WB
UT WOS:000288294000001
PM 20707981
DA 2020-12-08
ER

PT J
AU Farias, DF
   Cavalheiro, MG
   Viana, MP
   Queiroz, VA
   Rocha-Bezerra, LCB
   Vasconcelos, IM
   Morais, SM
   Carvalho, AFU
AF Farias, Davi F.
   Cavalheiro, Mariana G.
   Viana, Martonio P.
   Queiroz, Vanessa A.
   Rocha-Bezerra, Lady C. B.
   Vasconcelos, Ilka M.
   Morais, Selene M.
   Carvalho, Ana F. U.
TI Water extracts of Brazilian leguminous seeds as rich sources of
   larvicidal compounds against Aedes aegypti L.
SO ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS
LA English
DT Article
DE Aedes aegypti; larvicidal compounds; leguminous seeds; water extracts
ID ESSENTIAL OILS; PURIFICATION; RESISTANCE; CULICIDAE; DIPTERA;
   INSECTICIDE; ISRAELENSIS; BINDING; TOXINS; LARVAE
AB This study assessed the toxicity of seed water extracts of 15 leguminous species upon Aedes aegypti larvae. A partial chemical and biochemical characterization of water extracts, as well as the assessment of their acute toxicity in mice, were performed. The extracts of Amburana cearensis, Anadenanthera macrocarpa, Dioclea megacarpa, Enterolobium contortisiliquum and Piptadenia moniliformis caused 100% of mortalit y after 1 to 3 h of exposure. They showed LC50 and LC90 values ranging from 0.43 +/- 0.01 to 9.06 +/- 0.12 mg/mL and from 0.71 +/- 0.02 to 13.03 +/- 0.15 mg/mL, respectively. Among the secondary metabolite constituents, the seed water extracts showed tannins, phenols, flavones, favonols, xanthones, saponins and alkaloids. The extracts also showed high soluble proteins content (0.98 to 7.71 mg/mL), lectin (32 to 256 HU/mL) and trypsin inhibitory activity (3.64 +/- 0.43 to 26.19 +/- 0.05 gIT/kg of flour) The electrophoretic profiles showed a great diversity of protein bands, many of which already described as insecticide proteins. The extracts showed low toxicity to mice (LD50 > 0.15 +/- 0.01 g/kg body weight), but despite these promising results, further studies are necessary to understand the toxicity of these extracts and their constituents from primary and secondary metabolism upon Ae. aegypti.
C1 [Viana, Martonio P.; Carvalho, Ana F. U.] Univ Fed Ceara, Dept Biol, BR-60455760 Fortaleza, CE, Brazil.
   [Farias, Davi F.; Cavalheiro, Mariana G.; Rocha-Bezerra, Lady C. B.; Vasconcelos, Ilka M.] Univ Fed Ceara, Dept Bioquim & Biol Mol, BR-60455760 Fortaleza, CE, Brazil.
   [Queiroz, Vanessa A.; Morais, Selene M.] Univ Fed Ceara, Dept Quim, BR-60740000 Fortaleza, CE, Brazil.
RP Carvalho, AFU (corresponding author), Univ Fed Ceara, Dept Biol, Campus Pici, BR-60455760 Fortaleza, CE, Brazil.
EM aurano@ufc.br
RI Farias, Davi Felipe/AAH-1868-2020; Carvalho, Ana/K-7344-2018; Viana,
   Martonio/AAZ-4218-2020
OI Carvalho, Ana/0000-0001-5293-9317; Felipe Farias,
   Davi/0000-0001-5438-1919
FU Ministerio da Sa de, through Departamento de Ciencia e Tecnologia
   (DECIT); Secretaria de Ciencia, Tecnologia e Insumos Estrategicos
   (SCTIE); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Estado do Ceara (FUNCAP)
FX The authors wish to thank Ministerio da Sa de, through Departamento de
   Ciencia e Tecnologia (DECIT), Secretaria de Ciencia, Tecnologia e
   Insumos Estrategicos (SCTIE), Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do
   Estado do Ceara (FUNCAP) for their financial support.
CR Beserra EB, 2007, NEOTROP ENTOMOL, V36, P303, DOI 10.1590/S1519-566X2007000200019
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Carlini CR, 1997, J ECON ENTOMOL, V90, P340, DOI 10.1093/jee/90.2.340
   Carlini CR, 2002, TOXICON, V40, P1515, DOI 10.1016/S0041-0101(02)00240-4
   Carvalho AFU, 2003, MEM I OSWALDO CRUZ, V98, P569, DOI 10.1590/S0074-02762003000400027
   Choochote W, 2007, FITOTERAPIA, V78, P359, DOI 10.1016/j.fitote.2007.02.006
   Consoli R.A.G.B, 1994, PRINCIPAIS MOSQUITOS
   Corbel V, 2004, J MED ENTOMOL, V41, P712, DOI 10.1603/0022-2585-41.4.712
   de Mendonca FAC, 2005, FITOTERAPIA, V76, P629, DOI 10.1016/j.fitote.2005.06.013
   de Omena MC, 2007, BIORESOURCE TECHNOL, V98, P2549, DOI 10.1016/j.biortech.2006.09.040
   Dharmagadda VSS, 2005, BIORESOURCE TECHNOL, V96, P1235, DOI 10.1016/j.biortech.2004.10.020
   Fatope M. O., 1993, International Journal of Pharmacognosy, V31, P250
   Finney D. J., 1971, PROBIT ANAL
   GUBLER DJ, 1989, AM J TROP MED HYG, V40, P571
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   HODGE H C, 1949, Am Ind Hyg Assoc Q, V10, P93
   Jang YS, 2002, J AM MOSQUITO CONTR, V18, P210
   KAKADE ML, 1969, CEREAL CHEM, V46, P518
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Luna JD, 2005, J ETHNOPHARMACOL, V97, P199, DOI 10.1016/j.jep.2004.10.004
   Matos F.J.A., 1988, INTRO FITOQUIMICA EX
   MOREIRA J.C., 1977, PLANT PHYSIOL, V59, P783, DOI [10.1104/pp.59.5.783., DOI 10.1104/PP.59.5.783]
   MOREIRA RA, 1983, PLANTA, V158, P63, DOI 10.1007/BF00395404
   Moura FT, 2007, J AGR FOOD CHEM, V55, P260, DOI 10.1021/jf061623k
   Murugan K, 2007, BIORESOURCE TECHNOL, V98, P198, DOI 10.1016/j.biortech.2005.12.009
   OLIVA MLV, 1987, BRAZ J MED BIOL RES, V20, P767
   Pohlit Adrian Martin, 2004, Acta Amaz., V34, P97, DOI 10.1590/S0044-59672004000100012
   Polanczyk RA, 2003, REV SAUDE PUBL, V37, P813, DOI 10.1590/S0034-89102003000600020
   Ramos MV, 2006, MEM I OSWALDO CRUZ, V101, P503, DOI 10.1590/S0074-02762006000500004
   Sa RA, 2009, COMP BIOCHEM PHYS C, V149, P300, DOI 10.1016/j.cbpc.2008.08.004
   Silva Heloísa Helena Garcia da, 2004, Rev. Soc. Bras. Med. Trop., V37, P396, DOI 10.1590/S0037-86822004000500005
   Silva MH, 1997, J ECON ENTOMOL, V90, P299, DOI 10.1093/jee/90.2.299
   Silva WJ, 2008, BIORESOURCE TECHNOL, V99, P3251, DOI 10.1016/j.biortech.2007.05.064
   TANAKA AS, 1989, BRAZ J MED BIOL RES, V22, P1069
   VASCONCELOS IM, 1994, ARCH BIOCHEM BIOPHYS, V312, P357, DOI 10.1006/abbi.1994.1320
   Vasconcelos IM, 2004, TOXICON, V44, P385, DOI 10.1016/j.toxicon.2004.05.005
   Whetstone PA, 2007, TOXICON, V49, P576, DOI 10.1016/j.toxicon.2006.11.009
   *WHO, 1994, INT PROGR CHEM SAF I
   Wirth MC, 1997, J ECON ENTOMOL, V90, P1471, DOI 10.1093/jee/90.6.1471
   World Health Organization, 2005, WHOCDSWHOPESGCDPP200
   XAVIER-FILHO J., 1993, SEMENTES SUAS DEFESA
NR 41
TC 15
Z9 18
U1 0
U2 11
PU ACAD BRASILEIRA DE CIENCIAS
PI RIO JANEIRO
PA RUA ANFILOFIO DE CARVALHO, 29, 3 ANDAR, 20030-060 RIO JANEIRO, BRAZIL
SN 0001-3765
EI 1678-2690
J9 AN ACAD BRAS CIENC
JI An. Acad. Bras. Cienc.
PD SEP
PY 2010
VL 82
IS 3
BP 585
EP 594
DI 10.1590/S0001-37652010000300006
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 648JL
UT WOS:000281689200006
PM 21562687
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Farias, DF
   Batista, AB
   Feijao, AR
   Araujo, ES
   Marques, EC
   Oliveira, HP
   de Oliveira, JS
   Cavalheiro, MG
   de Sousa, NM
   da Rocha-Bezerra, LCB
   Vasconcelos, IM
   Carvalho, AFU
AF Farias, Davi Felipe
   Batista, Adelina Braga
   Feijao, Alexcyane Rodrigues
   Araujo, Eliane Silva
   Marques, Elton Camelo
   Oliveira, Henrique Pinho
   de Oliveira, Jefferson Soares
   Cavalheiro, Mariana Giovenardi
   de Sousa, Nathanna Mateus
   Brito da Rocha-Bezerra, Lady Clarissa
   Vasconcelos, Ilka Maria
   Urano Carvalho, Ana Fontenele
TI Nutritional, bioactive and enzymatic properties of Ouratea fieldingiana
   (Gardner) Engl. (Ochnaceae) fruits. A little-known plant from
   Northeastern Brazil
SO JOURNAL OF APPLIED BOTANY AND FOOD QUALITY
LA English
DT Article
ID AEDES-AEGYPTI; ANTIFUNGAL ACTIVITY; LARVICIDAL ACTIVITY; GLYCINE-MAX;
   PROTEINS; PURIFICATION; CULTIVARS; SEEDS
AB The species Ouratea fieldingiana is a bush belonging to the family Ochnaceae, occurring frequently in the "Caatinga" Dominium. This species and other members of the genus Ouratea are rarely studied and no data are available on the chemical composition or medical and industrial potential of this plant. Thus, this work aimed to study the nutritional, medical and industrial potential of O. fieldingiana fruits by determining the proximate composition, caloric value and the content of toxic and antinutritional factors. The search for biological and enzymatic activities with pharmacological and industrial interest was also conducted. The results showed that the dry fruits are rich in proteins (21.58 +/- 2.02 g/100g) and dietary fiber (46.72 +/- 0.52 g/100g), do not show trypsin inhibitors, toxins or tannins, and have low levels of urease (2.41 +/- 0.22 units kg(-1)) and lectins (780 and 3,098 HU/g protein in native erythrocytes and in protease-treated erythrocytes, respectively). The fruit aqueous extracts showed antibacterial activity (growth inhibition halo with diameter > 10 mm) against Cromobacterium violaceum, possibly due to a protein compound, and also amylolytic (starch degradation area > 60 mm(2)), hemolytic (100% hemolysis in rat and mouse erythrocytes') and strong anti-coagulant (persisted for more than 24 h) activities. The O. fieldingiana fruits are potentially nutritious, showing high protein and dietary fiber levels, as well as a low content of toxic and/or antinutritional compounds. The fruits aqueous extracts possess bioactive compounds presenting pharmacological and/or industrial interest.
C1 [de Sousa, Nathanna Mateus; Urano Carvalho, Ana Fontenele] Univ Fed Ceara, Dept Biol, Fortaleza, Ceara, Brazil.
   [Farias, Davi Felipe; Batista, Adelina Braga; Feijao, Alexcyane Rodrigues; Araujo, Eliane Silva; Marques, Elton Camelo; Oliveira, Henrique Pinho; de Oliveira, Jefferson Soares; Cavalheiro, Mariana Giovenardi; Brito da Rocha-Bezerra, Lady Clarissa; Vasconcelos, Ilka Maria] Univ Fed Ceara, Dept Bioquim & Biol Mol, Fortaleza, Ceara, Brazil.
RP Carvalho, AFU (corresponding author), Univ Fed Ceara, Dept Biol, Fortaleza, Ceara, Brazil.
EM aurano@ufc.br
RI Marques, Elton C/F-4924-2011; Carvalho, Ana/K-7344-2018; Oliveira,
   Jefferson S/Q-4888-2019; Oliveira, Jefferson/G-2729-2015; Farias, Davi
   Felipe/AAH-1868-2020
OI Marques, Elton C/0000-0002-9140-2819; Carvalho, Ana/0000-0001-5293-9317;
   Oliveira, Jefferson S/0000-0003-4192-8238; Oliveira,
   Jefferson/0000-0003-4192-8238; 
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [505.773/2004-0]
FX Many thanks to the Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq) for the funding received for the research project
   "Bioprospeccao da Caatinga Cearense com Potencial Nutricional e
   Bioativo" (Process 505.773/2004-0). We are also thankful to Ms Francisca
   Simoes Cavalcanti from Laboratorio de Produtos Naturais of Universidade
   Federal do Ceara (UFC) as well as to Mr Edson de Paula Nunes from
   Herbario Prisco Bezerra (UFC) for their field expeditions and botanical
   identification support.
CR AOAC, 1997, OFF METH AN ASS OFF
   ARAUJO JA, 2000, AGR SUSTENTABILIDADE
   BAETHGEN WE, 1989, COMMUN SOIL SCI PLAN, V20, P961, DOI 10.1080/00103628909368129
   BAUER AW, 1966, AM J CLIN PATHOL, V45, P493
   BERNHEIMER AW, 1988, METHOD ENZYMOL, V165, P213
   BOLLER T, 1993, MOL PLANT PATHOLOGY
   BOUQUET A, 1969, MEMOIRES ORSTOM, V36, P178
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BRADLEY DJ, 1992, CELL, V70, P21, DOI 10.1016/0092-8674(92)90530-P
   BRAGA R, 1976, PLANTAS NORDESTE BRA
   Bukowska B, 2004, TOXICOL LETT, V152, P73, DOI 10.1016/j.toxlet.2004.03.025
   Caruso C, 1999, PLANT SCI, V140, P87, DOI 10.1016/S0168-9452(98)00199-X
   Carvalho AFU, 2003, MEM I OSWALDO CRUZ, V98, P569, DOI 10.1590/S0074-02762003000400027
   DAHLGREN RMT, 1980, BOT J LINN SOC, V80, P91, DOI 10.1111/j.1095-8339.1980.tb01661.x
   Daniel JFD, 2005, J BRAZIL CHEM SOC, V16, P634, DOI 10.1590/S0103-50532005000400022
   Di Stasi L.C., 2002, PLANTAS MED AMAZONIA
   DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017
   EneObong HN, 1995, PLANT FOOD HUM NUTR, V48, P225, DOI 10.1007/BF01088444
   Farias DF, 2009, J AM MOSQUITO CONTR, V25, P386, DOI 10.2987/08-5851.1
   Ferreira D., 2006, FLAVONOIDS CHEM BIOC
   Ferreira PMP, 2009, AN ACAD BRAS CIENC, V81, P207, DOI 10.1590/S0001-37652009000200007
   HANKIN L, 1975, MYCOLOGIA, V67, P597, DOI 10.2307/3758395
   Carrim AJI, 2006, BRAZ ARCH BIOL TECHN, V49, P353, DOI 10.1590/S1516-89132006000400001
   JOLY ABB, 1988, BOT INTRO TAXONOMIA
   KAKADE ML, 1974, CEREAL CHEM, V51, P376
   KAPLAN A, 1969, METHOD BIOCHEM ANAL, P311
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   MAHAN LK, 1996, KRAUSES FOOD NUTR DI
   Maia FMM, 2000, J SCI FOOD AGR, V80, P453, DOI 10.1002/(SICI)1097-0010(200003)80:4&lt;453::AID-JSFA548&gt;3.0.CO;2-X
   Mar SS, 2003, BIOSCI BIOTECH BIOCH, V67, P1080, DOI 10.1271/bbb.67.1080
   Mechi R., 2005, Ciencia e Tecnologia de Alimentos, V25, P109, DOI 10.1590/S0101-20612005000100018
   Michaud D, 1996, ARCH INSECT BIOCHEM, V31, P451, DOI 10.1002/(SICI)1520-6327(1996)31:4&lt;451::AID-ARCH7&gt;3.0.CO;2-Y
   MOREIRA J.C., 1977, PLANT PHYSIOL, V59, P783, DOI [10.1104/pp.59.5.783., DOI 10.1104/PP.59.5.783]
   Ng TB, 2004, PEPTIDES, V25, P1215, DOI 10.1016/j.peptides.2004.03.012
   Pegnyemb DE, 2005, PHYTOCHEMISTRY, V66, P1922, DOI 10.1016/j.phytochem.2005.06.017
   Rajaganapathi J, 2002, CURR SCI INDIA, V82, P264
   RAJARAM N, 1991, J SCI FOOD AGR, V55, P423, DOI 10.1002/jsfa.2740550310
   ROBERTS WK, 1990, J GEN MICROBIOL, V136, P1771, DOI 10.1099/00221287-136-9-1771
   Ruegger Marcelo J.S., 2004, Braz. J. Bot., V27, P205, DOI 10.1590/S0100-84042004000200001
   Silva M. R., 2001, Ciencia e Tecnologia de Alimentos, V21, P176, DOI 10.1590/S0101-20612001000200010
   Vasconcelos I. M., 2006, Revista Brasileira de Botanica, V29, P617, DOI 10.1590/S0100-84042006000400012
   VASCONCELOS IM, 1994, ARCH BIOCHEM BIOPHYS, V312, P357, DOI 10.1006/abbi.1994.1320
   Vasconcelos IM, 2001, J NUTR BIOCHEM, V12, P55, DOI 10.1016/S0955-2863(00)00148-0
   Webster D, 2008, J ETHNOPHARMACOL, V115, P140, DOI 10.1016/j.jep.2007.09.014
   Ye XY, 2005, PROTEIN EXPRES PURIF, V40, P230, DOI 10.1016/j.pep.2004.06.032
NR 45
TC 0
Z9 0
U1 0
U2 5
PU DRUCKEREI LIDDY HALM
PI GOTTINGEN
PA BACKHAUSSTRASSE 9B, 37081 GOTTINGEN, GERMANY
SN 1439-040X
J9 J APPL BOT FOOD QUAL
JI J. Appl. Bot. Food Qual.
PD SEP
PY 2010
VL 83
IS 2
BP 151
EP 156
PG 6
WC Plant Sciences
SC Plant Sciences
GA 671NW
UT WOS:000283513800009
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Farias, DF
   Carvalho, AFU
   Oliveira, CC
   Sousa, NM
   Rocha-Bezerrra, LCB
   Ferreira, PMP
   Lima, GPG
   Hissa, DC
AF Farias, D. F.
   Carvalho, A. F. U.
   Oliveira, C. C.
   Sousa, N. M.
   Rocha-Bezerrra, L. C. B.
   Ferreira, P. M. P.
   Lima, G. P. G.
   Hissa, D. C.
TI Alternative method for quantification of alfa-amylase activity
SO BRAZILIAN JOURNAL OF BIOLOGY
LA English
DT Article
DE alfa-amylase; alternative method; quantification
AB A modification of the sensitive agar diffusion method was developed for macro-scale determination of alfa-amylase. The proposed modifications lower costs with the utilisation of starch as substrate and agar as supporting medium. Thus, a standard curve was built using alfa-amylase solution from Aspergillus oryzae, with concentrations ranging from 2.4 to 7.500 U.mL(-1). Clear radial diffusion zones were measured after 4 hours of incubation at 20 degrees C. A linear relationship between the logarithm of enzyme activities and the area of clear zones was obtained. The method was validated by testing alpha-amylase from barley at the concentrations of 2.4: 60: 300 and 1,500 U. mL(-1). The proposed method turned out to be simpler, faster, less expensive and able to determine on a macro-scale alpha-amylase over a wide range (2.4 to 7.500 U.mL(-1)) in scientific investigation as well as in teaching laboratory activities.
C1 [Farias, D. F.; Carvalho, A. F. U.; Sousa, N. M.; Rocha-Bezerrra, L. C. B.; Lima, G. P. G.; Hissa, D. C.] Univ Fed Ceara, Dept Biol, BR-60455970 Fortaleza, Ceara, Brazil.
   [Oliveira, C. C.] Univ Fed Ceara, Dept Farmacol, BR-60455970 Fortaleza, Ceara, Brazil.
   [Ferreira, P. M. P.] UFPI, BR-64600000 Picos, PI, Brazil.
RP Farias, DF (corresponding author), Univ Fed Ceara, Dept Biol, Campus Pici, BR-60455970 Fortaleza, Ceara, Brazil.
EM aurano@ufc.br
RI Farias, Davi Felipe/AAH-1868-2020; lima, giuseppina GPPL/C-5995-2012;
   Hissa, Denise/X-3314-2019; Ferreira, Paulo Michel Pinheiro/J-6783-2012
OI lima, giuseppina GPPL/0000-0002-1792-2605; Ferreira, Paulo Michel
   Pinheiro/0000-0001-6862-6497; Felipe Farias, Davi/0000-0001-5438-1919
CR Bergmeyer H., 1974, METHODS ENZYMATIC AN
   HANKIN L, 1975, MYCOLOGIA, V67, P597, DOI 10.2307/3758395
   MESTECKY J, 1969, ANAL BIOCHEM, V30, P190, DOI 10.1016/0003-2697(69)90389-3
   TAUSCHEL HD, 1982, ANAL BIOCHEM, V120, P262, DOI 10.1016/0003-2697(82)90346-3
   VOET D, 2004, BIOCHEMISTRY
NR 5
TC 7
Z9 7
U1 0
U2 32
PU INT INST ECOLOGY
PI SAO CARLOS
PA RUA BENTO CARLOS, 750 - CENTRO, SAO CARLOS, SP 00000, BRAZIL
SN 1519-6984
J9 BRAZ J BIOL
JI Braz. J. Biol.
PD MAY
PY 2010
VL 70
IS 2
BP 405
EP 407
DI 10.1590/S1519-69842010005000008
PG 3
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 607XX
UT WOS:000278541700024
PM 20552148
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Vasconcelos, IM
   Maia, FMM
   Farias, DF
   Campello, CC
   Carvalho, AFU
   Moreira, RD
   de Oliveira, JTA
AF Vasconcelos, Ilka Maria
   Machado Maia, Fernanda Maria
   Farias, Davi Felipe
   Campello, Claudio Cabral
   Urano Carvalho, Ana Fontenele
   Moreira, Renato de Azevedo
   Abreu de Oliveira, Jose Tadeu
TI Protein fractions, amino acid composition and antinutritional
   constituents of high-yielding cowpea cultivars
SO JOURNAL OF FOOD COMPOSITION AND ANALYSIS
LA English
DT Article
DE Vigna unguiculata; Cowpea; Protein fractions; Amino acids;
   Antinutritional factors; Trypsin inhibitors; Haemagglutinins; Food
   analysis; Food composition
ID VIGNA-UNGUICULATA; PROXIMATE COMPOSITION; CHEMICAL-COMPOSITION;
   PHASEOLUS-VULGARIS; NUTRITIVE-VALUE; SOY PRODUCTS; GLYCINE-MAX;
   IN-VITRO; SEEDS; DIGESTIBILITY
AB High-yielding cowpea (Vigna unguiculata) cultivars were analysed for major changes in seed protein types, amino acid profiles and antinutritional factors content. As usual, the globulins constitute the major seed proteins (493.2-573.3 g kg(-1) total seed protein), followed by albumins (201.0-248.0 g kg(-1)), basic glutelins (119.1-154.3 g kg(-1)), acid glutelins (82.4-92.3 g kg(-1)) and prolamins (13.2-20.2 g kg(-1)). The electrophoretic patterns of seeds and protein fractions for all cowpea cultivars resembled to each other both qualitatively and quantitatively. However, they showed slight differences in the amino acid composition with common prevalence of glutamine/glutamic acid, asparagine/aspartic acid and phenylalanine + tyrosine. The methionine + cysteine contents were low for all cultivars and their protein fractions. Trypsin inhibitory activity varied among the cultivars and was much higher in the albumins (198.67-393.43 g kg(-1) protein). Haemagglutinating activity was also higher in the albumin fraction and varied from 30,900 to 444,400 HU kg(-1) flour. In conclusion, all cultivars showed the usual compositional characteristics of V. unguiculata, but the content of antinutritional factors differed among the cultivars although they remained concentrated in albumin and globulin fractions. (C) 2009 Elsevier Inc. All rights reserved.
C1 [Vasconcelos, Ilka Maria; Moreira, Renato de Azevedo; Abreu de Oliveira, Jose Tadeu] Univ Fed Ceara, Dept Bioquim & Biol Mol, BR-60451970 Fortaleza, Ceara, Brazil.
   [Machado Maia, Fernanda Maria] Univ Estadual Ceara, Curso Nutr, Fortaleza, Ceara, Brazil.
   [Farias, Davi Felipe; Urano Carvalho, Ana Fontenele] Univ Fed Ceara, Dept Biol, BR-60455970 Fortaleza, Ceara, Brazil.
   [Campello, Claudio Cabral] Univ Estadual Ceara, Fac Vet, Fortaleza, Ceara, Brazil.
RP Vasconcelos, IM (corresponding author), Univ Fed Ceara, Dept Bioquim & Biol Mol, POB 6020,Campus Pici, BR-60451970 Fortaleza, Ceara, Brazil.
EM imvasco@ufc.br
RI Carvalho, Ana/K-7344-2018; Farias, Davi Felipe/AAH-1868-2020
OI Carvalho, Ana/0000-0001-5293-9317; Felipe Farias,
   Davi/0000-0001-5438-1919; Moreira, Renato de Azevedo/0000-0002-9626-6086
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Programa de Apoio a Nucleos de Excelencia (PRONEX); Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES; Programa
   Nacional de Cooperacao Academica (PROCAD); Fundacao de Amparo a Pesquisa
   do Estado do Ceara (FUNCAP)
FX This work was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq), Programa de Apoio a Nucleos de
   Excelencia (PRONEX), Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES), Programa Nacional de Cooperacao Academica (PROCAD) and
   Fundacao de Amparo a Pesquisa do Estado do Ceara (FUNCAP).
CR ADSULE RN, 1986, FOOD SCI NUTR, V25, P73
   AKINYELE IO, 1990, J FOOD SCI, V55, P701, DOI 10.1111/j.1365-2621.1990.tb05210.x
   Araujo AH, 2002, FOOD CHEM, V78, P143, DOI 10.1016/S0308-8146(01)00391-0
   Atherton K.T., 2002, GENETICALLY MODIFIED
   BAETHGEN WE, 1989, COMMUN SOIL SCI PLAN, V20, P961, DOI 10.1080/00103628909368129
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Carlini CR, 2002, TOXICON, V40, P1515, DOI 10.1016/S0041-0101(02)00240-4
   Casaretto JA, 1998, PHYTOCHEMISTRY, V49, P2279, DOI 10.1016/S0031-9422(98)00332-X
   EHLERS JD, 1997, FIELD CROPS RES, V53, P87
   FAO/ WHO/ UNU, 1985, FAO WHO UNU TECHN RE, V724
   Giami SY, 2005, J FOOD COMPOS ANAL, V18, P665, DOI 10.1016/j.jfca.2004.06.007
   GOPINATHAN MC, 1987, PLANT FOOD HUM NUTR, V34, P356
   GRANT G, 1995, BRIT J NUTR, V73, P17, DOI 10.1079/BJN19950005
   HAMERSTRAND GE, 1981, CEREAL CHEM, V58, P42
   Juliano BO, 1999, FOOD REV INT, V15, P399, DOI 10.1080/87559129909541197
   KAKADE ML, 1974, CEREAL CHEM, V51, P376
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lajolo FM, 2002, J AGR FOOD CHEM, V50, P6592, DOI 10.1021/jf020191k
   LARKINS BA, 1981, BIOCH PLANTS
   LAURENA AC, 1991, PLANT FOOD HUM NUTR, V41, P59, DOI 10.1007/BF02196383
   LIS N., 1972, METHOD ENZYMOL, V28, P360, DOI 10.1016/0076-6879(72)28046-6.
   Lopes ACD, 2001, PESQUI AGROPECU BRAS, V36, P515
   MAHAJAN R, 1988, PLANT FOOD HUM NUTR, V38, P163, DOI 10.1007/BF01091721
   MAHAN LK, 1996, KRAUSES FOOD NUTR DI
   Maia FMM, 2000, J SCI FOOD AGR, V80, P453, DOI 10.1002/(SICI)1097-0010(200003)80:4&lt;453::AID-JSFA548&gt;3.0.CO;2-X
   MARCONI E, 1993, FOOD CHEM, V47, P37, DOI 10.1016/0308-8146(93)90299-U
   Marconi E, 1997, FOOD CHEM, V59, P203, DOI 10.1016/S0308-8146(96)00172-0
   Mensa-Wilmot Y, 2001, NUTR RES, V21, P849, DOI 10.1016/S0271-5317(01)00302-5
   MOHAN VR, 1993, FOOD CHEM, V48, P367, DOI 10.1016/0308-8146(93)90319-B
   MOREIRA J.C., 1977, PLANT PHYSIOL, V59, P783, DOI [10.1104/pp.59.5.783., DOI 10.1104/PP.59.5.783]
   Nti CA, 1995, PLANT FOOD HUM NUTR, V48, P45, DOI 10.1007/BF01089199
   Nugdallah GA, 1997, PLANT FOOD HUM NUTR, V51, P277, DOI 10.1023/A:1007920221382
   Onwuliri VA, 2002, FOOD CHEM, V78, P1, DOI 10.1016/S0308-8146(00)00293-4
   PEDALINO M, 1990, COWPEA GENETIC RESOU
   PINTERSZAKACS M, 1990, J AGR FOOD CHEM, V38, P720, DOI 10.1021/jf00093a028
   Plahar WA, 1997, PLANT FOOD HUM NUTR, V51, P343, DOI 10.1023/A:1007994612607
   Preet K, 2000, INT J FOOD SCI NUTR, V51, P189, DOI 10.1080/09637480050029692
   Ragab DM, 2004, FOOD CHEM, V84, P207, DOI 10.1016/S0308-8146(03)00203-6
   Rangel A, 2004, FOOD CHEM, V87, P491, DOI 10.1016/j.foodchem.2003.12.023
   Rao TR, 2000, ASIAN PAC J ALLERGY, V18, P9
   Rivas-Vega ME, 2006, FOOD CHEM, V97, P41, DOI 10.1016/j.foodchem.2005.03.021
   RODRIGUEZ MS, 1991, PLANT FOOD HUM NUTR, V41, P1, DOI 10.1007/BF02196376
   Saikia P, 1999, FOOD CHEM, V67, P347, DOI 10.1016/S0308-8146(98)00206-4
   Uwaegbute AC, 2000, FOOD CHEM, V68, P141, DOI 10.1016/S0308-8146(99)00134-X
   Vasconcelos IM, 1997, J SCI FOOD AGR, V75, P419, DOI [10.1002/(SICI)1097-0010(199712)75:4&lt;419::AID-JSFA886&gt;3.0.CO;2-D, 10.1002/(SICI)1097-0010(199712)75:4<419::AID-JSFA886>3.3.CO;2-4]
   Vasconcelos IM, 2004, TOXICON, V44, P385, DOI 10.1016/j.toxicon.2004.05.005
NR 46
TC 59
Z9 62
U1 1
U2 30
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0889-1575
EI 1096-0481
J9 J FOOD COMPOS ANAL
JI J. Food Compos. Anal.
PD FEB
PY 2010
VL 23
IS 1
BP 54
EP 60
DI 10.1016/j.jfca.2009.05.008
PG 7
WC Chemistry, Applied; Food Science & Technology
SC Chemistry; Food Science & Technology
GA 578DR
UT WOS:000276274200008
DA 2020-12-08
ER

PT J
AU Guimaraes, LM
   Farias, DF
   Muchagata, RCC
   de Magalhaes, MQ
   Campello, CC
   Rocha, TL
   Vasconcelos, IM
   Carvalho, AFU
   Mulinari, F
   Grossi-De-Sa, MF
AF Guimaraes, Luciane Mourao
   Farias, Davi Felipe
   Carvalho Muchagata, Relinda Campos
   de Magalhaes, Mariana Quezado
   Campello, Claudio Cabral
   Rocha, Thales Lima
   Vasconcelos, Ilka Maria
   Urano Carvalho, Ana Fontenele
   Mulinari, Fernanda
   Grossi-de-Sa, Maria Fatima
TI Short-Term Evaluation in Growing Rats of Diet Containing Bacillus
   thuringiensis Cry1Ia12 Entomotoxin: Nutritional Responses and Some
   Safety Aspects
SO JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
LA English
DT Article
ID DELTA-ENDOTOXINS; 90-DAY SAFETY; MODE; CORN; TOXICITY; PROTEINS; COTTON;
   TOXIN
AB The Cry1Ia12 entomotoxin from a Brazilian Bacillus thuringiensis strain is currently being expressed in cotton cultivars to confer resistance to insect-pests. The present study aimed to assess the effects of a diet containing Cry1Ia12 protein on growing rats. A test diet containing egg white and Cry1Ia12 (0.1% of total protein) as a protein source was offered to rats for ten days. In addition, an acute toxicity bioassay was performed in rats with a single oral dose of the entomotoxin (12 mg/animal). No adverse effects were observed in the animals receiving the test diet when compared to those receiving a control diet (egg white). The analysed parameters included relative dry weight of internal organs, duodenum histology, blood biochemistry, and nutritional parameters. The results of the acute toxicity test showed no mortality or behaviour alteration. Thus, Cry1Ia12 toxin at the tested concentration does not cause deleterious effects on growing rats when incorporated in the diet for 10 days.
C1 [Urano Carvalho, Ana Fontenele] Univ Fed Ceara, Dept Biol, BR-60455970 Fortaleza, Ceara, Brazil.
   [Guimaraes, Luciane Mourao; Carvalho Muchagata, Relinda Campos; de Magalhaes, Mariana Quezado; Rocha, Thales Lima; Mulinari, Fernanda; Grossi-de-Sa, Maria Fatima] Embrapa Recursos Genet & Biotecnol, Dept Biotecnol, BR-70770900 Brasilia, DF, Brazil.
   [Farias, Davi Felipe; Vasconcelos, Ilka Maria] Univ Fed Ceara, Dept Bioquim & Biol Mol, BR-60451970 Fortaleza, Ceara, Brazil.
   [Campello, Claudio Cabral] Univ Estadual Ceara, Fac Vet, BR-60740000 Fortaleza, Ceara, Brazil.
   [Mulinari, Fernanda] Dept Vet Med, Uniao Pioneira Integracao Social, BR-70390125 Planaltina, DF, Brazil.
   [Grossi-de-Sa, Maria Fatima] Univ Catolica Brasilia, Dept Ciencias Genom & Biotecnol, BR-70790160 Brasilia, DF, Brazil.
RP Carvalho, AFU (corresponding author), Univ Fed Ceara, Dept Biol, BR-60455970 Fortaleza, Ceara, Brazil.
EM aurano@ufc.br
RI Grossi-de-Sa, Maria Fatima/N-7856-2017; Farias, Davi
   Felipe/AAH-1868-2020
OI GROSSI-DE-SA, MARIA FATIMA/0000-0001-8184-9599; Felipe Farias,
   Davi/0000-0001-5438-1919
FU Brazilian government EMBRAPA; CNPqNational Council for Scientific and
   Technological Development (CNPq); CAPESCAPES
FX This work was supported by grants from the Brazilian government EMBRAPA,
   CNPq, and CAPES.
CR Adams SM, 2001, BIOMARKERS, V6, P1, DOI 10.1080/135475001452724
   BAETHGEN WE, 1989, COMMUN SOIL SCI PLAN, V20, P961, DOI 10.1080/00103628909368129
   Constable A, 2007, FOOD CHEM TOXICOL, V45, P2513, DOI 10.1016/j.fct.2007.05.028
   Delaney B, 2008, FOOD CHEM TOXICOL, V46, pS71, DOI 10.1016/j.fct.2008.01.045
   Doull J, 2007, FOOD CHEM TOXICOL, V45, P2073, DOI 10.1016/j.fct.2007.08.033
   Dryzga MD, 2007, FOOD CHEM TOXICOL, V45, P1994, DOI 10.1016/j.fct.2007.04.017
   ENGLISH L, 1992, INSECT BIOCHEM MOLEC, V22, P1, DOI 10.1016/0965-1748(92)90093-T
   Garcia-Robles I, 2001, INSECT BIOCHEM MOLEC, V31, P849, DOI 10.1016/S0965-1748(01)00030-3
   GILL SS, 1992, ANNU REV ENTOMOL, V37, P615, DOI 10.1146/annurev.en.37.010192.003151
   Grossi-De-Sa MF, 2007, J BIOCHEM MOL BIOL, V40, P773
   Hammond BG, 2006, FOOD CHEM TOXICOL, V44, P1092, DOI 10.1016/j.fct.2006.01.003
   Hossain F, 2004, INT J OCCUP ENV HEAL, V10, P296, DOI 10.1179/oeh.2004.10.3.296
   Kilic A, 2008, FOOD CHEM TOXICOL, V46, P1164, DOI 10.1016/j.fct.2007.11.016
   KNOWLES BH, 1987, BIOCHIM BIOPHYS ACTA, V924, P509, DOI 10.1016/0304-4165(87)90167-X
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MCCLINTOCK JT, 1995, PESTIC SCI, V45, P95, DOI 10.1002/ps.2780450202
   MILLER DS, 1955, BRIT J NUTR, V9, P382, DOI 10.1079/BJN19550055
   NOTEBORN, 1995, GENETICALLY MODIFIED, P134
   Peng DH, 2007, FOOD CHEM TOXICOL, V45, P1179, DOI 10.1016/j.fct.2006.12.026
   Sanders PR, 1998, BIOTECHNOLOGY SAFETY, P241
   Schroder M, 2007, FOOD CHEM TOXICOL, V45, P339, DOI 10.1016/j.fct.2006.09.001
   Shelton AM, 2002, ANNU REV ENTOMOL, V47, P845, DOI 10.1146/annurev.ento.47.091201.145309
   van Haver E, 2008, FOOD CHEM TOXICOL, V46, pS2, DOI 10.1016/j.fct.2008.02.008
   Vasconcelos IM, 2004, TOXICON, V44, P385, DOI 10.1016/j.toxicon.2004.05.005
   Vasconcelos IM, 2001, J NUTR BIOCHEM, V12, P55, DOI 10.1016/S0955-2863(00)00148-0
   WOLFERSBERGER MG, 1992, J EXP BIOL, V172, P377
   BT COTTON INDIA STAT
NR 28
TC 4
Z9 5
U1 0
U2 3
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1110-7243
EI 1110-7251
J9 J BIOMED BIOTECHNOL
JI J. Biomed. Biotechnol.
PY 2010
AR 630267
DI 10.1155/2010/630267
PG 8
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA 664GZ
UT WOS:000282949700001
PM 20862341
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Farias, DF
   Cavalheiro, MG
   Viana, SM
   De Lima, GPG
   Da Rocha-Bezerra, LCB
   Ricardo, NMPS
   Carvalho, AFU
AF Farias, Davi F.
   Cavalheiro, Mariana G.
   Viana, Sayonara M.
   De Lima, Glauber P. G.
   Da Rocha-Bezerra, Lady Clarissa B.
   Ricardo, Nagila M. P. S.
   Carvalho, Ana F. U.
TI INSECTICIDAL ACTION OF SODIUM ANACARDATE FROM BRAZILIAN CASHEW NUT SHELL
   LIQUID AGAINST AEDES AEGYPTI
SO JOURNAL OF THE AMERICAN MOSQUITO CONTROL ASSOCIATION
LA English
DT Article
DE Sodium anacardate; Aedes aegypti; insecticidal action; dengue fever;
   Anacardium occidentale
ID LARVICIDAL ACTIVITY; ESSENTIAL OILS; EXTRACTS; LARVAE
AB Aedes aegypti is the major vector of 1 of the most concerning arboviruses or the world, the dengue fever. The only effective way of reducing the incidence of dengue fever is to control the vector mosquito, mainly by application of insecticides to its breeding places. This study was aimed at assessing the insecticidal activity of sodium anacardate, isolated from Brazilian cashew nut shell liquid (CNSL), against the eggs, 3rd instars or pupae of Ae. aegypti. In addition, the acute toxicity of sodium anacardate to mice was also investigated. Sodium anacardate showed toxicity against Ae. aegypti eggs (median effective concentration [EC50] = 162.93 +/- 29.93 mu g/ml), larvae (median lethal concentration [LC50] = 55.47 +/- 3.0 mu g/ml) and pupae (LC50 = 369.78 +/- 52.30 mu g/ml). On the other hand, even at high dose (0.3 g/kg body weight), this compound did not cause any adverse effects on mice, suggesting that this compound is safe to mammals. Therefore, sodium anacardate may be a viable low-cost alternative to help combat Ae. aegypti.
C1 [Farias, Davi F.; Cavalheiro, Mariana G.; Viana, Sayonara M.; De Lima, Glauber P. G.; Da Rocha-Bezerra, Lady Clarissa B.; Carvalho, Ana F. U.] Univ Fed Ceara, Dept Biol, BR-60451970 Fortaleza, Ceara, Brazil.
   [Ricardo, Nagila M. P. S.] Univ Fed Ceara, Dept Quim Organ & Inorgan, BR-60451970 Fortaleza, Ceara, Brazil.
RP Carvalho, AFU (corresponding author), Univ Fed Ceara, Dept Biol, Campus Pici, BR-60451970 Fortaleza, Ceara, Brazil.
RI Carvalho, Ana/K-7344-2018; Ricardo, Nagila Maria Pontes
   Silva/C-3630-2015; Farias, Davi Felipe/AAH-1868-2020
OI Carvalho, Ana/0000-0001-5293-9317; Ricardo, Nagila Maria Pontes
   Silva/0000-0003-1849-5403; Felipe Farias, Davi/0000-0001-5438-1919;
   Gomes de Lima, Glauber Pacelli/0000-0002-5366-4551
FU Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico
   (FUNCAP); Nucleo de Controle de Endemias Transnussiveis por Vetores
   (NUVET)
FX The authors wish to express their thanks to Fundacao Cearense de Apoio
   ao Desenvolvimento Cientifico e Tecnologico (FUNCAP) and Nucleo de
   Controle de Endemias Transnussiveis por Vetores (NUVET) for financial
   and technical support, respectively.
CR Andrade EHA, 2001, J FOOD COMPOS ANAL, V14, P227, DOI [10.1006/jfca.2000.0968, 10.1006/jfca.2000.0894]
   BUCKLEY D, 1971, APPL MICROBIOL, V21, P565, DOI 10.1128/AEM.21.4.565-568.1971
   Carvalho AFU, 2003, MEM I OSWALDO CRUZ, V98, P569, DOI 10.1590/S0074-02762003000400027
   Cavalcanti ESB, 2004, MEM I OSWALDO CRUZ, V99, P541, DOI 10.1590/S0074-02762004000500015
   Choochote W, 2007, FITOTERAPIA, V78, P359, DOI 10.1016/j.fitote.2007.02.006
   CONSOLI R A G B, 1988, Memorias do Instituto Oswaldo Cruz, V83, P87, DOI 10.1590/S0074-02761988000100012
   Consoli R.A.G.B, 1994, PRINCIPAIS MOSQUITOS
   Corbel V, 2004, J MED ENTOMOL, V41, P712, DOI 10.1603/0022-2585-41.4.712
   de Morals SM, 2007, BIOCHEM SYST ECOL, V35, P670, DOI 10.1016/j.bse.2007.05.002
   de Omena MC, 2007, BIORESOURCE TECHNOL, V98, P2549, DOI 10.1016/j.biortech.2006.09.040
   Fatope M. O., 1993, International Journal of Pharmacognosy, V31, P250
   Finney D. J., 1971, PROBIT ANAL
   Glare T.R., 2000, BACILLUS THURINGIENS
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Jang YS, 2002, J AM MOSQUITO CONTR, V18, P210
   Laurens A, 1997, PHYTOTHER RES, V11, P145, DOI 10.1002/(SICI)1099-1573(199703)11:2<145::AID-PTR40>3.0.CO;2-#
   Morais SM, 2006, J AM MOSQUITO CONTR, V22, P161, DOI 10.2987/8756-971X(2006)22[161:LAOEOF]2.0.CO;2
   MUROI H, 1993, J AGR FOOD CHEM, V41, P1780, DOI 10.1021/jf00034a049
   Murugan K, 2007, BIORESOURCE TECHNOL, V98, P198, DOI 10.1016/j.biortech.2005.12.009
   Ramos MV, 2006, MEM I OSWALDO CRUZ, V101, P503, DOI 10.1590/S0074-02762006000500004
   Silva WJ, 2008, BIORESOURCE TECHNOL, V99, P3251, DOI 10.1016/j.biortech.2007.05.064
   VASCONCELOS IM, 1994, ARCH BIOCHEM BIOPHYS, V312, P357, DOI 10.1006/abbi.1994.1320
   Wandscheer CB, 2004, TOXICON, V44, P829, DOI 10.1016/j.toxicon.2004.07.009
   WHO, 2005, GUID LAB FIELD TEST
NR 24
TC 21
Z9 23
U1 0
U2 11
PU AMER MOSQUITO CONTROL ASSOC
PI MOUNT LAUREL
PA 15000 COMMERCE PARKWAY, SUITE C, MOUNT LAUREL, NJ 08054 USA
SN 8756-971X
EI 1943-6270
J9 J AM MOSQUITO CONTR
JI J. Am. Mosq. Control Assoc.
PD SEP
PY 2009
VL 25
IS 3
BP 386
EP 389
DI 10.2987/08-5851.1
PG 4
WC Entomology
SC Entomology
GA 504EN
UT WOS:000270598300026
PM 19852234
DA 2020-12-08
ER

PT J
AU Ramos, MV
   Pereira, DA
   Souza, DP
   Araujo, ES
   Freitas, CDT
   Cavalheiro, MG
   Matos, MPV
   Carvalho, AFU
AF Ramos, Marcio V.
   Pereira, Danielle A.
   Souza, Diego P.
   Araujo, Eliane S.
   Freitas, Cleverson D. T.
   Cavalheiro, Mariana G.
   Matos, Mayara Patricia V.
   Carvalho, Ana F. U.
TI Potential of laticifer fluids for inhibiting Aedes aegypti larval
   development: evidence for the involvement of proteolytic activity
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Aedes aegypti; biological control; cysteine proteinases; latex; larvae;
   papain
ID CALOTROPIS-PROCERA; PAPAYA LATEX; CALLOSOBRUCHUS-MACULATUS; PLANT
   DEFENSE; PURIFICATION; PROTEINASE; PROTEASES; SEEDS
AB It has been shown previously that the laticifer fluid of Calotropis procera (Ait.) R.Br. is highly toxic to the egg hatching and larval development of Aedes aegypti L. In the present study, the larvicidal potential of other laticifer fluids obtained from Cryptostegia grandiflora R.Br., Plumeria rubra L. and Euphorbia tirucalli L. was evaluated. We attempted to correlate larvicidal activity with the presence of endogenous proteolytic activity in the protein fraction of the fluids. After collection, the fluids were processed by centrifugation and dialysis to obtain the soluble laticifer protein (LP) fractions and eliminate water insoluble and low molecular mass molecules. LP did not visibly affect egg hatching at the doses assayed. LP from Cr. grandiflora exhibited the highest larval toxicity, while P. rubra was almost inactive. E. tirucalli was slightly active, but its activity could not be correlated to proteins since no protein was detected in the fluid. The larvicidal effects of LP from C. procera and Cr. grandiflora showed a significant relationship with the proteolytic activity of cysteine proteinases, which are present in both materials. A purified cysteine proteinase (papain) from the latex of Carica papaya (obtained from Sigma) was similarly effective, whereas trypsin and chymotrypsin (both serine proteinases) were ineffective. The results provide evidence for the involvement of cysteine proteinase activity in the larvicidal action of some laticifer fluids. C. procera is an invasive species found in areas infested with Ae. aegypti and thus could prove useful for combating mosquito proliferation. This is the first report to present evidence for the use of proteolytic enzymes as chemical agents to destroy Ae. aegypti larvae.
C1 [Ramos, Marcio V.; Pereira, Danielle A.; Souza, Diego P.; Araujo, Eliane S.; Freitas, Cleverson D. T.; Cavalheiro, Mariana G.; Matos, Mayara Patricia V.] Univ Fed Ceara, Dept Bioquim & Biol Mol, BR-60451970 Fortaleza, Ceara, Brazil.
   [Carvalho, Ana F. U.] Univ Fed Ceara, Dept Biol, BR-60451970 Fortaleza, Ceara, Brazil.
RP Ramos, MV (corresponding author), Univ Fed Ceara, Dept Bioquim & Biol Mol, Campus Pici,Postal 6033, BR-60451970 Fortaleza, Ceara, Brazil.
EM vramos@ufc.br
RI da Silva Carlini, Celia Regina Ribeiro/H-4017-2011; Carvalho,
   Ana/K-7344-2018; FREITAS, CLEVERSON/B-7119-2016
OI da Silva Carlini, Celia Regina Ribeiro/0000-0002-7027-2445; Carvalho,
   Ana/0000-0001-5293-9317; 
FU FUNCAP; CNPqNational Council for Scientific and Technological
   Development (CNPq); PADCT; RENORBIO; International Foundation for
   ScienceInternational Foundation for Science [3070-3]
FX Financial support: FUNCAP, CNPq, PADCT, RENORBIO, International
   Foundation for Science (3070-3 to MVR)
CR ABE M, 1992, EUR J BIOCHEM, V209, P933, DOI 10.1111/j.1432-1033.1992.tb17365.x
   Alencar NMN, 2006, INFLAMM RES, V55, P559, DOI 10.1007/s00011-006-6025-y
   Lopes KLB, 2009, BOTANY, V87, P202, DOI 10.1139/B08-126
   BARRETT AJ, 1972, ANAL BIOCHEM, V47, P280, DOI 10.1016/0003-2697(72)90302-8
   BOLLER T, 1986, PLANT PROTEOLYTIC EN, V1, P67
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BRADY CJ, 1987, ANNU REV PLANT PHYS, V38, P155, DOI 10.1146/annurev.pp.38.060187.001103
   Braga IA, 2007, EPIDEMIOL SERV SAUDE, V16, P279
   Carlini CR, 2002, TOXICON, V40, P1515, DOI 10.1016/S0041-0101(02)00240-4
   Carvalho AFU, 2003, MEM I OSWALDO CRUZ, V98, P569, DOI 10.1590/S0074-02762003000400027
   Consoli R.A.G.B, 1994, PRINCIPAIS MOSQUITOS
   de Oliveira JS, 2007, TOXICOL IN VITRO, V21, P1563, DOI 10.1016/j.tiv.2007.05.007
   El Badwi SMA, 1998, DEUT TIERARZTL WOCH, V105, P425
   Freitas CDT, 2007, PLANT PHYSIOL BIOCH, V45, P781, DOI 10.1016/j.plaphy.2007.07.020
   Glazer AN, 1971, ENZYMES, VIII, P501
   KEMBHAVI AA, 1993, ARCH BIOCHEM BIOPHYS, V303, P208, DOI 10.1006/abbi.1993.1274
   KRAUT J, 1977, ANNU REV BIOCHEM, V46, P331, DOI 10.1146/annurev.bi.46.070177.001555
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LYNN KR, 1979, BIOCHIM BIOPHYS ACTA, V569, P193, DOI 10.1016/0005-2744(79)90054-8
   Macedo MLR, 2004, J AGR FOOD CHEM, V52, P2533, DOI 10.1021/jf035389z
   Nitsawang S, 2006, ENZYME MICROB TECH, V39, P1103, DOI 10.1016/j.enzmictec.2006.02.013
   *PAHO WHO, 2008, BRAZ HLTH SYST SERV
   Patel BK, 2003, J AGR FOOD CHEM, V51, P6326, DOI 10.1021/jf026184d
   Pechan T, 2002, P NATL ACAD SCI USA, V99, P13319, DOI 10.1073/pnas.202224899
   Porter AG, 1996, PARASITOL TODAY, V12, P175, DOI 10.1016/0169-4758(96)10013-2
   Ramos MV, 2007, PLANT SCI, V173, P349, DOI 10.1016/j.plantsci.2007.06.008
   Ramos MV, 2006, MEM I OSWALDO CRUZ, V101, P503, DOI 10.1590/S0074-02762006000500004
   Rudenskaya GN, 1998, FEBS LETT, V437, P237, DOI 10.1016/S0014-5793(98)01243-5
   SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2
   Siqueira JB, 2005, EMERG INFECT DIS, V11, P48, DOI 10.3201/eid1101.031091
   SMITH EL, 1955, J BIOL CHEM, V215, P67
   TAYLOR RM, 1993, FEBS LETT, V331, P76, DOI 10.1016/0014-5793(93)80300-J
   WHO, 2005, GUID LAB FIELD TEST
   *WHO, 2009, DENG DENG HAEM FEV
   XAVIERFILHO J, 1989, J AGR FOOD CHEM, V37, P1139, DOI 10.1021/jf00088a071
NR 35
TC 9
Z9 12
U1 0
U2 12
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD SEP
PY 2009
VL 104
IS 6
BP 805
EP 812
DI 10.1590/S0074-02762009000600001
PG 8
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 514VT
UT WOS:000271424800001
PM 19876551
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Carvalho, AFU
   Portela, MCC
   Sousa, MB
   Martins, FS
   Rocha, FC
   Farias, DF
   Feitosa, JPA
AF Carvalho, A. F. U.
   Portela, M. C. C.
   Sousa, M. B.
   Martins, F. S.
   Rocha, F. C.
   Farias, D. F.
   Feitosa, J. P. A.
TI Physiological and physico-chemical characterization of dietary fibre
   from the green seaweed Ulva fasciata Delile
SO BRAZILIAN JOURNAL OF BIOLOGY
LA English
DT Article
DE Ulva fasciata; dietary fibre; seaweeds; physiological and
   physico-chemical characteristics
ID CHEMICAL-COMPOSITION; EDIBLE SEAWEEDS; MARINE-ALGAE; CHOLESTEROL;
   POLYSACCHARIDES; MICROFLORA; METABOLISM; BINDING; FOODS; RAT
AB This work aims to assess the potential of the green seaweed Ulva fasciata Delile as ail alternative source of dietary fibre (DF). Total DF content was determined, some of its physico-chemical properties described and the physiological effects of U. fasciata meal on rats fed a hypercholesterolemic diet were investigated. U. fasciata may be considered a potential alternative source of DF with a total content of about 400 g.kg(-1) (dry basis) and interesting physico-chemical properties: water retention capacity of 8.74 g/water.g(-1) dry sample (seaweed meal) and 0.90 (seaweed carbohydrate extract), lipid adsorption capacity of 4.52 g/oil.g(-1) dry sample (seaweed meal) and 5.70 (seaweed carbohydrate extract), intrinsic viscosity of 2.4 dl.g(-1) (seaweed carbohydrate extract) and cation exchange capacity of 3.51 Eq.kg(-1) (seaweed carbohydrate extract). The diet containing seaweed meal was able to keep rats' total cholesterol (TC) down without causing any undesirable increase in LDL-C fraction. No evidence of toxic and/or antinutritional components in the seaweed meal was detected. Rats showed a fecal volume much greater (13 g) than that fed on cellulose diet (7 g) (p < 0.05). These properties confer on the seaweed the potential to be used in food technology for the acquisition of low-calorie food and might be important in body weight control, reduction of blood TC and LDL-C as well as in prevention of gastrointestinal diseases.
C1 [Carvalho, A. F. U.; Sousa, M. B.; Martins, F. S.; Rocha, F. C.; Farias, D. F.] Univ Fed Ceara, Dept Biol, BR-60455970 Fortaleza, Ceara, Brazil.
   [Portela, M. C. C.] Univ Fed Ceara, Dept Tecnol Alimentos, BR-60455970 Fortaleza, Ceara, Brazil.
   [Feitosa, J. P. A.] Univ Fed Ceara, Dept Quim Organ & Inorgan, BR-60455970 Fortaleza, Ceara, Brazil.
RP Carvalho, AFU (corresponding author), Univ Fed Ceara, Dept Biol, Av Mister Hull,S-N,Campus Pici, BR-60455970 Fortaleza, Ceara, Brazil.
EM aurano@ufc.br
RI Farias, Davi Felipe/AAH-1868-2020; Biguzzi, Felipe A/E-4724-2015;
   Feitosa, Judith P A/O-7165-2018
OI Felipe Farias, Davi/0000-0001-5438-1919; Portela, Masu Capistrano
   Camurca/0000-0002-1534-424X
FU FUNCAP
FX The authors are grateful to FUNCAP for an MSc scholarship to the student
   Masu Capistrano Camurca Portela.
CR Aguilera-Morales M, 2005, J FOOD COMPOS ANAL, V18, P79, DOI 10.1016/j.jfca.2003.12.012
   ALLAIN CC, 1974, CLIN CHEM, V20, P475
   ANDERSON DJ, 1988, AM J REPROD IMMUNOL, V17, P22
   Anderson J. W., 1988, AM J CARDIOL, V60, P17
   AOAC, 1997, OFF METH AN
   BAETHGEN WE, 1989, COMMUN SOIL SCI PLAN, V20, P961, DOI 10.1080/00103628909368129
   Bardocz S, 1996, BRIT J NUTR, V76, P613, DOI 10.1079/BJN19960067
   Bobin-Dubigeon C, 1997, SCI ALIMENT, V17, P619
   CAPREZ A, 1986, J CEREAL SCI, V4, P233, DOI 10.1016/S0733-5210(86)80025-X
   Chau CF, 1999, NUTR RES, V19, P257, DOI 10.1016/S0271-5317(98)00189-4
   CRAVEIRO AA, 1999, QUITOSANA FIBRA FUTU
   Davidson MH, 1998, NUTR RES, V18, P617, DOI 10.1016/S0271-5317(98)00048-7
   Durand M, 1997, REPROD NUTR DEV, V37, P267, DOI 10.1051/rnd:19970303
   Dvir I, 2000, BRIT J NUTR, V84, P469
   Femenia A, 1997, J FOOD SCI, V62, P635, DOI 10.1111/j.1365-2621.1997.tb15426.x
   Fleurence J., 1991, IND ALIMENTAIRES AGR, V108, P501
   FRANCO G, 1992, TABELA COMPOSICAO QU, P177
   GLICKSMAN M, 1987, HYDROBIOLOGIA, V151, P31, DOI 10.1007/BF00046103
   Hollander M., 1999, NONPARAMETRIC STAT M
   Jimenez-Escrig A, 2000, NUTR RES, V20, P585, DOI 10.1016/S0271-5317(00)00149-4
   JOLY AB, 1965, BOLM FAC FILOS CIENC, V294, P1
   KATCH FI, 1993, INTRO NUTR EXERCISE, P63
   KHOKHAR S, 1990, PLANT FOOD HUM NUTR, V40, P259, DOI 10.1007/BF02193849
   LAHAYE M, 1993, J APPL PHYCOL, V5, P195, DOI 10.1007/BF00004017
   Lahaye M, 1997, SCI ALIMENT, V17, P563
   LAHAYE M, 1991, J SCI FOOD AGR, V54, P587, DOI 10.1002/jsfa.2740540410
   Lahaye M, 2007, BIOMACROMOLECULES, V8, P1765, DOI 10.1021/bm061185q
   MACPHERSON R, 1993, CRC HDB DIETARY FIBR, P7
   MAHAN LK, 1996, KRAUSES FOOD NUTR DI
   MATZ AS, 1996, FORMULATION PROCESSI, P136
   Michel C, 1996, J APPL BACTERIOL, V80, P349, DOI 10.1111/j.1365-2672.1996.tb03230.x
   MICHEL F, 1988, J SCI FOOD AGR, V42, P77, DOI 10.1002/jsfa.2740420109
   NAUSS JL, 1983, LIPIDS, V18, P714, DOI 10.1007/BF02534538
   NYMAN M, 1995, EUROPEAN J CLIN NUTR, V49, P215
   OMAYE ST, 1982, CEREAL CHEM, V59, P440
   Potty VH, 1996, J FOOD SCI TECH MYS, V33, P1
   PROSKY L, 1988, J ASSOC OFF ANA CHEM, V71, P1017
   Ruperez P, 2001, EUR FOOD RES TECHNOL, V212, P349, DOI 10.1007/s002170000264
   Sizer F.S., 2007, NUTR CONCEPTS CONTRO
   Suzuki T, 1996, FISHERIES SCI, V62, P454, DOI 10.2331/fishsci.62.454
   TAYLOR WR, 1960, MARINE ALGAE E TROPI, P860
   WYATT GM, 1988, BRIT J NUTR, V60, P197, DOI 10.1079/BJN19880091
   WYNNE MJ, 1978, INTRO ALGAE STRUCTUR
NR 43
TC 38
Z9 40
U1 0
U2 17
PU INT INST ECOLOGY
PI SAO CARLOS
PA RUA BENTO CARLOS, 750 - CENTRO, SAO CARLOS, SP 00000, BRAZIL
SN 1519-6984
EI 1678-4375
J9 BRAZ J BIOL
JI Braz. J. Biol.
PD AUG
PY 2009
VL 69
IS 3
BP 969
EP 977
DI 10.1590/S1519-69842009000400028
PG 9
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 497TI
UT WOS:000270084900027
PM 19802460
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU de Oliveira, MN
   Freitas, ALP
   Carvalho, AFU
   Sarnpaio, TMT
   Farias, DF
   Teixeira, DIA
   Gouveia, ST
   Pereira, JG
   de Sena, MMDC
AF de Oliveira, Maria Nilka
   Ponte Freitas, Ana Lucia
   Urano Carvalho, Ana Fontenele
   Tavares Sarnpaio, Thereza Maria
   Farias, Davi Felipe
   Alves Teixeira, Darlio Inacio
   Gouveia, Sandro Thomaz
   Pereira, Juliana Gomes
   de Castro Catanho de Sena, Mariju Marrir
TI Nutritive and non-nutritive attributes of washed-up seaweeds from the
   coast of Ceara, Brazil
SO FOOD CHEMISTRY
LA English
DT Article
DE Washed-up seaweeds; Nutritive attributes; Non-nutritive attributes; Food
   alternative
ID DIETARY FIBER; MARINE-ALGAE; PHYSICOCHEMICAL PROPERTIES; EDIBLE
   SEAWEEDS; PHYTIC ACID; PRODUCTS; PURIFICATION; SEEDS
AB This study assesses the nutritive and non-nutritive attributes of washed-up seaweeds from the Brazilian coast. it covers a broad diversity of species (24 red, nine green and four brown) with reasonable levels of proteins (10-14.8%), high ash contents (13-25%), low lipids (below 1%) and high carbohydrate contents (60%). Toxic and/or antinutritional factors were detected, such as low levels of lectins (32 and 64 HU/g of meal for chicken and rabbit trypsin-treated erythrocytes, respectively), tannins (59 mg/100 g), phytic acid (0.45%), high levels of trypsin inhibitors (99.0% inhibition) and -amylase inhibitors (70.5%). The 0/80% fraction showed moderate toxicity to mice (LD50 of 63.8 mg kg(-1)). The presence of heavy metals such as cadmium (0.29 mg/100 g), chromium (0.23 mg/100 g), nickel (0.26 mg/100 g) and vanadium (3.56 mg/100 g) was also detected. Despite moderate toxicity and antinutritional limitations, washed-up seaweeds represent a potential food alternative for humans after appropriate processing and environmental remediation to guarantee food safety. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Urano Carvalho, Ana Fontenele; Farias, Davi Felipe] Univ Fed Ceara, Dept Biol, BR-60455970 Fortaleza, Ceara, Brazil.
   [de Oliveira, Maria Nilka; Tavares Sarnpaio, Thereza Maria] Univ Fed Ceara, Dept Econ Domest, BR-60451970 Fortaleza, Ceara, Brazil.
   [Ponte Freitas, Ana Lucia; Pereira, Juliana Gomes] Univ Fed Ceara, Dept Bioquim & Biol Mol, BR-60451970 Fortaleza, Ceara, Brazil.
   [Alves Teixeira, Darlio Inacio] Inst Terramar Pesquisa & Assessoria Pesca Artesan, BR-60135170 Fortaleza, Ceara, Brazil.
   [Gouveia, Sandro Thomaz; de Castro Catanho de Sena, Mariju Marrir] Univ Fed Ceara, Dept Quim Analit & Fis Quim, BR-60451970 Fortaleza, Ceara, Brazil.
RP Carvalho, AFU (corresponding author), Univ Fed Ceara, Dept Biol, Campus Pici, BR-60455970 Fortaleza, Ceara, Brazil.
EM aurano@ufc.br
RI Farias, Davi Felipe/AAH-1868-2020; Freitas, Ana/E-2010-2016; Carvalho,
   Ana/K-7344-2018
OI Freitas, Ana/0000-0002-7411-9691; Carvalho, Ana/0000-0001-5293-9317;
   Felipe Farias, Davi/0000-0001-5438-1919; GOUVEIA,
   SANDRO/0000-0001-5494-6705
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao Cearense de Amparo A Pesquisa (FUNCAP)
FX Thanks are due to Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq) and Fundacao Cearense de Amparo A Pesquisa (FUNCAP)
   for supporting Grants and a PhD scholarship.
CR A.O.A.C, 1990, OFF METH AN ASS OFF
   Aguilera-Morales M, 2005, J FOOD COMPOS ANAL, V18, P79, DOI 10.1016/j.jfca.2003.12.012
   AINOUZ IL, 1992, BOT MAR, V35, P475
   AINOUZ IL, 1991, BOT MAR, V34, P211, DOI 10.1515/botm.1991.34.3.211
   *ARG RES SERV USDA, 2001, NUTR DAT STAND REF
   BERNFELD P, 1955, METHOD ENZYMOL, V1, P149, DOI 10.1016/0076-6879(55)01021-5
   *BRAS AG NAC VIG S, 2000, 53 AG NAC VIG SANT
   CARRILLO S, 1992, CUBAN J AGR SCI, V26, P177
   CHERYAN M, 1980, CRC CR REV FOOD SCI, V13, P297, DOI 10.1080/10408398009527293
   Darcy-Vrillon B, 1993, INT J FOOD SCI NUTR, V44, P23
   Dawczynski C, 2007, FOOD CHEM, V103, P891, DOI 10.1016/j.foodchem.2006.09.041
   DOMINGUEZ SC, 2002, ARCHIVOS LATINOAMERI, V52, P1
   GARCIAVILLANOVA R, 1982, ANALYST, V107, P1503, DOI 10.1039/an9820701503
   Goni I, 2001, J AGR FOOD CHEM, V49, P2663, DOI 10.1021/jf001389c
   Goni I, 2000, NUTR RES, V20, P1367, DOI 10.1016/S0271-5317(00)80018-4
   GRANT G, 1983, BRIT J NUTR, V50, P207, DOI 10.1079/BJN19830090
   Gudiel-Urbano M, 2002, NUTR RES, V22, P323, DOI 10.1016/S0271-5317(01)00383-9
   HAMERSTRAND GE, 1981, CEREAL CHEM, V58, P42
   HATHCOCK JN, 1991, ADV EXP MED BIOL, V289, P273
   HODGE HC, 1944, AM IND HYG ASSOC J, V10, P94
   *I PLAN CEAR, 1995, ATL CEAR SUP ESTA
   JENSEN A, 1993, HYDROBIOLOGIA, V261, P15
   Jimenez-Escrig A, 2000, NUTR RES, V20, P585, DOI 10.1016/S0271-5317(00)00149-4
   KADAM SS, 1987, J SCI FOOD AGR, V39, P267, DOI 10.1002/jsfa.2740390310
   Kuda T, 1997, FISHERIES SCI, V63, P428, DOI 10.2331/fishsci.63.428
   Kuda T, 1998, FISHERIES SCI, V64, P582, DOI 10.2331/fishsci.64.582
   LAHAYE M, 1991, J SCI FOOD AGR, V54, P587, DOI 10.1002/jsfa.2740540410
   MABEAU S, 1993, TRENDS FOOD SCI TECH, V4, P103, DOI 10.1016/0924-2244(93)90091-N
   MacArtain P, 2007, NUTR REV, V65, P535, DOI 10.1111/j.1753-4887.2007.tb00278.x
   Mubarak AE, 2005, FOOD CHEM, V89, P489, DOI 10.1016/j.foodchem.2004.01.007
   OLIVEIRA AC, 2003, NUTRICAO, V16, P211
   PATEARROYO MA, 1995, ALIMENTARIA, V6, P115
   Rehman ZU, 2005, FOOD CHEM, V91, P327, DOI 10.1016/j.foodchem.2004.06.019
   ROGERS DJ, 1993, HYDROBIOLOGIA, V261, P589
   Ruperez P, 2002, FOOD CHEM, V79, P23, DOI 10.1016/S0308-8146(02)00171-1
   Ruperez P, 2001, EUR FOOD RES TECHNOL, V212, P349, DOI 10.1007/s002170000264
   SOSULSKI F, 1979, J AM OIL CHEM SOC, V56, P711, DOI 10.1007/BF02663047
   SOUTHGATE DAT, 1990, ROY SOC CH, V83, P10, DOI 10.1533/9781845698195.1.10
   THOMPSON LU, 1993, FOOD RES INT, V26, P131, DOI 10.1016/0963-9969(93)90069-U
   VASCONCELOS IM, 1994, ARCH BIOCHEM BIOPHYS, V312, P357, DOI 10.1006/abbi.1994.1320
   Vasconcelos IM, 2004, TOXICON, V44, P385, DOI 10.1016/j.toxicon.2004.05.005
   VASCONCELOS IM, 1991, J FOOD BIOCHEM, V15, P137, DOI 10.1111/j.1745-4514.1991.tb00150.x
   Wynne MJ, 2017, NOVA HEDWIG BEIH, V145
NR 43
TC 42
Z9 45
U1 1
U2 27
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0308-8146
EI 1873-7072
J9 FOOD CHEM
JI Food Chem.
PD JUL 1
PY 2009
VL 115
IS 1
BP 254
EP 259
DI 10.1016/j.foodchem.2008.12.004
PG 6
WC Chemistry, Applied; Food Science & Technology; Nutrition & Dietetics
SC Chemistry; Food Science & Technology; Nutrition & Dietetics
GA 426DF
UT WOS:000264687300041
DA 2020-12-08
ER

PT J
AU Vasconcelos, IM
   Brasil, ICF
   Oliveira, JTA
   Campello, CC
   Maia, FMM
   Campello, MVM
   Farias, DF
   Carvalho, AFU
AF Vasconcelos, Ilka M.
   Brasil, Isabel Cristiane F.
   Oliveira, Jose Tadeu A.
   Campello, Claudio C.
   Maia, Fernanda Maria M.
   Campello, Maria Veronica M.
   Farias, Davi F.
   Carvalho, Ana Fontenele U.
TI Combination of Chemical Analyses and Animal Feeding Trials as Reliable
   Procedures to Assess the Safety of Heat Processed Soybean Seeds
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE Safety assessment; extrusion; dry-toasting; antinutritional/toxic
   proteins; soybeans; Glycine max
ID FULL-FAT SOYBEANS; GLYCINE-MAX; ANTINUTRITIONAL FACTORS; BROILER CHICKS;
   AMINO-ACIDS; PROTEIN; DIGESTIBILITY; CULTIVARS; PRODUCTS; NITROGEN
AB This study assessed whether chemical analyses are sufficient to guarantee the safety of heat processing of soybeans (SB) for human/animal consumption. The effects of extrusion and dry-toasting were analyzed upon seed composition and performance of broiler chicks. None of these induced appreciable changes in protein content and amino acid composition. Conversely, toasting reduced all antinutritional proteins by over 85%. Despite that, the animals fed on toasted SB demonstrated a low performance (feed efficiency 57.8 g/100 g). Extrusion gave place to higher contents of antinutrients, particularly of trypsin inhibitors (27.53 g/kg flour), but animal performance was significantly (p < 0.05) better (feed efficiency 63.2 g/100 g). Upon the basis of chemical analyses, dry-toasting represents the treatment of choice. However, considering the results of the feeding trials, extrusion appears to be the safest method. In conclusion, in order to evaluate the reliability of any processing method intended to improve nutritional value, the combination of chemical and animal studies is necessary.
C1 [Carvalho, Ana Fontenele U.] Univ Fed Ceara, Dept Biol, BR-60455970 Fortaleza, Ceara, Brazil.
   [Vasconcelos, Ilka M.; Brasil, Isabel Cristiane F.; Oliveira, Jose Tadeu A.; Farias, Davi F.] Univ Fed Ceara, Dept Bioquim & Biol Mol, BR-60455970 Fortaleza, Ceara, Brazil.
   [Campello, Claudio C.; Campello, Maria Veronica M.] Univ Estadual Ceara, Fac Vet, Fortaleza, Ceara, Brazil.
   [Maia, Fernanda Maria M.] Univ Estadual Ceara, Curso Nutr, Fortaleza, Ceara, Brazil.
RP Carvalho, AFU (corresponding author), Univ Fed Ceara, Dept Biol, Campus Pici, BR-60455970 Fortaleza, Ceara, Brazil.
EM aurano@ufc.br
RI Farias, Davi Felipe/AAH-1868-2020
OI Felipe Farias, Davi/0000-0001-5438-1919
CR BAETHGEN WE, 1989, COMMUN SOIL SCI PLAN, V20, P961, DOI 10.1080/00103628909368129
   Bajpai S, 2005, FOOD CHEM, V89, P497, DOI 10.1016/j.foodchem.2004.02.055
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CASKEY CD, 1944, IND ENG CHEM ANAL ED, V16, P640
   Clarke E, 2005, ANIM FEED SCI TECH, V121, P125, DOI 10.1016/j.anifeedsci.2005.02.012
   CUSSAC V, 1992, J BACTERIOL, V174, P2466, DOI 10.1128/jb.174.8.2466-2473.1992
   GRANT G, 1995, BRIT J NUTR, V73, P17, DOI 10.1079/BJN19950005
   HAMERSTRAND GE, 1981, CEREAL CHEM, V58, P42
   Helrich K, 1990, OFFICIAL METHODS ANA, P79
   KAPLAN A, 1969, Methods of Biochemical Analysis, V17:, P311, DOI 10.1002/9780470110355.ch7
   Karr-Lilienthal LK, 2004, J AGR FOOD CHEM, V52, P6193, DOI 10.1021/jf049795+
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Leeson S, 1996, ANIM FEED SCI TECH, V57, P239, DOI 10.1016/0377-8401(95)00847-0
   LIENER IE, 1994, CRIT REV FOOD SCI, V34, P31, DOI 10.1080/10408399409527649
   Mendes WS, 2004, ARQ BRAS MED VET ZOO, V56, P207, DOI 10.1590/S0102-09352004000200011
   MOREIRA J.C., 1977, PLANT PHYSIOL, V59, P783, DOI [10.1104/pp.59.5.783., DOI 10.1104/PP.59.5.783]
   Olguin MC, 2003, J FOOD COMPOS ANAL, V16, P441, DOI 10.1016/S0889-1575(03)00005-X
   Orias F, 2002, J ANIM SCI, V80, P2493
   Palacios MF, 2004, J ANIM SCI, V82, P1108
   PINTERSZAKACS M, 1990, J AGR FOOD CHEM, V38, P720, DOI 10.1021/jf00093a028
   POLACCO JC, 1993, INT REV CYTOL, V145, P65, DOI 10.1016/S0074-7696(08)60425-8
   Rehman ZU, 2005, FOOD CHEM, V91, P327, DOI 10.1016/j.foodchem.2004.06.019
   ROSTAGNO HS, 2000, TABELAS BRASILEIRAS, P141
   RUBIO LA, 1990, BRIT J NUTR, V63, P419, DOI 10.1079/BJN19900130
   RUBIO LA, 1989, BRIT POULTRY SCI, V30, P15
   Suresh D, 2007, J FOOD COMPOS ANAL, V20, P346, DOI 10.1016/j.jfca.2006.10.002
   VASCONCELOS IM, 1994, ARCH BIOCHEM BIOPHYS, V312, P357, DOI 10.1006/abbi.1994.1320
   Vasconcelos IM, 1997, J SCI FOOD AGR, V75, P419, DOI [10.1002/(SICI)1097-0010(199712)75:4&lt;419::AID-JSFA886&gt;3.0.CO;2-D, 10.1002/(SICI)1097-0010(199712)75:4<419::AID-JSFA886>3.3.CO;2-4]
   Vasconcelos IM, 2001, J NUTR BIOCHEM, V12, P55, DOI 10.1016/S0955-2863(00)00148-0
   Wiriyaumpaiwong S, 2004, J FOOD ENG, V65, P371, DOI 10.1016/j.jfoodeng.2004.01.036
NR 30
TC 3
Z9 4
U1 0
U2 4
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
EI 1520-5118
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD JUN 10
PY 2009
VL 57
IS 11
BP 4668
EP 4673
DI 10.1021/jf803903h
PG 6
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
SC Agriculture; Chemistry; Food Science & Technology
GA 453YW
UT WOS:000266649800030
PM 19489620
DA 2020-12-08
ER

PT J
AU Ferreira, PMP
   Carvalho, AFU
   Farias, DF
   Cariolano, NG
   Melo, VMM
   Queiroz, MGR
   Martins, AMC
   Machado-Neto, JG
AF Ferreira, Paulo M. P.
   Carvalho, Ana F. U.
   Farias, Davi F.
   Cariolano, Nara G.
   Melo, Vania M. M.
   Queiroz, Maria G. R.
   Martins, Alice M. C.
   Machado-Neto, Joaquim G.
TI Larvicidal activity of the water extract of Moringa oleifera seeds
   against Aedes aegypti and its toxicity upon laboratory animals
SO ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS
LA English
DT Article
DE Aedes aegypti; Daphnia magna; larvicidal activity; Moringa oleifera
   seeds; toxicity
ID ESSENTIAL OIL; PROTEIN; COAGULATION; RESISTANCE; BACTERIAL; TREE
AB In this work, biological effects of the water extract of Moringa oleifera seeds (WEMOS) were assessed on eggs and 3(rd) instar larvae of Aedes aegypti and on its toxicity upon laboratory animals (Daphnia magna, mice and rats). Crude WEMOS showed a LC50 value of 1260 mu g/mL, causing 99.2 +/- 2.9% larvae mortality within 24 h at 5200 mu g/mL, though this larvicidal activity has been lost completely at 80 degrees C/10 min. WEMOS did not demonstrate capacity to prevent egg hatching. After extensive dialyses of the crude WEMOS into water-soluble dialyzable (DF) and non-dyalizable (NDF) fractions, only DF maintained its efficacy to kill larvae. Acute toxicity evaluations on daphnids (EC50 of 188.7 mu g/mL) and mice (LD50 of 446.5 mg/kg body weight) pointed out to low toxicity. Despite the thymus hypertrophy, WEMOS revealed to be harmless in orally and subacutely-treated rats. In conclusion, WEMOS has thermostable bioactive compounds against Ae. aegypti larvae with apparent molecular mass lower than 12 kDa and moderately toxic potential.
C1 [Ferreira, Paulo M. P.; Carvalho, Ana F. U.; Farias, Davi F.; Cariolano, Nara G.; Melo, Vania M. M.] Univ Fed Ceara, Dept Biol, BR-60455970 Fortaleza, Ceara, Brazil.
   [Queiroz, Maria G. R.; Martins, Alice M. C.] Univ Fed Ceara, Dept Anal Clin & Texicol, BR-60430270 Fortaleza, Ceara, Brazil.
   [Machado-Neto, Joaquim G.] Univ Estadual Paulista, Dept Defesa Fitossanit, BR-14870000 Jaboticabal, SP, Brazil.
RP Ferreira, PMP (corresponding author), Univ Fed Piaui, CSHNB, Sl 804,Rua Cicero Eduardo S-N, BR-64600000 Picos, PI, Brazil.
EM pmifepe@yahoo.com.br
RI Carvalho, Ana/K-7344-2018; Ferreira, Paulo Michel Pinheiro/J-6783-2012;
   Martins, Alice Maria Costa/AAX-3093-2020; Farias, Davi
   Felipe/AAH-1868-2020; Melo, Vania/E-2377-2015
OI Carvalho, Ana/0000-0001-5293-9317; Ferreira, Paulo Michel
   Pinheiro/0000-0001-6862-6497; Felipe Farias, Davi/0000-0001-5438-1919;
   Melo, Vania/0000-0002-3302-8857; QUEIROZ, MARIA
   GORETTI/0000-0002-0971-3571
FU Fundacao Cearense de Amparo a Pesquisa (FUNCAP); Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico/Departamento de Ciencia e
   Tecnologia (CNPq/DECIT),National Council for Scientific and
   Technological Development (CNPq)
FX The authors are grateful for the technical assistance of Berenice Alves.
   This investigation was supported by grants from Fundacao Cearense de
   Amparo a Pesquisa (FUNCAP) and Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico/Departamento de Ciencia e Tecnologia
   (CNPq/DECIT), agencies from Brazil.
CR A.O.A.C, 1990, OFF METH AN ASS OFF
   ALI GH, 2004, INT J ENVIRON STUD, V61, P699
   ARAUCO LRR, 2005, REV ECOTOX MEIO AMB, V15, P55
   BERGER MR, 1984, E AFR MED J, V61, P712
   Bharali Rupjyoti, 2003, Asian Pac J Cancer Prev, V4, P131
   Broin M, 2002, APPL MICROBIOL BIOT, V60, P114, DOI 10.1007/s00253-002-1106-5
   BROWN AWA, 1986, J AM MOSQUITO CONTR, V2, P123
   CACERES A, 1992, J ETHNOPHARMACOL, V36, P233, DOI 10.1016/0378-8741(92)90049-W
   Carvalho AFU, 2003, MEM I OSWALDO CRUZ, V98, P569, DOI 10.1590/S0074-02762003000400027
   Chuang PH, 2007, BIORESOURCE TECHNOL, V98, P232, DOI 10.1016/j.biortech.2005.11.003
   Chumark P, 2008, J ETHNOPHARMACOL, V116, P439, DOI 10.1016/j.jep.2007.12.010
   Consoli R.A.G.B, 1994, PRINCIPAIS MOSQUITOS
   de Omena MC, 2007, BIORESOURCE TECHNOL, V98, P2549, DOI 10.1016/j.biortech.2006.09.040
   Fakurazi S, 2008, FOOD CHEM TOXICOL, V46, P2611, DOI 10.1016/j.fct.2008.04.018
   FARIAS DF, 2004, REV U RURAL, V24, P201
   FERREIRA PMP, 2004, ATIVIDADE LARVICIDA
   Ferreira PMP, 2007, REPM, V1, P45
   GASSENSCHMIDT U, 1995, BBA-GEN SUBJECTS, V1243, P477, DOI 10.1016/0304-4165(94)00176-X
   GEERVANI P, 1981, INDIAN J MED RES, V74, P548
   GERDES C, 1997, COMO LIMPAR TRATAR A
   Ghebremichael KA, 2005, WATER RES, V39, P2338, DOI 10.1016/j.watres.2005.04.012
   GRABOW WOK, 1985, WATER SA, V11, P9
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Guevara AP, 1999, MUTAT RES-GEN TOX EN, V440, P181, DOI 10.1016/S1383-5718(99)00025-X
   Gupta R, 2005, ENVIRON TOXICOL PHAR, V20, P456, DOI 10.1016/j.etap.2005.05.005
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   HAMILTON MA, 1979, ENVIRON SCI TECHNOL, V7, P114
   HODGE HC, 1944, AM IND HYG ASSOC J, V10, P94
   IMBODEN JB, 1988, IMMUNOL TODAY, V9, P17, DOI 10.1016/0167-5699(88)91350-3
   Iqbal S, 2006, J FOOD COMPOS ANAL, V19, P544, DOI 10.1016/j.jfca.2005.05.001
   JAHN SAA, 1988, J AM WATER WORKS ASS, V80, P43
   Karalliedde LD, 2003, FOOD CHEM TOXICOL, V41, P1, DOI 10.1016/S0278-6915(02)00232-6
   Kumar V, 2004, PATHOLOGY BASIS DIS
   LITCHFIELD JT, 1949, J PHARMACOL EXP THER, V96, P99
   MADSEN M, 1987, J TROP MED HYG, V90, P101
   Makkar HPS, 1997, J AGR SCI, V128, P311, DOI 10.1017/S0021859697004292
   MALLEVIALLE J, 1984, J AWWA, V76, P431
   MARTYN CN, 1989, LANCET, V1, P59
   MAZZARRI MB, 1995, J AM MOSQUITO CONTR, V11, P315
   MORTON JF, 1991, ECON BOT, V45, P318, DOI 10.1007/BF02887070
   Ndabigengesere A, 1998, WATER RES, V32, P781, DOI 10.1016/S0043-1354(97)00295-9
   NDABIGENGESERE A, 1995, WATER RES, V29, P703, DOI 10.1016/0043-1354(94)00161-Y
   *OECD, 2004, 202 OECD, P260
   Oliveira JTA, 1999, J SCI FOOD AGR, V79, P815, DOI [10.1002/(SICI)1097-0010(19990501)79:6&lt;815::AID-JSFA290&gt;3.0.CO;2-P, 10.1002/(SICI)1097-0010(19990501)79:6<815::AID-JSFA290>3.0.CO;2-P]
   Ferreira PMP, 2008, REV NUTR, V21, P431, DOI 10.1590/S1415-52732008000400007
   RAMACHANDRAN C, 1980, ECON BOT, V34, P276, DOI 10.1007/BF02858648
   RANGASWANI S, 1946, CURR SCI, V5, P316
   Ruckmani K., 1998, Indian Journal of Pharmaceutical Sciences, V60, P33
   Santos AFS, 2005, WATER RES, V39, P975, DOI 10.1016/j.watres.2004.12.016
   *SESA, 2008, INF SEM DENG
   Siddhuraju P, 2003, J AGR FOOD CHEM, V51, P2144, DOI 10.1021/jf020444+
   Tatarazako N, 2007, ECOTOXICOLOGY, V16, P197, DOI 10.1007/s10646-006-0120-2
   THANGAM TS, 1991, BOT MAR, V34, P433, DOI 10.1515/botm.1991.34.5.433
   Waynforth B. H., 1980, INJECTION TECHNIQUES
   *WHO, 1999, 29 WHO
   WHO, 2005, GUID LAB FIELD TEST
   ZUCKER E, 1985, 540985006 USEPA
NR 57
TC 32
Z9 38
U1 0
U2 14
PU ACAD BRASILEIRA DE CIENCIAS
PI RIO JANEIRO
PA RUA ANFILOFIO DE CARVALHO, 29, 3 ANDAR, 20030-060 RIO JANEIRO, BRAZIL
SN 0001-3765
EI 1678-2690
J9 AN ACAD BRAS CIENC
JI An. Acad. Bras. Cienc.
PD JUN
PY 2009
VL 81
IS 2
BP 207
EP 216
DI 10.1590/S0001-37652009000200007
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 462KM
UT WOS:000267351400007
PM 19488625
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Ramos, SCS
   de Oliveira, JCS
   da Camara, CAG
   Castelar, I
   Carvalho, AFFU
   Lima, JV
AF Ramos, Suzana C. S.
   de Oliveira, Jose C. S.
   da Camara, Claudio A. G.
   Castelar, Ivan
   Carvalho, Ana F. F. U.
   Lima-Filho, Jose V.
TI Antibacterial and cytotoxic properties of some plant crude extracts used
   in Northeastern folk medicine
SO REVISTA BRASILEIRA DE FARMACOGNOSIA-BRAZILIAN JOURNAL OF PHARMACOGNOSY
LA English
DT Article
DE Artemia salina; cytotoxicity; antibacterial activity; Croton; Protium;
   Muntingia calabura
ID CROTON-CAJUCARA BENTH; ESSENTIAL OIL; ANTIMICROBIAL ACTIVITY;
   CHEMICAL-COMPOSITION; NATURAL-PRODUCTS; BRINE SHRIMP; RAIN-FOREST;
   CONSTITUENTS; ANTIFUNGAL; BRAZIL
AB In the present study, 32 hexane and ethanol extracts of Protium bahianum, R heptaphyllum, Croton sellowii, C. rhamnifolius, C. jacobinensis, C. micans and Muntingia calabura were screened for antibacterial activity by the disc-diffusion method. Cytotoxicity assays using the brine shrimp Artemia salina Leach as a model were performed to determine lethal doses for 50% of individuals (LC50 mu g/mL). Antibacterial activity was found in flowers hexane extracts of M. calabura against B. subtilis, and leaves ethanol extracts against S. aureus and B. subtilis at concentration of 1mg/mL. Among 32 extracts, 19 showed low or no toxicity (LC50 > 250 mu g/mL), 6 showed moderate toxicity (LC50 between 80 mu g/mL and 250 mu g/mL), and 7 were highly toxic (LC50 < 80 mu g/mL).
C1 [Ramos, Suzana C. S.; Lima-Filho, Jose V.] Univ Fed Rural Pernambuco, Dept Biol, Lab Microbiol & Imunol, BR-52171900 Recife, PE, Brazil.
   [de Oliveira, Jose C. S.; da Camara, Claudio A. G.] Univ Fed Rural Pernambuco, Dept Quim, Lab Prod Nat Bioativos, BR-52171900 Recife, PE, Brazil.
   [Castelar, Ivan] Univ Fed Ceara, Dept Econ Aplicada, BR-60020181 Fortaleza, Ceara, Brazil.
   [Carvalho, Ana F. F. U.] Univ Fed Ceara, Dept Biol, Lab Fisiol Anim, BR-60455760 Fortaleza, Ceara, Brazil.
RP Ramos, SCS (corresponding author), Univ Fed Rural Pernambuco, Dept Biol, Lab Microbiol & Imunol, Campus Dois Irmaos, BR-52171900 Recife, PE, Brazil.
EM jvitor@db.ufrpe.br
RI , Oliveira/D-5978-2016; Lima-Filho, Jose V/B-6497-2015; Lima-Filho, Jose
   Vitor/G-5343-2012
OI , Oliveira/0000-0003-4117-371X; Lima-Filho, Jose/0000-0002-0987-8042
CR Adam K, 1998, J AGR FOOD CHEM, V46, P1739, DOI 10.1021/jf9708296
   Agra MD, 2008, REV BRAS FARMACOGN, V18, P472, DOI 10.1590/S0102-695X2008000300023
   Agra Maria de Fátima, 2007, Rev. bras. farmacogn., V17, P114, DOI 10.1590/S0102-695X2007000100021
   Alves TMD, 2000, MEM I OSWALDO CRUZ, V95, P367
   Alviano WS, 2005, ORAL MICROBIOL IMMUN, V20, P101, DOI 10.1111/j.1399-302X.2004.00201.x
   BARA M.T.F., 1998, REV BRASILEIRA FARMA, V7-8, P21, DOI [10.1590/S0102-695X1998000100003, DOI 10.1590/S0102-695X1998000100003>.ACESS0]
   Barbosa-Filho José M., 2007, Rev. bras. farmacogn., V17, P141, DOI 10.1590/S0102-695X2007000100022
   BAUER AW, 1966, AM J CLIN PATHOL, V45, P493
   Bighetti EJB, 1999, J PHARM PHARMACOL, V51, P1447, DOI 10.1211/0022357991777100
   Brandao MGL, 2008, REV BRAS FARMACOGN, V18, P127, DOI 10.1590/S0102-695X2008000100022
   Bruneton J, 1999, PHARMACOGNOSY PHYTOC
   BURKE BA, 1981, J CHEM SOC PERK T 1, P2666, DOI 10.1039/p19810002666
   Cardoso-Lopes EM, 2008, REV BRAS FARMACOGN, V18, P655, DOI 10.1590/S0102-695X2008000500002
   CARVALHO AFU, 1988, CIENC CULT, V40, P1109
   Correa MFP, 2008, REV BRAS FARMACOGN, V18, P785, DOI 10.1590/S0102-695X2008000500025
   CORREA MP, 1978, DICIONARIO PLANTAS U, V3
   COSTA AF, 1975, FARMACOGNOSIA, P841
   Costa VCO, 2008, REV BRAS FARMACOGN, V18, P245, DOI 10.1590/S0102-695X2008000200019
   DOLABELA MF, 1997, THESIS UFMG BELO HOR
   Finney D. J., 1971, PROBIT ANAL
   Fontenelle ROS, 2008, J APPL MICROBIOL, V104, P1383, DOI 10.1111/j.1365-2672.2007.03707.x
   Giang PM, 2005, CHEM PHARM BULL, V53, P296, DOI 10.1248/cpb.53.296
   Hiruma-Lima CA, 2002, PHYTOMEDICINE, V9, P523, DOI 10.1078/09447110260573155
   Holetz FB, 2002, MEM I OSWALDO CRUZ, V97, P1027, DOI 10.1590/S0074-02762002000700017
   KANEDA N, 1991, J NAT PROD, V54, P196, DOI 10.1021/np50073a019
   Leal-Cardoso Jose Henrique, 1999, Anais da Academia Brasileira de Ciencias, V71, P207
   Loguercio Andrea Pinto, 2005, Cienc. Rural, V35, P371, DOI 10.1590/S0103-84782005000200019
   MARINIBETTOLO R, 1979, PHYTOCHEMISTRY, V18, P520
   Martins AP, 2000, PLANTA MED, V66, P647, DOI 10.1055/s-2000-8623
   Matos F.J.A., 1988, INTRO FITOQUIMICA EX
   MCCHESNEY JD, 1991, J NAT PROD, V54, P1625, DOI 10.1021/np50078a021
   MEYER BN, 1982, PLANTA MED, V45, P31, DOI 10.1055/s-2007-971236
   Nakamura CV, 1999, MEM I OSWALDO CRUZ, V94, P675, DOI 10.1590/S0074-02761999000500022
   Nascimento GGF, 2000, BRAZ J MICROBIOL, V31, P247
   Nunes XP, 2008, REV BRAS FARMACOGN, V18, P718, DOI 10.1590/S0102-695X2008000500015
   Palmeira SF, 2004, FLAVOUR FRAG J, V19, P69, DOI 10.1002/ffj.1298
   Parra AL, 2001, PHYTOMEDICINE, V8, P395, DOI 10.1078/0944-7113-00044
   Peres MTLP, 1997, J ETHNOPHARMACOL, V56, P223, DOI 10.1016/S0378-8741(97)00039-1
   Pott A, 1994, PLANTAS PANTANAL
   Rodriguez JA, 2004, HUM EXP TOXICOL, V23, P455, DOI 10.1191/0960327104ht473oa
   Siani AC, 1999, J ETHNOPHARMACOL, V66, P57, DOI 10.1016/S0378-8741(98)00148-2
   Silva Tania Maria S., 2007, Rev. bras. farmacogn., V17, P35, DOI 10.1590/S0102-695X2007000100008
   Sousa FCF, 2008, REV BRAS FARMACOGN, V18, P642, DOI 10.1590/S0102-695X2008000400023
   Suffredini IB, 2004, BRAZ J MED BIOL RES, V37, P379, DOI 10.1590/S0100-879X2004000300015
   Vieira Regine Helena Silva dos Fernandes, 2001, Revista do Instituto de Medicina Tropical de Sao Paulo, V43, P145
   Volpato AMM, 2001, REV VIS ACAD, V2, P7
NR 46
TC 12
Z9 12
U1 0
U2 15
PU SOC BRASILEIRA FARMACOGNOSIA
PI CURITIBA-PR
PA C/O PROF CID AIMBIRE DE MORAES SANTOS, UFPR-LAB FARM, RUA PREF LOTHARIO
   MEISSNER, 632-JD BOTANICO, CURITIBA-PR, 80210-170, BRAZIL
SN 0102-695X
J9 REV BRAS FARMACOGN
JI Rev. Bras. Farmacogn.-Braz. J. Pharmacogn.
PD APR-JUN
PY 2009
VL 19
IS 2A
BP 376
EP 381
DI 10.1590/S0102-695X2009000300007
PG 6
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 487YC
UT WOS:000269313800007
OA Other Gold, Green Published
DA 2020-12-08
ER

PT J
AU Cavalheiro, MG
   Farias, DF
   Fernandes, GS
   Nunes, EP
   Cavalcanti, FS
   Vasconcelos, IM
   Melo, VMM
   Carvalho, AFU
AF Cavalheiro, Mariana G.
   Farias, Davi F.
   Fernandes, Georgia Sampaio
   Nunes, Edson P.
   Cavalcanti, Francisca S.
   Vasconcelos, Ilka M.
   Melo, Vania M. M.
   Carvalho, Ana F. U.
TI "Biological and enzymatic activities of aqueous extract of seeds from
   Caesalpinia ferrea Mart., Leguminosae."
SO REVISTA BRASILEIRA DE FARMACOGNOSIA-BRAZILIAN JOURNAL OF PHARMACOGNOSY
LA Portuguese
DT Article
DE Caesalpinia ferrea; Leguminosae; biological activities; enzymatic
   activities; seeds
ID MEDICINAL-PLANTS; ALPHA-AMYLASE; MUNGO SEEDS; PROTEIN; ANTIBACTERIAL;
   PURIFICATION; COTYLEDONS; AFFINITY; MEDIA
AB "Biological and enzymatic activities of aqueous extract of seeds from Caesalpinia ferrea Mart.; Leguminosae." Caesalpinia ferrea Mart. is a species belonging to,Leguminosae family commonly known in Brazil as "juca" or "pau-ferro". It occurs in Brazil from the Northeast. Region to the State, of Rio de Janeiro and it is widely utilized in folk medicine due to its several therapeutic properties such as anti-inflammatory, analgesic, antimicrobial and antithermic, which indicate the presence of Compounds of pharmacological interest., Besides, many studies with plants look for the presence of compounds with industrial applications. Based upon the therapeutic, and bioactive propertied described for this species so far, this work aimed to investigate several biological activities in the water extract of C. ferrea seeds. The results indicated the presence of the following activities: cellulase, amylase,, anticoagulant And larvicide against A. aegypti in the water extract of C. ferrea seeds. Nevertheless, the extract did not show the other activities assayed: Acute toxic activity, hemolytic, heparinasic, antibacterial and antifungal activities.
C1 [Cavalheiro, Mariana G.; Nunes, Edson P.; Melo, Vania M. M.; Carvalho, Ana F. U.] Univ Fed Ceara, Dept Biol, BR-60455970 Fortaleza, Ceara, Brazil.
   [Cavalcanti, Francisca S.] Univ Fed Ceara, Dept Quim Organ & Inorgan, BR-60455970 Fortaleza, Ceara, Brazil.
   [Farias, Davi F.; Fernandes, Georgia Sampaio; Vasconcelos, Ilka M.] Univ Fed Ceara, Dept Bioquim & Biol Mol, BR-60455970 Fortaleza, Ceara, Brazil.
RP Cavalheiro, MG (corresponding author), Univ Fed Ceara, Dept Biol, Av Humberto Monte S-N, BR-60455970 Fortaleza, Ceara, Brazil.
EM aurano@ufc.br
RI Farias, Davi Felipe/AAH-1868-2020; Carvalho, Ana/K-7344-2018
OI Carvalho, Ana/0000-0001-5293-9317
CR ALMEIDA CFC, 2005, J ARID ENVIRON, V62, P127
   Aqil F, 2003, WORLD J MICROB BIOT, V19, P653, DOI 10.1023/A:1025128104056
   BACCHI EM, 10 BRAZ S MED PLANTS
   BAUER AW, 1966, AM J CLIN PATHOL, V45, P493
   BERNHEIMER AW, 1988, METHOD ENZYMOL, V165, P213
   Braga R., 1976, PLANTAS NORDESTE ESP
   Bukowska B, 2004, TOXICOL LETT, V152, P73, DOI 10.1016/j.toxlet.2004.03.025
   Carvalho JCT, 1996, J ETHNOPHARMACOL, V53, P175, DOI 10.1016/0378-8741(96)01441-9
   CARVALHO JCT, 1993, THESIS U SAO PAULO
   Cechinel V, 1998, QUIM NOVA, V21, P99, DOI 10.1590/S0100-40421998000100015
   Cheeke P.R., 1998, NATURAL TOXICANTS FE
   Chen ZJ, 1998, AM J BOT, V85, P492, DOI 10.2307/2446432
   Cronquist A, 1981, INTEGRATED SYSTEM CL
   Cruz MCS, 2007, J ETHNOPHARMACOL, V111, P409, DOI 10.1016/j.jep.2006.12.005
   Di Stasi L.C., 2002, PLANTAS MED AMAZONIA
   EYER P, 1975, MOL PHARMACOL, V11, P326
   FRASSON APZ, 2002, THESIS U FEDERAL SAN
   HANKIN L, 1975, MYCOLOGIA, V67, P597, DOI 10.2307/3758395
   Carrim AJI, 2006, BRAZ ARCH BIOL TECHN, V49, P353, DOI 10.1590/S1516-89132006000400001
   KOHNO A, 1991, PLANT CELL PHYSIOL, V32, P459
   KOSHIBA T, 1981, PLANT CELL PHYSIOL, V22, P979
   Lee ST, 2001, J NAT TOXINS, V10, P273
   Leon R, 1998, ENZYME MICROB TECH, V23, P483, DOI 10.1016/S0141-0229(98)00078-7
   Luna JD, 2005, J ETHNOPHARMACOL, V97, P199, DOI 10.1016/j.jep.2004.10.004
   MAIA G.N., 2004, CAATINGA ARVORES ARB
   Mar SS, 2003, BIOSCI BIOTECH BIOCH, V67, P1080, DOI 10.1271/bbb.67.1080
   MERKER MP, 1986, TOXICON, V24, P451, DOI 10.1016/0041-0101(86)90077-2
   MINAMIKAWA T, 1979, BOT MAG TOKYO, V92, P1, DOI 10.1007/BF02488296
   Nielsen Ruby Ilum, 1998, Mycologist, V12, P69
   Petersen S. B., 1994, LIPASES THEIR STRUCT
   Pizarro A P, 1999, Rev Soc Bras Med Trop, V32, P23, DOI 10.1590/S0037-86821999000100005
   Rajaganapathi J, 2002, CURR SCI INDIA, V82, P264
   ROBERTS WK, 1990, J GEN MICROBIOL, V136, P1771, DOI 10.1099/00221287-136-9-1771
   Ruegger Marcelo J.S., 2004, Braz. J. Bot., V27, P205, DOI 10.1590/S0100-84042004000200001
   Saeed MA, 2001, FITOTERAPIA, V72, P807, DOI 10.1016/S0367-326X(01)00292-1
   Sudhakar M, 2006, FITOTERAPIA, V77, P378, DOI 10.1016/j.fitote.2006.02.011
   Svendsen A, 1997, METHOD ENZYMOL, V284, P317
   THOMAS G, 1988, 10 BRAZ S MED PLANTS
   VASCONCELOS IM, 1994, ARCH BIOCHEM BIOPHYS, V312, P357, DOI 10.1006/abbi.1994.1320
   WHO, 2005, GUID LAB FIELD TEST
   WISEMAN A, 1995, HDB ENZYME BIOTECHNO
   Woldemichael GM, 2003, Z NATURFORSCH C, V58, P70
   YAMAMOTO T, 1995, ENZYME CHEM MOL BIOL
NR 43
TC 17
Z9 22
U1 0
U2 9
PU SOC BRASILEIRA FARMACOGNOSIA
PI CURITIBA-PR
PA C/O PROF CID AIMBIRE DE MORAES SANTOS, UFPR-LAB FARM, RUA PREF LOTHARIO
   MEISSNER, 632-JD BOTANICO, CURITIBA-PR, 80210-170, BRAZIL
SN 0102-695X
J9 REV BRAS FARMACOGN
JI Rev. Bras. Farmacogn.-Braz. J. Pharmacogn.
PD APR-JUN
PY 2009
VL 19
IS 2B
BP 586
EP 591
DI 10.1590/S0102-695X2009000400014
PG 6
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 521ER
UT WOS:000271903600015
OA Other Gold
DA 2020-12-08
ER

PT J
AU Carvalho, AFU
   Araujo, AJ
   Farias, DF
   Rocha-Bezerra, LCB
   Cavalheiro, MG
AF Carvalho, A. F. U.
   Araujo, A. J.
   Farias, D. F.
   Rocha-Bezerra, L. C. B.
   Cavalheiro, M. G.
TI Development and reproductive performance of Swiss mice in an enriched
   environment
SO BRAZILIAN JOURNAL OF BIOLOGY
LA English
DT Article
DE environmental enrichment; development; reproductive performance; mice
ID BEHAVIOR; EXPLORATION; PREFERENCE; ANIMALS; STRESS
AB The present study investigated the effects of environment enrichment on the development and reproductive performance of an outbred Swiss strain. Physical enrichment consisted of free access of animals to tubular devices of different shapes and sizes. The development evaluation was done by monitoring growth rate during 39 days, from weaning (21 days) to the onset of sexual maturity (60 days of age). Over five consecutive gestations (105 days), the following variables were monitored: litter size, number of animals born alive; number of pups alive at 12 hours and on days 4, 9, 12, 15 and 18; number of animals weaned per litter; average weight of litters on days 4, 9, 12, 15 and 18. The reproductive performance was then evaluated using the inclusion of these variables in the indices of gestation and birth, viability, lactation, survival success, mating success and production. The results showed that the environmental enrichment did not influence, in a significant way, the evaluated parameters. However, there is no reason to deprive the animals from an enriched environment where they can develop their natural instinctive behaviour and guarantee health and well-being.
C1 [Carvalho, A. F. U.; Araujo, A. J.; Farias, D. F.; Rocha-Bezerra, L. C. B.; Cavalheiro, M. G.] Univ Fed Ceara, Dept Biol, Lab Fisiol Anim, BR-60455760 Fortaleza, Ceara, Brazil.
RP Carvalho, AFU (corresponding author), Univ Fed Ceara, Dept Biol, Lab Fisiol Anim, Av Mister Hull S-N,Campus Pici, BR-60455760 Fortaleza, Ceara, Brazil.
EM aurano@ufc.br
RI Farias, Davi Felipe/AAH-1868-2020; Araujo, Ana Jersia/D-1049-2019
OI Araujo, Ana Jersia/0000-0001-7182-7097; Felipe Farias,
   Davi/0000-0001-5438-1919
CR Boehm GW, 1996, BRAIN RES, V726, P11, DOI 10.1016/S0006-8993(96)00299-5
   Broom DM, 1993, STRESS ANIMAL WELFAR
   FORGAYS DG, 1952, J COMP PHYSIOL PSYCH, V45, P322, DOI 10.1037/h0053731
   GONYOU HW, 1986, J ANIM SCI, V62, P1769
   Hebb D., 1947, AM PSYCHOL, V2, P306, DOI DOI 10.1037/H0028720
   HULS WL, 1991, LAB ANIM SCI, V41, P609
   Inglis C.A., 2004, EFFECTS ENRICHMENT D
   ITURRIAN WB, 1968, LAB ANIM CARE, V18, P160
   JENSEN P, 1993, APPL ANIM BEHAV SCI, V37, P161, DOI 10.1016/0168-1591(93)90108-2
   MANOSEVI.M, 1970, J COMP PHYSIOL PSYCH, V71, P459
   MANOSEVITZ M, 1972, J COMP PHYSIOL PSYCH, V79, P67, DOI 10.1037/h0032547
   Marashi V, 2004, PHYSIOL BEHAV, V82, P765, DOI 10.1016/j.physbeh.2004.05.009
   Marashi V, 2003, HORM BEHAV, V43, P281, DOI 10.1016/S0018-506X(03)00002-3
   MENCH JA, 1994, LAB ANIMAL, V23, P38
   MIRONE L, 1948, SCIENCE, V108, P139, DOI 10.1126/science.108.2797.139
   Potgieter FJ, 1997, J S AFR VET ASSOC, V68, P8
   Prior H, 1995, J EXP ANIM SCI, V37, P57
   RENNER MJ, 1986, J COMP PSYCHOL, V100, P229, DOI 10.1037/0735-7036.100.3.229
   Rottger C, 2001, ZOOLOGY, V104, P8
   Sachser N, 1998, PSYCHONEUROENDOCRINO, V23, P891, DOI 10.1016/S0306-4530(98)00059-6
   *UFAW, 1986, UFAW HDB CAR MAN LAB
   Van de Weerd HA, 2004, ATLA-ALTERN LAB ANIM, V32, P69, DOI 10.1177/026119290403202s14
   Van de Weerd HA, 1998, APPL ANIM BEHAV SCI, V55, P369, DOI 10.1016/S0168-1591(97)00043-9
   Van Loo PLP, 2001, PHYSIOL BEHAV, V72, P675, DOI 10.1016/S0031-9384(01)00425-5
   von Holst D, 1998, ADV STUD BEHAV, V27, P1
   WIDMAN DR, 1990, PHYSIOL BEHAV, V47, P57, DOI 10.1016/0031-9384(90)90042-3
NR 26
TC 9
Z9 9
U1 0
U2 6
PU INT INST ECOLOGY
PI SAO CARLOS
PA RUA BENTO CARLOS, 750 - CENTRO, SAO CARLOS, SP 00000, BRAZIL
SN 1519-6984
EI 1678-4375
J9 BRAZ J BIOL
JI Braz. J. Biol.
PD FEB
PY 2009
VL 69
IS 1
BP 153
EP 160
DI 10.1590/S1519-69842009000100020
PG 8
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 432CY
UT WOS:000265112300019
PM 19347159
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Ferreira, PMP
   Farias, DF
   Oliveira, JTD
   Carvalho, ADU
AF Pinheiro Ferreira, Paulo Michel
   Farias, Davi Felipe
   de Abreu Oliveira, Jose Tadeu
   Urano Carvalho, Ana de Fatima
TI Moringa oleifera: bioactive compounds and nutritional potential
SO REVISTA DE NUTRICAO-BRAZILIAN JOURNAL OF NUTRITION
LA English
DT Review
DE Protease Inhibitors; Moringa oleifera; Nutritive value
ID SEED OIL; TREE; COAGULATION; EXTRACT; ANTIOXIDANTS; STENOPETALA;
   BACTERIAL; SOLVENT; LECTIN; WATERS
AB This work aims to review the nutritional properties of the Moringa oleifera tree, emphasizing its man constituents and nutritional applications for humans and animals. Moringa oleifera (Moringaceae) is a cosmopolitan tree that grows in many tropical countries showing uncountable folk uses due to its various nutritional and pharmacological applications. The young leaves, flowers and pods are common vegetables in the Asian diet. All parts of this plant are renewable sources of tocopherols (gamma and alpha), phenolic compounds, beta-carotene, vitamin C and total proteins, including the essentials sulfur amino acids, methionine and cysteine. The seed protein and fat contents are higher than those reported for important grain legumes and soybean varieties, respectively. Unsaturated fatty acids, especially oleic acid, carbohydrates and minerals are present in the seed in reasonable amounts. In general, there are low concentrations of antinutritional factors in the plant, although the seeds possess glucosionolates (65.5 mu mol/g dry matter), phytates (41g/kg) and hemagglutination activity while the leaves have appreciable amounts of saponins (80g/kg), besides low quantity of phytates (21g/kg) and tannins (12g/kg). Taking into consideration the excellent nutritional properties, the low toxicity of the seeds and the excellent ability of the plant to adopt to poor soils and dry climates, Moringa oleifera can be an alternative to some legumious seeds as a source of high-quality protein, oil and antioxidant compounds and a way to treat water in rural areas where appropriate water resources are not available.
C1 [Urano Carvalho, Ana de Fatima] Univ Fed Ceara, Dept Biol, BR-60455970 Fortaleza, Ceara, Brazil.
   [Farias, Davi Felipe; de Abreu Oliveira, Jose Tadeu] Univ Fed Ceara, Dept Bioquim & Biol Mol, BR-60455970 Fortaleza, Ceara, Brazil.
   [Pinheiro Ferreira, Paulo Michel] Univ Fed Ceara, Fac Med, Dept Fisiol & Farmacol, BR-60455970 Fortaleza, Ceara, Brazil.
RP Carvalho, ADU (corresponding author), Univ Fed Ceara, Dept Biol, Av Mister Hall S-N,Campus Pici, BR-60455970 Fortaleza, Ceara, Brazil.
EM aurano@ufc.br
RI Carvalho, Ana/K-7344-2018; Farias, Davi Felipe/AAH-1868-2020; Ferreira,
   Paulo Michel Pinheiro/J-6783-2012
OI Carvalho, Ana/0000-0001-5293-9317; Ferreira, Paulo Michel
   Pinheiro/0000-0001-6862-6497; Felipe Farias, Davi/0000-0001-5438-1919
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [505.773/2004-0, 501.617/2003-5]
FX We thank Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq), for sponsoring the study (505.773/2004-0 and 501.617/2003-5) and
   for a providing a scholarship to Paulo Michel Pinheiro Ferreira.
CR Abdulkarim SM, 2005, FOOD CHEM, V93, P253, DOI 10.1016/j.foodchem.2004.09.023
   Abdulla M, 2000, BIOFACTORS, V12, P45, DOI 10.1002/biof.5520120108
   Amaya D. R., 1992, Horticultura Brasileira, V10, P126
   BERGER MR, 1984, E AFR MED J, V61, P712
   Bharali Rupjyoti, 2003, Asian Pac J Cancer Prev, V4, P131
   CARCERES A, 1992, J ETHNOPHARMACOL, V36, P233
   DELAVEAU P, 1980, Plantes Medicinales et Phytotherapie, V14, P29
   Dhar B, 1982, B MED ETHNOBOT RES, V3, P280
   Donli PO, 2003, PEST MANAG SCI, V59, P1060, DOI 10.1002/ps.595
   EILERT U, 1981, PLANTA MED, V42, P55, DOI 10.1055/s-2007-971546
   FARIAS DF, 2004, REV U RURAL S, V24, P7
   Ferrao A. M., 1970, AGRON ANGOLANA, V8, P3
   FERREIRA PMP, 2004, ATIVIDADE LARVICIDA
   FISH BC, 1991, J AGR FOOD CHEM, V39, P727, DOI 10.1021/jf00004a021
   Foidl N., 2001, P 1 WORKSH WHAT DEV
   *FOOD DRUG ADM, 2001, 000069 GRAS FAO
   GERDES G, 1997, TECHNICAL B ESPLAR C
   Ghebremichael KA, 2005, WATER RES, V39, P2338, DOI 10.1016/j.watres.2005.04.012
   GILANI AH, 1994, PHYTOTHER RES, V8, P87, DOI 10.1002/ptr.2650080207
   GRABOW WOK, 1985, WATER SA, V11, P9
   Gupta M, 1999, FITOTERAPIA, V70, P244, DOI 10.1016/S0367-326X(99)00029-5
   HODGE HC, 1944, AM IND HYG ASSOC J, V10, P94
   Jahn A.A., 1986, UNASYLVA, V38, P23
   JANG MCA, 1995, CLIN CHIM ACTA, V235, P207
   Kawada N, 1998, HEPATOLOGY, V27, P1265, DOI 10.1002/hep.510270512
   Kummar V., 2004, PATHOLOGY BASIS DIS
   MACHADO DIS, 2005, J CHROMATOGR, V1105, P111
   MADSEN M, 1987, J TROP MED HYG, V90, P101
   Makkar HPS, 1997, J AGR SCI, V128, P311, DOI 10.1017/S0021859697004292
   Mehta LK, 2003, J ETHNOPHARMACOL, V86, P191, DOI 10.1016/S0378-8741(03)00075-8
   MORTON JF, 1991, ECON BOT, V45, P318, DOI 10.1007/BF02887070
   NDABIGENGESERE A, 1995, WATER RES, V29, P703, DOI 10.1016/0043-1354(94)00161-Y
   Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9
   Odee D, 1998, DRYLAN BIODIVERS, V2, P7
   Okuda T, 1999, WATER RES, V33, P3373, DOI 10.1016/S0043-1354(99)00046-9
   Oliveira JTA, 1999, J SCI FOOD AGR, V79, P815, DOI [10.1002/(SICI)1097-0010(19990501)79:6&lt;815::AID-JSFA290&gt;3.0.CO;2-P, 10.1002/(SICI)1097-0010(19990501)79:6<815::AID-JSFA290>3.0.CO;2-P]
   PAL SK, 1995, PHYTOTHER RES, V9, P463, DOI 10.1002/ptr.2650090618
   RAMACHANDRAN C, 1980, ECON BOT, V34, P276, DOI 10.1007/BF02858648
   RANGASWAMI S., 1946, Current Science, V15, P316
   Rao A V, 2001, Indian J Exp Biol, V39, P858
   Santos AFS, 2005, WATER RES, V39, P975, DOI 10.1016/j.watres.2004.12.016
   Siddhuraju P, 2003, J AGR FOOD CHEM, V51, P2144, DOI 10.1021/jf020444+
   SIGUEL EN, 1993, AM J CARDIOL, V71, P916, DOI 10.1016/0002-9149(93)90906-S
   SILVA A. R., 1999, MORINGA NOVA HORTALI
   SINGH U, 1992, ECON BOT, V46, P310, DOI 10.1007/BF02866630
   Soliva CR, 2005, ANIM FEED SCI TECH, V118, P47, DOI 10.1016/j.anifeedsci.2004.10.005
   Stephensen CB, 2001, ANNU REV NUTR, V21, P167, DOI 10.1146/annurev.nutr.21.1.167
   THOMPSON LU, 1993, FOOD RES INT, V26, P131, DOI 10.1016/0963-9969(93)90069-U
   Tsaknis J, 1999, J AGR FOOD CHEM, V47, P4495, DOI 10.1021/jf9904214
   Vasconcelos IM, 2001, J NUTR BIOCHEM, V12, P55, DOI 10.1016/S0955-2863(00)00148-0
   VERMA SC, 1976, CURR SCI INDIA, V45, P769
   *WHO, 1985, REP JOIN FAO WHO UNU, V724
NR 52
TC 93
Z9 99
U1 0
U2 87
PU PONTIFICIA UNIVERSIDADE CATOLICA CAMPINAS
PI CAMPINAS
PA NUCLEO EDITORACAO SBI-CCV, CAMPUS II AV JOHN BOYD DUNLOP S-N PREDIO
   ONTOLOGIA JD IPAUSSURAMA, CAMPINAS, SP 13060-904, BRAZIL
SN 1415-5273
J9 REV NUTR
JI Rev. Nutr.
PD JUL-AUG
PY 2008
VL 21
IS 4
BP 431
EP 437
DI 10.1590/S1415-52732008000400007
PG 7
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA 367TJ
UT WOS:000260575200007
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Carvalho, AF
   Santos, MS
   Monteiro, HSA
   Freitas, SM
   Morhy, L
   Nascimento, NRF
   Fonteles, MC
AF Carvalho, A. F.
   Santos-Neto, M. S.
   Monteiro, H. S. A.
   Freitas, S. M.
   Morhy, L.
   Nascimento, N. R. F.
   Fonteles, M. C.
TI BTCI enhances guanylin-induced natriuresis and promotes renal glomerular
   and tubular effects
SO BRAZILIAN JOURNAL OF BIOLOGY
LA English
DT Article
DE natriuresis; kidney; Bowman-Birk protease inhibitors; BTCI; cyclic GMP;
   Vignia unguiculata
ID HEAT-STABLE ENTEROTOXIN; ESCHERICHIA-COLI; CHYMOTRYPSIN INHIBITOR;
   CYCLIC-GMP; CYCLASE; KIDNEY; UROGUANYLIN; PEPTIDE; PLASMA; RAT
AB Guanylin and uroguanylin are small cysteine-rich peptides involved in the regulation of fluid and electrolyte homeostasis through binding and activation of guanylyl cyclases signaling molecules expressed in intestine and kidney, Guanylin is less potent than uroguanylin as a natriuretic agent and is degraded in vitro by chymotrypsin due to unique structural features in the bioactive moiety of the peptide. Thus, the aim of this study was to verify whether or not guanylin is degraded by chymotrypsin-like proteases present in the kidney brush-border membranes. The isolated perfused rat kidney assay was used in this regard. Guanylin (0.2 mu M) induced no changes in kidney function. However, when pretreated by the black-eyed pea trypsin and chymotrypsin inhibitor (BTCI - 1.0 mu M; guanylin - 0.2 mu M) it promoted increases in urine flow (Delta UF of 0.25 +/- 0.09 mL.g(-1)/min, P < 0.05) and Na+ excretion (% Delta ENa+ of 18.20 +/- 2.17, P < 0.05). BTCI (1.0 mu M) also increased %ENa+ (from 22.8 +/- 1.30 to 34.4 +/- 3.48, P < 0.05, 90 minutes). Furthermore, BTCI (3.0 mu M) induced increases in glomerular filtration rate (GFR; from 0.96 +/- 0.02 to 1.28 +/- 0.02 mL.g(-1)/min, P < 0.05, 60 minutes). The present paper strongly suggests that chymotrypsin-like proteases play a role in renal metabolism of guanylin and describes for the first time renal effects induced by a member of the Bowman-Birk family of protease inhibitors.
C1 [Carvalho, A. F.; Santos-Neto, M. S.; Monteiro, H. S. A.; Nascimento, N. R. F.] Univ Fed Ceara, Inst Biomed IBIMED, BR-660434 Fortaleza, Ceara, Brazil.
   [Freitas, S. M.; Morhy, L.] Univ Brasilia, Lab Biofis, Dept Biol Celular, BR-70910900 Brasilia, DF, Brazil.
   [Fonteles, M. C.] Univ Presbiteriana Mackenzie, BR-01302907 Sao Paulo, Brazil.
RP Carvalho, AF (corresponding author), Univ Fed Ceara, Inst Biomed IBIMED, CP 660434, BR-660434 Fortaleza, Ceara, Brazil.
EM reitoria@mackenzie.com.br
OI Nascimento, Nilberto/0000-0001-6156-5927
CR CARPICK BW, 1993, INFECT IMMUN, V61, P4710, DOI 10.1128/IAI.61.11.4710-4715.1993
   Carrithers SL, 2000, REGUL PEPTIDES, V95, P65, DOI 10.1016/S0167-0115(00)00139-7
   CURRIE MG, 1992, P NATL ACAD SCI USA, V89, P947, DOI 10.1073/pnas.89.3.947
   Date Y, 1996, INTERNAL MED, V35, P171, DOI 10.2169/internalmedicine.35.171
   Fonteles MC, 1998, AM J PHYSIOL-RENAL, V275, pF191
   FONTELES MC, 1983, AM J PHYSIOL, V244, pF235
   Forte LR, 2000, ANNU REV PHYSIOL, V62, P673, DOI 10.1146/annurev.physiol.62.1.673
   FORTE LR, 1989, AM J PHYSIOL, V257, pF874
   Freitas S. M. de, 1997, FEBS Letters, V409, P121, DOI 10.1016/S0014-5793(97)00419-5
   Greenberg RN, 1997, J INVEST MED, V45, P276
   Hamra FK, 1996, ENDOCRINOLOGY, V137, P257, DOI 10.1210/en.137.1.257
   HAMRA FK, 1993, P NATL ACAD SCI USA, V90, P10464, DOI 10.1073/pnas.90.22.10464
   Hamra FK, 1996, AM J PHYSIOL-GASTR L, V270, pG708
   HUGHES JM, 1978, NATURE, V271, P755, DOI 10.1038/271755a0
   KITA T, 1994, AM J PHYSIOL, V266, pF342
   KUHN M, 1993, FEBS LETT, V318, P205, DOI 10.1016/0014-5793(93)80022-M
   LIMA AAM, 1992, PHARMACOL TOXICOL, V70, P163, DOI 10.1111/j.1600-0773.1992.tb00449.x
   London RM, 1999, AM J PHYSIOL-RENAL, V276, pF882
   MARTINEZMALDONADO M, 1978, J PHYSIOL-LONDON, V280, P487, DOI 10.1113/jphysiol.1978.sp012396
   MORHY L, 1987, AN ACAD BRAS CIENC, V59, P71
   NAKAZATO M, 1994, BIOCHEM BIOPH RES CO, V205, P1966, DOI 10.1006/bbrc.1994.2901
   Nakazato M, 1996, BIOCHEM BIOPH RES CO, V220, P586, DOI 10.1006/bbrc.1996.0447
   Potthast R, 2001, ENDOCRINOLOGY, V142, P3087, DOI 10.1210/en.142.7.3087
   RABKIN R, 1983, MINER ELECTROL METAB, V9, P212
   Santos-Neto MS, 2003, PHARMACOL TOXICOL, V92, P114, DOI 10.1034/j.1600-0773.2003.920302.x
   SCHULZ S, 1992, J BIOL CHEM, V267, P16019
   SCHULZ S, 1990, CELL, V63, P941, DOI 10.1016/0092-8674(90)90497-3
   VENTURA MM, 1966, AN ACAD BRAS CIENC, V38, P553
   WALSER M, 1955, J CLIN INVEST, V34, P1520, DOI 10.1172/JCI103204
NR 29
TC 8
Z9 8
U1 0
U2 1
PU INT INST ECOLOGY
PI SAO CARLOS
PA RUA BENTO CARLOS, 750 - CENTRO, SAO CARLOS, SP 00000, BRAZIL
SN 1519-6984
EI 1678-4375
J9 BRAZ J BIOL
JI Braz. J. Biol.
PD FEB
PY 2008
VL 68
IS 1
BP 149
EP 154
DI 10.1590/S1519-69842008000100021
PG 6
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 309BW
UT WOS:000256436300020
PM 18470390
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Ramos, MV
   Bandeira, GD
   de Freitas, CDT
   Nogueira, NA
   Alencar, NM
   de Sousa, PA
   Carvalho, AF
AF Ramos, Marcio Viana
   Bandeira, Glais de Paiva
   de Freitas, Cleverson Diniz Teixeira
   Pinto Nogueira, Nadia Accioly
   Nunes Alencar, Nylane Maria
   Simao de Sousa, Petronio Augusto
   Urano Carvalho, Ana Fontenele
TI Latex constituents from Calotropis procera (R. Br.) display toxicity
   upon egg hatching and larvae of Aedes aegypti (Linn.)
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE dengue; larvicidal; laticiferous plants; plant proteins; tropical
   diseases
ID PROTEINS; PLANTS
AB Calotropis procera R. Br. (Asclepiadaceae) is a well-known medicinal plant with leaves, roots, and hark being exploited by popular medicine to fight many human and animal diseases. This work deals with the fractionation of the crude latex produced by the green parts of the plant and aims to evaluate its toxic effects upon egg hatching and larval development of Aedes aegypti. The whole latex was shown to cause 100% mortality of 3rd instars within 5 min. It was fractionated into water-soluble dialyzable (DF) and non-dialyzable (NDF) rubber-free materials. Both fractions were partially effective to prevent egg hatching and most of individuals growing under experimental conditions died before reaching 2nd instars or stayed in 1st instars. Besides, the fractions were very toxic to 3rd instars causing 100% mortality within 24 h. When both fractions were submitted to heat-treatment the toxic effects were diminished considerably suggesting low thermostability of the toxic compounds. Polyacrylamide gel electrophoresis of both fractions and their newly fractionated peaks obtained through ion exchange chromatography or desalting attested the presence of proteins in both materials. When submitted to protease digestion prior to larvicidal assays NDF lost most of its toxicity but DF was still strongly active. It may be possible that the highly toxic effects of the whole latex from C. procera upon egg hatching and larvae development should be at least in part due to its protein content found in NDF However the toxicity seems also to involve non protein molecules present in DE
C1 Univ Fed Ceara, Dept Bioquim & Biol Mol, BR-60451970 Fortaleza, Ceara, Brazil.
   Univ Fed Ceara, Dept Anal Clin & Toxicol, BR-60451970 Fortaleza, Ceara, Brazil.
   Univ Fed Ceara, Dept Fisiol & Farmacol, BR-60451970 Fortaleza, Ceara, Brazil.
   Univ Fed Ceara, Dept Biol, BR-60451970 Fortaleza, Ceara, Brazil.
   Univ Estadual Ceara, Fortaleza, Ceara, Brazil.
RP Ramos, MV (corresponding author), Univ Fed Ceara, Dept Bioquim & Biol Mol, Campus Pici, BR-60451970 Fortaleza, Ceara, Brazil.
EM vramos@ufc.br; aurano@ufc.br
RI Carvalho, Ana/K-7344-2018; FREITAS, CLEVERSON/B-7119-2016
OI Carvalho, Ana/0000-0001-5293-9317; Accioly Pinto Nogueira,
   Nadia/0000-0003-0489-9108
CR Al-Mezaine HS, 2005, AM J OPHTHALMOL, V139, P199, DOI 10.1016/j.ajo.2004.07.062
   Alencar NMN, 2004, PLANTA MED, V70, P1144, DOI 10.1055/s-2004-835842
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Carvalho AFU, 2003, MEM I OSWALDO CRUZ, V98, P569, DOI 10.1590/S0074-02762003000400027
   Consoli R.A.G.B, 1994, PRINCIPAIS MOSQUITOS
   da-Cunha MP, 2005, MEM I OSWALDO CRUZ, V100, P441, DOI 10.1590/S0074-02762005000400017
   Dewan S, 2000, J ETHNOPHARMACOL, V73, P307, DOI 10.1016/S0378-8741(00)00272-5
   Dhar D. N., 1973, E PHARM, V176, P99
   Dubey VK, 2003, PHYTOCHEMISTRY, V62, P1057, DOI 10.1016/S0031-9422(02)00676-3
   DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017
   El Badwi SMA, 1998, DEUT TIERARZTL WOCH, V105, P425
   GIRDHAR G, 1984, Pesticides (Bombay), V18, P26
   Haque MA, 2000, J STORED PROD RES, V36, P281, DOI 10.1016/S0022-474X(99)00048-X
   Hillyer JF, 2002, HISTOCHEM CELL BIOL, V117, P431, DOI 10.1007/s00418-002-0408-0
   Jain S. C., 1996, Fitoterapia, V67, P275
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Larhsini M., 1997, Fitoterapia, V68, P371
   LITCHFIELD JT, 1949, J PHARMACOL EXP THER, V96, P99
   MAILLARD M, 1993, HUMAN MED AGENTS PLA
   Manju Singhi, 2004, Dengue Bulletin, V28, P184
   Miller LC, 1944, P SOC EXP BIOL MED, V57, P261
   Morsy Tosson A., 2001, Journal of the Egyptian Society of Parasitology, V31, P107
   Pereira Lucilene S., 1999, Revista Brasileira de Botanica, V22, P27, DOI 10.1590/S0100-84041999000100005
   RAMOS MV, 1998, PHYSL MOL BIOL PLANT, V4, P165
   SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2
   SEIBER JN, 1982, PHYTOCHEMISTRY, V21, P2343, DOI 10.1016/0031-9422(82)85202-3
   Sharma P, 2000, FITOTERAPIA, V71, P77, DOI 10.1016/S0367-326X(99)00121-5
   Shivkar YM, 2003, MEDIAT INFLAMM, V12, P299, DOI 10.1080/096293503310001619708
   Wititsuwannakul R, 1998, PHYTOCHEMISTRY, V47, P183, DOI 10.1016/S0031-9422(97)00329-4
   Yeang HY, 2002, METHODS, V27, P32, DOI 10.1016/S1046-2023(02)00049-X
NR 30
TC 37
Z9 48
U1 0
U2 2
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD AUG
PY 2006
VL 101
IS 5
BP 503
EP 510
DI 10.1590/S0074-02762006000500004
PG 8
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 079SV
UT WOS:000240199100004
PM 17072453
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Carvalho, AFU
   Melo, VMM
   Craveiro, AA
   Machado, MIL
   Bantim, MB
   Rabelo, EF
AF Carvalho, AFU
   Melo, VMM
   Craveiro, AA
   Machado, MIL
   Bantim, MB
   Rabelo, EF
TI Larvicidal activity of the essential oil from Lippia sidoides Cham.
   against Aedes aegypti Linn.
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Lippia sidoides; larvicidal activity; thymol
AB The aim of this work was to study the larvicidal activity of Lippia sidoides essential oil against Aedes aegypti larvae. The essential oil and its hydrolate (saturated solution of essential oil in water) were obtained by vapor extraction and their chemical composition determined by GL-chromatography coupled to mass spectroscopy. Bioassays were run with the essential oil, pure and diluted hydrolate and with their main constituents thymol and carvacrol. The results obtained showed that L. sidoides essential oil and its hydrolate have larvicidal action against the mosquito A. aegypti, causing an almost instantaneous mortality. Thymol, an alkylated phenol derivative and one of the major components of L. sidoides essential oil, was identified as the active principle responsible for the larvicidal action, causing 100% larval mortality at the lowest tested concentration of 0.017% (14,A). These results suggest that the essential oil of L. sidoides is promising as larvicide against A. aegypti and could be useful in the search of newer, more selective, and biodegradable larvicidal natural compounds to be used in official combat programs and at home.
C1 Univ Fed Ceara, Dept Biol, BR-60455900 Fortaleza, Ceara, Brazil.
   Univ Fed Ceara, Parque Desenvolvimento Tecnol, BR-60455900 Fortaleza, Ceara, Brazil.
RP Carvalho, AFU (corresponding author), Univ Fed Ceara, Dept Biol, Campus Pici, BR-60455900 Fortaleza, Ceara, Brazil.
RI Carvalho, Ana/K-7344-2018; Melo, Vania/E-2377-2015
OI Carvalho, Ana/0000-0001-5293-9317; Melo, Vania/0000-0002-3302-8857
CR BANTIM MB, 2000, MONOGRAPH U FEDERAL
   CEPLEANU F, 1993, THESIS U LAUSANNE LA
   Consoli R.A.G.B, 1994, PRINCIPAIS MOSQUITOS
   *EPA, THYM RER EL DEC RED
   GLUBER D, 1989, AM J TROP MED HYG, V40, P571
   *GOOD SCENTS CO, MAT SAF DAT SHEET TH
   LITCHFIELD JT, 1949, J PHARMACOL EXP THER, V96, P99
   MAILLARD M, 1993, HUMAN MED AGENT PLAN
   MATOS FJA, 1994, FARMACIAS VIVAS
   *MERCK CO, 1976, ENC CHEM DRUGS, P238
   THANGAM TS, 1991, BOT MAR, V34, P433, DOI 10.1515/botm.1991.34.5.433
NR 11
TC 122
Z9 141
U1 0
U2 19
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD JUN
PY 2003
VL 98
IS 4
BP 569
EP 571
DI 10.1590/S0074-02762003000400027
PG 3
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 698HN
UT WOS:000183993100027
PM 12937776
OA DOAJ Gold
DA 2020-12-08
ER

EF